Iso3,Location Name,AMRO subregions,Causename Eng,Year,Sex,Age group,Measure Name En,Metric Name En,Value,Value Low,Value Up
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,0.22,4.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.13,0.22,4.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.64,3.16,19.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,9.52,3.1,19.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.12,0.06,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.13,5.3,32.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,15.94,5.19,32.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.19,0.11,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,8.72,0.88,20.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,8.72,0.88,20.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.52,8.05,49.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,24.23,7.89,48.66
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.29,0.16,0.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.29,15.21,77.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,39.7,14.88,76.94
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.59,0.33,0.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,40.12,16.78,73.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.34,16.34,71.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.79,0.44,1.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.35,6.17,36.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,17.88,5.91,35.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.46,0.26,0.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.68,6.42,44.36
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,20.94,6.01,43.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.73,0.41,1.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.98,2.19,26.07
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,11.74,2.05,25.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.24,0.14,0.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.37,0.69,17.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.13,0.56,17.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.24,0.13,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.45,2.87,9.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.22,2.74,9.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.23,0.14,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.9,7.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.69,1.7,6.85
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.33,0.19,0.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.93,1.4,5.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.81,1.33,5.28
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.66,1.27,5.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.66,1.27,5.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.91,0.96,3.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.91,0.96,3.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.7,0.87,3.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.43,0.71,2.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.73,2.63
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.27,0.64,2.39
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.15,0.09,0.24
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.08,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.08,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.56,1.92
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.3,0.17,0.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.63,2.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.05,0.51,1.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.21,0.12,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.78,0.35,1.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.78,0.35,1.47
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.34,1.17,4.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.05,1.03,3.52
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.29,0.14,0.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.07,3.77,21.9
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,10.82,3.63,21.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.97,3.74,21.71
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,10.73,3.6,21.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.11,3.67
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.43,0.11,3.67
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.23,1.81,12.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.18,1.78,12.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.41,3.02,20.99
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,10.34,2.98,20.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,0.45,14.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.84,0.45,14.95
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.75,4.58,31.78
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,15.65,4.52,31.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.11,0.06,0.16
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.59,8.67,48.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,25.38,8.55,48.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.21,0.12,0.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,23.86,8.46,46.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,23.24,8.1,45.79
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.62,0.36,0.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.38,3.1,21.54
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.22,3.01,21.3
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.16,0.09,0.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,2.09,25.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.6,2.09,25.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,0.51,16.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.46,0.51,16.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.22,7.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.36,2.22,7.83
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.01,1.51,5.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.43,5.27
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.13,0.08,0.21
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.0,0.9,3.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.78
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.13,0.08,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.72,2.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.67,2.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.2,0.61,2.18
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.55,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.98,0.49,1.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.89,0.44,1.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.43,1.63
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.39,1.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.73,0.36,1.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.34,1.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.23,0.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.51,0.23,0.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.6,0.26,1.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.59,0.26,1.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.18,0.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.43,0.17,0.85
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.4,1.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.88,0.39,1.54
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.58,1.98,13.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.49,1.93,13.34
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.09,0.05,0.14
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.23,1.9,12.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,6.15,1.85,12.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.16,5.59
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.16,0.13,5.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.05,0.02,0.09
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.87,3.47,20.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,9.7,3.38,20.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.16,0.09,0.28
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.29,5.73,33.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,16.02,5.58,33.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.27,0.14,0.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,8.91,0.64,22.55
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,8.72,0.54,22.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.19,0.1,0.35
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.86,8.74,51.1
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,24.44,8.52,50.39
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.41,0.22,0.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.84,16.86,79.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,40.2,16.51,78.66
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.64,0.34,1.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.08,16.64,71.26
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.08,16.64,71.26
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.07,6.44,35.32
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,17.69,6.23,34.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.37,0.21,0.6
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.42,7.46,42.46
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,20.41,6.9,40.84
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.02,0.56,1.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,12.09,2.64,26.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,12.09,2.64,26.69
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.66,0.72,17.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.0,0.36,16.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.66,0.36,1.09
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.48,2.91,9.71
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.31,2.81,9.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.29
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,2.06,7.77
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.73,1.8,7.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.44,0.26,0.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.48,5.79
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.83,1.35,5.41
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.24,0.14,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.9,1.36,5.58
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.67,1.24,5.22
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.23,0.13,0.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.9,0.92,3.61
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.9,0.92,3.61
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.69,2.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.42,0.69,2.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.69,2.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.27,0.63,2.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.19
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.7,2.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.07,0.55,1.96
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.43
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.72,2.37
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.45
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.6,0.34,0.92
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.03,0.01,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.72,2.48
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.05,0.51,1.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.37,0.2,0.59
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.37,1.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.79,0.37,1.5
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.02,0.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.41,1.19,4.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.06,1.03,3.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.35,0.16,0.6
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.08,4.0,22.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,10.83,3.86,21.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.25,0.14,0.41
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.0,3.98,21.86
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,10.75,3.84,21.44
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.25,0.14,0.42
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.09,3.81
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.38,0.09,3.81
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.14,1.82,12.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.14,1.82,12.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.12,3.0,20.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,10.12,3.0,20.72
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.55,0.36,15.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.55,0.36,15.31
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.39,4.56,31.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,15.39,4.56,31.51
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.19,8.75,47.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,25.19,8.75,47.62
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,23.94,7.45,44.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,23.94,7.45,44.98
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.35,2.86,20.91
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.32,2.85,20.87
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,2.0,24.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.6,2.0,24.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.4,0.54,16.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.4,0.54,16.74
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.5,2.27,8.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.38,2.21,7.88
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.44,5.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.44,5.12
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.9,3.82
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.86,0.84,3.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.7,2.89
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.68,2.84
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.68
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.53,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.53,2.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.56,2.08
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.9,0.41,1.7
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.15,0.38
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.48,1.75
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.37,1.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.38,1.36
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.33,1.25
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.55,0.26,1.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.5,0.23,0.97
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.27,1.15
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.59,0.26,1.11
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.18,0.9
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.42,0.16,0.86
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.39,1.57
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.88,0.39,1.56
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.52,1.9,13.23
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.5,1.88,13.2
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.19,1.82,12.53
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,6.16,1.8,12.49
ARG,Argentina,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.68,2.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.68,2.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.05,6.09,16.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,10.05,6.09,16.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.31,8.34,23.36
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.31,8.34,23.36
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.7,2.01,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.7,2.01,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.96,13.97,39.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.96,13.97,39.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,37.28,22.82,59.35
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,37.28,22.82,59.35
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,34.49,20.18,56.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,34.49,20.18,56.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.7,17.55,53.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,31.7,17.55,53.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.11,9.25,31.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.11,9.25,31.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.93,4.46,17.9
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,9.93,4.46,17.9
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.57,5.38,20.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,11.57,5.38,20.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.93,2.77,14.55
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,7.93,2.77,14.55
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.81,1.84,11.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.81,1.84,11.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,2.0,7.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.12,2.0,7.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.81,1.41,4.65
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.81,1.41,4.65
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.11,0.99,3.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.11,0.99,3.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.89,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.89,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.45,0.58,2.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.45,0.58,2.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.36,2.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.09,0.36,2.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.38,1.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.96,0.38,1.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.39,1.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.79,0.39,1.48
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.24,1.03
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.56,0.24,1.03
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.2,0.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.45,0.2,0.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.4,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.11,0.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.26,0.11,0.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.95,5.29,16.89
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,9.95,5.29,16.89
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.69,5.13,16.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,9.69,5.13,16.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.61,0.29,1.08
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.61,0.29,1.08
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.07,2.5,8.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.07,2.5,8.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.99,3.39,12.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.99,3.39,12.04
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.83,0.88,3.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.83,0.88,3.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.68,5.66,20.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,11.68,5.66,20.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.75,9.29,31.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,18.75,9.29,31.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.74,8.12,28.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,16.74,8.12,28.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.74,6.95,26.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,14.74,6.95,26.67
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.88,2.87,15.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.88,2.87,15.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,1.71,8.34
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.4,1.71,8.34
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.07,1.43,10.14
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.07,1.43,10.14
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.94,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.67,1.94,6.06
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.72,1.26,4.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,2.72,1.26,4.84
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.8,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.87,0.8,3.62
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.51,2.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.23,0.51,2.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.95,0.39,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,0.95,0.39,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.29,1.77
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.9,0.29,1.77
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.36,1.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.69,0.36,1.24
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.23,0.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.49,0.23,0.91
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.18,0.78
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.18,0.78
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.12,0.63
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.31,0.12,0.63
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.13,0.05,0.29
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.29
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.68,2.11,8.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.68,2.11,8.37
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.32,1.94,7.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,4.32,1.94,7.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.3,0.67,2.12
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.3,0.67,2.12
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,6.02,16.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,10.27,6.02,16.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.55,8.09,23.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.55,8.09,23.5
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.94,6.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.74,1.94,6.13
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.01,13.35,38.79
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,24.01,13.35,38.79
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,37.48,22.24,59.1
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,37.48,22.24,59.1
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,34.67,19.34,55.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,34.67,19.34,55.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.86,16.44,52.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,31.86,16.44,52.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.94,8.79,30.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,17.94,8.79,30.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.84,4.34,18.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,9.84,4.34,18.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.57,5.11,21.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,11.57,5.11,21.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.02,3.31,16.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,8.02,3.31,16.22
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.64,1.62,11.69
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.64,1.62,11.69
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,1.91,7.45
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.12,1.91,7.45
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,1.33,4.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.76,1.33,4.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.11,0.98,3.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,2.11,0.98,3.83
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.01,0.95,3.68
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,2.01,0.95,3.68
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.61,2.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,1.43,0.61,2.71
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.38,2.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.11,0.38,2.11
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.97,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.38,1.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.38,1.46
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.25,1.07
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.07
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.2,0.86
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.46,0.2,0.86
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.17,0.76
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.17,0.76
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.1,0.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.26,0.1,0.51
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.97,5.11,16.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,9.97,5.11,16.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.72,4.96,16.59
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,9.72,4.96,16.59
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.29,1.15
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.63,0.29,1.15
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.05,2.63,8.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.05,2.63,8.97
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.95,3.41,12.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,6.95,3.41,12.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.82,0.83,3.33
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.82,0.83,3.33
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.46,5.63,20.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,11.46,5.63,20.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.4,9.68,32.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,18.4,9.68,32.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.47,8.13,29.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,16.47,8.13,29.42
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.54,6.58,26.26
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,14.54,6.58,26.26
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,8.03,2.88,14.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,8.03,2.88,14.87
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.42,1.77,8.17
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.42,1.77,8.17
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.71,10.23
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.09,1.71,10.23
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.63,1.84,6.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.63,1.84,6.25
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,1.35,4.61
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,2.76,1.35,4.61
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.82,3.53
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.53
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.45,2.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.23,0.45,2.49
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,0.94,0.38,1.82
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.34,1.7
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.87,0.34,1.7
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.35,1.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.68,0.35,1.16
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.23,0.88
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.49,0.23,0.88
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.18,0.75
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.12,0.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.31,0.12,0.6
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.07,0.41
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.41
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.31
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.05,0.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.28
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.02,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.08,0.02,0.18
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.12,8.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.65,2.12,8.43
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.3,1.96,7.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,4.3,1.96,7.8
ARG,Argentina,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.55,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.06,0.55,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,28.68,14.41,50.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,28.68,14.41,50.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.56,23.97,82.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,47.34,23.84,81.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.22,0.13,0.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.63,5.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.16,1.63,5.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,79.64,40.13,137.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,79.26,39.91,136.95
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.37,0.22,0.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,114.08,57.27,199.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,114.08,57.27,199.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,119.39,60.14,206.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,118.82,59.81,205.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.57,0.33,0.91
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,124.68,63.0,212.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,123.54,62.34,210.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.14,0.66,1.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,97.13,49.52,163.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,95.74,48.68,161.12
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.39,0.83,2.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,72.18,36.74,122.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,71.23,36.16,121.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.95,0.58,1.46
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,79.62,40.33,137.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,77.9,39.26,135.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.72,1.07,2.62
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,66.51,32.41,109.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,66.06,32.13,108.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.45,0.28,0.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,57.96,30.43,99.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,57.49,30.15,98.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.47,0.28,0.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.77,27.65,92.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,52.22,27.33,91.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.55,0.32,0.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.64,21.19,79.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,44.92,20.72,78.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.72,0.46,1.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,40.19,19.3,70.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,39.92,19.13,69.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.76,19.89,68.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,38.76,19.89,68.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.21,16.36,61.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,35.21,16.36,61.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,30.87,14.75,52.93
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,30.18,14.31,51.9
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.69,0.44,1.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.12,13.44,51.44
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,28.73,13.19,50.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.39,0.25,0.58
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,26.85,11.74,49.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,26.85,11.74,49.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,25.32,10.6,43.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,24.4,9.98,42.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.92,0.62,1.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.07,0.04,0.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,23.86,9.92,42.68
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,23.09,9.45,41.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.77,0.47,1.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.85,9.31,42.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,22.85,9.31,42.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.2,0.11,0.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.75,9.14,39.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.26,8.35,37.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,1.49,0.78,2.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.45,26.8,91.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,52.94,26.49,90.99
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.51,0.31,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.26,26.68,91.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,52.75,26.37,90.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.52,0.32,0.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.24,1.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.53,0.24,1.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.92,5.73,27.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.92,5.73,27.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.29,9.57,42.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.2,9.51,42.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,0.72,3.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.59,0.72,3.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.26,16.0,71.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,37.11,15.9,71.51
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.15,0.1,0.23
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,55.06,22.59,108.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,55.06,22.59,108.25
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,55.6,23.85,107.05
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,55.36,23.71,106.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.23,0.15,0.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,56.12,25.1,105.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,55.65,24.81,105.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.47,0.29,0.69
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,42.32,19.2,78.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,40.91,18.36,76.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.41,0.84,2.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.26,11.79,55.24
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.85,11.54,54.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.65
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,32.06,12.16,60.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,32.06,12.16,60.36
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,25.9,10.93,50.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,25.9,10.93,50.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,22.89,8.07,44.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,22.89,8.07,44.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.26,7.05,37.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,19.66,6.68,36.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.6,0.37,0.95
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,17.59,5.39,32.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,17.17,5.13,32.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.42,0.26,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,15.26,4.72,29.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.94,4.52,29.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.32,0.2,0.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,14.61,4.43,28.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.61,4.43,28.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,13.28,4.28,27.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.73,3.93,26.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.55,0.35,0.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,11.69,3.45,22.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,11.12,3.09,21.89
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.56,0.36,0.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.04,3.15,22.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,10.53,2.82,21.45
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.51,0.32,0.75
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.28,2.79,21.61
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,9.84,2.5,20.94
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.45,0.28,0.67
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.96,2.23,19.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.96,2.23,19.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.81,2.13,18.97
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.43,1.9,18.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.38,0.23,0.59
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.95,2.0,19.34
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.55,1.75,18.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.12,0.08,0.19
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.46,2.13,17.55
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.56,1.59,16.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.91,0.54,1.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,22.73,9.1,43.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,22.47,8.94,43.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.27,0.16,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,22.01,8.7,42.22
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,21.72,8.53,41.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.28,0.17,0.43
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.57,1.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.11,0.57,1.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,14.34,52.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,29.27,14.31,52.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.06,0.03,0.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.33,23.78,84.58
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,48.05,23.62,84.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.28,0.15,0.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.2,1.64,5.73
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.2,1.64,5.73
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,79.77,39.25,139.61
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,79.31,38.99,138.82
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.46,0.26,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,114.93,56.12,205.62
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,114.69,55.98,205.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.24,0.13,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,120.03,59.03,210.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,119.32,58.64,208.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.71,0.39,1.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,125.14,61.94,214.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,123.97,61.3,212.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.17,0.65,2.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,96.81,54.4,169.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,96.81,54.4,169.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,72.17,38.08,124.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,71.37,37.59,122.94
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.8,0.49,1.23
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,80.45,42.55,134.74
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,78.13,41.14,131.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,2.31,1.41,3.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,66.47,33.91,114.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,66.47,33.91,114.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.02,0.02,0.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,59.37,29.08,100.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,58.11,28.31,98.78
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.25,0.76,1.92
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.18,26.49,90.89
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,50.78,26.26,90.26
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.39,0.23,0.63
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.46,23.52,78.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,44.54,22.94,77.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.92,0.58,1.4
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,19.39,68.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,39.9,19.07,68.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.52,0.32,0.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.77,18.14,66.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,39.23,17.81,65.48
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.53,0.33,0.84
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.01,15.75,59.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,35.01,15.75,59.81
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,30.69,14.93,53.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,30.69,14.93,53.11
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.54,14.15,50.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,29.14,13.89,50.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.39,0.26,0.6
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.04,13.14,48.24
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.14,12.55,46.86
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.6,1.38
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.1,0.07,0.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,26.46,12.11,44.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,24.74,10.98,42.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.73,1.13,2.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.1,0.06,0.15
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,24.37,10.82,42.14
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,23.16,10.07,40.27
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,1.22,0.75,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.58,9.44,39.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,22.58,9.44,39.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.24,0.12,0.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.84,9.63,38.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.14,8.74,35.85
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,1.7,0.89,2.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.66,27.21,92.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,53.13,26.89,92.03
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.53,0.32,0.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.69,27.2,92.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,53.15,26.88,92.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.54,0.33,0.85
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.25,0.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.54,0.25,0.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.74,26.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.98,5.74,26.88
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.17,9.36,41.17
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.17,9.36,41.17
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.55,0.72,2.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.55,0.72,2.83
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.56,15.43,67.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,36.56,15.43,67.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,54.57,22.34,105.13
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,54.57,22.34,105.13
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.77,23.09,101.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,54.77,23.09,101.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.97,23.83,98.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,54.97,23.83,98.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,40.65,17.5,72.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,40.65,17.5,72.72
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.17,11.77,53.39
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,29.05,11.7,53.21
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,32.01,13.34,58.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,32.01,13.34,58.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,26.77,9.88,48.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,26.77,9.88,48.29
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,24.17,9.69,45.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,23.56,9.32,44.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.61,0.37,0.9
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,19.7,7.21,38.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,19.7,7.21,38.56
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,16.95,6.55,33.42
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.65,6.37,32.96
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.46
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.85,5.25,29.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.75,5.19,29.04
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.11,0.07,0.16
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,14.82,4.65,28.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.82,4.65,28.47
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.46,4.4,25.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.46,4.4,25.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,3.87,24.8
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,10.9,2.91,22.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.54,0.95,2.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.03,0.08
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.62,3.55,23.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,10.37,2.76,21.5
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.25,0.78,1.87
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.66,3.18,21.7
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,9.75,2.59,20.33
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.59,1.37
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.09,2.42,19.76
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.82,2.25,19.35
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.27,0.17,0.41
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.04,0.02,0.06
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.82,2.21,19.28
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.35,1.93,18.57
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.46,0.28,0.71
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.35,2.35,20.3
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.49,1.82,18.98
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.86,0.52,1.32
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.88,1.77,17.54
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.54,1.57,17.02
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.34,0.2,0.52
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,22.55,9.07,41.99
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,22.41,8.99,41.79
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.14,0.08,0.2
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,21.91,8.72,40.96
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,21.73,8.61,40.69
ARG,Argentina,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.18,0.11,0.27
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.31,1.23,3.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.31,1.23,3.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,46.22,22.27,82.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,46.22,22.27,82.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,98.27,47.27,170.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,95.99,45.79,167.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.28,1.48,3.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.86,3.64,11.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.86,3.64,11.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,164.53,79.15,286.25
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,160.72,76.67,280.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.81,2.48,5.58
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,182.04,87.35,323.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,182.04,87.35,323.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,246.48,118.39,429.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,240.69,114.63,420.51
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,5.79,3.76,8.49
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.16,0.11,0.24
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,310.76,149.35,534.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,299.2,141.83,517.14
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,11.57,7.51,16.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.23,0.15,0.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,293.16,152.62,486.44
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,277.92,142.72,463.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,15.24,9.89,22.48
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.13,0.09,0.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,187.92,92.41,320.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,180.05,87.26,308.88
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,7.87,5.15,11.54
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.19,0.13,0.28
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,223.31,108.38,378.94
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,211.79,100.77,362.17
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,11.52,7.61,16.77
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,161.82,75.25,274.73
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,158.19,72.86,269.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.62,2.38,5.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,125.54,58.19,225.89
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,122.04,55.89,220.8
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.5,2.3,5.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,106.43,52.22,189.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,102.83,49.84,184.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.6,2.38,5.29
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,89.32,39.39,159.32
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,85.5,36.81,153.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,3.82,2.58,5.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,73.21,31.86,133.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,71.83,30.93,131.69
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.38,0.94,1.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,69.77,31.61,129.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,69.77,31.61,129.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,57.67,23.08,107.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,57.67,23.08,107.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.14,0.1,0.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,51.74,21.44,94.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,48.04,18.87,89.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.69,2.57,5.25
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.08,0.06,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.97,18.52,87.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,44.88,17.07,84.71
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,2.09,1.45,2.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,14.73,78.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,40.79,14.73,78.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.27,0.19,0.38
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.96,16.63,74.64
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,36.23,13.41,68.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,4.73,3.22,6.53
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.41,0.25,0.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,39.14,17.17,69.76
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,34.78,14.43,63.41
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,4.36,2.75,6.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.54,15.7,61.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,34.54,15.7,61.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.33,0.76,2.07
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,41.33,20.59,69.87
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,31.62,15.04,54.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,9.71,5.55,15.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,121.77,58.59,210.74
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,117.58,55.84,204.61
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.19,2.75,6.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,121.29,58.28,210.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,117.08,55.52,203.85
ARG,Argentina,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,4.21,2.76,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.54,2.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.15,0.54,2.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.33,10.0,51.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,26.33,10.0,51.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.9,27.53,115.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,62.06,26.99,113.87
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.84,0.54,1.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.41,1.6,6.26
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.41,1.6,6.26
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.13,46.01,192.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,103.73,45.11,190.31
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.4,0.91,2.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,103.74,39.11,202.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.74,39.11,202.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,157.41,68.84,287.98
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,155.29,67.47,284.91
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.12,1.38,3.06
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,210.62,98.32,373.12
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,206.4,95.58,367.02
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,4.22,2.74,6.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.19,0.12,0.27
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,227.29,117.95,385.42
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,215.01,109.81,367.69
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,12.28,8.14,17.73
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,151.4,71.63,260.33
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,148.08,69.44,255.54
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,3.31,2.19,4.79
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,179.07,81.5,304.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,179.07,81.5,304.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,138.64,64.37,241.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,138.64,64.37,241.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,105.51,46.1,183.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,105.51,46.1,183.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,87.25,37.59,153.99
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,83.74,35.32,148.88
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.51,2.27,5.1
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,73.17,31.51,129.72
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,69.5,28.99,124.52
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,3.67,2.51,5.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,58.01,22.02,106.4
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.69,20.46,103.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.32,1.56,3.29
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,54.28,18.29,99.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,54.28,18.29,99.95
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.11,0.07,0.15
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,44.67,15.18,86.63
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.39,13.04,81.97
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,3.28,2.14,4.67
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,38.44,12.98,75.41
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,35.29,10.88,70.96
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,3.15,2.1,4.45
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.13,0.09,0.18
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,35.87,11.92,70.44
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.74,9.83,66.04
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,3.13,2.09,4.4
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.14,0.1,0.2
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,32.82,10.67,64.55
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.72,8.59,60.21
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.1,2.09,4.34
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,26.8,8.53,54.9
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.8,8.53,54.9
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.3,0.19,0.43
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,27.66,8.59,55.24
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,25.04,6.9,51.46
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,2.62,1.69,3.78
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.27,0.18,0.39
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.94,7.99,55.77
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.36,5.61,50.65
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,3.59,2.38,5.11
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.74,0.47,1.08
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.6,9.28,55.19
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,23.21,5.85,47.35
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,5.39,3.43,7.84
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,90.92,40.95,160.82
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,88.84,39.58,157.83
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,2.08,1.37,2.99
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,88.34,39.52,156.59
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,86.16,38.09,153.46
ARG,Argentina,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,2.18,1.44,3.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.4,1.24,4.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.4,1.24,4.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,48.27,22.58,86.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,47.4,22.07,85.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.87,0.52,1.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.04,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.59,49.34,176.04
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,97.46,47.39,171.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,3.13,1.95,4.72
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.94,3.58,11.86
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.94,3.58,11.86
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,166.03,81.44,290.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,160.86,78.22,282.8
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,5.17,3.22,7.78
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,187.4,87.33,336.45
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,183.87,85.24,330.9
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,3.53,2.09,5.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.11,0.07,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,249.69,122.39,437.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,241.8,117.47,425.27
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,7.89,4.92,11.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.17,0.11,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,312.14,157.53,538.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,299.88,149.78,519.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,12.26,7.75,18.22
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,282.17,148.84,475.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,282.17,148.84,475.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.1,0.07,0.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,188.6,94.29,322.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,182.97,90.64,314.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.63,3.65,8.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.26,0.17,0.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,231.57,117.8,385.63
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,215.93,107.65,362.48
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,15.64,10.15,23.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,163.72,79.21,286.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,163.72,79.21,286.55
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,134.04,60.45,235.89
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,124.45,54.25,221.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,9.59,6.19,14.03
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,105.18,50.59,186.68
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,102.56,48.9,182.76
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.62,1.69,3.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,89.75,40.67,160.76
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,84.81,37.34,153.68
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,4.94,3.32,7.08
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,74.57,31.68,133.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,71.84,29.86,129.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.72,1.82,3.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,72.97,29.9,128.05
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,70.22,28.09,123.98
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.75,1.81,4.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,57.84,22.72,107.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,57.84,22.72,107.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,48.15,19.24,92.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,48.15,19.24,92.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.82,18.69,87.94
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,45.1,17.54,85.45
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.72,1.15,2.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.18,0.12,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,45.11,17.98,82.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,41.16,15.36,76.87
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,3.95,2.63,5.71
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.53,0.36,0.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,45.87,20.65,81.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,36.71,14.52,68.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.16,6.13,12.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,0.59,0.36,0.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.88,19.47,72.46
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,34.92,15.06,62.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,6.96,4.41,10.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.26,15.9,58.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,34.26,15.9,58.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,1.58,0.89,2.48
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,43.05,21.71,71.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,31.5,15.2,53.56
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,11.55,6.5,18.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.13
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,122.97,60.06,213.25
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,119.0,57.51,207.36
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.98,2.55,5.89
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,122.94,59.95,213.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,118.92,57.36,207.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.03,2.58,5.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.54,2.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.17,0.54,2.12
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.46,10.33,52.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,26.46,10.33,52.3
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.27,27.13,111.77
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,62.27,27.13,111.77
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.38,1.55,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.38,1.55,6.15
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,102.67,44.73,184.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,102.67,44.73,184.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,102.84,39.92,203.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,102.84,39.92,203.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,154.33,67.19,276.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,154.33,67.19,276.96
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,205.58,94.34,349.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,205.58,94.34,349.75
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,218.8,110.32,362.5
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,218.8,110.32,362.5
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,151.08,71.11,257.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,150.51,70.75,256.67
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.57,0.36,0.82
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,181.65,85.16,310.69
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,181.65,85.16,310.69
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,142.41,64.02,246.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,142.41,64.02,246.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,110.57,51.62,189.58
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,107.68,49.79,185.38
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.89,1.83,4.2
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,84.72,35.01,150.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.72,35.01,150.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,71.04,29.1,129.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.46,27.36,126.28
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.58,1.74,3.67
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,55.97,20.85,106.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.04,20.23,105.19
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.93,0.62,1.32
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,53.42,18.59,103.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.42,18.59,103.95
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.19,13.68,81.99
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.19,13.68,81.99
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.33,0.21,0.46
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,42.99,17.06,80.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.47,11.46,68.22
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.52,5.6,12.11
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.31,0.2,0.43
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,39.82,14.91,74.42
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.4,10.0,63.93
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.43,4.91,10.49
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.28,0.19,0.4
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,36.1,12.39,67.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.96,8.29,58.88
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,6.14,4.1,8.59
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.18,0.12,0.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.7,9.7,58.81
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.53,7.58,54.34
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,3.16,2.13,4.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.32,0.21,0.47
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,29.02,9.25,58.01
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,24.91,6.56,52.1
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,4.11,2.7,5.91
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.58,0.38,0.84
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,31.91,10.79,62.26
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.37,5.84,51.33
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,7.55,4.96,10.93
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,0.27,0.17,0.4
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,25.11,7.04,52.56
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,23.11,5.81,49.64
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.0,1.23,2.92
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,90.38,40.57,158.51
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,89.53,40.01,157.31
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.85,0.56,1.21
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,88.26,39.37,155.16
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,87.12,38.63,153.54
ARG,Argentina,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.14,0.75,1.63
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,1.55,10.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.33,1.55,10.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.19,11.61,44.93
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,24.56,10.5,42.61
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.63,1.11,2.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.86,19.44,75.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,41.12,17.59,71.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.74,1.85,3.89
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.8,6.34,43.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.8,6.34,43.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.65,29.54,114.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.5,26.73,108.42
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.16,2.82,5.91
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.12,0.08,0.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.4,52.69,184.82
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,103.09,47.07,173.01
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.31,5.62,11.81
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.17,0.12,0.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,132.96,75.46,208.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,121.9,67.95,192.99
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,11.06,7.5,15.76
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.09,0.06,0.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,82.81,43.64,134.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,77.3,39.86,126.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.5,3.77,7.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.13,0.09,0.18
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,105.19,54.49,165.37
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,97.49,49.15,154.58
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,7.7,5.34,10.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,71.11,36.67,115.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,68.59,34.94,112.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.51,1.72,3.6
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,50.0,24.09,87.88
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,47.56,22.42,84.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.44,1.67,3.4
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.05,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,39.71,18.48,70.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,37.22,16.75,66.75
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.48,1.73,3.52
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,33.38,14.1,60.31
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.94,12.36,56.99
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.44,1.73,3.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.11,9.79,50.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.23,9.17,48.93
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.89,0.63,1.2
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,25.05,9.56,49.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,25.05,9.56,49.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.54,4.87,38.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.54,4.87,38.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.09,0.07,0.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,17.16,4.91,34.9
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.68,3.1,31.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.48,1.81,3.4
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.05,0.04,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.6,3.45,30.37
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.2,2.43,28.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.4,1.02,1.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.27,1.56,24.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.27,1.56,24.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.16,0.11,0.21
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.18,4.08,25.29
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.5,2.18,21.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,2.68,1.9,3.55
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.23,0.15,0.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,11.73,5.32,21.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.25,3.68,17.82
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,2.48,1.64,3.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.5,5.23,15.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.5,5.23,15.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.76,0.46,1.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.83,8.44,20.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.28,5.07,12.3
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.55,3.37,8.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,45.05,22.03,75.47
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,42.14,20.03,71.35
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.92,2.0,4.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,45.08,22.02,75.61
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.16,20.01,71.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.92,2.0,4.13
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.87,1.65,11.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.87,1.65,11.67
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,12.65,46.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.38,12.29,45.74
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.53,0.36,0.76
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.98,21.14,77.71
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.09,20.54,76.44
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.89,0.6,1.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,6.72,47.54
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,23.92,6.72,47.54
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.1,32.01,117.65
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,66.75,31.1,115.73
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.35,0.91,1.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.04,0.03,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.9,57.07,187.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.21,55.27,183.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.69,1.81,3.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.12,0.09,0.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,147.37,85.46,233.47
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,139.3,79.86,222.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,8.07,5.6,11.16
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,101.51,53.21,163.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,99.38,51.73,160.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.14,1.48,2.96
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,125.25,64.45,197.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,125.25,64.45,197.19
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,96.84,49.22,157.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,96.84,49.22,157.17
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,69.5,32.72,114.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.5,32.72,114.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,55.5,26.02,94.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,53.42,24.62,91.16
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,2.08,1.4,2.92
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,46.75,22.69,79.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,44.36,20.97,75.95
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.39,1.71,3.29
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,37.23,15.22,65.78
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.79,14.21,63.79
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.44,1.01,1.98
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,35.54,12.93,62.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.54,12.93,62.45
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.06,0.04,0.09
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.16,9.14,53.94
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.24,7.84,51.32
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.92,1.29,2.62
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,7.97,47.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,22.07,6.7,45.33
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.84,1.27,2.5
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,22.02,7.21,43.55
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.23,5.97,41.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.79,1.24,2.42
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.08,0.05,0.11
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,19.78,6.31,38.48
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,18.06,5.12,36.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.72,1.2,2.34
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,16.16,5.39,32.38
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,16.16,5.39,32.38
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.16,0.11,0.23
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,16.34,5.03,32.26
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.87,4.05,30.2
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.47,0.98,2.06
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.16,0.11,0.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.27,4.39,32.12
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.2,2.97,29.27
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.07,1.42,2.85
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.41,0.27,0.58
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,16.68,5.17,32.24
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,13.71,3.23,28.02
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,2.97,1.94,4.22
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.1,26.86,89.71
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,52.78,25.95,87.88
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.32,0.91,1.83
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.04,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.93,26.04,88.14
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.57,25.1,86.25
ARG,Argentina,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.36,0.94,1.89
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.3,1.99,11.89
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.66,1.59,10.92
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.64,0.39,0.97
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.16,13.65,46.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,24.9,12.18,43.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.26,1.47,3.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.05,0.03,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.83,22.53,76.73
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,41.09,20.11,71.34
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.73,2.42,5.39
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,25.41,8.01,47.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.83,6.42,44.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.58,1.59,3.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.4,34.37,117.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.7,30.68,108.85
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,5.7,3.69,8.23
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.13,0.08,0.18
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.5,60.79,186.38
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,102.68,55.0,173.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.82,5.8,12.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,125.57,68.59,197.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,125.57,68.59,197.91
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.07,0.05,0.1
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,84.37,44.25,136.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,80.54,41.66,130.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.82,2.59,5.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.17,0.12,0.25
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,112.6,60.72,176.25
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,102.16,53.62,161.32
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,10.44,7.1,14.93
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,73.45,38.33,121.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,73.45,38.33,121.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.13,0.09,0.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,56.7,27.67,95.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,50.02,23.17,86.51
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.68,4.51,9.44
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.22,18.03,70.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.41,16.81,67.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,1.81,1.22,2.6
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.08,0.06,0.11
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,12.94,62.2
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.67,10.7,57.87
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,3.16,2.24,4.33
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.0,9.38,51.23
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.25,8.16,48.8
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.75,1.23,2.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,26.77,9.32,48.8
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.99,8.1,46.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,1.78,1.22,2.53
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.95,5.12,40.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.95,5.12,40.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,2.84,33.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.28,2.84,33.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.05,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.0,2.89,31.17
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.0,2.2,29.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.01,0.68,1.39
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.11,0.07,0.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.65,2.95,28.6
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.34,1.38,25.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,2.3,1.57,3.19
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.3,0.21,0.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,14.86,5.95,28.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.64,2.29,21.95
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.22,3.67,7.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.34,0.22,0.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,13.29,6.35,23.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.31,3.68,17.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.98,2.66,5.53
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.48,5.27,14.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.48,5.27,14.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.91,0.55,1.35
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.9,8.85,22.37
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.26,4.83,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,6.64,4.01,9.82
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,46.12,23.04,77.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.41,21.22,73.21
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.71,1.81,3.86
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,46.34,23.09,77.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,43.6,21.26,73.66
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.74,1.83,3.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.01,1.86,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.01,1.86,12.54
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.7,12.52,44.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.7,12.52,44.74
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.02,20.65,73.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.02,20.65,73.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,24.15,7.49,50.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.15,7.49,50.43
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.93,31.39,112.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,66.93,31.39,112.15
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.5,55.19,173.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.5,55.19,173.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,142.59,81.92,221.58
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,142.59,81.92,221.58
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,101.88,53.13,164.17
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,101.56,52.91,163.71
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.33,0.21,0.46
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,127.95,66.63,207.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,127.95,66.63,207.45
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,100.26,50.11,164.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,100.26,50.11,164.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,72.61,36.05,118.44
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,70.95,34.96,116.09
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.66,1.09,2.35
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.18,23.38,90.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.18,23.38,90.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.74,19.69,79.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,44.07,18.51,77.28
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.67,1.18,2.3
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.97,13.87,66.9
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.37,13.44,66.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.6,0.42,0.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,34.39,12.98,66.4
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,34.39,12.98,66.4
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.3,8.06,52.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.3,8.06,52.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.19,0.13,0.26
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,26.45,10.86,48.83
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.48,7.49,42.06
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,4.97,3.37,6.77
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.18,0.12,0.24
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,24.32,9.13,44.81
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.06,6.23,39.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.26,2.9,5.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.16,0.11,0.21
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,21.81,7.09,40.09
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,18.39,4.74,35.48
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.42,2.35,4.61
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.12,0.08,0.16
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,18.14,5.87,35.03
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,16.06,4.42,32.2
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,2.08,1.46,2.84
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.19,0.13,0.27
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.29,5.36,34.08
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.84,3.69,30.66
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,2.45,1.67,3.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.33,0.23,0.46
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,18.62,6.08,35.78
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.28,3.13,29.71
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.33,2.95,6.07
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.15,0.1,0.22
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.72,3.89,30.98
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,13.63,3.2,29.41
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.09,0.69,1.56
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.1,26.69,89.57
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.6,26.35,88.88
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.5,0.34,0.69
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.23,26.03,88.51
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.56,25.58,87.59
ARG,Argentina,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.67,0.46,0.92
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.19,1.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.01,0.75
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.31,2.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.44,0.02,1.25
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.51,0.3,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.34
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.34
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,0.48,3.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.67,0.03,1.9
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.77,0.45,1.18
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,0.9,5.82
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.17,0.0,3.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.54,0.9,2.36
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.85,1.61,9.83
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.84,0.49,6.55
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.01,1.12,3.27
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.66,1.4,9.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.71,0.86,8.17
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.95,0.54,1.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.26,1.75,10.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.9,0.97,8.5
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.37,0.78,2.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.3,1.21,8.95
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.87,0.96,8.28
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.42,0.24,0.67
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.41,1.13,9.67
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,4.05,0.92,9.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.36,0.21,0.58
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,1.23,9.26
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.04,1.03,8.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.33,0.2,0.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,0.8,7.65
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.15,0.61,7.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.32,0.19,0.5
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.88,0.38,4.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.76,0.31,4.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.12,0.07,0.18
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.0,3.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.34,0.0,3.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.31,0.88
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.56,0.31,0.88
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.91,0.55,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.66,0.4,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.39
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.53,1.31
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.14,0.09,0.22
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.5,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.5,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.03,0.07
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,1.14,2.6
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.61,1.4
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.52,1.2
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.09,0.05,0.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.85,1.11,2.76
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.94,0.59,1.36
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.9,0.52,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.63,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.01,0.63,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.33,0.18,0.54
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.74,5.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.78,0.48,1.14
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,2.38,1.26,3.91
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.25,0.69,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.74,0.39,3.87
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.52,0.3,0.82
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.27,0.7,4.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.75,0.4,3.89
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.52,0.3,0.83
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.11,1.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.81
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.17,0.1,0.25
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.19,1.77
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.53,0.02,1.35
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.28,0.17,0.42
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.29,2.68
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.8,0.03,2.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.43,0.26,0.63
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.27,0.52,4.96
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.42,0.0,3.71
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.85,0.52,1.26
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.86,1.96,11.49
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.67,0.62,8.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,2.19,1.34,3.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,1.82,12.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.24,1.45,11.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.6,0.37,0.93
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.38,11.24
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.09,1.38,11.24
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.77,1.77,12.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.77,1.77,12.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.03,1.83,12.56
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.03,1.83,12.56
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.61,2.2,12.93
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.91,1.78,11.9
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.69,0.42,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,2.02,11.23
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.87,1.56,10.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.74,0.46,1.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.97,6.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.55,0.66,5.43
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.48,0.3,0.72
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.85,0.0,4.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.85,0.0,4.45
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.8,2.16
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.64,0.35,1.07
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.71,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.37,0.83,2.08
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.42,1.1
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.65,0.41,0.98
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.95,2.27
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.76,0.46,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.77,0.49,1.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.04,0.03,0.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,1.09,2.49
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.83,0.51,1.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.9,0.58,1.28
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.62,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.97,0.62,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.75,1.11,2.57
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.0,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.76,0.48,1.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.14,1.38,3.15
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.05,0.68,1.53
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.1,0.7,1.62
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.21,0.13,0.3
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.48,1.55,3.66
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.99,0.63,1.44
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.5,0.93,2.21
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.83,0.91,5.75
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.42,0.65,5.13
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.41,0.25,0.62
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.84,0.94,5.73
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.4,0.67,5.06
ARG,Argentina,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.44,0.27,0.67
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.08,0.31
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.13,0.07,0.22
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.36,1.19
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.42,0.24,0.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.6,1.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.43,0.19,0.82
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.7,0.4,1.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.67,0.32,1.24
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.51,0.27,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.73,0.91,2.99
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.66,0.3,1.25
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.07,0.62,1.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.51,4.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.16,0.54,2.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.63,0.97,2.61
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,2.77,0.43,6.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.77,0.43,6.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.15,1.19,8.6
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.52,0.83,7.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.63,0.36,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.03,0.02,0.05
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.53,1.96,10.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.66,0.88,7.68
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.87,1.08,3.05
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.68,1.01,8.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.68,1.01,8.04
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.68,1.37,9.6
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.69,0.8,8.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.0,0.56,1.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.25,8.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.94,1.11,8.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.25,0.14,0.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.54,0.82,7.31
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.12,0.57,6.66
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.42,0.25,0.65
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.44,4.16
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.75,0.31,3.81
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.22,0.13,0.35
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.13,3.66
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.32,0.0,3.33
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.2,0.13,0.33
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.55,0.32,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.55,0.32,0.89
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.4,1.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.65,0.4,1.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.57,1.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.44,1.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.21,0.13,0.32
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.02,0.01,0.03
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.8,1.91
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.8,0.5,1.18
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.48,0.31,0.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.61,3.82
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.62,1.42
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.62,1.0,2.4
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.13,0.07,0.2
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.35,1.39,3.55
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.95,0.6,1.38
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,1.4,0.79,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.01,0.64,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.39,0.2,0.65
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.63,1.92,5.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.78,0.5,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,2.85,1.43,4.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.71,4.3
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.66,0.43,3.52
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.49,0.28,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.19,0.72,4.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.7,0.44,3.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.49,0.29,0.79
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.09
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.01,0.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.87
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.02,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.51,0.02,1.43
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.03,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.77,0.03,2.17
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.0,3.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.38,0.0,3.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.59,0.57,8.34
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.59,0.57,8.34
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.25,1.58,10.85
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.15,1.52,10.7
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.1,0.06,0.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.0,1.48,10.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.0,1.48,10.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,1.65,10.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.36,1.65,10.96
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.53,2.25,13.26
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.02,1.95,12.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.5,0.3,0.76
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.09,2.16,12.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.09,2.16,12.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.16,1.52,10.64
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.64,1.2,9.86
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.52,0.32,0.78
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.7,0.65,5.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.51,0.54,5.41
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.0,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.0,4.69
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.34,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.63,0.34,1.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.07,0.04,0.1
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,1.54,3.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.7,0.41,1.08
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.77,1.12,2.67
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.07,0.05,0.11
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.51,1.58,3.74
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.76,0.46,1.15
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.76,1.12,2.59
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.63,3.72
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.82,0.51,1.22
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.75,1.12,2.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.04,0.03,0.07
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.73,1.08,2.58
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.96,0.61,1.41
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.77,0.47,1.16
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.09,0.06,0.14
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.35,3.2
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.63,1.45
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.16,0.72,1.75
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.18,0.11,0.27
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.36,2.14,5.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.04,0.67,1.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.32,1.46,3.5
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.08,0.05,0.12
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.96,2.29
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.98,0.62,1.46
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.56,0.34,0.83
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.56,0.78,5.29
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.37,0.66,5.01
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.19,0.12,0.28
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.64,0.85,5.37
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.38,0.68,4.98
ARG,Argentina,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.32,3.17,10.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.05,2.96,10.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.27,0.21,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.68,15.17,50.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,29.17,14.78,49.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.51,0.39,0.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.67,24.37,80.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,46.86,23.74,79.79
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.81,0.63,1.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.75,11.9,40.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.75,11.12,39.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.0,0.79,1.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,35.56,117.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,68.38,34.65,116.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.19,0.91,1.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.13,58.06,191.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,111.77,57.02,189.7
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.36,1.04,1.71
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,117.42,62.18,196.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.01,61.14,194.65
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.41,1.04,1.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.95,25.73,84.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,48.8,24.86,83.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.15,0.87,1.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,61.92,31.66,103.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.88,30.88,102.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.04,0.78,1.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.41,15.62,55.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,30.24,14.75,53.77
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.17,0.87,1.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,18.51,8.8,33.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,17.18,7.77,31.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.33,1.03,1.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.61,5.71,20.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,10.86,5.13,19.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.75,0.58,0.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,8.57,4.36,15.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.76,3.71,14.56
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.81,0.65,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.32,3.6,13.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,6.62,3.05,12.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.7,0.55,0.84
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,3.18,12.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,6.28,2.78,12.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.52,0.41,0.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,6.29,3.1,10.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.53,2.5,9.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.77,0.6,0.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,5.14,2.41,9.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,4.79,2.13,9.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.35,0.28,0.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.7,2.12,8.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,4.45,1.93,8.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.25,0.2,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.06,1.71,8.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,3.96,1.63,7.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.32,1.45,6.16
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,3.17,1.33,5.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.15,0.12,0.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.49,1.55,6.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,3.32,1.42,6.24
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.17,0.13,0.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,1.24,5.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,2.86,1.13,5.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.14,0.11,0.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,4.78,2.33,8.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.51,2.13,7.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.27,0.2,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,30.84,15.81,52.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,30.13,15.26,51.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.72,0.55,0.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.74,16.25,54.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,30.98,15.67,53.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.76,0.58,0.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.0,0.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.04,0.0,0.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.95,1.84,6.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.74,1.68,6.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.22,0.15,0.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.45,9.34,31.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,17.95,8.94,30.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.49,0.4,0.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.0,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.11,0.0,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.53,14.95,50.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,28.74,14.31,49.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.79,0.64,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.69,6.87,25.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,13.99,6.29,24.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.71,0.58,0.87
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,42.91,21.74,73.1
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,41.8,20.81,71.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.1,0.93,1.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.4,35.7,118.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,67.93,34.45,116.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.47,1.26,1.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,70.69,37.65,110.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,69.54,36.68,109.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.15,0.98,1.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.9,14.69,48.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.55,14.39,47.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.35,0.3,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,35.68,17.99,61.87
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,35.5,17.83,61.67
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.18,0.15,0.21
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.73,8.38,31.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.54,8.22,31.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.13,4.45,18.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,10.02,4.37,18.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.07,3.34,13.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.95,3.24,12.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.47,2.43,10.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.14,2.14,10.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.33,0.29,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.85,2.14,9.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,4.56,1.89,8.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.29,0.25,0.34
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.11,8.89
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,4.37,1.83,8.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.33,0.28,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.25,1.81,7.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,4.06,1.65,7.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.82,1.63,7.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,3.54,1.39,6.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.28,0.24,0.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.45,6.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,3.26,1.31,6.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.16,0.14,0.19
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.21,5.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,2.87,1.21,5.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,1.35,4.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,2.4,1.29,4.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.3,4.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,2.53,1.25,4.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.06,0.05,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.16,1.03,3.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,2.15,1.03,3.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.55,6.19
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,3.29,1.46,6.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.13,0.09,0.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.56,9.37,31.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,18.18,9.06,30.88
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.37,0.31,0.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.52,9.33,31.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,18.15,9.02,30.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.37,0.31,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.13,3.04,10.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.01,2.95,10.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.12,0.09,0.15
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.31,14.87,50.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,28.99,14.63,49.67
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.32,0.24,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.11,23.89,80.49
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,46.59,23.51,79.83
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.52,0.38,0.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.13,11.46,39.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.69,11.12,39.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.44,0.34,0.55
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.74,34.87,117.45
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,67.98,34.31,116.48
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.76,0.56,0.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.74,56.94,190.71
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,110.68,56.18,189.35
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.06,0.76,1.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,116.32,61.51,195.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,115.14,60.68,194.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.18,0.83,1.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.41,25.92,83.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,48.25,25.1,82.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.15,0.82,1.43
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,61.75,33.43,102.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.68,32.69,101.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.08,0.74,1.33
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.39,15.89,55.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,30.22,15.07,53.72
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.17,0.82,1.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,18.56,8.9,32.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,17.04,7.8,30.82
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,1.52,1.1,1.86
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.58,5.9,20.73
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,10.8,5.33,19.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.78,0.57,0.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,8.85,4.29,16.83
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.92,3.59,15.7
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.93,0.7,1.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.58,3.66,13.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,6.67,2.97,12.69
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.91,0.68,1.11
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.09,3.33,12.79
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,6.23,2.69,11.74
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.86,0.64,1.05
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,6.53,3.24,11.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.57,2.52,9.92
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.96,0.72,1.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,5.06,2.5,9.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,4.71,2.24,8.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.34,0.26,0.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.58,2.18,8.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,4.33,1.99,8.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.25,0.19,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.9,1.73,7.2
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,3.78,1.64,7.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.14
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.41,1.63,6.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,3.09,1.38,6.03
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.32,0.24,0.39
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.53,1.62,6.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,3.28,1.43,6.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.25,0.19,0.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.9,1.14,5.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,2.83,1.08,5.85
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.09
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,4.86,2.37,8.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.51,2.12,7.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.35,0.26,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,30.61,15.81,52.25
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,29.93,15.32,51.42
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.68,0.49,0.84
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.33,16.18,53.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,30.6,15.65,52.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.73,0.53,0.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.94,1.97,6.8
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.76,1.83,6.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.18,0.14,0.22
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.3,9.41,30.27
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,17.99,9.16,29.9
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.31,0.25,0.38
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,15.08,48.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,28.83,14.68,47.91
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.49,0.4,0.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.76,7.39,25.52
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,14.13,6.87,24.76
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.63,0.52,0.77
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,42.64,21.94,70.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,41.94,21.36,69.68
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.7,0.58,0.85
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.62,35.49,112.47
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,67.85,34.85,111.54
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.76,0.63,0.93
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,70.56,37.54,112.46
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,69.56,36.71,111.28
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.99,0.82,1.18
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.71,14.65,47.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,28.36,14.37,47.55
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.34,0.28,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,36.13,18.83,60.98
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,35.93,18.67,60.75
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.19,0.16,0.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.65,8.22,30.97
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.34,7.97,30.6
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.91,4.39,18.73
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,9.83,4.32,18.63
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.92,3.03,12.74
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.81,2.94,12.62
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.11,0.09,0.12
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.54,2.43,10.64
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.11,2.07,10.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.43,0.36,0.51
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.91,2.25,9.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,4.54,1.94,8.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.37,0.31,0.44
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.72,2.17,9.36
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,4.38,1.89,8.96
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.34,0.28,0.4
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.12,7.94
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,4.02,1.84,7.53
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.34,0.29,0.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.59,6.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,3.49,1.39,6.65
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.25,0.2,0.3
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.36,1.45,6.46
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,3.22,1.33,6.29
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.85,1.26,5.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,2.85,1.26,5.81
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.5,1.37,4.31
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,2.44,1.31,4.23
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.07,0.05,0.08
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.62,1.32,4.66
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,2.56,1.28,4.59
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.2,1.09,4.04
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,2.19,1.08,4.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.55,6.26
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,3.33,1.48,6.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.1,0.07,0.13
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.49,9.43,30.95
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,18.19,9.18,30.58
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.33,9.32,30.78
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,18.02,9.06,30.41
BRA,Brazil,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.31,0.25,0.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.46,2.45
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.46,2.45
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.38,6.03,21.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,12.38,6.03,21.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.68,10.6,36.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,20.68,10.6,36.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.66,1.33,7.17
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.66,1.33,7.17
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.22,17.02,59.14
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,33.22,17.02,59.14
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,21.39,75.59
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,43.08,21.39,75.59
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.8,24.23,83.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,46.8,24.23,83.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.35,26.93,90.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,50.35,26.93,90.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.46,21.11,69.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,39.46,21.11,69.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,24.45,12.75,41.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,24.45,12.75,41.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,28.77,14.84,46.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,28.77,14.84,46.62
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,21.15,11.21,34.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,21.15,11.21,34.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.66,8.28,27.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.66,8.28,27.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.71,6.91,24.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,13.71,6.91,24.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.62,5.72,18.54
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,10.62,5.72,18.54
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,8.15,4.42,13.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,8.15,4.42,13.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.8,4.3,12.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.8,4.3,12.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.32,2.85,8.87
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.32,2.85,8.87
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,1.82,5.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.47,1.82,5.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.51,4.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.88,1.51,4.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.01,1.05,3.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.01,1.05,3.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.21,0.61,2.06
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.21,0.61,2.06
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.49,1.65
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.96,0.49,1.65
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.42,1.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.79,0.42,1.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.27,0.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.15,9.41,31.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,18.15,9.41,31.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.57,9.64,32.15
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,18.57,9.64,32.15
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.54,2.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.13,0.54,2.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.86,5.15,17.11
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.86,5.15,17.11
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.13,7.63,25.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,14.13,7.63,25.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,1.57,6.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.31,1.57,6.07
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.62,12.21,40.13
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,22.62,12.21,40.13
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.81,17.8,58.36
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,33.81,17.8,58.36
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.4,17.04,55.61
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,31.4,17.04,55.61
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.13,16.34,53.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,29.13,16.34,53.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.79,9.65,31.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,17.79,9.65,31.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,5.47,17.84
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,10.52,5.47,17.84
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,11.86,6.36,19.04
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,11.86,6.36,19.04
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.77,4.34,14.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.77,4.34,14.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.38,3.56,12.21
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,7.38,3.56,12.21
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.17,3.05,10.91
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.17,3.05,10.91
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.6,2.38,8.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.6,2.38,8.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.57,1.89,6.26
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.57,1.89,6.26
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.85,5.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.39,1.85,5.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.48,1.32,4.1
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.48,1.32,4.1
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.86,2.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.69,0.86,2.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.42,0.71,2.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.42,0.71,2.37
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.51,1.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.51,1.74
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.66,0.33,1.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.66,0.33,1.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.25,0.93
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.51,0.25,0.93
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.22,0.8
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.44,0.22,0.8
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.13,0.52
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.28,0.13,0.52
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.92,5.27,17.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.92,5.27,17.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.64,5.11,16.77
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,9.64,5.11,16.77
BRA,Brazil,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.46,2.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.25,0.46,2.46
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.99,5.94,21.33
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,11.99,5.94,21.33
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.4,10.14,35.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,19.4,10.14,35.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.36,7.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.67,1.36,7.2
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.18,16.3,56.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.18,16.3,56.29
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,41.77,21.14,73.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,41.77,21.14,73.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.81,23.16,78.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,43.81,23.16,78.83
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.73,25.07,83.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,45.73,25.07,83.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,34.59,18.69,60.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,34.59,18.69,60.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.18,11.09,35.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,21.18,11.09,35.69
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,24.89,13.06,39.81
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,24.89,13.06,39.81
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.98,9.54,28.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,17.98,9.54,28.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.46,7.07,24.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,14.46,7.07,24.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.21,6.11,22.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.21,6.11,22.49
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,9.68,5.08,17.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.68,5.08,17.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.49,3.99,13.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.49,3.99,13.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.19,3.9,12.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.19,3.9,12.08
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.01,2.68,8.64
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,5.01,2.68,8.64
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.82,5.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.39,1.82,5.7
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.84,1.52,4.75
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.84,1.52,4.75
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.03,1.08,3.39
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.03,1.08,3.39
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.59,2.18
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.25,0.59,2.18
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.48,1.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.48,1.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.43,1.43
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.81,0.43,1.43
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.28,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.54,0.28,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.43,8.6,28.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,16.43,8.6,28.67
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.67,8.73,29.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,16.67,8.73,29.02
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.53,1.96
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.12,0.53,1.96
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.64,5.04,16.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.64,5.04,16.79
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.65,7.3,23.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.65,7.3,23.86
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.28,1.55,5.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,3.28,1.55,5.73
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.88,11.69,38.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,21.88,11.69,38.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.14,17.48,57.72
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,33.14,17.48,57.72
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.33,16.31,53.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,30.33,16.31,53.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.71,15.21,48.6
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,27.71,15.21,48.6
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.34,8.64,28.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,16.34,8.64,28.03
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.53,4.86,16.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,9.53,4.86,16.38
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,10.61,5.45,18.56
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,10.61,5.45,18.56
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.97,4.14,13.09
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,7.97,4.14,13.09
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.71,3.26,11.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.71,3.26,11.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,2.55,10.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.61,2.55,10.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.36,2.4,7.85
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.36,2.4,7.85
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.89,5.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.42,1.89,5.92
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,1.81,5.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.27,1.81,5.47
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.43,1.36,4.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.43,1.36,4.05
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.87,2.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.69,0.87,2.78
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.41,0.72,2.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.41,0.72,2.35
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.52,1.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.52,1.76
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.34,1.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.68,0.34,1.23
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.26,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.53,0.26,0.95
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.23,0.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.46,0.23,0.82
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.14,0.53
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.28,0.14,0.53
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.38,4.93,16.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.38,4.93,16.28
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.01,4.74,15.63
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,9.01,4.74,15.63
BRA,Brazil,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.49,1.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.96,0.49,1.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.19,0.16,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,42.47,26.89,63.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,28.07,14.58,46.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,14.4,12.31,16.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.4,0.35,0.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,76.25,50.8,110.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,47.17,25.66,76.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,29.08,25.14,33.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.8,1.44,4.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.8,1.44,4.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.65,0.56,0.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,122.48,81.6,177.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,75.76,41.22,123.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,46.71,40.39,54.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.72,0.61,0.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,156.93,99.67,233.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,102.84,53.42,169.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,54.09,46.25,63.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.95,0.82,1.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,177.45,118.43,257.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,109.28,59.49,177.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,68.17,58.94,79.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,1.16,1.01,1.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,196.97,136.26,279.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,115.41,65.25,185.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,81.56,71.01,93.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,1.24,1.08,1.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,169.57,121.03,229.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,88.5,50.49,137.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,81.07,70.54,92.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,1.23,1.08,1.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,124.29,92.69,163.98
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.85,32.46,86.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,68.44,60.23,77.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,1.15,1.01,1.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,135.43,99.74,180.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,66.08,38.78,101.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,69.34,60.97,78.9
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,1.25,1.11,1.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,119.74,90.3,156.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.25,28.69,78.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,69.49,61.61,77.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,1.31,1.17,1.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,104.7,81.75,134.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,38.54,22.94,60.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,66.16,58.81,73.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,1.17,1.02,1.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,83.09,64.72,106.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.9,18.09,46.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,53.19,46.63,60.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.89,0.8,1.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,59.67,46.59,78.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.42,14.14,38.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,36.25,32.46,40.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.65,0.58,0.73
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,44.47,33.79,60.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,20.16,12.15,32.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,24.31,21.64,27.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.54,0.48,0.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.83,28.98,53.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,19.41,11.74,31.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,19.42,17.24,21.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.47,0.41,0.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.23,22.71,43.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,16.76,10.01,27.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,14.47,12.7,16.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.35,0.31,0.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,24.02,16.42,33.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.84,8.29,23.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,9.18,8.13,10.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.38,0.34,0.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.56,16.44,33.06
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.3,8.22,22.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,9.26,8.21,10.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.43,0.39,0.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,22.89,16.46,32.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,13.51,8.12,21.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,9.38,8.34,10.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.37,0.32,0.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,18.47,12.87,26.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.15,7.29,19.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,6.31,5.58,7.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.52,0.44,0.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,18.15,12.57,26.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.61,6.94,18.49
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,6.54,5.62,7.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.51,0.43,0.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,18.05,12.41,25.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,11.36,6.77,18.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,6.69,5.64,7.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.95,0.79,1.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,17.41,11.97,24.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.46,6.25,16.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,6.95,5.72,8.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.72,0.63,0.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,81.83,58.59,112.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,42.27,23.92,67.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,39.57,34.67,44.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.76,0.67,0.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,84.96,61.09,116.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,43.35,24.6,68.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,41.61,36.49,47.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.01,0.0,0.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.14,2.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.33,0.14,0.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,1.18,0.0,1.63
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.93,7.53,22.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.52,4.42,17.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,4.41,3.11,5.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,17.05,40.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.23,8.18,27.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,10.67,8.86,12.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.04,0.0,0.06
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,0.41,6.58
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.96,0.41,1.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,3.44,0.0,4.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.24,0.2,0.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,27.29,64.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,25.99,13.1,44.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,17.09,14.19,19.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.18,0.15,0.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,48.01,27.8,77.69
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,34.74,16.15,62.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,13.27,11.66,15.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.33,0.29,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.65,39.51,90.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,37.36,18.86,63.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,23.29,20.64,26.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.47,0.41,0.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,50.5,102.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.83,21.42,65.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,32.71,29.08,36.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.33,0.3,0.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,52.88,35.97,75.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.07,16.64,51.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,21.82,19.33,24.52
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.32,0.28,0.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,37.74,26.57,52.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,19.87,10.58,32.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,17.87,15.99,20.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.37,0.33,0.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,45.36,32.33,62.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,23.2,12.43,37.6
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,22.15,19.9,24.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.27,0.25,0.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,32.93,22.97,46.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.77,9.28,30.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,15.16,13.69,16.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.35,0.32,0.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,32.08,23.48,43.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,14.18,7.5,23.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,17.9,15.99,20.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.25,0.23,0.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.28,16.62,32.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,11.86,6.38,19.94
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,11.43,10.24,12.89
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,15.87,10.6,23.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,10.21,5.51,17.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,5.65,5.1,6.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.8,9.89,21.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,9.63,5.3,15.92
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,5.17,4.59,5.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.16,0.14,0.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.11,10.23,21.97
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,9.39,5.23,15.54
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.72,5.0,6.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,13.09,8.58,19.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.17,5.11,14.58
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,3.92,3.48,4.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.2,0.18,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.94,9.6,19.9
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,8.75,5.0,14.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,5.18,4.61,5.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.17,0.15,0.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.64,8.5,18.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.41,4.76,13.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.22,3.74,4.71
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.13,0.12,0.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,6.99,16.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,7.94,4.45,13.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.91,2.54,3.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.11,0.1,0.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.26,5.61,13.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.36,3.97,11.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.91,1.65,2.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.27,0.21,0.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.88,6.09,14.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.03,3.81,11.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,2.85,2.28,3.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.2,0.16,0.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.58,5.98,14.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.94,3.84,11.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.64,2.14,3.08
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.7,0.52,0.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.58,7.27,16.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.46,3.46,10.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,5.12,3.8,6.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.21,0.18,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,26.9,18.02,38.83
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,15.41,8.06,25.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.49,9.96,12.97
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.22,0.19,0.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,27.37,18.45,39.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,15.63,8.21,26.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,11.74,10.25,13.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.94,0.49,1.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.94,0.49,1.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.08,0.07,0.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.64,19.62,52.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,27.46,14.37,44.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.18,5.25,7.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.26,0.22,0.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.74,40.89,96.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,46.42,25.13,74.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,18.32,15.75,21.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.75,1.42,4.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.75,1.42,4.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.41,0.35,0.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,104.06,65.72,154.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,74.61,40.4,120.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,29.45,25.32,34.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.31,0.26,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,124.29,72.67,191.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.97,52.85,164.09
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,23.32,19.82,27.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.6,0.52,0.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.58,95.24,223.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,107.61,58.29,173.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,42.97,36.94,50.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.87,0.76,1.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,175.37,116.52,253.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,113.88,63.43,181.85
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,61.49,53.09,71.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.99,0.86,1.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,152.26,107.4,209.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,87.45,51.19,135.25
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,64.81,56.21,74.42
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,1.2,1.05,1.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,121.27,90.47,161.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.24,32.44,85.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,66.03,58.03,75.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,1.13,1.0,1.31
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,134.19,98.62,181.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.77,38.5,102.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,68.42,60.12,78.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,1.21,1.08,1.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,117.03,89.33,154.4
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,49.81,29.38,77.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,67.22,59.95,76.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,1.47,1.3,1.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,112.61,87.72,142.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,38.46,22.32,58.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,74.15,65.4,84.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,1.18,1.03,1.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,83.57,64.84,108.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.68,17.92,46.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,53.89,46.91,62.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,1.0,0.88,1.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,63.73,49.67,82.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.07,13.79,35.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,40.66,35.89,46.46
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.83,0.73,0.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,50.62,38.7,66.57
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,19.77,11.55,31.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,30.85,27.15,35.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.87,0.77,1.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,50.13,38.37,66.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.97,10.88,30.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,31.16,27.49,35.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.58,0.5,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.26,24.91,46.98
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,16.47,9.46,26.3
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,17.8,15.44,20.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.34,0.29,0.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,23.51,16.4,34.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.69,8.73,23.79
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,8.82,7.68,10.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.4,0.35,0.45
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.62,16.63,33.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.11,8.31,22.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,9.51,8.32,10.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.49,0.43,0.55
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.77,16.97,32.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,13.28,7.72,20.94
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,10.49,9.25,11.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.77,0.67,0.88
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,25.36,18.59,33.99
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.18,7.14,18.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,13.19,11.44,15.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.7,0.59,0.81
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.99,14.84,28.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.56,6.77,17.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,9.44,8.07,10.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.25,0.2,0.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,9.21,20.87
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,11.21,6.53,17.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.23,2.68,3.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,1.22,1.0,1.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,19.27,13.37,26.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.36,6.08,16.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,8.91,7.29,10.48
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.68,0.59,0.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,77.11,54.59,106.63
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.76,23.67,65.95
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,35.35,30.92,40.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.73,0.64,0.84
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,80.44,57.33,110.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,42.63,24.24,67.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,37.81,33.09,43.47
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.13,1.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.32,0.13,0.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.47,0.0,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.92,6.98,21.53
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,9.36,4.14,17.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,3.56,2.84,4.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.09,0.08,0.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.68,13.35,36.36
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.05,7.76,28.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,6.62,5.59,7.59
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.02,0.0,0.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,0.39,3.74
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.95,0.39,1.79
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,1.37,0.0,1.96
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.34,21.38,58.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,25.73,12.43,46.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,10.61,8.95,12.16
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.16,0.14,0.18
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,46.37,25.87,77.41
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,34.28,15.18,63.7
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.09,10.69,13.71
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.21,0.18,0.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,51.81,30.93,83.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.99,17.91,66.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,14.82,13.02,16.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.25,0.22,0.28
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,56.87,35.64,88.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.52,20.45,68.61
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,17.36,15.19,19.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.29,0.25,0.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,49.83,33.94,72.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,30.93,17.35,50.64
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,18.9,16.59,21.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.34,0.3,0.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,38.93,27.9,54.02
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,19.92,10.95,32.68
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,19.01,16.95,21.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.4,0.36,0.45
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,47.54,34.91,65.77
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,23.47,13.46,38.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,24.07,21.46,27.01
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.46,0.41,0.51
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,43.27,32.28,56.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,17.9,9.4,28.43
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,25.37,22.88,28.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.29,0.26,0.33
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,29.28,20.77,41.07
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,14.44,7.58,24.35
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,14.84,13.19,16.72
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.23,0.2,0.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.18,15.68,31.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,11.85,6.43,19.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,10.33,9.24,11.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.18,0.17,0.21
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,17.75,12.36,25.54
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,10.27,5.64,17.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,7.48,6.72,8.44
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.19,0.17,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.58,11.55,23.62
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,9.67,5.42,15.8
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,6.91,6.13,7.82
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.17,0.15,0.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.4,10.53,21.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,9.42,5.28,15.03
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.98,5.25,6.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.51,11.72,23.39
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.23,5.3,15.11
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,7.28,6.42,8.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.18,0.16,0.2
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.45,9.12,19.38
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,8.81,5.0,14.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,4.64,4.12,5.15
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.16,0.14,0.17
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.33,8.3,18.04
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.48,4.89,13.75
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,3.85,3.41,4.29
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.83,7.19,16.23
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.03,4.74,13.1
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.8,2.45,3.13
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.11,0.1,0.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.28,5.55,13.78
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.39,3.91,11.66
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.89,1.64,2.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.27,0.21,0.32
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.12,6.23,14.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.06,3.79,11.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,3.06,2.43,3.56
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.32,0.25,0.37
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.2,7.02,16.5
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.03,3.72,11.65
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.16,3.3,4.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.55,0.41,0.67
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.42,6.59,15.12
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.4,3.63,10.26
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,4.02,2.95,4.86
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.2,0.17,0.22
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.94,17.32,38.11
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,15.39,8.07,26.19
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,10.55,9.25,11.91
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.21,0.19,0.24
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.57,17.9,38.76
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,15.56,8.21,26.34
BRA,Brazil,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,11.01,9.69,12.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.95,4.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.21,0.95,4.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.25,0.21,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,69.04,41.32,107.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,50.27,25.43,84.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,18.77,15.89,22.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.52,0.45,0.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,151.2,92.47,233.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,113.69,60.32,189.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,37.51,32.15,43.86
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.77,11.9
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.46,2.77,11.9
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.84,0.72,0.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,242.86,148.52,375.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,182.61,96.88,304.83
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,60.25,51.63,70.44
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.94,0.79,1.11
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,253.34,152.63,391.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,182.8,92.94,307.33
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,70.54,59.7,83.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,1.22,1.04,1.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,351.45,215.47,542.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,263.53,140.12,439.39
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,87.93,75.35,102.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,1.49,1.28,1.72
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,444.75,275.22,685.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,340.29,184.98,564.97
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,104.46,90.24,120.93
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,1.56,1.35,1.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,422.25,268.25,632.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,320.16,180.1,515.75
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,102.09,88.15,116.84
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,1.5,1.31,1.71
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,265.1,174.74,386.34
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,181.09,101.4,290.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,84.02,73.34,95.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,1.38,1.2,1.57
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,301.55,194.76,441.48
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,218.57,122.53,346.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,82.98,72.22,95.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,1.53,1.34,1.72
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,234.88,158.14,336.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,150.3,83.76,241.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,84.58,74.38,95.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,1.63,1.44,1.83
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,191.56,133.23,269.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,109.43,60.72,177.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,82.13,72.51,92.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,1.42,1.24,1.63
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,149.19,103.56,212.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,84.53,47.25,137.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,64.67,56.31,74.13
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,1.31,1.16,1.49
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,120.25,84.62,170.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,66.95,37.56,110.54
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,53.3,47.06,60.34
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.99,0.87,1.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,91.73,62.88,132.6
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,55.07,30.7,90.92
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,36.66,32.18,41.68
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.84,0.74,0.96
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,83.19,55.8,121.67
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,53.16,29.51,87.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,30.04,26.3,34.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.73,0.64,0.84
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,64.42,42.75,95.28
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,41.7,23.07,69.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,22.72,19.67,25.96
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,48.13,30.57,71.64
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.43,17.76,54.86
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.7,12.81,16.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.54,0.47,0.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.31,28.38,66.28
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.2,16.91,51.37
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,13.11,11.47,14.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.5,0.44,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,38.75,25.21,58.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.95,15.68,46.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,10.8,9.52,12.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.49,0.43,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,31.7,20.59,47.05
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.35,13.25,37.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.35,7.33,9.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.87,0.73,1.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,32.73,21.47,48.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.2,12.53,36.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,10.52,8.94,12.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,1.0,0.83,1.18
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,34.14,22.66,50.22
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.08,11.76,34.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,13.06,10.9,15.42
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.73,1.42,2.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,33.39,22.07,48.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.77,11.71,33.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,12.62,10.36,14.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.92,0.8,1.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,169.3,108.98,251.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,118.9,65.22,194.21
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,50.39,43.76,57.77
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.98,0.85,1.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,175.92,113.59,261.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,122.92,67.53,200.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,53.0,46.07,60.69
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.02,0.0,0.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.38,0.68,5.13
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.46,0.68,2.7
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,1.92,0.0,2.43
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.09,0.06,0.1
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,35.46,18.52,58.12
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,28.83,14.02,50.26
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.63,4.5,7.85
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.22,0.18,0.25
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.49,51.84,144.91
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,74.64,39.03,126.6
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,15.85,12.81,18.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.07,0.0,0.09
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.89,1.98,14.99
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.27,1.98,7.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,5.62,0.0,7.1
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.35,0.29,0.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,144.86,82.99,232.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,119.49,62.48,202.69
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,25.37,20.51,29.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.26,0.22,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,123.43,67.45,203.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.9,50.62,180.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,19.53,16.83,22.74
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.48,0.42,0.55
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,206.2,119.8,330.62
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,171.85,89.97,291.22
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,34.35,29.82,39.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.69,0.6,0.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,283.95,168.97,450.04
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,235.67,126.94,394.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,48.28,42.03,55.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.49,0.43,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,283.38,171.33,422.25
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,251.09,143.31,385.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,32.28,28.02,36.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.46,0.4,0.52
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,184.0,114.26,278.06
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,158.14,91.53,248.77
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,25.87,22.73,29.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.52,0.46,0.58
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,228.93,143.76,345.49
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,197.8,116.29,310.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,31.13,27.46,35.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.39,0.35,0.44
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,167.73,103.58,259.89
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,145.89,84.26,235.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,21.84,19.32,24.48
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.52,0.46,0.59
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,130.44,84.03,196.61
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.13,60.88,166.82
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,26.31,23.14,29.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.36,0.32,0.41
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,95.04,59.78,143.87
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,78.52,45.16,125.08
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,16.52,14.62,18.79
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.18,42.16,108.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,60.44,33.56,97.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,9.74,8.6,11.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.24,0.21,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,58.07,34.75,89.76
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,49.31,27.11,79.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,8.76,7.64,9.98
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.27,0.24,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,57.26,34.66,88.4
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,47.43,26.2,77.19
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,9.82,8.47,11.2
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.2,0.18,0.23
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,43.79,25.52,68.02
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,37.51,20.07,60.81
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,6.28,5.45,7.21
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.31,0.27,0.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,37.63,22.87,59.43
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,29.6,15.88,50.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.02,6.99,9.07
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.3,0.26,0.33
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,34.15,20.43,54.09
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,26.94,14.16,45.94
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.21,6.27,8.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.28,0.24,0.32
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.38,17.08,46.76
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,23.29,11.82,39.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,6.09,5.27,6.88
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.26,0.22,0.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.6,14.45,37.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,20.19,10.71,32.35
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,4.41,3.74,5.03
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.55,0.43,0.65
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,25.27,14.79,38.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,19.37,10.1,31.51
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,5.9,4.68,6.94
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.4,0.32,0.47
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,23.56,13.44,36.45
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.33,9.26,30.3
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,5.23,4.18,6.15
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,1.36,1.01,1.65
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.99,17.32,43.39
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.07,9.97,31.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,9.92,7.34,12.01
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.31,0.27,0.36
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,111.37,67.13,171.8
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,94.29,52.63,152.29
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,17.08,14.49,19.5
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.33,0.28,0.38
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,114.08,69.01,175.78
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,96.59,54.07,155.82
BRA,Brazil,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,17.49,14.94,19.95
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.19,0.95,4.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.19,0.95,4.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,57.28,31.97,92.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,49.21,25.2,82.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,8.07,6.77,9.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.33,0.28,0.39
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,135.09,79.34,213.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,111.42,59.19,185.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,23.67,20.14,27.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.41,2.78,11.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,6.41,2.78,11.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.53,0.45,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,217.12,127.51,343.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,179.08,95.14,298.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,38.04,32.38,44.78
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.4,0.34,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,210.01,117.97,336.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,179.56,92.44,300.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,30.44,25.52,36.71
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.78,0.66,0.91
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,313.88,184.79,495.46
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,258.37,137.55,430.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,55.51,47.24,65.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,1.13,0.96,1.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,411.82,247.79,644.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,332.67,180.07,552.6
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,79.15,67.72,92.33
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,1.26,1.08,1.46
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,395.77,248.42,600.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,313.41,177.67,504.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,82.36,70.76,95.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,1.47,1.28,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,258.12,170.97,376.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,176.79,100.27,282.23
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,81.33,70.7,93.82
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,1.37,1.18,1.59
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,297.03,194.0,432.18
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,214.58,122.65,336.52
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,82.44,71.34,95.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,1.48,1.31,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,229.15,155.61,328.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,147.05,83.27,234.07
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,82.09,72.34,93.99
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,1.83,1.6,2.09
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,199.51,140.59,275.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,107.4,59.98,170.39
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,92.11,80.61,105.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.44,1.24,1.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,148.45,103.8,212.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,82.93,47.24,136.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,65.52,56.56,76.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,1.47,1.28,1.7
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,125.69,87.6,177.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,65.91,35.48,108.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,59.78,52.12,69.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,1.27,1.1,1.47
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,100.7,69.69,142.77
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,54.01,29.12,88.69
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,46.69,40.56,54.08
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,1.35,1.17,1.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,100.17,70.31,140.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,51.98,28.44,84.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,48.19,41.88,55.96
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.9,0.78,1.05
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,69.01,45.76,100.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,41.03,21.72,68.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,27.97,24.04,32.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.54,0.46,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,47.44,30.51,71.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.32,18.36,55.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.13,12.15,16.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.55,0.47,0.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.25,28.61,66.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,30.96,17.11,51.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,13.29,11.49,15.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,39.67,25.88,58.72
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.59,15.33,44.96
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,12.08,10.55,13.76
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,1.01,0.88,1.17
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,28.19,57.47
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.35,13.13,37.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,17.44,15.06,20.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.08,0.9,1.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,36.03,24.13,51.8
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.14,12.36,35.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,13.89,11.77,16.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.48,0.4,0.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.22,16.71,41.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,20.93,11.53,33.94
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,6.29,5.17,7.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,2.22,1.8,2.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,36.85,24.65,52.48
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,20.69,11.52,33.28
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,16.16,13.12,19.2
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.88,0.76,1.02
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,161.88,103.5,242.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,116.55,64.3,189.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,45.33,39.21,52.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.95,0.82,1.1
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,168.47,108.28,251.11
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,119.95,66.28,194.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,48.52,42.0,56.22
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.66,3.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.45,0.66,2.57
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.76,0.0,0.98
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.07,0.05,0.08
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.85,18.03,56.87
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,28.59,13.94,50.71
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,5.27,4.09,6.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.13,0.11,0.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,84.22,46.95,136.6
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,74.46,38.9,125.24
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.76,8.04,11.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.03,0.0,0.04
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,1.95,10.4
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.23,1.95,7.52
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,2.22,0.0,2.88
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.22,0.18,0.25
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.96,75.22,218.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,119.32,62.33,200.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,15.63,12.89,18.21
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.24,0.2,0.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,121.19,65.94,203.99
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,103.48,50.57,183.55
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,17.7,15.38,20.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.3,0.26,0.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,193.37,108.54,313.68
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,171.64,89.79,288.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,21.73,18.75,25.18
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.36,0.31,0.42
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,260.62,148.22,415.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,235.14,126.33,386.27
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,25.49,21.89,29.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.43,0.37,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,279.36,172.12,417.81
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,251.38,148.05,385.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,27.98,24.07,32.23
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.49,0.42,0.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,185.11,116.5,277.12
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,157.78,92.6,245.86
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,27.33,23.89,31.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.56,0.49,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,232.81,146.26,348.13
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,199.03,116.6,309.53
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,33.78,29.66,38.61
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.66,0.58,0.75
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,182.52,119.03,269.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,146.2,87.02,228.44
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,36.31,32.01,41.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.43,0.37,0.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,125.75,79.95,188.67
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.15,61.13,163.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,21.6,18.82,24.76
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,92.43,56.76,143.09
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,77.65,43.79,126.16
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,14.78,12.97,16.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.31,0.28,0.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,44.64,110.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,59.82,33.46,96.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,12.71,11.18,14.54
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,60.32,37.17,92.45
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,48.84,27.19,79.24
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,11.47,9.98,13.2
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.28,0.24,0.33
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,57.03,35.23,87.58
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,46.9,26.5,75.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,10.13,8.73,11.66
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.37,0.32,0.43
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,49.09,30.21,75.38
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,37.57,20.27,62.03
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,11.52,9.94,13.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.27,0.23,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,36.78,21.78,57.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,29.69,15.62,49.56
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,7.09,6.15,8.06
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.27,0.23,0.31
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,33.41,19.91,52.63
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,26.9,14.27,45.21
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,6.52,5.64,7.41
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.27,0.23,0.3
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.88,17.4,45.9
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,23.14,12.45,39.36
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,5.74,4.94,6.54
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.25,0.21,0.29
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.41,14.29,37.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,20.12,10.69,32.41
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,4.29,3.6,4.93
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.54,0.42,0.64
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,25.56,15.11,38.95
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,19.35,10.21,31.62
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,6.21,4.9,7.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.62,0.49,0.73
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,26.59,15.89,40.5
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.46,9.48,30.89
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,8.13,6.41,9.61
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,1.06,0.77,1.28
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,26.6,15.83,40.26
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,18.91,10.22,30.91
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,7.69,5.61,9.35
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.3,0.25,0.34
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,109.82,66.52,168.94
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,94.24,53.13,151.02
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,15.58,13.38,17.92
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.32,0.28,0.37
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,112.41,68.4,172.49
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,96.1,54.34,153.75
BRA,Brazil,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,16.31,14.05,18.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.22,2.24,6.58
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.72,1.84,5.97
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.5,0.4,0.61
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,17.36,9.91,27.18
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,16.43,9.16,26.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.93,0.74,1.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.88,15.92,43.65
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,26.39,14.72,41.85
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.49,1.2,1.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,15.86,8.43,24.73
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,13.97,6.93,22.45
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.88,1.5,2.28
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.69,23.23,63.7
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,38.52,21.48,61.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.17,1.75,2.62
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.31,37.3,100.76
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,61.86,35.32,97.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.45,1.98,2.94
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,76.73,48.55,113.67
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,74.32,46.53,110.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.41,2.02,2.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.01,32.4,77.69
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,49.01,29.86,74.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.01,2.54,3.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,63.27,39.38,94.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.15,36.76,91.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.12,2.62,3.67
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,48.45,30.24,71.91
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,45.17,27.44,68.15
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.28,2.8,3.77
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,36.85,22.87,55.58
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,33.29,19.83,51.46
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.57,3.04,4.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.49,17.52,44.75
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,26.87,15.33,41.6
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.62,2.19,3.14
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,28.68,17.71,42.26
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,22.95,12.93,35.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,5.73,4.78,6.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.12,0.11,0.14
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.46,14.29,35.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,18.89,10.45,29.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,4.57,3.84,5.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.1,0.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,22.79,13.64,33.94
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.7,10.14,29.23
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,4.09,3.5,4.71
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.12,0.1,0.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.37,10.57,27.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,13.78,7.55,22.96
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,3.6,3.02,4.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.65,7.56,19.1
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.05,5.36,16.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.6,2.21,3.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.02,6.56,16.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.3,5.1,14.85
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.73,1.46,2.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.67,5.11,13.63
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.21,4.72,13.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.46,0.39,0.56
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,6.96,4.2,10.29
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,6.56,3.86,9.83
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.4,0.34,0.46
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.93,9.83
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.05,3.51,9.21
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.52,0.43,0.62
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.69,3.99,10.23
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,5.8,3.27,9.16
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.88,0.72,1.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.26,3.09,7.88
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.97,2.87,7.54
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.28,0.22,0.35
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,29.18,17.77,44.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.03,15.97,41.56
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.15,1.8,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,30.9,18.84,46.66
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,28.57,16.89,43.93
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.33,1.95,2.73
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.0,0.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.25,0.0,0.3
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.09,2.96,9.97
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.67,2.76,9.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.42,0.2,0.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.91,14.72,43.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.12,14.19,42.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.79,0.53,0.95
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.0,0.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.72,0.0,0.87
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.08,23.57,69.59
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,41.82,22.72,68.06
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.27,0.85,1.53
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.12,11.08,36.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,21.22,10.34,35.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.89,0.74,1.08
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.34,34.28,100.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,60.82,33.04,98.99
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.52,1.24,1.82
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.12,56.08,161.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,98.02,54.36,158.68
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.1,1.72,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,132.52,80.97,191.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,131.04,79.71,190.02
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.49,1.26,1.77
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.03,61.16,147.25
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,96.55,59.89,145.52
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.48,1.27,1.72
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.7,80.19,189.68
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,124.79,78.53,187.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.91,1.66,2.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,100.07,62.08,155.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,98.78,60.96,154.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.28,1.12,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,70.81,45.36,109.22
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.28,44.06,107.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.53,1.3,1.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.8,32.03,77.47
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,50.66,31.06,76.16
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.13,0.98,1.31
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.75,23.75,58.74
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,38.4,22.59,57.17
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.35,1.16,1.57
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.62,18.54,48.1
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,30.35,17.46,46.61
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.27,1.08,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.78,18.01,47.51
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.31,16.76,45.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.48,1.25,1.72
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,22.39,12.61,35.41
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.45,11.83,34.32
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.93,0.78,1.09
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,16.5,9.47,27.36
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.31,8.46,25.99
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.19,1.01,1.37
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.06,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.1,8.54,24.89
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.56,7.21,23.13
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.55,1.32,1.76
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.19,7.25,21.49
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.15,5.49,19.2
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.03,1.76,2.29
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,11.08,6.29,16.6
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.5,4.97,14.79
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.58,1.32,1.81
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.1,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.24,5.59,15.65
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.02,4.61,14.22
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.22,0.98,1.44
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.06,0.04,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.26,4.58,14.53
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.52,4.0,13.63
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.74,0.58,0.89
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.16,0.11,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.8,5.51,15.19
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.67,4.69,13.8
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.13,0.82,1.38
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,50.71,30.6,77.43
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,49.58,29.7,76.11
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.13,0.9,1.32
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.07,32.1,81.04
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.87,31.12,79.64
BRA,Brazil,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.2,0.97,1.4
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.92,2.1,6.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.7,1.93,6.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.22,0.17,0.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.96,9.63,26.54
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,16.38,9.17,25.84
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.58,0.46,0.7
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.26,15.48,42.66
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,26.33,14.74,41.54
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.93,0.74,1.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.77,7.92,23.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,13.96,7.27,22.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.81,0.65,1.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.78,22.59,62.25
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,38.42,21.51,60.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.36,1.09,1.64
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.35,36.43,98.39
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,61.48,34.94,96.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.87,1.49,2.24
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.03,0.02,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,76.31,47.88,113.53
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,74.35,46.26,111.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,1.97,1.62,2.35
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.1,32.63,76.82
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,49.1,30.13,73.31
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.99,2.5,3.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,63.72,39.66,92.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,60.55,37.1,88.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.16,2.56,3.75
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,48.72,30.11,71.58
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,45.52,27.42,67.9
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.2,2.69,3.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,37.6,24.29,55.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,33.62,20.89,50.44
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.98,3.39,4.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.67,18.45,45.58
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,27.02,16.23,42.42
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.64,2.22,3.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,29.48,17.43,43.33
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,23.04,11.99,35.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,6.43,5.45,7.55
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.16,0.14,0.19
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.74,15.01,36.57
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,18.84,9.98,29.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,5.9,5.03,6.85
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.18,0.16,0.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,25.16,16.03,36.66
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,18.6,10.41,29.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,6.56,5.62,7.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.14,0.12,0.16
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.1,10.66,27.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,13.68,6.88,22.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.42,3.78,5.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.1,0.08,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,7.55,19.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.23,5.41,16.69
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.49,2.13,2.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.08,6.56,17.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.4,5.13,15.24
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.68,1.43,1.97
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.73,5.15,13.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.22,4.72,13.16
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.52,0.43,0.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.39,4.56,10.81
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,6.57,3.85,9.85
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.71,0.96
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,6.66,4.03,9.99
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.04,3.51,9.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.62,0.52,0.73
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.23,3.67,9.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,5.8,3.33,9.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.42,0.35,0.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.31,3.12,8.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,4.95,2.84,7.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.36,0.27,0.44
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,29.28,17.86,43.82
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.09,16.04,41.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.18,1.83,2.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.01,18.95,46.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,28.59,16.92,43.53
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.42,2.03,2.83
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.09,0.0,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.09,0.0,0.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.08,3.09,10.21
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.8,2.92,9.86
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.28,0.17,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.02,14.9,42.92
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.57,14.59,42.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.46,0.32,0.57
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.0,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.28,0.0,0.34
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,43.3,23.88,68.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,42.57,23.38,67.87
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.73,0.51,0.91
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.59,11.63,38.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,21.8,10.99,37.08
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.79,0.64,0.96
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.86,34.74,99.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,61.92,34.0,98.72
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.94,0.73,1.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,100.37,56.27,157.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,99.3,55.44,156.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.07,0.82,1.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,134.14,85.66,194.09
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,132.88,84.68,192.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.26,0.98,1.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.84,62.45,146.56
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,97.31,61.21,144.68
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.53,1.24,1.88
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,128.63,79.6,189.81
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,126.6,77.93,187.31
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,2.03,1.67,2.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,102.03,65.78,153.8
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,99.96,64.08,151.28
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,2.07,1.7,2.52
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.14,45.49,105.51
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.93,44.51,104.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.21,0.97,1.48
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.45,31.25,79.77
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,50.48,30.44,78.6
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.98,0.81,1.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.7,23.85,59.37
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,38.0,22.43,57.32
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.7,1.42,2.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.63,18.71,48.35
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,30.02,17.37,46.4
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.61,1.34,1.94
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.33,18.2,46.61
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,28.85,16.98,44.84
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.48,1.22,1.77
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.05,0.04,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.2,12.97,36.79
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.55,11.61,34.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.66,1.37,2.01
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,16.41,9.03,26.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.4,8.19,25.41
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.02,0.83,1.22
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.88,8.32,23.98
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.49,7.16,22.36
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.38,1.16,1.62
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.81,7.36,20.42
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,10.93,5.77,18.26
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.88,1.59,2.17
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,10.86,6.19,16.65
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.35,4.97,14.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.5,1.22,1.76
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.15,5.68,15.78
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,8.91,4.71,14.29
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.24,0.98,1.49
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.62,5.14,15.37
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.5,4.27,13.99
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.12,0.87,1.38
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.12,0.08,0.15
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.39,5.34,14.5
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.53,4.74,13.43
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.85,0.6,1.06
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,51.14,31.23,77.18
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,50.09,30.4,75.89
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.05,0.83,1.28
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,53.37,32.65,80.52
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.22,31.73,79.12
BRA,Brazil,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.15,0.92,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.65,2.99,4.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,3.61,2.97,4.39
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.22,5.98,8.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.99,5.87,8.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.6,9.61,14.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.18,0.67
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,11.23,9.42,13.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.18,0.15,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.73,11.24,16.83
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.07,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,13.56,11.16,16.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.23,0.19,0.27
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.93,14.02,20.53
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.54,0.27,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,16.39,13.75,19.56
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.27,0.23,0.32
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.98,16.67,24.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.9,0.45,1.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,19.09,16.22,22.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.26,0.22,0.31
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,19.08,15.37,23.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.87,0.82,3.33
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,17.2,14.55,20.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.2,0.17,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.39,11.17,18.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.98,1.48,5.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.41,9.7,13.37
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.16,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.16,9.12,15.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.69,1.27,4.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.48,7.85,11.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.14,10.78,18.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.49,1.68,5.77
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,10.65,9.09,12.42
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.22,0.19,0.25
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.83,11.54,18.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.76,1.9,6.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,11.07,9.63,12.79
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.18,0.15,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.29,8.7,15.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.19,1.78,5.43
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,8.1,6.91,9.7
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.26,0.23,0.3
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,10.24,16.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.21,1.06,3.89
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,10.51,9.17,12.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,8.34,6.78,10.36
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.25,0.63,2.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,7.09,6.14,8.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.17,0.14,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.98,5.7,8.58
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.55,1.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,6.0,5.15,7.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.13,0.11,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.2,3.51,5.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.52
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,3.88,3.34,4.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.1,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.86,2.36,3.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.46
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.57,2.2,2.99
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.76,2.64
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.87,1.6,2.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.88,1.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.86,0.72,1.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.09,0.08,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.74,1.45,2.12
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.49,1.3,1.73
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.29,0.25,0.35
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.56,2.92,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.29,2.76,3.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.41,0.34,0.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,4.6,6.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,5.34,4.43,6.36
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.7,0.58,0.83
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,4.41,6.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.31,0.19,0.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.13,4.21,6.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.15,0.13,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.29,7.41,11.63
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.33,0.66,2.25
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,7.96,6.75,9.38
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.16,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.75,7.76,12.22
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.45,0.72,2.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,8.3,7.04,9.77
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.0,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.46,0.0,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.02,0.01,0.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.62,1.04,2.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.59,1.03,1.98
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.09,3.1,5.04
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.37
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,3.89,3.01,4.67
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.02,0.0,0.02
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.36,0.0,1.93
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,1.36,0.0,1.92
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.09,0.07,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.55,4.97,8.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.15,0.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,6.23,4.82,7.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.8,3.91,5.88
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.14,0.05,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.66,3.86,5.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.91,7.23,10.87
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.22,0.86
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,8.44,7.01,10.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.17,0.14,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.77,10.35,15.55
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.77,0.37,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,12.0,9.97,14.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.12,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,9.49,7.09,12.49
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.66,0.63,3.23
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,7.83,6.46,9.26
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.82,6.37,11.94
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.65,1.2,4.78
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,6.17,5.17,7.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.11,0.1,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.34,6.89,12.51
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.45,1.13,4.55
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,6.89,5.76,7.96
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.24,5.8,11.3
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,1.45,5.28
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,5.21,4.35,6.03
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.13,0.11,0.15
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.04,7.16,13.61
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.27,1.39,5.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,6.78,5.77,7.79
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.08,0.07,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.72,4.73,9.54
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.88,1.43,5.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.85,3.3,4.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.49,3.0,6.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.08,0.94,4.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.41,2.06,2.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.06,0.05,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.23,2.29,4.53
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.2,0.58,2.19
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.03,1.72,2.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.28,2.46,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.53,1.63
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.3,1.93,2.66
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.04,0.03,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.58,1.2,2.01
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.34,0.17,0.56
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.24,1.03,1.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,1.31,2.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.5
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.37,1.14,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,1.23,1.95
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.3,0.17,0.47
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.27,1.06,1.48
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,1.12,1.76
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.14,0.96,1.32
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.88,1.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.4
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.86,0.72,1.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.18,0.13,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.06,1.55,2.54
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.18,0.45
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.76,1.37,2.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.14,0.11,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,1.63,2.6
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.28,0.17,0.43
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.85,1.47,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.49,0.36,0.59
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.91,2.86,4.86
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.38,0.23,0.57
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,3.54,2.63,4.29
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.08,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,5.28,3.87,6.97
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.19,0.55,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.09,3.32,4.82
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,5.48,4.02,7.26
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,1.3,0.6,2.34
BRA,Brazil,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,4.18,3.42,4.91
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.6,1.27,2.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.56,1.25,1.94
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.68,3.81,5.75
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,4.45,3.69,5.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.1,0.08,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.52,6.12,9.25
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.18,0.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,7.15,5.93,8.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.08,0.06,0.1
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.04,4.78,7.65
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.07,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,5.87,4.71,7.3
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.15,0.12,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.98,8.93,13.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.55,0.27,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,10.43,8.66,12.53
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.21,0.18,0.25
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.63,12.83,19.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.9,0.45,1.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,14.73,12.38,17.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.22,0.19,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.28,12.95,20.54
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.87,0.85,3.4
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,14.4,12.1,17.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.2,0.17,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.16,10.86,18.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.01,1.5,5.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.15,9.36,13.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.16,0.13,0.19
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.48,9.23,16.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.7,1.31,4.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.78,7.92,11.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.19,0.16,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.03,10.74,18.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.52,1.86,5.74
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,10.51,8.88,12.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.25,0.21,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.29,12.61,21.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.83,1.9,6.43
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,12.46,10.72,14.79
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.18,0.15,0.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.41,8.5,15.58
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.21,1.64,5.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,8.21,6.86,10.03
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.29,0.25,0.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,13.96,11.13,17.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.2,1.03,3.8
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,11.76,10.09,13.86
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.24,0.21,0.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,8.32,12.78
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.24,0.62,2.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.03,7.7,10.67
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.27,0.23,0.32
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,10.6,8.68,13.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.55,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,9.62,8.13,11.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,4.27,6.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.32,0.17,0.52
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.79,4.1,5.59
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.09,0.08,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,2.25,3.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.29,0.16,0.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.47,2.08,2.93
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,1.71,2.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.85,1.55,2.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.04,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.95,1.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.96,0.79,1.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.18,0.16,0.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.37,2.83,4.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.1,2.67,3.66
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.32,0.26,0.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.86,3.15,4.69
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.27,0.17,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.58,2.99,4.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.2,0.16,0.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.84,2.26,3.55
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.41
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,2.57,2.1,3.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.9,0.73,1.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.86,5.5,8.32
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.32,0.2,0.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,6.54,5.3,7.84
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.14,0.12,0.17
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.45,6.64,10.75
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.34,0.67,2.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,7.11,5.97,8.48
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.03,7.08,11.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.46,0.73,2.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,7.56,6.35,9.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.18,0.0,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.18,0.0,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.02,0.01,0.02
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.95,1.6
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.25,0.94,1.53
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.99,3.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.36
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,2.37,1.9,2.88
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.01,0.0,0.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.53,0.0,0.77
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.53,0.0,0.77
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.11,3.19,5.19
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.15,0.58
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,3.79,3.04,4.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.06,0.05,0.07
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.32,3.58,5.29
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.28
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.19,3.53,5.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.74,4.63,7.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.21,0.85
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,5.28,4.42,6.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.09,0.07,0.11
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.05,5.62,8.98
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.76,0.37,1.38
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,6.29,5.25,7.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.1,0.09,0.12
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,8.49,6.35,11.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.67,0.67,3.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,6.82,5.67,8.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.11,0.1,0.14
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.1,6.63,12.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.65,1.21,4.57
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,6.44,5.42,7.63
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.12,0.11,0.15
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.91,7.47,13.01
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.42,1.09,4.13
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,7.48,6.38,8.87
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.15,0.13,0.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.61,8.61,15.22
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.04,1.43,5.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.57,7.18,10.18
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.11,0.09,0.13
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.72,6.05,12.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.26,1.46,5.61
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,5.46,4.59,6.46
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.27,4.25,8.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.9,1.43,4.99
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.37,2.83,3.98
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,3.6,7.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.08,0.93,3.95
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,3.1,2.67,3.54
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,2.77,5.16
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.19,0.57,2.16
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.58,2.2,3.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.32,2.51,4.35
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,0.98,0.54,1.62
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.34,1.97,2.73
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.07,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.58,2.04,3.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.34,0.17,0.57
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,2.24,1.87,2.64
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,1.17,1.89
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.31,0.17,0.49
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.19,1.0,1.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.43,1.12,1.79
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.3,0.17,0.47
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.14,0.96,1.33
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,1.06,1.67
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.28,0.16,0.43
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.07,0.9,1.24
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.05,0.04,0.06
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.84,1.37
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.39
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.83,0.68,0.97
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.17,0.13,0.2
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.62,2.65
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.44
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.86,1.44,2.21
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.22,0.17,0.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.11,2.4,3.76
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.27,0.17,0.42
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.84,2.23,3.34
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.37,0.27,0.45
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.08,2.21,3.86
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.36,0.22,0.56
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.71,1.99,3.3
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.07,0.06,0.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.86,3.6,6.45
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.19,0.55,2.08
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,3.67,3.05,4.37
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.08,0.06,0.09
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,5.14,3.8,6.82
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,1.3,0.6,2.26
BRA,Brazil,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,3.84,3.19,4.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.39,0.8,7.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.99,0.6,6.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.4,0.2,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.2,6.5,27.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,14.4,6.03,26.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.8,0.47,1.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.33,10.41,44.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.06,9.66,42.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.28,0.75,2.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.05,3.09,27.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,11.5,2.32,24.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.54,0.77,2.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.2,15.05,64.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,33.35,13.97,61.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.85,1.08,2.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.27,25.35,97.2
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,52.16,24.0,94.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.11,1.35,3.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.59,22.86,96.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,51.32,21.62,92.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.27,1.25,3.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,26.76,9.56,51.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,23.84,7.91,46.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.92,1.65,4.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.91,11.55,58.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,27.52,9.01,51.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,4.4,2.54,7.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,18.78,5.77,38.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.7,4.62,35.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.08,1.16,3.35
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.53,2.65,29.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.19,0.76,24.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.34,1.89,5.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.05,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.31,1.8,21.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.91,0.42,16.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.4,1.38,4.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,6.96,3.65,12.31
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.48,2.78,10.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,1.47,0.87,2.27
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.7,2.98,10.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.27,2.14,7.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.43,0.84,2.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.11,3.2,10.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.05,2.01,7.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.07,1.18,3.27
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.62,1.86,6.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.97,1.47,5.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.65,0.39,1.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,2.35,7.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.21,1.1,4.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,1.95,1.25,2.97
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,1.71,5.29
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.97,1.0,3.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.12,0.72,1.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.86,2.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.65,0.86,2.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,1.13,3.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.21,0.6,2.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.85,0.52,1.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.19,1.12,3.75
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.6,0.76,2.83
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.59,0.35,0.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.61,0.76,2.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.15,0.51,2.18
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.47,0.26,0.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.02,1.48,5.16
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.72,1.31,4.68
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.31,0.18,0.49
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.05,6.26,30.19
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,14.44,5.34,27.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.61,0.92,2.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.53,6.48,31.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,14.8,5.49,28.29
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.73,0.99,2.78
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.45,1.16,7.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.37,0.48,5.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.08,0.68,1.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,4.73,22.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,11.05,3.84,20.83
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.39,0.88,2.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.9,7.56,36.62
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,17.68,6.15,33.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.22,1.41,3.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.03,0.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.22,4.45,27.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,9.08,1.85,21.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.14,2.6,6.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,28.7,10.9,52.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,25.49,8.87,48.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.21,2.04,4.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,41.94,16.42,74.61
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.52,14.87,71.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.41,1.56,3.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.4,15.21,69.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,38.14,14.43,67.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.26,0.78,1.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.13,5.77,32.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,16.38,5.29,31.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.75,0.47,1.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,18.63,6.04,35.24
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,17.66,5.42,33.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.98,0.63,1.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.63,2.41,24.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.15,2.09,24.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.49,0.32,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.13,0.68,18.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.66,0.38,17.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.48,0.3,0.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,2.74,9.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.93,2.47,8.59
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.43,0.26,0.64
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.84,1.87,6.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.18,1.43,5.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.67,0.44,0.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,1.7,6.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.53,1.18,4.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.81,0.52,1.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.03,2.17,7.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.36,1.12,4.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,1.67,1.05,2.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.96,3.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.95,0.96,3.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.34,4.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.58,0.78,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.87,0.56,1.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.03,1.11,3.47
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.42,0.72,2.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.61,0.4,0.89
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.48,0.82,2.58
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.22,0.63,2.19
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.27,0.19,0.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.04,0.55,1.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.88,0.44,1.62
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.15,0.1,0.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.52,1.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.0,0.48,1.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.32,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.72,0.32,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.66,2.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.36,0.65,2.43
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.26,4.08,21.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.3,3.47,19.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.96,0.61,1.43
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.09,4.05,20.91
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,10.18,3.47,19.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.91,0.58,1.36
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,0.41,6.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.0,0.41,6.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.62,6.15,30.41
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,15.02,5.77,29.54
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.6,0.38,0.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.9,9.8,48.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,23.94,9.19,47.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.96,0.61,1.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.62,1.58,26.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,11.62,1.58,26.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.4,14.33,70.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,35.0,13.44,68.82
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.4,0.89,2.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,57.81,25.35,109.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,55.19,23.69,105.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.61,1.66,3.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,58.54,25.46,100.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,54.03,23.05,92.78
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,4.52,2.4,7.67
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.37,11.46,56.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,24.9,8.97,48.74
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.47,2.49,7.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.24,14.13,66.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,29.3,11.29,58.8
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,4.95,2.85,8.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,19.9,6.73,43.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.78,5.0,38.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.12,1.74,4.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.08,0.04,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,14.65,4.09,30.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.61,1.85,23.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,4.03,2.23,6.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.13,0.07,0.21
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.15,3.79,28.49
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.36,0.5,18.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,5.79,3.28,9.69
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.16,0.09,0.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,12.18,6.56,20.99
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.55,2.73,10.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,6.63,3.82,10.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.2,0.11,0.32
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,11.46,6.23,19.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.29,2.13,8.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,7.17,4.1,11.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.28,0.16,0.44
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.92,7.58,23.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.07,2.03,7.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,9.85,5.55,15.66
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.15,0.09,0.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.73,4.27,13.16
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.95,1.48,5.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.78,2.79,7.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.08,0.05,0.12
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.3,2.39,7.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.19,1.05,4.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,2.11,1.34,3.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.76,2.16,6.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.95,0.98,3.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,1.81,1.18,2.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.07,0.05,0.09
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.86,4.88
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.63,0.88,2.95
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,1.41,0.98,1.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.19,0.12,0.28
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,4.44,2.58,7.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.2,0.6,2.18
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.24,1.99,4.85
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.59,1.96,5.92
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.59,0.77,2.86
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,2.0,1.19,3.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.08,0.04,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.14,1.03,3.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.14,0.51,2.15
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.99,0.52,1.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.91,6.36
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.74,1.33,4.75
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,1.0,0.57,1.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,18.04,7.32,34.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,15.11,5.64,29.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.93,1.67,4.7
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.75,7.72,35.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,15.38,5.78,30.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.38,1.93,5.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.72,0.43,5.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.47,0.28,5.57
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.53,4.76,24.51
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,11.84,4.31,23.48
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.7,0.45,1.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.95,7.58,39.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,18.84,6.87,37.38
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.11,0.71,1.65
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,1.68,22.98
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,9.55,1.08,21.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.96,0.6,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.09,11.06,56.91
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,27.48,10.02,54.51
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.62,1.04,2.4
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.99,19.08,85.94
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,42.81,17.67,82.73
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.18,1.41,3.22
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,41.0,16.7,76.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,41.0,16.7,76.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.12,5.95,35.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,17.43,5.52,34.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.69,0.43,1.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,20.16,5.68,41.69
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,19.19,5.07,40.24
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.96,0.61,1.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.21,1.61,24.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.73,1.29,24.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.48,0.32,0.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.76,0.92,17.46
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.82,0.33,16.07
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.95,0.59,1.4
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.2,3.27,10.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.03,2.56,8.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.17,0.71,1.76
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.57,1.69,6.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.26,1.5,6.35
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.31,0.2,0.45
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.94,1.46,5.56
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.58,1.23,5.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.36,0.23,0.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.73,1.36,5.3
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.41,1.15,4.81
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.33,0.21,0.5
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,1.31,4.34
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.96,1.01,3.63
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.47,0.3,0.71
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,0.79,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.57,0.79,2.87
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.8,2.72
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.41,0.72,2.55
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.47,0.81,2.53
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.21,0.63,2.14
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.26,0.18,0.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.63,2.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.88,0.45,1.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.28,0.18,0.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.59,2.06
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.99,0.47,1.79
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.18,0.11,0.26
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.34,1.47
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.72,0.3,1.39
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.05,0.04,0.08
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.74,2.6
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.37,0.65,2.37
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.15,0.09,0.23
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.58,4.1,22.77
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,11.02,3.74,21.93
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.56,0.36,0.84
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.34,4.05,22.25
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,10.78,3.7,21.42
CHL,Chile,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.56,0.35,0.83
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.28,5.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.06,1.28,5.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,16.15,40.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.66,16.15,40.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.98,25.1,63.29
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,40.98,25.1,63.29
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,3.79,16.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,9.03,3.79,16.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.62,40.2,101.36
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,65.62,40.2,101.36
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,93.8,58.44,138.87
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,93.8,58.44,138.87
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.88,56.45,139.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,90.88,56.45,139.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,88.37,54.73,139.6
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,88.37,54.73,139.6
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.44,30.39,82.17
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,53.44,30.39,82.17
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.43,15.47,47.02
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,29.43,15.47,47.02
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.49,19.26,55.19
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,34.49,19.26,55.19
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.49,11.32,38.98
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,23.49,11.32,38.98
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.85,7.16,27.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.85,7.16,27.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.72,5.32,22.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.72,5.32,22.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,9.94,4.99,18.42
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.94,4.99,18.42
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.51,3.43,13.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.51,3.43,13.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.29,2.56,13.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.29,2.56,13.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.46,7.94
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.65,2.46,7.94
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.98,1.35,5.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.98,1.35,5.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.15,4.64
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.56,1.15,4.64
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.0,0.88,3.55
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.0,0.88,3.55
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.37,0.51,2.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.37,0.51,2.54
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.41,2.03
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.07,0.41,2.03
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.34,2.04
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.99,0.34,2.04
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.31,1.2
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.65,0.31,1.2
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,27.6,15.8,43.48
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.6,15.8,43.48
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.33,14.92,41.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,26.33,14.92,41.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.6,3.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.72,0.6,3.49
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.41,8.81,22.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,14.41,8.81,22.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.31,12.01,31.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,20.31,12.01,31.44
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,1.76,10.31
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,5.1,1.76,10.31
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.48,19.21,50.28
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,32.48,19.21,50.28
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.4,32.11,74.68
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,50.4,32.11,74.68
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.59,26.93,67.96
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,44.59,26.93,67.96
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.63,22.5,62.22
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.63,22.5,62.22
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.25,10.73,35.33
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,21.25,10.73,35.33
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.21,5.14,19.8
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.21,5.14,19.8
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.76,5.97,22.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,12.76,5.97,22.72
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.51,3.25,16.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.51,3.25,16.05
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.45,2.03,12.9
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.45,2.03,12.9
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.87,2.54,8.39
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.87,2.54,8.39
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.66,1.9,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.66,1.9,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.34,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.71,1.34,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.27,4.43
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.6,1.27,4.43
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.75,3.1
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.67,0.75,3.1
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.36,2.24
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.09,0.36,2.24
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.91,0.34,1.81
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.91,0.34,1.81
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.68,0.32,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.68,0.32,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.88
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.88
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.13,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.32,0.13,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.3,0.12,0.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.3,0.12,0.58
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.38,6.75,20.12
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.38,6.75,20.12
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.15,5.98,18.3
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,11.15,5.98,18.3
CHL,Chile,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.14,1.22,5.96
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.14,1.22,5.96
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.98,16.1,42.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.98,16.1,42.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.87,24.32,63.62
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,40.87,24.32,63.62
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,3.52,17.15
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,9.03,3.52,17.15
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.14,38.77,101.39
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,65.14,38.77,101.39
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,95.38,58.79,146.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,95.38,58.79,146.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.04,55.04,140.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,91.04,55.04,140.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,87.29,51.81,134.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,87.29,51.81,134.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.87,31.69,85.91
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,53.87,31.69,85.91
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.15,16.41,47.5
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,29.15,16.41,47.5
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.03,19.91,56.12
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,34.03,19.91,56.12
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.09,12.65,37.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,23.09,12.65,37.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.57,8.22,27.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,16.57,8.22,27.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.34,5.86,21.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.34,5.86,21.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.11,4.11,19.07
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,10.11,4.11,19.07
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.53,3.12,13.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.53,3.12,13.94
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.21,2.53,13.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.21,2.53,13.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.65,2.54,7.93
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.65,2.54,7.93
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.01,1.31,5.32
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.01,1.31,5.32
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.56,1.08,4.59
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.56,1.08,4.59
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.77,3.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.97,0.77,3.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.5,2.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.35,0.5,2.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.4,2.01
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.06,0.4,2.01
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.34,1.92
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.99,0.34,1.92
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.31,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.65,0.31,1.26
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,27.58,15.86,44.06
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,27.58,15.86,44.06
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,25.99,14.83,41.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,25.99,14.83,41.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.5,3.35
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.72,0.5,3.35
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,7.94,22.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,14.28,7.94,22.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.09,11.49,31.53
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,20.09,11.49,31.53
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.95,1.45,9.65
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.95,1.45,9.65
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.98,18.3,50.2
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,31.98,18.3,50.2
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.29,29.26,77.33
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,50.29,29.26,77.33
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.36,26.02,68.79
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,44.36,26.02,68.79
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.28,23.25,61.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,39.28,23.25,61.48
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.18,10.89,34.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,21.18,10.89,34.55
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.09,5.26,19.34
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.09,5.26,19.34
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.67,6.22,21.67
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,12.67,6.22,21.67
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.51,3.37,16.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.51,3.37,16.52
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.14,2.22,11.99
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.14,2.22,11.99
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.86,2.48,8.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.86,2.48,8.71
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.7,1.86,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.7,1.86,6.25
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.3,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.71,1.3,4.7
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.27,4.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,2.59,1.27,4.46
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.66,3.11
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.65,0.66,3.11
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.39,2.1
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.06,0.39,2.1
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.36,1.74
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.9,0.36,1.74
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.69,0.32,1.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.69,0.32,1.28
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.86
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.86
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.14,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.32,0.14,0.63
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.13,0.61
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.31,0.13,0.61
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.37
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.3,6.59,20.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.3,6.59,20.08
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.92,5.79,17.98
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,10.92,5.79,17.98
CHL,Chile,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.95,0.5,1.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.95,0.5,1.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,27.19,13.38,47.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.78,13.18,46.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.4,0.21,0.69
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.15,23.61,78.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,45.11,22.97,76.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.04,0.64,1.6
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.81,1.46,4.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.81,1.46,4.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,73.9,37.81,125.68
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,72.23,36.78,123.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.67,1.03,2.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,101.8,50.04,176.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.26,49.24,173.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.54,0.8,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.63,54.04,179.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,103.22,52.55,175.91
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.42,1.49,3.71
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,108.93,57.49,182.72
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,105.77,55.4,178.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.17,2.08,4.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,82.22,43.85,137.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,79.06,42.11,132.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,3.16,1.74,5.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.09,0.05,0.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,60.1,29.97,103.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,55.19,27.05,96.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.91,2.92,7.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,70.9,35.72,121.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,62.46,30.54,108.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,8.44,5.18,12.96
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,53.5,26.08,95.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.34,24.19,90.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.16,1.89,4.91
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.1,0.06,0.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,46.9,22.11,84.18
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.64,18.99,76.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,5.26,3.11,8.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.1,0.06,0.15
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.04,17.96,68.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,35.7,15.38,61.59
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.34,2.58,6.87
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,32.29,14.3,59.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,29.78,12.71,55.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.51,1.59,3.68
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.52,12.18,50.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,24.98,10.59,46.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.54,1.58,3.83
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.06,0.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,28.04,12.76,50.14
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.28,10.44,44.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.76,2.31,5.82
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.83,8.81,39.82
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.67,8.08,38.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,1.16,0.73,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.14,0.09,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.41,8.44,38.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,16.69,6.03,32.5
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.71,2.42,5.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.08,0.05,0.12
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.88,7.03,33.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,15.74,5.64,29.96
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,2.14,1.39,3.2
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,5.12,26.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,14.44,5.12,26.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.12,0.07,0.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.11,5.58,29.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,13.14,4.3,26.15
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.96,1.28,2.94
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.13,0.08,0.2
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,14.02,4.9,27.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,12.32,3.82,24.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,1.7,1.07,2.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.14,0.08,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,14.08,4.8,27.23
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,12.28,3.72,24.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.81,1.08,2.81
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,12.16,3.88,23.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,11.0,3.16,21.81
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,1.16,0.72,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,44.2,21.88,76.49
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.57,20.29,72.44
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.63,1.59,4.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.06,0.04,0.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,44.83,22.06,77.79
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,41.95,20.32,73.36
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,2.88,1.74,4.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.5,0.24,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.5,0.24,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,6.23,28.26
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.77,5.74,27.37
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.67,0.49,0.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.75,10.24,44.45
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,22.77,9.56,43.07
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.98,0.67,1.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,0.7,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.49,0.7,2.63
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.98,16.38,71.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,36.41,15.3,68.89
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.57,1.08,2.21
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,53.96,23.22,105.86
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,51.4,21.35,102.47
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,2.56,1.86,3.39
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.12,23.31,101.38
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,51.86,21.76,98.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.26,1.55,3.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,54.26,23.39,97.55
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,52.25,22.1,94.54
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.01,1.29,3.01
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,18.34,72.92
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,38.32,17.67,71.22
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.11,0.68,1.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,27.26,11.26,50.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,26.16,10.55,48.99
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.1,0.71,1.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.33,12.73,55.62
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,29.62,11.63,53.06
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.71,1.1,2.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,24.43,9.74,46.56
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,23.5,9.07,45.31
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.93,0.67,1.25
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,20.68,7.54,39.76
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,19.78,6.98,38.45
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.9,0.56,1.32
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.25,6.24,32.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.52,5.79,31.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.73,0.46,1.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,14.77,4.51,28.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,13.93,3.96,27.34
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.85,0.56,1.26
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.99,3.99,25.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,11.99,3.35,24.18
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.0,0.64,1.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.71,4.57,27.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.65,3.28,23.87
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.05,1.29,3.13
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,9.99,2.68,20.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.99,2.68,20.65
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,11.01,3.44,24.24
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.01,2.11,21.25
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,2.01,1.33,2.99
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.05,0.1
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.28,3.12,22.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.62,2.01,19.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.66,1.11,2.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.06,0.04,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.33,2.72,19.19
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.11,1.89,17.48
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.22,0.82,1.7
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.6,1.27,16.16
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.22,1.03,15.61
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.38,0.25,0.55
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,7.05,1.22,15.17
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,6.77,1.05,14.75
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.28,0.18,0.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.79,1.18,14.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.79,1.18,14.58
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.63,1.2,14.52
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.21,0.95,13.88
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.41,0.25,0.64
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,21.35,8.69,40.28
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,20.35,8.02,38.83
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.0,0.66,1.46
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,21.11,8.43,39.95
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,20.08,7.74,38.43
CHL,Chile,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.04,0.68,1.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.48,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.97,0.48,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,12.07,48.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,26.66,12.07,48.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.73,22.5,79.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,44.86,21.93,78.11
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.87,0.57,1.27
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.38,4.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.79,1.38,4.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,72.89,35.86,126.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,71.49,34.96,124.49
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.39,0.91,2.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,100.36,45.33,183.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,100.36,45.33,183.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,105.25,51.79,182.65
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,103.22,50.46,179.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.03,1.33,2.96
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.48,57.37,181.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,105.69,54.9,176.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.79,2.47,5.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.09,0.05,0.15
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,85.25,42.38,144.11
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,79.16,39.04,134.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,6.09,3.34,10.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.13,0.08,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,62.08,29.79,105.71
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,54.89,25.57,94.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,7.19,4.21,11.4
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.15,0.09,0.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,71.13,33.83,123.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,61.91,28.25,108.45
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.22,5.58,14.55
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.08,0.05,0.13
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,54.6,26.24,90.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,50.02,23.45,82.93
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,4.58,2.79,7.13
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.07,0.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,48.12,22.98,80.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.99,19.36,70.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.13,3.62,9.5
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.22,0.13,0.35
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,45.1,20.23,80.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,35.0,14.4,64.72
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,10.1,5.83,15.91
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.27,0.17,0.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.59,18.74,67.17
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,28.78,11.92,51.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,10.82,6.83,16.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.34,0.21,0.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,36.55,17.55,63.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,24.36,9.97,44.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,12.19,7.57,18.43
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.48,0.3,0.74
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,40.19,19.74,69.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,22.94,9.15,43.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,17.25,10.59,26.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.26,0.16,0.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.52,13.52,50.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,20.43,8.47,38.14
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,8.1,5.05,12.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.15,0.1,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.7,7.93,37.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,16.83,5.42,32.12
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,3.87,2.51,5.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,19.86,7.91,35.99
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,16.11,5.46,30.39
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,3.76,2.44,5.6
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.17,0.11,0.25
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,18.76,7.88,33.43
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.15,5.52,28.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,3.61,2.36,5.33
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.41,0.27,0.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,20.14,8.49,37.38
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.97,3.87,26.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,7.17,4.62,10.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.4,0.25,0.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.5,6.99,33.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,12.29,3.71,25.23
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,5.21,3.27,7.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.28,0.17,0.44
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.01,5.64,31.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,12.35,3.47,25.93
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.67,2.16,5.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.49,0.3,0.75
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.68,5.92,27.66
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,11.09,3.7,22.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,3.6,2.22,5.44
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.12,0.07,0.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,46.28,22.25,79.83
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,41.42,19.3,72.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.86,2.95,7.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,47.23,22.66,81.36
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,41.56,19.22,72.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,5.67,3.44,8.75
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.21,0.95
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.49,0.21,0.95
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.25,4.93,25.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.1,4.82,25.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.28,9.44,42.46
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,21.75,9.09,41.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.54,0.35,0.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.41,0.61,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.41,0.61,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.48,15.03,67.59
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,34.62,14.47,66.33
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.86,0.56,1.26
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,49.83,18.45,96.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,49.23,18.02,96.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.59,0.43,0.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,51.09,21.64,97.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,49.84,20.82,95.48
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.25,0.81,1.84
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,52.16,24.36,97.6
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,50.35,23.22,94.87
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.81,1.14,2.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,37.0,14.43,63.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,37.0,14.43,63.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,26.76,10.32,49.16
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,25.52,9.52,47.32
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.24,0.79,1.84
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,30.2,12.09,56.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,28.51,10.99,53.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.69,1.09,2.54
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,24.0,10.0,45.65
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,23.08,9.32,44.4
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.92,0.68,1.24
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,21.6,7.36,39.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,19.81,6.26,37.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.79,1.1,2.69
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.5,6.55,37.19
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.51,5.34,34.17
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.99,1.21,3.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,14.46,3.97,28.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,14.07,3.72,27.94
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.39,0.25,0.57
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.56,3.37,25.97
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,11.97,2.99,25.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.59,0.38,0.88
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,12.05,3.61,25.8
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.65,3.36,25.18
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.4,0.25,0.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,2.38,23.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,9.81,1.7,21.56
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,1.04,0.68,1.53
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.09,2.23,19.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.09,2.23,19.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.02,0.02,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.97,1.93,18.96
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,8.43,1.58,18.2
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.53,0.36,0.76
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.06,0.04,0.08
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.81,1.56,18.51
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,7.6,0.75,16.78
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.21,0.81,1.73
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.74,1.48,16.62
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,7.05,1.04,15.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.69,0.44,1.01
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.14,0.09,0.22
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,7.9,1.69,16.67
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,6.61,0.89,14.68
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.29,0.79,1.98
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.04,0.02,0.07
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,7.21,1.25,15.52
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,6.64,0.91,14.63
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.56,0.34,0.89
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.36,0.22,0.56
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.7,2.32,17.71
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.05,0.71,13.61
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,2.64,1.61,4.1
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,20.54,7.89,38.92
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,19.77,7.39,37.79
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.77,0.5,1.14
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,20.28,7.62,38.58
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,19.43,7.07,37.31
CHL,Chile,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.85,0.55,1.27
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.78,7.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,4.02,1.78,7.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.07,0.05,0.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,67.68,35.26,112.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,62.07,31.8,104.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,5.61,3.46,8.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.16,0.1,0.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,139.2,74.77,230.93
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,127.86,67.47,214.02
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,11.33,7.29,16.91
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,11.84,5.25,21.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,11.84,5.25,21.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.25,0.16,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,222.91,119.73,369.81
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,204.76,108.05,342.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,18.15,11.68,27.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.29,0.18,0.44
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,248.76,130.5,413.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,227.2,117.18,379.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,21.57,13.32,33.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.36,0.23,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,317.12,170.84,525.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,290.87,153.94,486.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,26.25,16.9,39.17
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.43,0.28,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,375.99,205.58,621.98
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,345.71,185.6,577.83
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,30.28,19.98,44.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.5,0.32,0.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,335.39,179.84,544.92
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,302.95,159.1,496.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,32.44,20.74,48.19
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.64,0.42,0.94
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,220.21,112.26,366.04
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,184.45,88.89,313.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,35.76,23.38,52.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.88,0.57,1.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,267.66,140.39,438.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,214.84,106.15,361.27
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,52.83,34.24,77.1
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.44,0.3,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,182.28,92.47,310.6
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,158.02,76.02,275.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,24.25,16.45,34.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.76,0.5,1.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,156.69,72.67,269.85
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,118.51,47.46,213.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,38.18,25.22,55.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.64,0.42,0.94
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,125.27,55.86,213.76
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,96.03,36.74,171.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,29.24,19.12,42.76
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.34,0.23,0.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,92.91,42.01,166.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,79.26,32.59,147.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,13.66,9.42,19.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.37,0.25,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,77.64,34.3,140.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,63.96,25.03,120.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,13.68,9.26,19.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.55,0.37,0.8
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,81.63,36.73,143.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,61.82,23.52,115.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,19.82,13.21,28.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.21,0.15,0.31
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,53.53,21.64,102.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,46.9,17.14,93.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,6.63,4.5,9.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.79,0.56,1.09
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,57.41,26.34,101.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,36.65,11.69,73.46
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,20.76,14.65,28.53
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.46,0.32,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,45.65,18.92,83.6
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,33.7,10.48,67.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,11.95,8.43,16.42
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.69,8.86,58.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,29.69,8.86,58.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.56,0.39,0.79
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,35.6,14.33,65.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,25.93,7.66,51.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.67,6.67,13.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,0.78,0.53,1.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,34.09,14.0,62.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,24.44,7.47,49.18
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,9.65,6.53,13.64
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.87,0.58,1.26
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,35.05,14.25,65.98
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,23.59,6.68,49.49
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,11.46,7.57,16.5
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,1.05,0.71,1.46
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,30.56,13.2,54.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,22.9,8.04,44.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,7.67,5.16,10.67
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.38,0.25,0.56
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,144.94,74.24,242.93
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,125.23,61.32,214.07
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,19.71,12.92,28.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.43,0.28,0.62
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,148.17,75.43,248.9
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,127.16,61.63,218.22
CHL,Chile,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,21.01,13.8,30.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.23,0.83,4.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.23,0.83,4.38
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.18,0.13,0.25
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,50.88,26.96,85.89
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,36.99,17.03,67.23
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,13.88,9.94,18.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.25,0.18,0.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,103.17,53.89,171.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,85.01,40.98,146.42
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,18.16,12.91,24.72
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.58,2.46,12.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.58,2.46,12.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.4,0.28,0.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,165.02,86.2,273.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,135.98,65.55,234.2
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,29.05,20.65,39.54
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.71,0.51,0.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,188.84,101.07,317.03
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,135.58,62.94,245.47
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,53.26,38.12,71.57
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.57,0.41,0.78
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,235.1,123.25,389.1
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,193.21,93.46,332.07
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,41.9,29.79,57.03
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.46,0.32,0.63
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,274.66,142.21,450.71
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,242.48,119.54,406.11
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,32.18,22.67,44.61
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.26,0.18,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,256.53,131.72,426.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,239.53,119.7,402.59
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,17.0,12.02,24.15
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.2,0.14,0.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,165.14,80.2,281.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,153.59,71.99,265.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.55,8.21,16.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.26,0.18,0.36
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,196.17,99.67,326.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,180.43,88.5,305.32
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,15.74,11.17,21.56
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.15,0.11,0.2
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,144.97,66.3,256.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,136.7,60.21,245.5
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.27,6.09,11.08
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.16,0.11,0.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,112.66,47.54,201.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,104.85,42.04,190.99
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,7.81,5.5,10.74
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.16,0.11,0.22
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,91.43,42.2,158.65
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.17,37.15,148.53
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,7.26,5.06,10.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.33,0.24,0.45
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,82.0,36.86,140.77
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.63,27.04,122.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,13.37,9.82,18.34
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.42,0.3,0.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,71.02,31.96,122.87
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.45,20.91,101.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,15.57,11.04,21.66
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.89,0.62,1.24
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,85.27,41.51,142.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.62,19.42,98.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,31.65,22.09,44.33
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.38,15.11,78.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.38,15.11,78.43
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.72,0.53,0.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,53.03,24.7,94.21
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.03,10.71,68.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,19.0,13.99,25.25
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.68,0.51,0.9
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,49.02,22.31,87.71
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.34,9.95,65.75
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.68,12.36,21.96
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.63,0.47,0.82
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,43.82,19.21,79.28
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,30.13,8.95,61.59
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.68,10.26,17.69
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.45,0.33,0.58
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,34.47,12.8,63.62
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.74,7.12,53.68
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,7.73,5.68,9.95
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.36,0.25,0.48
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,30.64,10.27,58.12
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,26.29,7.16,52.4
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,4.35,3.11,5.73
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,24.57,6.92,49.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.57,6.92,49.86
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.56,0.37,0.77
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,31.32,10.16,58.7
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,27.23,7.43,53.06
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,4.09,2.73,5.64
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.27,0.19,0.37
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,110.99,54.8,188.19
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,96.58,44.53,168.47
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,14.41,10.27,19.72
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.3,0.22,0.41
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,111.92,54.72,190.35
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,97.61,44.51,170.75
CHL,Chile,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,14.32,10.21,19.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.11,1.7,7.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,4.11,1.7,7.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,62.27,30.22,109.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,62.27,30.22,109.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.87,71.03,230.96
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,128.44,65.48,218.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.43,5.55,12.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,11.83,4.89,22.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,11.83,4.89,22.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.19,0.13,0.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.13,113.21,368.08
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,204.7,104.36,348.61
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,13.43,8.85,19.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,229.11,112.02,400.12
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,229.11,112.02,400.12
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.28,0.18,0.4
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,313.39,163.23,527.83
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,293.75,150.29,499.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,19.64,12.94,28.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.52,0.34,0.75
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,386.21,207.46,638.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,349.6,183.35,585.11
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,36.6,24.12,53.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.96,0.61,1.45
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,369.2,197.6,594.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,306.55,157.83,500.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,62.65,39.77,94.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.98,0.63,1.45
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,239.56,124.54,394.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,185.69,89.73,314.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,53.87,34.81,79.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.96,0.62,1.42
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,275.79,146.64,454.52
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,218.08,109.5,369.14
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,57.7,37.15,85.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.64,0.43,0.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,192.93,97.86,324.05
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,157.49,73.97,272.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,35.43,23.89,51.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.89,0.58,1.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,165.05,81.87,276.34
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,120.27,52.52,210.68
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,44.78,29.35,65.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.51,0.96,2.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,164.05,81.02,276.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,95.47,37.22,174.98
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,68.58,43.8,101.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,1.47,1.0,2.11
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,137.84,69.72,231.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,78.25,29.22,145.43
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,59.58,40.5,85.78
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,1.86,1.24,2.68
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,129.91,68.37,215.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,63.07,23.84,118.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,66.84,44.53,96.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,2.57,1.68,3.74
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,152.13,82.34,248.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,60.1,22.41,114.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,92.03,59.93,133.84
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,1.52,1.03,2.18
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,94.37,50.63,157.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,47.33,18.7,89.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,47.03,31.93,67.54
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.84,0.59,1.15
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,58.98,26.94,103.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,37.06,11.41,73.13
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,21.91,15.53,30.14
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.79,0.56,1.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,53.4,23.83,93.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,34.14,10.22,67.44
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,19.27,13.62,26.55
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.73,0.51,1.01
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.01,19.72,81.7
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,30.25,8.63,59.91
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,15.75,11.09,21.79
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,2.09,1.43,2.95
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,61.82,32.01,104.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,25.86,7.45,53.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,35.96,24.56,50.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,2.33,1.56,3.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,53.69,27.18,92.01
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,24.44,7.52,50.47
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,29.25,19.65,41.54
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,1.8,1.17,2.62
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,47.2,21.87,85.84
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,23.63,6.58,51.58
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,23.56,15.28,34.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,3.31,2.21,4.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,47.06,24.79,78.24
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,22.92,8.66,44.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,24.14,16.13,34.03
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.75,0.49,1.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,159.22,82.5,265.27
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,126.19,60.85,216.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,33.03,21.65,48.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.9,0.59,1.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,165.11,85.62,274.7
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,127.4,60.87,219.53
CHL,Chile,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,37.71,24.76,55.17
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.21,0.71,4.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.21,0.71,4.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.04,0.03,0.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,39.7,17.55,70.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,36.48,15.25,65.79
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,3.22,2.31,4.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.13,0.09,0.18
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,94.53,47.32,161.35
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,85.3,40.81,148.59
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.23,6.51,12.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.37,2.06,12.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.37,2.06,12.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.21,0.14,0.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.5,75.33,256.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,135.8,64.97,236.56
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,14.7,10.36,20.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.17,0.12,0.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,147.15,65.82,259.09
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,134.71,56.89,242.04
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.44,8.92,17.05
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.3,0.21,0.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,216.54,108.9,368.91
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,195.11,93.79,339.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,21.43,15.11,29.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.41,0.29,0.58
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,275.91,145.76,462.87
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,246.79,125.36,422.48
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,29.12,20.4,40.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,243.58,120.13,401.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,243.58,120.13,401.16
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.22,0.16,0.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,167.62,80.27,284.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,156.11,72.15,268.71
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.51,8.12,15.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.26,0.18,0.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,201.41,98.66,339.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,185.77,87.58,318.23
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,15.65,11.08,21.63
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.15,0.11,0.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,147.52,69.83,255.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,139.27,63.79,244.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,8.24,6.04,10.99
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.31,0.22,0.43
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,120.82,50.44,209.93
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,105.24,39.53,188.31
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,15.58,10.91,21.62
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.44,0.3,0.61
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,104.71,51.8,184.8
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.82,37.96,157.03
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,19.89,13.84,27.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,74.51,32.31,131.6
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.35,27.82,123.19
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.15,4.49,8.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.22,0.16,0.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.67,26.11,113.95
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,55.16,20.74,103.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,7.51,5.37,10.26
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.17,0.12,0.24
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,59.52,24.48,112.22
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,53.31,20.17,103.55
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,6.21,4.31,8.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.34,0.25,0.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,51.92,20.47,94.59
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,41.32,12.84,80.3
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,10.6,7.63,14.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,34.12,10.72,67.81
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,34.12,10.72,67.81
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.28,0.21,0.36
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,38.05,13.64,72.46
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,32.08,9.21,64.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,5.97,4.44,7.8
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.63,0.47,0.82
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,43.06,17.36,78.37
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,29.49,7.28,60.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.57,10.08,17.71
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.82,0.6,1.06
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.71,17.25,72.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,26.53,6.82,54.38
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,14.19,10.42,18.28
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,1.67,1.15,2.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,42.53,18.79,73.73
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,26.1,7.33,51.53
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,16.44,11.46,22.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.63,0.46,0.86
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,32.58,12.7,58.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,24.35,6.76,47.69
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,8.23,5.94,11.2
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,3.6,2.4,5.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,53.29,25.9,87.76
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,27.07,8.44,51.35
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,26.22,17.47,36.41
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.21,0.15,0.29
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,106.99,51.05,183.57
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,97.77,44.52,170.89
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,9.22,6.53,12.67
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.28,0.2,0.39
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,108.37,51.38,186.32
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,98.42,44.33,172.66
CHL,Chile,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,9.95,7.04,13.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.96,4.69,17.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.58,1.85,11.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.38,2.84,6.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.12,0.08,0.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.72,19.09,58.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.07,13.36,46.19
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.65,5.74,12.57
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.19,0.13,0.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,57.2,30.58,94.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,43.35,21.39,73.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,13.85,9.18,20.14
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.22,0.15,0.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,38.29,18.03,67.64
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.47,7.12,42.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,16.83,10.91,24.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.28,0.18,0.4
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,82.73,44.23,136.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,62.7,30.94,106.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,20.03,13.28,29.12
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.32,0.22,0.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,121.0,66.79,195.08
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,98.21,51.46,162.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,22.79,15.33,32.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.38,0.25,0.55
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,140.96,80.9,218.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.21,64.45,182.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,24.75,16.45,35.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.46,0.32,0.66
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,98.14,55.22,152.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,72.32,37.66,116.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,25.82,17.56,36.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.61,0.41,0.86
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,123.21,71.1,189.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,86.52,46.5,137.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,36.7,24.6,51.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.32,0.23,0.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,81.13,47.4,127.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,63.55,34.87,102.92
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.58,12.54,24.29
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.55,0.38,0.78
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,73.46,38.86,116.68
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,45.89,19.83,77.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,27.57,19.02,39.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.46,0.32,0.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,58.02,29.1,91.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,36.89,14.75,61.6
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,21.13,14.35,29.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.22,0.16,0.31
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,40.21,18.22,69.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,31.1,11.62,56.58
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,9.11,6.6,12.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.25,0.18,0.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.69,15.1,61.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.51,8.6,48.53
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.19,6.5,12.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.37,0.26,0.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.14,17.73,64.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.87,8.5,46.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,13.26,9.23,18.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.15,0.1,0.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.67,8.09,47.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.1,4.87,41.18
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,4.57,3.22,6.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.55,0.4,0.72
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,28.78,13.5,49.77
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.4,2.99,30.83
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,14.38,10.5,18.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.32,0.23,0.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,21.37,8.55,39.34
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.09,2.5,28.45
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,8.28,6.05,10.9
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.31,1.83,25.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.31,1.83,25.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.34,0.25,0.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.94,6.36,28.83
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.99,2.11,20.82
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.94,4.25,8.01
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.52,0.36,0.7
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,15.5,6.75,28.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.24,2.35,19.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,6.26,4.41,8.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.59,0.41,0.81
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.7,7.32,31.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.99,2.0,20.55
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,7.7,5.33,10.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.72,0.5,0.95
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.51,6.77,23.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.29,3.11,16.23
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,5.22,3.66,6.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.27,0.19,0.39
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.23,29.27,87.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,39.95,19.56,66.79
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,14.28,9.72,20.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.3,0.21,0.43
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,57.4,30.87,92.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.25,20.54,70.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,15.15,10.33,21.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.15,0.11,0.19
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.42,10.07,26.68
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.39,1.98,12.18
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,11.03,8.09,14.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.85,26.01,69.24
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,30.51,15.55,50.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,14.34,10.45,19.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.31,0.23,0.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,71.74,41.6,110.75
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,48.81,24.87,80.25
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,22.93,16.72,30.5
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.56,0.41,0.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,66.82,38.61,102.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.51,7.58,46.71
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,42.3,31.03,55.64
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.45,0.33,0.6
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,103.47,60.0,159.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,70.4,35.88,115.74
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,33.08,24.12,44.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.36,0.26,0.48
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.81,78.28,208.8
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.63,60.07,174.76
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,25.19,18.21,34.04
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.2,0.15,0.28
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,151.53,86.01,238.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,138.16,76.2,219.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,13.38,9.81,18.54
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.15,0.11,0.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,103.35,55.98,165.93
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,94.49,49.48,153.96
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.86,6.5,11.97
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.99,72.62,200.34
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,115.07,63.88,184.45
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.92,8.74,15.88
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.11,0.08,0.15
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,94.97,48.63,156.56
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,88.74,43.93,148.35
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,6.23,4.7,8.2
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.63,35.4,117.06
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,65.73,31.11,109.15
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,5.9,4.29,7.9
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.12,0.09,0.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,57.41,28.25,95.72
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,51.87,24.26,88.21
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,5.54,3.99,7.51
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.27,0.2,0.36
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,54.28,26.72,88.03
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,43.44,18.53,73.47
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,10.84,8.19,14.56
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.34,0.25,0.46
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,48.36,23.55,79.27
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.77,14.38,62.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,12.58,9.17,17.1
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.71,0.51,0.98
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,60.62,31.67,95.52
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.08,13.36,60.61
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,25.55,18.31,34.91
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.17,10.44,50.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.17,10.44,50.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.55,0.42,0.71
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,36.5,18.34,60.53
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.93,7.23,41.86
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,14.57,11.11,18.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.53,0.41,0.67
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,16.49,57.44
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,21.0,6.66,41.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,12.83,9.84,16.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.49,0.38,0.62
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.37,14.09,53.42
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,19.79,5.91,40.13
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,10.58,8.18,13.3
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.38,0.28,0.48
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,24.41,10.12,43.39
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,17.93,5.3,35.17
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,6.48,4.82,8.23
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.29,0.21,0.38
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,21.47,7.91,39.33
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.91,5.33,34.73
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,3.56,2.59,4.59
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,16.49,5.13,32.87
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,16.49,5.13,32.87
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.43,0.3,0.58
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,22.25,7.68,40.04
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.1,5.52,35.82
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,3.14,2.16,4.22
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.21,0.16,0.29
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,62.48,33.92,99.77
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,51.16,25.63,84.65
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.31,8.29,15.11
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.24,0.17,0.31
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,64.86,34.85,104.07
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,53.62,26.6,89.06
CHL,Chile,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,11.24,8.25,15.02
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.58,1.62,11.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.58,1.62,11.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.09,0.06,0.13
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.72,17.71,55.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.38,13.44,46.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.33,4.27,9.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.14,0.1,0.2
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,53.73,28.22,88.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,43.64,21.42,74.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,10.09,6.8,14.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.59,6.26,43.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,21.59,6.26,43.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.21,0.14,0.3
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.54,41.26,129.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,63.8,31.31,108.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,14.75,9.95,20.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.39,0.26,0.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,127.75,71.5,204.11
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,100.26,52.96,165.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,27.49,18.54,39.1
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.73,0.48,1.06
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,164.27,95.06,250.12
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,116.64,63.51,180.8
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,47.62,31.55,69.31
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.71,0.48,1.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,112.15,64.23,172.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,73.15,37.98,116.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,39.0,26.25,55.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.66,0.44,0.95
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,128.94,75.83,194.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,89.05,49.2,137.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,39.9,26.62,57.03
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.46,0.33,0.65
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,89.32,50.11,141.39
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,63.71,32.05,105.1
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,25.6,18.07,36.29
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.64,0.44,0.91
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,79.43,44.27,125.62
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,47.2,22.17,79.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,32.23,22.1,45.79
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,1.09,0.72,1.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,86.57,48.35,133.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,37.12,15.52,62.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,49.45,32.83,70.79
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.98,0.7,1.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.63,38.26,113.81
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,30.97,9.95,58.15
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,39.66,28.3,55.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,1.25,0.87,1.75
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,70.14,39.54,111.27
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,25.24,8.36,48.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,44.9,31.18,63.01
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,1.72,1.16,2.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,86.09,50.21,133.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.55,8.71,46.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,61.54,41.5,86.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,1.05,0.74,1.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,51.17,28.89,82.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,18.79,5.94,37.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,32.38,22.95,45.09
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.58,0.43,0.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,29.82,14.58,51.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.66,3.42,31.08
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,15.16,11.16,19.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.52,0.38,0.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,26.0,11.93,45.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.18,2.5,28.38
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,12.82,9.43,16.96
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.45,0.33,0.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,20.93,8.42,37.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.22,1.28,24.8
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,9.71,7.14,13.03
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,1.28,0.91,1.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,32.2,18.02,51.84
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.12,2.34,21.86
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,22.08,15.68,29.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,1.52,1.06,2.07
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,28.04,15.62,45.67
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.28,2.5,20.04
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,18.77,13.12,25.64
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,1.21,0.82,1.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,24.75,12.83,43.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.96,2.14,21.28
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,15.8,10.69,22.06
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,2.26,1.58,3.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,24.62,14.61,37.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.2,3.16,15.62
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,16.41,11.45,22.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.52,0.36,0.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,63.83,35.64,100.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,40.44,19.7,67.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,23.39,15.94,33.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.62,0.43,0.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,69.26,38.8,108.9
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,42.68,20.66,71.21
CHL,Chile,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,26.58,18.14,37.69
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.13,4.07,15.47
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.58,2.19,12.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.55,1.88,3.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.1,0.07,0.14
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.52,21.15,60.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,31.27,15.9,50.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,7.25,5.25,9.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.16,0.12,0.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,61.32,33.67,96.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,49.78,25.31,81.17
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,11.54,8.37,15.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.13,0.1,0.18
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,35.32,15.75,59.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,25.44,8.48,46.6
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,9.88,7.27,13.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.23,0.17,0.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,89.42,49.1,141.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,72.58,36.9,118.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,16.83,12.2,22.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.32,0.23,0.44
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,135.71,77.64,210.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,112.92,61.22,179.78
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,22.79,16.42,30.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,140.67,77.3,218.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,140.67,77.3,218.77
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.17,0.12,0.23
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,105.41,56.6,167.7
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,96.69,50.23,156.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.72,6.37,11.7
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.2,0.14,0.26
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,131.88,72.33,207.5
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,120.02,63.64,191.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.85,8.69,15.94
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.11,0.08,0.15
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,97.17,52.65,155.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,90.96,48.0,147.37
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,6.22,4.65,8.09
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.23,0.17,0.32
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,77.84,37.38,125.52
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,66.09,28.85,109.64
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,11.75,8.53,15.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.33,0.24,0.45
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,67.83,36.5,114.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,52.67,25.54,93.73
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,15.16,10.96,20.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,47.77,23.32,79.84
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,42.79,19.56,73.18
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,4.98,3.75,6.66
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.17,0.13,0.23
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.39,19.09,71.42
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,35.45,14.7,63.53
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,5.94,4.39,7.9
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.14,0.1,0.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.82,17.97,71.16
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,34.81,14.39,64.35
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.02,3.58,6.82
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.26,0.2,0.34
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.45,15.25,61.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.31,9.17,50.94
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,8.14,6.09,10.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,21.97,7.07,42.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,21.97,7.07,42.85
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.21,0.16,0.27
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,25.57,9.88,47.4
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,20.95,6.33,41.57
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.62,3.55,5.83
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.48,0.37,0.61
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.16,13.45,53.19
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,19.67,5.38,39.95
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,10.49,8.06,13.24
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.69,0.52,0.88
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.78,13.86,50.98
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,17.89,4.98,35.93
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,11.89,8.88,15.05
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,1.31,0.92,1.75
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,30.97,15.0,51.24
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.88,5.65,33.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,13.09,9.35,17.25
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.5,0.37,0.67
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.96,10.07,39.4
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,16.44,5.28,30.68
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,6.52,4.79,8.72
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,2.77,1.9,3.74
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,39.28,20.61,61.71
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,19.1,6.78,34.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,20.18,13.83,27.25
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.16,0.12,0.22
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,59.41,31.35,95.55
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,52.27,26.13,85.99
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,7.14,5.22,9.56
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.22,0.16,0.29
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,62.4,32.69,100.76
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,54.69,27.06,90.46
CHL,Chile,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,7.71,5.63,10.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.47,0.23,0.9
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.43,0.22,0.8
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.46,2.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.31,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.84,0.45,1.49
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.85,0.74,3.85
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.5,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.35,0.72,2.38
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.82,0.9,3.46
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.65,0.85,3.07
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.68,1.07,5.57
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.03,2.13
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.96,1.05,3.44
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.42,1.22,7.38
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.2,0.0,3.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.22,1.22,3.76
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,1.83,10.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.91,0.53,6.48
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.26,1.3,3.64
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.79,2.03,11.33
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.67,0.79,7.98
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.12,1.24,3.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.15,2.76,13.54
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.86,0.83,8.36
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.29,1.93,5.18
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.37,1.91,10.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.93,1.03,8.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.44,0.88,2.24
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.95,1.89,11.51
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.94,0.71,8.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.01,1.19,3.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.17,1.68,11.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.81,0.87,8.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,1.36,0.81,2.19
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.52,0.86,7.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.96,0.5,6.84
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.56,0.36,0.86
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,0.61,4.77
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.7,0.26,4.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.52,0.34,0.77
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,0.49,4.6
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.33,0.0,3.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.72,0.49,1.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.01,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.76,0.42,1.24
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.25,0.16,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.7,1.68
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.38,0.21,0.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.72,0.48,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.02,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.47,1.16
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.55
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.41,0.28,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.29,0.17,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.05,0.04,0.08
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.75,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.92,0.61,1.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.09,0.06,0.14
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.83,1.97
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.21,0.13,0.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,1.1,0.7,1.65
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.11,0.07,0.18
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.68,1.03,2.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.19,0.11,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.48,0.91,2.27
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.14,0.09,0.2
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.21,0.75,1.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.23,0.15,0.35
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.98,0.61,1.48
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.87,1.03,5.68
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.67,0.33,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.2,0.69,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.08,1.1,6.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.83,0.37,4.08
CHL,Chile,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.26,0.73,2.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.7,1.78
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.11,0.69,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.83,0.91,3.12
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.45,0.9,2.21
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.92,1.46,5.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.6,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.32,1.44,3.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.44,2.69,6.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,4.26,2.63,6.42
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,2.11,7.21
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.86,0.03,2.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.35,2.08,5.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.02,1.62,7.54
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.44,0.0,3.57
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.57,1.62,3.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.91,1.43,10.2
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.67,0.68,8.26
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.25,0.75,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.18,2.05,12.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.34,1.52,11.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.85,0.53,1.28
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.3,12.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.33,1.59,11.29
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.13,0.71,1.67
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.42,2.27,12.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.8,1.87,11.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.62,0.4,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.77,1.89,13.86
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.23,1.55,13.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.54,0.34,0.82
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.55,2.43,12.62
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.98,2.08,11.74
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.57,0.35,0.88
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.45,1.87,10.96
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.43,1.23,9.43
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.02,0.64,1.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.62,1.38,7.17
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.45,0.67,5.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.17,0.72,1.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,1.83,8.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.94,0.4,4.7
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,2.38,1.44,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.59,0.28,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.28,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.99,1.22,3.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.43,0.23,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.56,0.99,2.32
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,1.24,2.95
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.64
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.58,1.02,2.31
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.07,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,1.26,2.83
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.53
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.62,1.06,2.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.04,0.03,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.67,1.34
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.4
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.72,0.51,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.04,0.03,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.48,1.06
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.3,0.18,0.45
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.45,0.3,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.15,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.26,0.15,0.39
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.07,0.04,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.54,1.3
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.37,0.23,0.56
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.5,0.31,0.74
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.52,1.36,6.76
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.39,0.65,5.05
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.13,0.7,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.7,1.42,7.13
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.57,0.71,5.42
CHL,Chile,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.13,0.7,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.34,1.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.3,0.01,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.62,0.33,1.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.47,0.55,3.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.48,0.02,1.39
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.99,0.53,1.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.06,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.17,0.06,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.8,4.53
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.7,0.03,2.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.45,0.78,2.5
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.87,1.45,8.12
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.16,0.0,3.45
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.71,1.45,4.67
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.07,0.04,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.26,3.02,13.83
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.84,0.54,6.48
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,4.42,2.48,7.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.06,0.03,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,2.65,12.88
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.6,0.8,7.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.2,1.85,5.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.06,0.03,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.44,2.94,13.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.8,0.84,7.92
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.64,2.1,5.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.04,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.02,2.13,11.63
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.89,0.83,8.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.12,1.3,3.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.28,2.31,11.89
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.89,0.92,8.16
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.39,1.39,3.74
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.07,0.04,0.12
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.89,2.79,13.13
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.65,0.94,7.83
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.23,1.86,5.3
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.32,2.05,10.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.83,0.51,6.44
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,2.48,1.54,3.75
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.07,0.05,0.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.23,1.94,7.57
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.64,0.27,3.78
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.58,1.67,3.8
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.1,0.06,0.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.71,2.29,8.27
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.33,0.0,3.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.38,2.29,4.88
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.06,0.04,0.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.29,1.4,3.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.51,0.27,0.87
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,1.78,1.14,2.61
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.73,1.72
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.38,0.21,0.59
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.77,0.52,1.13
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.04,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.76,1.81
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.34,0.2,0.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.87,0.56,1.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.05,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.79,1.93
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,1.02,0.62,1.5
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.2,0.13,0.3
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,3.68,2.42,5.39
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.22,0.14,0.33
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,3.46,2.28,5.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.27,0.17,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.49,2.2,5.24
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.33
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.27,2.07,4.91
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.24,0.14,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.3,2.02,5.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.2,0.12,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.1,1.91,4.79
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.43,0.26,0.65
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.37,2.05,5.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.24,0.15,0.36
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,3.12,1.89,4.78
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.04,0.03,0.07
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.49,1.43,6.55
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.64,0.34,3.6
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.85,1.09,2.95
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.05,0.03,0.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.89,1.62,7.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.8,0.38,3.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,2.09,1.24,3.31
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.18,0.51
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.26,0.16,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.47,2.09
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.37,0.01,0.92
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.75,0.46,1.16
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.75,3.32
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.59,0.02,1.47
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.19,0.73,1.85
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.19,0.69,1.98
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.41
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.01,0.62,1.58
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.59,1.09,4.84
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.85,0.03,2.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.73,1.06,2.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,1.43,7.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.43,0.0,3.62
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.35,1.43,3.67
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.72,0.81,8.15
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.72,0.81,8.15
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.25,2.14,12.57
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.39,1.61,11.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.86,0.53,1.32
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,6.5,2.35,12.95
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.36,1.66,11.24
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.14,0.69,1.7
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.63,2.21,13.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.0,1.81,12.31
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.63,0.39,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.48,2.56,15.08
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.38,1.88,13.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.09,0.68,1.65
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.03,0.02,0.06
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.32,3.01,14.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.75,2.04,11.59
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,1.57,0.96,2.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.01,1.48,10.2
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.54,1.19,9.47
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.47,0.29,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,0.89,6.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.45,0.52,5.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.61,0.37,0.94
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.01,0.01,0.02
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,0.27,5.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.85,0.0,4.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.47,0.27,0.73
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.87,2.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.3,1.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.95,0.57,1.44
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.43,0.24,0.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.43,0.24,0.68
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.03,0.02,0.05
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.67,1.64
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.61
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.71,0.45,1.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,1.22,2.86
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.33,0.2,0.51
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,1.61,1.02,2.35
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.08,0.05,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,1.08,2.18
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.16,0.38
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,1.33,0.92,1.8
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.2,0.13,0.29
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.17,1.39,3.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.29,0.17,0.43
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.88,1.21,2.71
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.08,0.06,0.11
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.92,1.89
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.14,0.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.09,0.77,1.52
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.45,0.27,0.66
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.61,2.16,5.37
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.36,0.22,0.54
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,3.24,1.94,4.84
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.12,6.25
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.41,0.66,5.1
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.75,0.46,1.14
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.24,6.76
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.6,0.72,5.49
CHL,Chile,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.83,0.51,1.27
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.09,1.7,10.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.7,1.57,9.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.39,0.13,0.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.21,10.26,42.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,22.42,9.98,40.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.79,0.28,1.76
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,17.87,73.94
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,39.05,17.39,70.88
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.37,0.48,3.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,21.84,7.3,43.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.18,6.73,39.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.66,0.57,3.73
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.74,26.86,111.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,58.68,26.13,106.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.06,0.73,4.6
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,98.28,45.74,176.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,95.84,44.86,170.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.44,0.88,5.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,90.64,42.83,155.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,87.87,41.81,149.22
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.78,1.03,5.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,38.99,15.8,72.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,37.61,15.26,69.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.38,0.54,2.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,37.37,13.75,71.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,37.37,13.75,71.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,17.01,3.89,37.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,17.01,3.89,37.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.59,3.42,29.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.21,2.41,24.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.38,1.01,4.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.42,1.29,22.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.39,0.48,18.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,2.03,0.8,4.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.54,0.38,14.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.54,0.38,14.83
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,5.02,1.59,11.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,5.02,1.59,11.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.94,2.53,9.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.94,2.53,9.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,2.21,7.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.31,2.21,7.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.61,1.85,6.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.61,1.85,6.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.3,1.72,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,3.3,1.72,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.87,1.55,5.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.87,1.55,5.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.33,0.15,0.63
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.73,3.64,14.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.2,1.11,3.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.53,2.53,11.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.18,0.08,0.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.35,2.52,10.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.32,1.14,4.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.03,1.38,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.93,0.91,3.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.93,0.91,3.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.61,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,3.43,1.61,6.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,23.58,9.78,43.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.65,9.42,42.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.92,0.36,1.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,25.67,10.78,47.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,24.75,10.43,45.55
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.92,0.35,1.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,0.93,7.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.88,0.73,6.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.46,0.2,0.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.2,5.58,27.25
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.83,5.42,26.53
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.37,0.16,0.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.67,9.7,47.35
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,24.03,9.42,46.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.64,0.27,1.26
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,14.28,3.99,30.53
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.32,3.14,26.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.96,0.84,3.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.01,0.01,0.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.99,14.54,71.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.03,14.13,69.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.96,0.41,1.89
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,58.76,24.66,109.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,58.76,24.66,109.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.5,23.43,95.99
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,53.5,23.43,95.99
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.67,8.67,43.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,22.63,8.65,43.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,22.71,8.28,42.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,22.71,8.28,42.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.83,1.46,23.43
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,9.83,1.46,23.43
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.84,0.49,16.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.84,0.49,16.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.01,0.01,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.83,2.48,8.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.52,2.34,8.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.31,0.14,0.59
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,1.62,6.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.47,1.62,6.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.14,1.52,5.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.14,1.52,5.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,1.49,5.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.03,1.49,5.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.42,5.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.42,5.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,1.25,4.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,2.42,1.25,4.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.16,3.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,2.22,1.16,3.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,1.05,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.96,1.05,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.81,2.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,1.52,0.81,2.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.74,0.87,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.74,0.87,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.63,2.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.38,0.63,2.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.33,4.68
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,2.71,1.33,4.68
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.43,26.8
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,13.8,5.35,26.44
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.18,0.08,0.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.01,5.87,28.65
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,14.82,5.79,28.29
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.36,1.54,11.27
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.76,1.33,9.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.59,0.21,1.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.71,9.38,41.69
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,22.02,9.14,40.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.69,0.24,1.55
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,39.72,16.4,72.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,38.51,15.98,70.21
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.21,0.42,2.72
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.01,0.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.26,6.68,48.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.67,5.79,43.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.58,0.9,5.82
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,59.99,24.77,110.14
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,58.16,24.14,106.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.83,0.63,4.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,95.5,42.26,169.34
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,94.41,41.88,166.91
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.1,0.38,2.44
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.15,0.05,0.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,98.25,42.02,174.18
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,88.69,38.65,153.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,9.57,3.37,20.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.05,0.02,0.11
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,40.79,15.43,76.09
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,37.48,14.23,68.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.31,1.2,7.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,39.25,14.27,74.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,37.83,13.72,71.04
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.42,0.54,3.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,19.55,5.0,40.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,16.9,3.95,35.46
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.65,1.05,5.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.96,1.86,23.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,9.96,1.86,23.17
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.74,0.51,15.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.74,0.51,15.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,0.36,13.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.19,0.36,13.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.83,1.54,10.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.83,1.54,10.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.88,2.46,9.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.88,2.46,9.2
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.23,2.11,7.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,4.23,2.11,7.58
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,3.52,1.75,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,3.52,1.75,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.22,1.65,5.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,3.22,1.65,5.87
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.8,1.51,4.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.8,1.51,4.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.3,0.12,0.66
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.52,3.39,14.95
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.13,1.11,3.84
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,5.36,2.28,11.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.16,0.07,0.36
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.23,2.38,10.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.27,1.13,4.13
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,2.94,1.25,6.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.92,0.9,3.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.92,0.9,3.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.39,1.64,6.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,3.39,1.64,6.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,24.03,9.33,44.94
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.58,8.81,41.79
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.45,0.52,3.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,26.08,10.23,48.52
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,24.52,9.67,45.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,1.56,0.56,3.4
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.0,0.63,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.0,0.63,6.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.13,5.78,26.45
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,13.94,5.7,26.08
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.66,10.09,46.15
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,24.32,9.95,45.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.34,0.14,0.65
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.99,2.72,28.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.99,2.72,28.16
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.16,15.2,69.56
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.66,14.99,68.57
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.51,0.21,0.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.01,0.01,0.03
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.39,27.19,109.32
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,59.4,26.77,107.39
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.99,0.42,1.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,53.74,25.31,98.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,53.74,25.31,98.98
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.58,8.75,44.63
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,22.52,8.72,44.51
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,22.81,7.43,46.74
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,22.55,7.31,46.24
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.26,0.12,0.5
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.99,1.18,24.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,9.99,1.18,24.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.0,0.4,15.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.0,0.4,15.38
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.5,2.3,8.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,4.5,2.3,8.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.64,6.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,3.5,1.64,6.86
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.15,1.56,5.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,3.15,1.56,5.96
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.56,5.81
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,3.05,1.56,5.81
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.44,4.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.44,4.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.06,0.02,0.12
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.99,7.54
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,2.41,1.19,4.31
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,1.77,0.8,3.23
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.23,1.6,5.78
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,2.22,1.14,3.92
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.01,0.46,1.85
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,1.07,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.97,1.07,3.41
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.74,2.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,1.53,0.74,2.67
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.75,0.83,3.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,1.75,0.83,3.1
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.61,2.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,1.39,0.61,2.61
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.73,1.34,4.71
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,2.73,1.34,4.71
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,14.09,5.61,27.22
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,13.94,5.54,26.93
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.15,0.07,0.29
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.0,6.01,28.9
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,14.85,5.95,28.6
PRY,Paraguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.15,0.07,0.29
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.52,0.09,1.14
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.52,0.09,1.14
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.1,1.71,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,5.1,1.71,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.95,3.59,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,8.95,3.59,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.66,0.29,3.66
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.66,0.29,3.66
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.59,6.25,30.64
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,15.59,6.25,30.64
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,20.19,7.06,41.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,20.19,7.06,41.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.59,9.24,44.2
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,22.59,9.24,44.2
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,24.9,11.34,47.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,24.9,11.34,47.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.32,7.59,36.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.32,7.59,36.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.28,4.69,24.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,12.28,4.69,24.87
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.58,5.16,27.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,13.58,5.16,27.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.06,3.8,20.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.06,3.8,20.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.3,2.69,17.05
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.3,2.69,17.05
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.8,2.19,13.99
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.8,2.19,13.99
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.29,1.73,10.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.29,1.73,10.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.05,1.6,7.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.05,1.6,7.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.8,1.83,6.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.8,1.83,6.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.1,4.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.45,1.1,4.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.56,3.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.5,0.56,3.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.49,2.48
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.22,0.49,2.48
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.83,0.39,1.57
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.83,0.39,1.57
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.21,1.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.48,0.21,1.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.16,0.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.39,0.16,0.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.1,0.4
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.2,0.1,0.4
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.68,3.38,17.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,8.68,3.38,17.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.13,3.58,18.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,9.13,3.58,18.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.1,0.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.38,0.1,0.83
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.29,1.11,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.29,1.11,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.08,1.84,10.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,5.08,1.84,10.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.31,2.67
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.22,0.31,2.67
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.83,3.19,18.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,8.83,3.19,18.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.84,4.42,26.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.84,4.42,26.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.64,4.63,25.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,12.64,4.63,25.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.44,4.82,25.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,12.44,4.82,25.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.98,2.69,16.09
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.98,2.69,16.09
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.31,1.92,10.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.31,1.92,10.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.6,1.58,11.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.6,1.58,11.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.45,1.98,7.81
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,4.45,1.98,7.81
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.73,1.59,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.73,1.59,6.77
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.07,1.4,6.55
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.07,1.4,6.55
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.83,4.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.15,0.83,4.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.63,3.19
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.65,0.63,3.19
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.63,2.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.54,0.63,2.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.35,2.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.06,0.35,2.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.34,1.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.34,1.28
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.27,1.07
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.58,0.27,1.07
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.17,0.78
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.4,0.17,0.78
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.09,0.52
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.24,0.09,0.52
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.07,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.19,0.07,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.04,0.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.04,0.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.28,1.56,8.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.28,1.56,8.62
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.44,1.61,8.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,4.44,1.61,8.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.02,1.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.38,0.02,1.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.16,1.01,9.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.16,1.01,9.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.91,2.77,17.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,7.91,2.77,17.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.06,3.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.22,0.06,3.54
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.83,4.85,30.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,13.83,4.85,30.1
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,16.81,4.33,37.71
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.81,4.33,37.71
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.27,7.29,43.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,20.27,7.29,43.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.62,10.15,49.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,23.62,10.15,49.38
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,18.32,7.89,36.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,18.32,7.89,36.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.29,4.72,24.13
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,12.29,4.72,24.13
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.55,5.29,24.35
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,13.55,5.29,24.35
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.32,3.56,21.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.32,3.56,21.94
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.27,2.91,16.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.27,2.91,16.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.87,1.82,13.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.87,1.82,13.92
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.08,1.37,11.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.08,1.37,11.43
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.98,1.46,8.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.98,1.46,8.06
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.87,1.85,6.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.87,1.85,6.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.05,4.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.45,1.05,4.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.58,2.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.53,0.58,2.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.5,2.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.24,0.5,2.34
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.84,0.38,1.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.84,0.38,1.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.48,0.21,0.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.48,0.21,0.96
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.16,0.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.39,0.16,0.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.34,0.11,0.68
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.1,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.21,0.1,0.41
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.26,3.02,17.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,8.26,3.02,17.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.64,3.18,17.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,8.64,3.18,17.79
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.35,0.05,0.91
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.35,0.05,0.91
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.04,0.86,6.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,3.04,0.86,6.82
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.78,1.61,10.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,4.78,1.61,10.08
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.16,2.93
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.12,0.16,2.93
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.34,2.81,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,8.34,2.81,17.59
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.0,3.56,26.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,12.0,3.56,26.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.01,4.15,25.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,12.01,4.15,25.02
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.01,4.73,23.61
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,12.01,4.73,23.61
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.9,2.71,15.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,7.9,2.71,15.65
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.26,1.92,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.26,1.92,10.46
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.61,1.68,12.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.61,1.68,12.49
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,1.97,7.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,4.38,1.97,7.88
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.67,1.59,6.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.67,1.59,6.89
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,1.24,5.75
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.09,1.24,5.75
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.24,1.0,4.36
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.24,1.0,4.36
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.72,3.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.67,0.72,3.24
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.68,2.86
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.52,0.68,2.86
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.38,2.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.07,0.38,2.15
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.32,1.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.71,0.32,1.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.25,1.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.58,0.25,1.12
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.17,0.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.41,0.17,0.84
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.09,0.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.26,0.09,0.51
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.07,0.39
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.39
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.04,0.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.16,0.04,0.33
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.16,1.48,8.5
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,4.16,1.48,8.5
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.28,1.52,8.76
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,4.28,1.52,8.76
PRY,Paraguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.06,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.14,0.06,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.74,2.5,13.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.84,1.09,8.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,2.89,1.4,5.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.08,0.04,0.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.37,4.76,24.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,6.33,1.81,13.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,6.04,2.95,10.58
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.18,0.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.44,0.18,0.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.15,0.07,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.55,8.3,42.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,11.03,3.16,24.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,10.52,5.14,18.43
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.16,0.08,0.3
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,28.47,10.53,58.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.05,4.5,36.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,12.42,6.02,22.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.22,0.11,0.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.16,12.37,63.42
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,16.35,4.66,35.73
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,15.81,7.72,27.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.27,0.13,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.72,14.16,68.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,16.63,4.81,35.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,19.09,9.35,32.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.32,0.15,0.54
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,33.05,13.44,63.94
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,12.29,3.35,28.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,20.76,10.09,35.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.18,0.09,0.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.2,7.31,35.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,8.09,2.15,17.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,10.12,5.16,17.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,8.79,1.42,20.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,8.79,1.42,20.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.5,0.89,16.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,6.5,0.89,16.07
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.28,0.15,0.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,19.76,10.5,33.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.55,2.86,9.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,14.2,7.64,24.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.39,0.21,0.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.22,11.72,36.43
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.41,2.2,7.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,17.81,9.51,29.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.56,1.83,5.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.56,1.83,5.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.24,1.77,5.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.24,1.77,5.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.12,1.74,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.12,1.74,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.92,1.71,4.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.92,1.71,4.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,1.55,4.37
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.71,1.55,4.37
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.49,4.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.6,1.49,4.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.44,1.41,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.44,1.41,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,1.89,1.02,3.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,34.91,19.03,57.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.2,1.26,3.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,32.72,17.77,53.71
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,1.04,0.56,1.71
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,19.96,10.91,32.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,2.06,1.18,3.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,17.9,9.72,29.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.99,1.14,3.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.99,1.14,3.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.71,1.01,2.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,1.71,1.01,2.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.13,0.07,0.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.91,5.33,24.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,6.14,1.91,13.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,6.77,3.43,11.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.12,0.06,0.21
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,13.18,5.32,25.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,6.39,1.9,13.78
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,6.79,3.41,11.62
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.01,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.05,0.01,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.4,2.14,7.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.43,0.53,2.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.97,1.61,4.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.79,2.31,8.48
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,2.4,1.02,4.68
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,2.39,1.29,3.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.05,0.03,0.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.32,4.02,14.73
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,4.17,1.77,8.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,4.15,2.25,6.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.17,0.09,0.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.66,9.11,32.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.95,2.22,12.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,12.71,6.88,20.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.08,0.04,0.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.4,6.0,21.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,6.17,2.63,12.03
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,6.22,3.37,9.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.39,3.02,11.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,6.39,3.02,11.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.64,2.35,8.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,4.64,2.35,8.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.46,2.36,7.57
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.84,1.43,5.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.62,0.93,2.55
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,3.08,1.57,5.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,3.08,1.57,5.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.2,1.07,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,2.2,1.07,3.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.86,3.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.72,0.86,3.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.25,0.15,0.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.84,7.29,20.56
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.41,0.7,2.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,11.43,6.6,18.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.2,0.61,2.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.2,0.61,2.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.6,2.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.15,0.6,2.02
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.57,1.97
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.12,0.57,1.97
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.61,1.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.61,1.91
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.58,1.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.07,0.58,1.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.03,0.56,1.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.03,0.56,1.81
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.98,0.52,1.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.98,0.52,1.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.47,1.59
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.9,0.47,1.59
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.46,1.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.86,0.46,1.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.46,1.5
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.88,0.46,1.5
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.43,1.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.74,0.43,1.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.0,2.03,6.95
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.24,1.04,4.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.77,0.98,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.04
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.98,2.0,6.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.31,1.08,4.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.67,0.93,2.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.13,0.05,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.06,0.03,0.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,7.88,2.81,15.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.54,0.79,7.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.34,2.02,8.24
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.07,0.03,0.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.18,4.05,22.45
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,6.05,1.65,12.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,5.14,2.4,9.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.17,0.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.42,0.17,0.85
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.12,0.06,0.23
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,19.56,7.08,39.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,10.57,2.89,22.4
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,8.98,4.19,16.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.25,0.12,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,33.76,12.01,67.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,14.91,3.25,32.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,18.84,8.75,35.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.18,0.09,0.35
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.32,10.6,58.88
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,15.75,4.27,33.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,13.56,6.33,25.49
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.12,0.06,0.22
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.03,9.24,50.23
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,16.57,5.26,34.65
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,8.47,3.98,15.58
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,1.07,0.5,1.86
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,82.32,35.66,146.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,12.13,3.1,24.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,70.2,32.56,121.35
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.38,0.19,0.66
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.05,13.55,58.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,7.92,1.96,16.76
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,24.13,11.6,41.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.19,0.1,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,20.17,7.09,39.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,8.66,1.06,19.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,11.51,6.03,19.57
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.32,0.17,0.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.92,10.14,45.13
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,6.34,0.82,15.96
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.58,9.32,29.17
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.4,2.69,9.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.4,2.69,9.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.31,2.23,7.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,4.31,2.23,7.25
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.87,5.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,3.5,1.87,5.99
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.17,1.77,5.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.17,1.77,5.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.06,1.72,5.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.06,1.72,5.12
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.83,1.68,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.83,1.68,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,2.61,1.52,4.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,2.61,1.52,4.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.5,1.45,4.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,2.5,1.45,4.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.36,1.36,3.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,2.36,1.36,3.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,1.8,0.99,3.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,33.23,18.16,54.72
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,2.13,1.2,3.45
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,31.13,16.96,51.27
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.99,0.54,1.64
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,19.06,10.43,31.39
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.99,1.12,3.26
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,17.09,9.31,28.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.92,1.07,3.16
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,1.92,1.07,3.16
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.92,2.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,1.64,0.92,2.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.18,0.09,0.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.43,6.8,30.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,5.97,1.77,12.32
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,10.46,5.03,18.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.19,0.09,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,17.52,7.19,32.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,6.18,1.76,12.87
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,11.34,5.44,19.83
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.4,0.53,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.4,0.53,2.8
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.73,1.67,7.18
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,2.37,0.96,4.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.36,0.71,2.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.05,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.03,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.52,2.91,12.52
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,4.14,1.68,8.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.37,1.23,4.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.87,2.24,11.79
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,5.87,2.24,11.79
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.05,0.03,0.09
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.74,4.35,18.7
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,6.16,2.5,12.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.58,1.85,6.6
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.1,0.05,0.19
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.46,6.38,25.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,6.44,2.74,12.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,7.01,3.64,12.93
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.49,8.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,4.69,2.49,8.41
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.53,2.91,9.77
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.85,1.45,5.14
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.68,1.46,4.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.19,0.1,0.33
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,14.44,7.75,25.28
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,3.11,1.57,5.67
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.33,6.18,19.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.04,3.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,2.22,1.04,3.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.84,3.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.72,0.84,3.11
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.4,0.72,2.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,1.4,0.72,2.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.17,0.62,2.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,1.17,0.62,2.1
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.6,1.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.13,0.6,1.98
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.57,1.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.1,0.57,1.89
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.6,1.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.1,0.6,1.92
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.49,0.26,0.82
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.11,7.38,23.36
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.08,0.58,1.9
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,13.03,6.8,21.46
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.28,0.15,0.47
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,8.52,4.45,14.15
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.04,0.55,1.84
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,7.48,3.9,12.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.51,1.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.99,0.51,1.75
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.46,1.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.46,1.63
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.44,1.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.87,0.44,1.53
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.45,1.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.86,0.45,1.51
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.37,1.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.75,0.37,1.34
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,4.06,2.0,7.38
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.24,1.03,4.2
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.82,0.97,3.19
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.18,2.06,7.61
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.3,1.06,4.31
PRY,Paraguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.88,1.0,3.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.65,0.15,1.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.65,0.15,1.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.1,7.25,45.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,17.58,5.24,36.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.52,2.02,8.69
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.13,0.06,0.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.19,27.65,121.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,55.82,23.42,104.29
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,9.37,4.23,17.66
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.09,0.47,4.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,2.09,0.47,4.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.23,0.1,0.43
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.56,48.16,212.41
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,97.23,40.79,181.65
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,16.33,7.36,30.76
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.26,0.11,0.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,92.74,30.66,190.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,73.32,22.0,152.95
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,19.43,8.67,37.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.34,0.15,0.64
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,169.59,72.12,316.91
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,145.05,61.06,270.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,24.53,11.06,46.22
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.42,0.19,0.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,243.75,112.14,439.16
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,214.29,98.77,384.34
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,29.46,13.37,54.82
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.49,0.22,0.89
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,241.18,114.32,418.67
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,209.17,99.71,360.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,32.01,14.61,58.27
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.28,0.13,0.51
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,136.17,60.02,247.09
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,120.44,52.56,218.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,15.73,7.46,28.31
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,132.87,57.8,242.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,132.87,57.8,242.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,87.11,33.97,167.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,87.11,33.97,167.5
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.45,0.22,0.83
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.62,35.47,167.48
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,63.61,24.16,125.76
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,23.01,11.3,41.72
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.59,0.29,1.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,77.64,30.35,147.73
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,50.52,16.93,100.56
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,27.12,13.42,47.17
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,42.74,13.94,85.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,42.74,13.94,85.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.67,11.53,68.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,34.67,11.53,68.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.88,11.58,62.9
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,32.88,11.58,62.9
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.58,7.75,49.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,24.58,7.75,49.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,18.22,5.6,37.18
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,18.22,5.6,37.18
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.02,6.91,32.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,17.02,6.91,32.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.37,8.72,25.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.37,8.72,25.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,3.25,1.68,5.68
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,68.29,35.75,117.1
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.27,7.01,19.55
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,55.99,28.75,97.55
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,1.78,0.92,3.11
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,42.26,22.14,72.15
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.61,6.42,18.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,30.63,15.73,53.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.73,5.62,17.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.73,5.62,17.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.99,5.85,18.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.99,5.85,18.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.21,0.1,0.38
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,80.7,34.46,149.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,70.09,29.48,129.77
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,10.61,4.98,19.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,0.19,0.09,0.35
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,84.6,36.38,155.83
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,73.99,31.44,136.4
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,10.61,4.95,19.43
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.43,0.11,0.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.43,0.11,0.94
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.09,0.05,0.14
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,19.82,7.47,38.23
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,13.32,4.04,27.44
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.5,3.43,10.8
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.07,0.04,0.12
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,52.85,23.3,95.67
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,47.62,20.54,86.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,5.22,2.76,8.68
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.36,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.38,0.36,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.12,0.06,0.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.81,40.47,166.22
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,82.74,35.68,151.14
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,9.08,4.79,15.08
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.37,0.2,0.61
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,83.42,31.59,160.53
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,55.61,16.92,114.33
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,27.81,14.67,46.2
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.18,0.1,0.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.99,60.51,247.74
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,123.38,53.33,225.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,13.61,7.18,22.61
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,188.35,88.24,331.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,188.35,88.24,331.37
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,212.23,113.15,339.87
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,212.23,113.15,339.87
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.08,0.04,0.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,146.07,73.54,243.28
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,142.56,71.55,237.57
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,3.51,1.99,5.7
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,169.31,86.57,281.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,169.31,86.57,281.45
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,123.31,60.07,212.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,123.31,60.07,212.24
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.63,37.73,152.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,86.63,37.73,152.99
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.54,0.31,0.89
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,88.9,40.79,153.59
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,64.09,26.74,113.29
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,24.81,14.05,40.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,48.44,20.23,89.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.44,20.23,89.26
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,38.56,15.11,71.62
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,38.56,15.11,71.62
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,36.62,13.9,66.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,36.62,13.9,66.78
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.78,9.26,52.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.78,9.26,52.36
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,20.4,5.48,42.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,20.4,5.48,42.79
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,18.07,4.82,38.32
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,18.07,4.82,38.32
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.96,3.95,32.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,14.96,3.95,32.39
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.41,3.77,25.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,12.41,3.77,25.3
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,12.08,3.85,24.81
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,12.08,3.85,24.81
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.39,3.13,25.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,11.39,3.13,25.03
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,12.23,4.95,23.46
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,12.23,4.95,23.46
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.06,0.04,0.11
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,78.82,37.18,136.47
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,74.96,35.09,130.13
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,3.85,2.09,6.34
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.06,0.03,0.1
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,81.14,38.56,140.04
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,77.49,36.59,134.02
PRY,Paraguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,3.65,1.97,6.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.07,1.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.51,0.07,1.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.09,0.04,0.18
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.48,6.92,49.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,16.68,3.98,35.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.8,2.94,13.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.11,0.05,0.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.36,25.03,117.33
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,54.35,21.56,101.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,8.0,3.47,15.73
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.23,4.4
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,1.64,0.23,4.4
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.19,0.08,0.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.07,43.78,205.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,95.07,37.71,177.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,14.0,6.08,27.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.39,0.17,0.77
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,100.2,29.78,208.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,70.7,17.02,150.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,29.5,12.76,58.3
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.29,0.12,0.56
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,163.89,66.01,307.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,142.74,56.83,266.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,21.14,9.18,41.57
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.19,0.08,0.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,225.45,101.03,403.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,212.39,95.31,377.98
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,13.06,5.71,25.39
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,1.65,0.72,3.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,319.15,141.24,566.35
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,211.06,94.12,365.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,108.1,47.13,201.19
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.59,0.26,1.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,157.97,66.65,286.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,120.99,50.07,217.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,36.99,16.58,68.3
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.28,0.13,0.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,151.3,65.46,270.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,134.4,57.34,239.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,16.9,8.12,31.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.49,0.24,0.88
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,115.37,44.62,217.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,88.17,31.43,169.1
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,27.2,13.19,48.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,64.33,23.39,124.45
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,64.33,23.39,124.45
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,49.81,16.71,96.89
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,49.81,16.71,96.89
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,41.23,11.56,82.91
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,41.23,11.56,82.91
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,33.9,11.03,66.32
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,33.9,11.03,66.32
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.49,12.54,60.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,32.49,12.54,60.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.66,8.24,48.31
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,24.66,8.24,48.31
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,18.37,5.1,38.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,18.37,5.1,38.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,17.06,6.56,32.81
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,17.06,6.56,32.81
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.24,8.6,25.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,15.24,8.6,25.43
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,3.09,1.56,5.48
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,65.36,33.65,113.84
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,12.2,6.86,19.63
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,53.16,26.79,94.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.69,0.86,3.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,40.73,21.08,70.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,11.56,6.38,18.83
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,29.17,14.7,51.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.68,5.76,17.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.68,5.76,17.74
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,10.98,5.85,18.07
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,10.98,5.85,18.07
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.28,0.13,0.52
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,86.1,35.2,158.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,69.92,27.94,128.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,16.18,7.25,30.23
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.29,0.13,0.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,91.09,37.5,167.68
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,73.59,29.68,134.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,17.5,7.82,32.73
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.4,0.07,1.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.4,0.07,1.01
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.95,3.66,26.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.95,3.66,26.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.05,0.02,0.08
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.02,22.33,90.92
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,46.83,20.73,85.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,3.19,1.61,5.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.21,3.26
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.28,0.21,3.26
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.08,0.04,0.14
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,87.26,38.96,158.63
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,81.7,36.16,148.54
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,5.56,2.8,10.09
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,54.68,15.61,111.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,54.68,15.61,111.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.12,0.06,0.22
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,130.86,58.61,237.42
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,122.47,54.4,222.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,8.39,4.22,15.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.23,0.12,0.42
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,204.05,99.93,358.67
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,187.61,91.66,328.85
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,16.44,8.27,29.82
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,213.49,112.41,355.75
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,213.49,112.41,355.75
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.1,0.05,0.17
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,149.03,76.04,251.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,143.24,73.0,241.53
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,5.79,3.04,10.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.41,0.21,0.7
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,195.25,101.32,328.04
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,170.73,88.45,285.68
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,24.52,12.87,42.36
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,125.88,62.93,212.62
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,125.88,62.93,212.62
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,86.53,40.69,150.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,86.53,40.69,150.49
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,63.71,29.41,112.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,63.71,29.41,112.78
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,48.25,17.78,88.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.25,17.78,88.13
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,38.24,14.31,71.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,38.24,14.31,71.72
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,35.9,14.44,69.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,35.9,14.44,69.02
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.24,9.31,52.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.24,9.31,52.21
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,1.28,0.71,2.06
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,53.99,24.72,95.39
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,20.56,6.02,41.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,33.43,18.71,53.97
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.73,0.41,1.18
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,37.45,15.94,68.88
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,18.27,5.21,37.93
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,19.18,10.73,30.96
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.19,4.12,33.2
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,15.19,4.12,33.2
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,12.65,3.92,26.03
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,12.65,3.92,26.03
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,12.06,3.74,24.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,12.06,3.74,24.6
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.1,3.31,22.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,11.1,3.31,22.16
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.93,3.91,24.51
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,11.93,3.91,24.51
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.09,0.05,0.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,79.37,38.02,138.37
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,75.16,35.81,131.1
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.21,2.21,7.27
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.09,0.05,0.15
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,81.9,39.5,142.44
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,77.58,37.24,134.95
PRY,Paraguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,4.32,2.26,7.5
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.28,0.99,9.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,3.91,0.85,8.31
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.37,0.14,0.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.69,8.23,33.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,17.96,7.96,31.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.73,0.27,1.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.55,14.34,58.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.28,13.87,55.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.27,0.47,2.74
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,18.37,4.26,38.99
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,16.77,3.65,35.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.6,0.61,3.31
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.91,21.54,87.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,47.0,20.83,83.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.91,0.71,4.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.39,38.22,134.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,76.18,37.42,129.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.2,0.8,4.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,0.04,0.02,0.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,91.54,47.95,146.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,89.08,46.96,141.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.47,0.99,5.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,61.86,30.92,104.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,60.16,30.22,101.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.69,0.7,3.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,70.86,37.47,118.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,70.86,37.47,118.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,51.0,24.93,87.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,51.0,24.93,87.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,0.06,0.03,0.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,40.02,17.19,75.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,36.72,15.78,68.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.3,1.41,6.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.04,0.16
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,33.05,13.07,62.84
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.29,11.52,55.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.76,1.56,7.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,26.4,10.01,49.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,26.4,10.01,49.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.23,6.39,41.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,21.23,6.39,41.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,20.17,5.01,40.32
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,20.17,5.01,40.32
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.63,2.6,31.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.63,2.6,31.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,10.2,1.54,22.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.2,1.54,22.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.71,3.11,19.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.71,3.11,19.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.03,5.27,14.4
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,9.03,5.27,14.4
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.48,0.24,0.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.61,8.36,26.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.25,4.33,10.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.36,4.03,15.52
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.26,0.13,0.49
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,11.25,6.05,18.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.68,3.85,10.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,4.57,2.2,8.49
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.3,3.41,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.3,3.41,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,3.02,8.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.44,3.02,8.37
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,32.63,15.06,57.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,31.55,14.61,54.98
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.08,0.44,2.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,33.73,15.79,58.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,32.7,15.38,56.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.03,0.42,2.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.43,2.02,12.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.69,1.65,11.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.74,0.36,1.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.7,12.46,46.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,26.11,12.17,44.98
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.59,0.29,1.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,46.39,21.65,79.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,45.36,21.15,78.14
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.03,0.51,1.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,27.51,8.63,54.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.35,7.07,48.96
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,3.16,1.56,5.48
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,32.47,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,68.02,31.71,117.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.55,0.76,2.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.89,55.33,182.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,109.89,55.33,182.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,144.19,84.69,214.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,144.19,84.69,214.57
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,109.64,59.46,173.76
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,109.09,59.17,172.81
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.55,0.29,0.95
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,135.2,74.74,215.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,135.2,74.74,215.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,103.79,54.98,170.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,103.79,54.98,170.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,72.23,34.27,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,72.23,34.27,119.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.09,0.04,0.15
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,55.92,23.79,96.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,52.02,21.72,89.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.9,2.07,6.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,16.76,71.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,39.43,16.76,71.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.35,11.97,57.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,31.35,11.97,57.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,29.92,10.67,54.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.92,10.67,54.53
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.51,6.72,42.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.51,6.72,42.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.94,3.18,34.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,15.94,3.18,34.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,2.7,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,13.98,2.7,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.39,2.07,26.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.39,2.07,26.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.54,2.28,20.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.54,2.28,20.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.07,2.32,19.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.07,2.32,19.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.76,1.88,20.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.76,1.88,20.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.4,2.98,16.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.4,2.98,16.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.91,27.15,89.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.4,26.89,88.15
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.5,0.26,0.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,55.19,28.12,90.64
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,54.72,27.88,89.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.47,0.24,0.81
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,4.74,1.04,9.72
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,4.19,0.83,8.59
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.56,0.2,1.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,18.85,8.15,32.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,18.22,7.92,31.14
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.63,0.23,1.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.0,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.97,14.26,56.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,31.86,13.86,54.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.11,0.4,2.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,20.59,4.5,42.18
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,18.18,3.61,37.28
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.41,0.89,4.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.8,21.54,85.78
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,48.12,20.93,82.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.67,0.61,3.52
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.01,0.0,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.03,38.01,127.92
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,77.07,37.67,125.73
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.96,0.34,2.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,0.12,0.05,0.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,98.45,47.54,164.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,90.38,44.47,147.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,8.07,3.07,17.78
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,0.05,0.02,0.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,64.19,30.08,109.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,60.94,28.81,102.75
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.25,1.27,6.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,74.14,37.74,122.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,72.09,36.92,118.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,2.05,0.83,4.33
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.02,0.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,55.25,23.97,96.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,51.79,22.53,89.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.47,1.43,6.8
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,37.79,15.37,69.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,37.79,15.37,69.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.3,11.65,54.62
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,29.3,11.65,54.62
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,25.59,7.94,47.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,25.59,7.94,47.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.81,6.07,39.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,20.81,6.07,39.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,19.81,6.04,38.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,19.81,6.04,38.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.89,3.27,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.89,3.27,31.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,10.5,1.12,24.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,10.5,1.12,24.13
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.89,2.84,20.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.89,2.84,20.17
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,9.06,5.23,14.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,9.06,5.23,14.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.45,0.21,0.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.04,7.79,26.04
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.28,4.26,11.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,7.76,3.54,14.92
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.25,0.12,0.48
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.97,5.8,18.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.71,3.86,10.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.26,1.94,8.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.33,3.56,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.33,3.56,10.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.44,3.08,8.42
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.44,3.08,8.42
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,33.47,14.72,58.23
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,32.02,14.15,55.18
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.45,0.57,3.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,34.73,15.48,60.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,33.2,14.88,56.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,1.53,0.6,3.25
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.47,1.63,10.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,5.47,1.63,10.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.01
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.87,12.53,44.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,25.53,12.36,43.94
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.34,0.16,0.64
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.13,21.85,77.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.54,21.57,76.66
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.59,0.28,1.11
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,23.66,7.03,44.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,23.66,7.03,44.44
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,68.02,32.94,117.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,67.13,32.51,115.54
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.89,0.42,1.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.05
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,110.64,57.82,187.12
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,108.89,56.99,183.85
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.75,0.83,3.27
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,145.25,81.89,227.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,145.25,81.89,227.88
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,110.73,60.88,176.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,109.94,60.5,175.26
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.79,0.38,1.41
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.05,0.03,0.1
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,140.15,78.96,221.19
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,136.81,77.37,215.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,3.34,1.59,5.97
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,106.27,58.19,169.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,106.27,58.19,169.67
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,71.9,37.33,117.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,71.9,37.33,117.61
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.87,24.59,90.09
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,51.87,24.59,90.09
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.19,14.51,69.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,39.19,14.51,69.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.04,11.21,57.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,31.04,11.21,57.79
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,29.22,11.1,56.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,29.22,11.1,56.71
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.96,6.74,42.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,21.96,6.74,42.68
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.41,0.23,0.63
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,26.66,10.07,49.93
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,16.09,3.81,33.46
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,10.56,6.26,16.47
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,20.24,6.73,40.08
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,14.17,3.14,30.63
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,6.06,3.59,9.45
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.59,2.23,26.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.59,2.23,26.83
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.77,2.51,20.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,9.77,2.51,20.87
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.03,2.26,19.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.03,2.26,19.22
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.49,2.08,17.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.49,2.08,17.39
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.03,1.93,17.82
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.03,1.93,17.82
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,54.31,27.9,89.9
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.59,27.52,88.69
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.71,0.37,1.21
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,55.66,28.86,91.77
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,54.97,28.5,90.58
PRY,Paraguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.69,0.36,1.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.9,0.35,1.87
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.87,0.34,1.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.03,0.01,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.98,0.8,4.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.17,0.08,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.82,0.73,3.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.04,0.02,0.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.45,1.4,7.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.29,0.13,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.16,1.27,6.52
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.86,1.51,8.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.05,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,3.74,1.47,7.76
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.07,0.03,0.14
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,2.11,10.61
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.44,0.2,0.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.75,1.91,9.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.08,0.03,0.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.46,2.68,13.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.35,1.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,5.73,2.33,11.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.09,0.04,0.18
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.62,2.51,16.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.61,0.0,4.18
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,6.01,2.51,11.93
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.05,0.02,0.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.84,1.3,10.24
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.29,0.24,5.22
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.54,1.06,5.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.26,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.26,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.53,0.46,5.67
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.53,0.46,5.67
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.96,1.66,12.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.83,0.42,6.38
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.13,1.24,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.08,0.04,0.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.15,2.09,12.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,2.63,0.53,5.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.52,1.56,6.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,0.0,4.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,1.95,0.0,4.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.19,2.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.14,0.19,2.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.86,0.46,1.48
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.86,0.46,1.48
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.12,0.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.23,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.23,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.11,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.21,0.11,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.12,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.19,0.12,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.54,0.27,0.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.56,4.51,17.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.18,0.09,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.41,4.39,17.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.3,0.15,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.31,2.52,9.69
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.18,0.1,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,5.15,2.4,9.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.1,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.2,0.1,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.89,0.92,6.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.07,0.16,2.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.83,0.76,3.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.89,0.92,6.03
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.03,0.15,2.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,1.86,0.77,3.74
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.37,1.27,3.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.33,1.26,3.89
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.07,1.1,3.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.38
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.87,1.01,3.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.04,0.02,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.6,1.92,6.09
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.35,0.16,0.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,3.26,1.76,5.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.13,0.07,0.22
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.12,5.45,16.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,9.97,5.39,16.65
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.06,0.04,0.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.4,2.88,9.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.24,0.98
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,4.88,2.64,8.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.41,1.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.88,0.41,1.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.94,0.0,5.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.99,1.12,8.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.69,0.38,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.3,0.74,2.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.71,0.4,5.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.71,0.4,5.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.58,6.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,0.58,6.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.09,0.52,7.21
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.09,0.52,7.21
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.24,5.83,21.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.07,0.57,6.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,9.17,5.25,14.93
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,0.41,5.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.18,0.41,5.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,0.38,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.28,0.38,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.53,1.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.01,0.53,1.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.15,0.56
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.15,0.56
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.27,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.14,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.25,0.14,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.24,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.19,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.13,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.21,0.13,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.32,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.64,1.02,5.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.24,0.24,2.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.4,0.77,2.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.52,0.96,4.87
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,1.2,0.23,2.68
PRY,Paraguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,1.32,0.73,2.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.52,2.79
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.31,0.51,2.73
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.02,0.01,0.04
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.71,0.68,3.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.16,0.08,0.3
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.54,0.61,3.2
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.01,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.99,1.2,6.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.29,0.13,0.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.7,1.06,5.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.07,0.03,0.16
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,5.8,2.27,12.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.13,0.04,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,5.67,2.22,11.83
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.05,0.02,0.12
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.51,1.81,9.25
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.43,0.2,0.8
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.08,1.61,8.45
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,1.36,6.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.73,0.35,1.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.54,1.01,5.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.31,0.13,0.63
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,21.81,8.13,45.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.54,0.0,3.9
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,20.26,8.13,41.11
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.1,0.04,0.2
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.66,2.88,18.19
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.35,0.36,5.37
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,6.3,2.52,12.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,4.19,1.07,9.7
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.28,0.35,5.62
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.91,0.72,4.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.06,0.02,0.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.32,1.96,13.13
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.82,0.57,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.5,1.39,6.98
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.91,0.56,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.91,0.56,6.15
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.58,0.49,5.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,2.58,0.49,5.53
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.0,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,1.87,0.0,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.19,2.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.11,0.19,2.46
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.46,1.51
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,0.87,0.46,1.51
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.12,0.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.26,0.12,0.47
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.22,0.11,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.11,0.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.21,0.11,0.32
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.11,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.19,0.11,0.29
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.51,0.24,0.99
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,9.08,4.11,17.14
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.18,0.09,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.9,3.99,16.9
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.28,0.13,0.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,5.06,2.3,9.54
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.18,0.1,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.88,2.19,9.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.17,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.1,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.21,0.1,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.91,1.33,8.16
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.08,0.2,2.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,2.83,1.13,5.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.05,0.02,0.1
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,4.12,1.42,8.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.05,0.19,2.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.07,1.22,6.25
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.07
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.02,0.01,0.03
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.49,0.75,2.63
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.2,0.09,0.37
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.3,0.66,2.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.03,0.02,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.61,1.31,4.6
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.34,0.16,0.64
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.26,1.15,3.95
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.05,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.31
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.05,0.02,0.08
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.93,1.97,6.92
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.24,0.97
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.41,1.73,5.96
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.09,0.05,0.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.56,3.81,13.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.87,0.42,1.59
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,6.68,3.39,11.68
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.91,0.0,4.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,1.91,0.0,4.82
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.04,0.02,0.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.93,1.57,10.01
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.67,0.4,6.17
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.26,1.18,3.84
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.16,0.08,0.27
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,12.24,5.49,22.34
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,2.65,0.5,6.06
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,9.59,4.99,16.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,0.54,6.71
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,3.03,0.54,6.71
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.24,0.53,7.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.24,0.53,7.5
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.85,0.55,6.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.85,0.55,6.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.0,5.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.15,0.0,5.23
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.26,0.23,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.26,0.23,2.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.02,0.53,1.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.02,0.53,1.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.31,0.15,0.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.31,0.15,0.55
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.31,0.18,0.49
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,8.33,4.95,13.24
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.26,0.14,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,8.07,4.81,12.81
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.18,0.11,0.28
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.88,2.9,7.75
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.25,0.13,0.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,4.63,2.76,7.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.23,0.13,0.36
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.21,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.22,0.13,0.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.2,0.12,0.33
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.27,0.16,0.43
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.75,1.02,5.35
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,1.23,0.22,2.77
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.52,0.8,2.58
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.05
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.05,5.4
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,1.2,0.22,2.7
PRY,Paraguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,1.59,0.83,2.71
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.78,0.46,5.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.78,0.46,5.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.69,4.79,24.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,12.69,4.79,24.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.36,7.69,38.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,20.36,7.69,38.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.52,1.75,22.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,10.52,1.75,22.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.01,11.33,57.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,30.01,11.33,57.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.69,20.51,90.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,48.69,20.51,90.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Deaths,Rate,0.22,0.12,0.34
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,60.77,25.87,103.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,46.59,18.25,80.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,14.18,7.62,22.73
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,30.66,12.07,55.99
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,20.73,6.5,39.97
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,9.94,5.57,16.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Deaths,Rate,0.16,0.09,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,34.14,13.15,62.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,24.35,7.61,46.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.8,5.54,16.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,23.26,9.09,45.46
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,13.7,3.54,30.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,9.57,5.55,15.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Deaths,Rate,0.17,0.1,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,17.03,5.46,34.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.58,0.56,20.97
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,8.44,4.9,13.48
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Deaths,Rate,0.15,0.08,0.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.54,4.3,25.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.59,0.45,14.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.94,3.85,11.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,2.09,8.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,4.38,2.09,8.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Deaths,Rate,0.04,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.69,2.38,8.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.39,1.63,6.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.3,0.76,2.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Deaths,Rate,0.11,0.06,0.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,6.99,3.71,12.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.22,1.51,6.31
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.78,2.2,5.87
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.39,1.21,4.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.39,1.21,4.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.8,0.89,3.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.8,0.89,3.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.61,0.81,2.9
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.61,0.81,2.9
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.36,0.7,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.36,0.7,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,1.01,0.49,1.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,1.01,0.49,1.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Deaths,Rate,0.05,0.02,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.92,0.94,3.35
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.31,0.64,2.4
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.59,0.31,0.95
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Deaths,Rate,0.15,0.07,0.22
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,2.89,1.41,4.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.96,0.44,1.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,1.89,1.0,3.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.38,1.19,4.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.38,1.19,4.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.07,0.04,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,16.63,6.55,30.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,12.91,4.46,24.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.72,2.09,5.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Deaths,Rate,0.07,0.04,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,16.27,6.44,30.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,12.57,4.36,24.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,3.71,2.08,5.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.08,0.12,5.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,2.08,0.12,5.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.98,2.72,18.62
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,8.98,2.72,18.62
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,14.37,4.35,29.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,14.37,4.35,29.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,7.84,0.44,19.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,7.84,0.44,19.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.15,6.41,43.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,21.15,6.41,43.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,33.83,12.09,66.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,33.83,12.09,66.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,31.44,11.58,57.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.44,11.58,57.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.43,3.96,27.59
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,13.43,3.96,27.59
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,15.41,4.23,33.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,15.41,4.23,33.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,8.78,0.57,20.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.78,0.57,20.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,0.43,15.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.33,0.43,15.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.98,2.1,7.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.98,2.1,7.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Deaths,Rate,0.1,0.06,0.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,6.61,3.75,11.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.6,1.18,5.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,4.01,2.58,5.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.46,1.85,6.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.08,0.96,4.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.38,0.89,2.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,0.91,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.91,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.63,0.77,3.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.63,0.77,3.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.61,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.32,0.61,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.46,0.76,2.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.17,0.56,2.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.29,0.2,0.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Deaths,Rate,0.03,0.01,0.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.62,0.94,2.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.0,0.51,1.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.62,0.44,0.88
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.35,1.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.71,0.35,1.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.44,1.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.84,0.39,1.54
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.37,1.39
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.58,0.25,1.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.19,0.12,0.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.58,2.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.17,0.53,2.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.93,2.79,18.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,8.7,2.64,17.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.23,0.15,0.34
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.08,2.59,16.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,7.82,2.42,16.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.26,0.17,0.39
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.15,0.54,6.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,2.74,0.32,6.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.41,0.21,0.72
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.94,4.8,25.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,12.0,4.31,23.69
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.94,0.49,1.64
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,20.64,7.66,40.38
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,19.14,6.87,37.77
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.5,0.79,2.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,11.84,2.01,25.68
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,10.29,1.21,22.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.55,0.8,2.72
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,30.43,11.29,59.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,28.22,10.13,55.7
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.21,1.16,3.85
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,48.32,20.22,92.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,45.46,18.71,87.19
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,2.85,1.5,4.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Deaths,Rate,0.24,0.13,0.4
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,62.21,27.22,107.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,46.3,18.76,81.74
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,15.91,8.46,26.22
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Deaths,Rate,0.15,0.08,0.24
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,28.88,11.33,53.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,20.42,6.68,40.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,8.46,4.66,13.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Deaths,Rate,0.12,0.07,0.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.1,12.28,59.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,23.79,8.18,46.99
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,7.31,4.1,12.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Deaths,Rate,0.13,0.07,0.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,20.79,7.11,42.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,13.55,2.98,30.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,7.24,4.12,11.52
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.06,0.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.98,4.13,29.31
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.1,0.75,19.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,5.87,3.38,9.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Deaths,Rate,0.11,0.06,0.17
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.34,3.09,21.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.51,0.45,13.57
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.84,2.63,7.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.27,2.0,8.09
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,4.27,2.0,8.09
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.82,6.93
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,3.29,1.56,6.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.45,0.25,0.7
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.42,2.21,8.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,3.13,1.47,6.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,1.3,0.74,2.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.32,1.15,4.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.32,1.15,4.13
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.76,0.84,3.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.76,0.84,3.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.58,0.76,2.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.58,0.76,2.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.66,2.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.33,0.66,2.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Deaths,Rate,0.08,0.05,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.27,3.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.98,0.47,1.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,1.19,0.8,1.6
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Deaths,Rate,0.07,0.05,0.12
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.22,1.2,3.64
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,1.29,0.63,2.29
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.92,0.57,1.36
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Deaths,Rate,0.04,0.04,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,0.75,2.76
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.93,0.45,1.75
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.6,0.3,1.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Deaths,Rate,0.1,0.05,0.19
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,3.19,1.64,5.32
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,2.32,1.16,3.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.82,0.48,1.35
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.06,0.03,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,15.97,6.22,30.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,12.5,4.31,24.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.47,1.9,5.69
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Deaths,Rate,0.06,0.03,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.62,6.12,29.55
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,12.19,4.23,23.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,3.43,1.88,5.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,0.41,5.89
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,1.98,0.11,5.15
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.49,0.3,0.74
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,9.68,3.42,18.83
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,8.97,2.95,17.79
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.71,0.46,1.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,15.39,5.43,29.92
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,14.26,4.69,28.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.13,0.74,1.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Deaths,Rate,0.03,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,9.23,1.54,22.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,7.41,0.42,19.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.82,1.13,2.77
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Deaths,Rate,0.03,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,22.67,8.0,44.08
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,21.01,6.91,41.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.66,1.09,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,35.53,14.18,65.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,34.02,13.13,63.05
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.51,1.05,2.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,31.9,11.3,58.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,31.9,11.3,58.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.01,4.11,28.26
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,13.37,3.72,27.3
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.64,0.4,0.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,15.05,3.22,33.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,15.05,3.22,33.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,9.19,1.39,21.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.07,0.66,19.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.12,0.72,1.61
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.75,1.76,17.27
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,5.54,0.43,13.94
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.21,1.33,3.33
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.95,2.07,6.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.95,2.07,6.96
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,2.21,7.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.59,1.17,5.23
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,1.62,1.02,2.41
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.86,1.48,5.21
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.08,0.98,4.04
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.78,0.5,1.16
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.63,1.37,4.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.96,0.96,3.84
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.66,0.42,1.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.64,0.8,2.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.64,0.8,2.98
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.64,2.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,1.32,0.64,2.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Deaths,Rate,0.01,0.01,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.71,2.44
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,1.17,0.58,2.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.21,0.14,0.3
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Deaths,Rate,0.01,0.01,0.03
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.46,0.81,2.43
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,1.0,0.51,1.78
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.46,0.3,0.65
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.35,1.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.71,0.35,1.37
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.43,1.63
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.84,0.39,1.56
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.05,0.03,0.07
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.64,0.29,1.25
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.14
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.06,0.04,0.1
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Deaths,Rate,0.02,0.0,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,1.24,0.6,2.18
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,1.18,0.53,2.06
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.08,0.05,0.11
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.28,3.04,18.38
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,8.65,2.63,17.45
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.63,0.4,0.93
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.38,2.79,16.53
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,7.79,2.42,15.66
URY,Uruguay,Southern Cone,Amphetamine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.59,0.38,0.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.68,1.01,5.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.68,1.01,5.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.44,12.63,36.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,22.44,12.63,36.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.31,17.54,52.85
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,31.31,17.54,52.85
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,7.74,2.92,14.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,7.74,2.92,14.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,50.24,28.15,84.82
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,50.24,28.15,84.82
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,77.53,45.03,124.08
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,77.53,45.03,124.08
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,70.37,40.1,118.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,70.37,40.1,118.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.51,35.36,112.46
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,63.51,35.36,112.46
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,35.06,17.49,62.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,35.06,17.49,62.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.62,8.14,34.61
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,18.62,8.14,34.61
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.66,9.21,40.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,21.66,9.21,40.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.91,6.36,28.58
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,14.91,6.36,28.58
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.74,3.52,19.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.74,3.52,19.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.54,2.39,16.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.54,2.39,16.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.43,1.74,11.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.43,1.74,11.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.21,1.68,8.12
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.21,1.68,8.12
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.96,7.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.18,1.96,7.44
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.78,1.3,5.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.78,1.3,5.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.93,0.8,3.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.93,0.8,3.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.67,0.68,3.23
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.67,0.68,3.23
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.32,0.53,2.49
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.32,0.53,2.49
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.31,1.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.31,1.88
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.29,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.74,0.29,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.7,0.33,1.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.7,0.33,1.33
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.2,0.84
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.45,0.2,0.84
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,19.8,10.16,34.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.8,10.16,34.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.69,9.53,32.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,18.69,9.53,32.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.55,0.83,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.55,0.83,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.58,7.22,20.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.58,7.22,20.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.91,9.45,28.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.91,9.45,28.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.45,2.37,7.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.45,2.37,7.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.06,15.13,46.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,27.06,15.13,46.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,43.21,24.99,70.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,43.21,24.99,70.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,37.72,21.14,64.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,37.72,21.14,64.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,32.49,17.48,58.29
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,32.49,17.48,58.29
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.01,7.17,30.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,17.01,7.17,30.15
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.6,3.15,16.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.6,3.15,16.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.9,3.52,19.66
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.9,3.52,19.66
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.67,2.01,13.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.67,2.01,13.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.86,1.15,10.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.86,1.15,10.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.5,1.41,6.65
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.5,1.41,6.65
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.49,1.13,4.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.49,1.13,4.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.79,3.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.86,0.79,3.62
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.75,3.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.77,0.75,3.53
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.25,0.45,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.25,0.45,2.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.85,0.3,1.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.85,0.3,1.83
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.72,0.28,1.45
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.72,0.28,1.45
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.57,0.26,1.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.57,0.26,1.02
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.15,0.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.37,0.15,0.73
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.1,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.26,0.1,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.1,0.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.1,0.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.05,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.15,0.05,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,10.13,5.03,17.95
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.13,5.03,17.95
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.7,4.27,15.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,8.7,4.27,15.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,0.9,5.24
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,2.6,0.9,5.24
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.23,12.36,34.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,22.23,12.36,34.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.09,17.04,52.11
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,31.09,17.04,52.11
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,7.39,2.57,14.9
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,7.39,2.57,14.9
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.55,27.16,83.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,49.55,27.16,83.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,76.34,43.92,116.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,76.34,43.92,116.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,69.57,38.84,115.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,69.57,38.84,115.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,63.06,33.95,114.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,63.06,33.95,114.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,34.54,17.03,63.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,34.54,17.03,63.75
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.54,8.22,34.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,18.54,8.22,34.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.76,9.5,39.96
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,21.76,9.5,39.96
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,15.29,6.21,28.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,15.29,6.21,28.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.62,4.15,20.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,10.62,4.15,20.81
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.35,2.54,15.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,7.35,2.54,15.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.41,1.38,12.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,5.41,1.38,12.1
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.18,1.6,8.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,4.18,1.6,8.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,2.06,7.14
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,4.12,2.06,7.14
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.35,5.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,2.79,1.35,5.18
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.84,3.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,1.97,0.84,3.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.7,3.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,1.69,0.7,3.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.33,0.52,2.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,1.33,0.52,2.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.34,1.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.93,0.34,1.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.3,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.74,0.3,1.47
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.34,1.27
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.71,0.34,1.27
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.19,0.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.44,0.19,0.87
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,19.6,9.93,34.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.6,9.93,34.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,18.47,9.31,32.52
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,18.47,9.31,32.52
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,0.81,2.55
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,1.54,0.81,2.55
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.46,6.64,20.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,12.46,6.64,20.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,16.64,8.74,28.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,16.64,8.74,28.34
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.35,2.29,7.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,4.35,2.29,7.22
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,26.45,13.89,45.05
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,26.45,13.89,45.05
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,42.45,22.63,69.17
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,42.45,22.63,69.17
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,36.9,19.37,62.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,36.9,19.37,62.94
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.6,16.25,56.99
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,31.6,16.25,56.99
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,16.2,7.44,28.38
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,16.2,7.44,28.38
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.32,3.29,15.89
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.32,3.29,15.89
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.72,3.84,19.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.72,3.84,19.7
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.4,1.83,13.2
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,6.4,1.83,13.2
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.73,1.11,9.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.73,1.11,9.79
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.53,1.67,6.68
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.53,1.67,6.68
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.46,1.02,4.57
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,2.46,1.02,4.57
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.84,0.74,3.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,1.84,0.74,3.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.78,0.72,3.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.78,0.72,3.43
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.23,0.46,2.41
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,1.23,0.46,2.41
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.83,0.27,1.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.83,0.27,1.67
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.71,0.26,1.4
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.71,0.26,1.4
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.25,1.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.56,0.25,1.07
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.15,0.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.37,0.15,0.74
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.11,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.25,0.11,0.51
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.1,0.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.25,0.1,0.5
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.06,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.15,0.06,0.31
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.87,4.76,17.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.87,4.76,17.48
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.46,4.04,15.06
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.46,4.04,15.06
URY,Uruguay,Southern Cone,Cannabis use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.1,0.57,1.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.1,0.57,1.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,30.71,15.38,52.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,30.71,15.38,52.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,49.16,25.02,83.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,49.16,25.02,83.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.65,5.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.16,1.65,5.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,78.9,40.16,133.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,78.9,40.16,133.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,113.31,56.68,192.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,113.31,56.68,192.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,114.78,58.4,193.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,114.78,58.4,193.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,116.18,60.05,195.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,116.18,60.05,195.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Deaths,Rate,0.49,0.29,0.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,116.81,61.18,193.81
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,84.83,42.17,143.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,31.98,19.01,50.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Deaths,Rate,0.46,0.28,0.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,81.97,42.54,137.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,56.09,26.84,97.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,25.88,15.7,40.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Deaths,Rate,0.49,0.31,0.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,95.13,50.77,157.09
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.45,32.13,112.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,29.68,18.63,45.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Deaths,Rate,0.43,0.27,0.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,73.91,38.74,126.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,49.84,23.89,88.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,24.07,14.85,38.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Deaths,Rate,0.43,0.26,0.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,62.63,31.81,105.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.05,18.91,72.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,21.58,12.9,32.7
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Deaths,Rate,0.45,0.27,0.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,53.94,26.1,94.31
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,33.27,13.85,60.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,20.66,12.25,33.4
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,27.14,11.67,48.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,27.14,11.67,48.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Deaths,Rate,0.11,0.07,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.65,11.28,47.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,22.61,8.72,41.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,4.04,2.55,6.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Deaths,Rate,0.33,0.21,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,33.67,15.88,57.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,21.94,8.47,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,11.73,7.41,17.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.94,5.46,34.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,17.94,5.46,34.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.27,4.58,27.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,14.27,4.58,27.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.52,4.54,26.53
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.52,4.54,26.53
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.54,4.5,24.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.54,4.5,24.65
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,11.14,3.22,22.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,11.14,3.22,22.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Deaths,Rate,0.29,0.17,0.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,13.98,5.1,26.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.16,2.76,21.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.81,2.34,5.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Deaths,Rate,0.93,0.56,1.37
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,22.1,10.01,39.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.94,2.56,20.95
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,12.12,7.45,18.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.57,2.13,18.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.57,2.13,18.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Deaths,Rate,0.19,0.11,0.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.35,26.97,90.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.53,20.99,75.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,9.83,5.98,15.26
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Deaths,Rate,0.19,0.12,0.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.49,26.35,89.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,42.6,20.33,73.88
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,9.88,6.01,15.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.28,1.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.63,0.28,1.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.3,7.37,33.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,17.3,7.37,33.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.7,12.04,52.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,27.7,12.04,52.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,0.81,3.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.81,0.81,3.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.32,19.27,83.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.32,19.27,83.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,63.6,27.04,124.19
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,63.6,27.04,124.19
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,64.37,27.98,121.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,64.37,27.98,121.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.11,28.88,119.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,65.11,28.88,119.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,47.47,20.29,86.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,47.47,20.29,86.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.2,13.4,59.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,32.2,13.4,59.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,36.51,17.07,65.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,36.51,17.07,65.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,29.6,12.42,58.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,29.6,12.42,58.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,24.87,8.96,45.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,24.87,8.96,45.38
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.51,7.28,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,20.51,7.28,39.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Deaths,Rate,0.13,0.08,0.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,21.92,9.09,40.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.82,5.78,33.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,5.11,3.31,7.39
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.08,5.85,31.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.32,4.71,28.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.76,1.14,2.54
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.87,4.69,27.6
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,13.87,4.69,27.6
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.06,3.55,25.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.06,3.55,25.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.82,2.41,20.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.82,2.41,20.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Deaths,Rate,0.06,0.05,0.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.69,3.11,20.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,9.36,2.09,19.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.33,1.02,1.69
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Deaths,Rate,0.13,0.1,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.69,3.92,21.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.82,1.71,17.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.87,2.21,3.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.36,1.65,19.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.36,1.65,19.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Deaths,Rate,0.11,0.07,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.52,1.87,18.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.46,1.22,16.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.07,0.65,1.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Deaths,Rate,0.17,0.1,0.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.4,2.4,19.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.35,1.1,15.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,2.07,1.28,3.15
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Deaths,Rate,0.18,0.1,0.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.98,1.67,16.7
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.68,0.89,14.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.31,0.78,2.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.49,10.61,48.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,25.13,10.36,47.54
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.36,0.24,0.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,23.92,9.71,45.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,23.4,9.36,44.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.51,0.34,0.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.16,0.59,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,1.16,0.59,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,32.8,15.94,55.82
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,32.12,15.58,54.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.68,0.36,1.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,53.25,26.15,90.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,51.25,25.01,87.59
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.0,1.13,3.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,1.67,5.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,3.31,1.67,5.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,84.89,41.68,144.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,81.7,39.88,139.63
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,3.19,1.81,5.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Deaths,Rate,0.03,0.02,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,119.96,58.25,204.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,117.41,56.89,199.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.55,1.35,4.28
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Deaths,Rate,0.06,0.04,0.11
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,123.62,60.68,210.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,118.92,58.01,203.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,4.7,2.66,7.62
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Deaths,Rate,0.09,0.05,0.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,127.13,63.02,217.32
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,120.36,59.09,206.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,6.77,3.93,10.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Deaths,Rate,0.52,0.3,0.83
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,120.99,61.6,201.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,86.94,41.56,146.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,34.04,20.04,54.56
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Deaths,Rate,0.36,0.22,0.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,77.91,40.24,130.51
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,57.1,27.75,97.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,20.81,12.49,32.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Deaths,Rate,0.35,0.22,0.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,86.71,47.06,144.67
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,65.46,33.91,111.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,21.25,13.14,33.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Deaths,Rate,0.32,0.2,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,69.9,36.51,115.89
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,52.05,25.52,87.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,17.85,11.0,28.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Deaths,Rate,0.29,0.17,0.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,56.29,28.7,92.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,41.81,20.03,70.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,14.48,8.67,21.76
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Deaths,Rate,0.31,0.18,0.5
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,47.21,22.86,84.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,33.12,14.6,61.75
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,14.08,8.26,22.45
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,27.51,11.58,48.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,27.51,11.58,48.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Deaths,Rate,0.04,0.02,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.16,9.82,43.52
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,22.81,8.98,41.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,1.35,0.84,2.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Deaths,Rate,0.11,0.06,0.17
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,26.32,10.96,47.99
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,22.4,8.52,42.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,3.93,2.45,5.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.71,6.42,32.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,17.71,6.42,32.44
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.94,4.93,27.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,13.94,4.93,27.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,13.3,4.49,26.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,13.3,4.49,26.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.47,3.92,24.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.47,3.92,24.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Deaths,Rate,0.26,0.18,0.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,15.43,6.2,27.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.98,3.26,21.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,4.47,2.95,6.2
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Deaths,Rate,0.38,0.24,0.55
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,14.47,5.53,26.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.06,2.7,20.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,4.41,2.83,6.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Deaths,Rate,0.3,0.19,0.45
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,13.5,4.7,25.18
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.7,2.42,19.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.77,2.28,5.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Deaths,Rate,0.73,0.44,1.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,13.92,5.37,26.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.8,2.03,18.66
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,5.12,3.34,7.35
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Deaths,Rate,0.16,0.09,0.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,53.1,26.36,90.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,44.62,21.28,76.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,8.48,5.08,13.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Deaths,Rate,0.16,0.1,0.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,52.13,25.72,88.81
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,43.65,20.64,75.48
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,8.47,5.08,13.33
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.66,0.31,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.66,0.31,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Deaths,Rate,0.0,0.0,0.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,17.91,7.8,34.97
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,17.61,7.62,34.51
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.3,0.18,0.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,28.74,12.72,55.27
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,28.23,12.42,54.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.5,0.3,0.8
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.87,3.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,1.86,0.87,3.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,45.67,20.21,87.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,44.87,19.73,86.57
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.8,0.48,1.27
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,65.25,28.35,127.61
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,64.14,27.67,125.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.12,0.67,1.75
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,66.4,29.36,127.78
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,65.22,28.66,125.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.18,0.7,1.87
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,67.5,30.34,127.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,66.27,29.6,125.96
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.23,0.73,1.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,47.8,21.01,86.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,47.8,21.01,86.73
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.02,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,34.04,14.33,62.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,32.82,13.55,60.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.22,0.78,1.86
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,37.69,16.12,67.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,37.69,16.12,67.3
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Deaths,Rate,0.04,0.03,0.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,31.72,13.07,57.84
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,29.6,11.65,54.68
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,2.13,1.41,3.16
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Deaths,Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,12.32,53.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,25.16,9.72,47.47
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,4.16,2.6,6.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.78,8.23,43.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,21.78,8.23,43.94
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Deaths,Rate,0.05,0.03,0.07
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,19.67,7.2,37.24
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,17.61,5.86,34.22
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.06,1.33,3.02
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,15.59,4.85,30.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.61,4.22,28.58
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,0.98,0.62,1.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.14,4.41,28.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.33,3.92,27.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.81,0.49,1.25
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,11.66,2.78,24.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,11.66,2.78,24.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,9.71,2.14,20.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,9.71,2.14,20.36
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Deaths,Rate,0.05,0.03,0.05
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.13,2.83,20.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,9.16,2.08,19.43
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.97,0.74,1.21
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Deaths,Rate,0.1,0.07,0.12
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,10.63,3.64,20.98
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,8.52,2.02,18.34
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.11,1.62,2.64
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.14,1.44,16.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,8.14,1.44,16.77
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Deaths,Rate,0.08,0.05,0.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,8.17,1.75,17.23
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,7.47,1.34,16.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,0.7,0.42,1.1
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Deaths,Rate,0.06,0.04,0.08
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.27,2.1,18.06
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,7.52,1.64,16.91
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.75,0.46,1.14
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Deaths,Rate,0.18,0.11,0.29
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.13,1.79,17.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,6.79,1.02,14.92
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.34,0.79,2.13
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,26.35,10.99,49.72
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,25.52,10.46,48.46
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.83,0.53,1.26
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,24.66,10.0,46.74
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,23.78,9.44,45.41
URY,Uruguay,Southern Cone,Cocaine use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.88,0.56,1.32
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.78,1.58,6.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.78,1.58,6.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,61.98,30.23,106.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,61.98,30.23,106.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,121.23,60.41,207.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,121.23,60.41,207.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,10.89,4.56,19.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,10.89,4.56,19.91
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.56,96.95,333.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,194.56,96.95,333.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,224.3,110.13,383.42
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,224.3,110.13,383.42
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,281.55,140.71,481.3
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,281.55,140.71,481.3
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,336.43,170.02,575.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,336.43,170.02,575.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Deaths,Rate,3.61,2.36,5.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,532.12,305.17,841.45
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,296.19,151.32,492.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,235.93,153.86,349.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Deaths,Rate,2.55,1.64,3.79
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,322.5,175.76,523.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,177.31,82.19,307.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,145.19,93.57,215.98
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Deaths,Rate,2.23,1.43,3.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,347.04,184.53,563.64
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,212.85,98.19,363.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,134.2,86.34,199.99
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Deaths,Rate,2.32,1.51,3.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,280.63,151.8,461.64
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,151.95,68.25,271.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,128.68,83.56,190.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Deaths,Rate,2.23,1.41,3.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,225.22,117.66,374.17
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,112.94,46.36,207.11
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,112.28,71.3,167.05
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Deaths,Rate,2.21,1.39,3.35
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,188.53,96.26,318.08
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,88.29,33.22,165.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,100.23,63.05,152.15
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,71.25,28.93,131.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,71.25,28.93,131.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.42,0.27,0.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,73.32,31.5,131.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,58.24,21.72,109.29
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,15.08,9.79,22.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Deaths,Rate,1.22,0.8,1.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,100.84,49.08,172.22
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,57.05,20.66,107.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,43.79,28.41,64.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,43.96,14.25,83.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,43.96,14.25,83.93
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,33.75,10.28,68.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.75,10.28,68.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,31.22,9.3,64.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.22,9.3,64.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,27.96,8.02,58.63
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,27.96,8.02,58.63
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,23.73,5.39,49.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.73,5.39,49.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Deaths,Rate,1.4,0.92,2.02
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,40.88,17.79,73.26
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.58,5.78,46.78
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,18.31,12.0,26.47
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Deaths,Rate,4.45,2.93,6.45
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,80.0,44.04,128.46
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.69,5.78,44.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,58.32,38.22,84.34
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.54,6.54,45.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,21.54,6.54,45.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Deaths,Rate,1.0,0.64,1.48
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,175.32,91.65,291.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,121.24,56.77,211.06
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,54.08,34.88,80.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Deaths,Rate,1.03,0.66,1.53
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,172.79,89.93,287.82
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,118.76,55.09,207.54
URY,Uruguay,Southern Cone,Drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,54.03,34.84,80.29
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,1.11,3.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.18,1.11,3.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,38.62,16.75,72.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,38.62,16.75,72.12
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,83.78,37.98,150.52
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,83.78,37.98,150.52
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.27,3.19,10.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.27,3.19,10.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,134.07,60.78,240.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,134.07,60.78,240.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,139.84,60.18,262.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,139.84,60.18,262.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.35,87.95,349.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,194.35,87.95,349.5
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,246.27,114.4,432.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,246.27,114.4,432.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,240.69,116.64,403.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,240.69,116.64,403.62
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,156.73,72.5,270.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,156.73,72.5,270.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,189.31,89.9,318.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,189.31,89.9,318.31
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,144.0,67.23,254.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,144.0,67.23,254.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,109.8,45.57,199.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,109.8,45.57,199.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,88.39,37.26,158.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,88.39,37.26,158.37
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Deaths,Rate,2.09,1.51,2.79
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,159.35,93.0,250.4
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,74.45,31.68,136.85
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,84.91,61.32,113.55
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.72,0.52,0.96
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,89.93,45.55,151.24
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,60.7,24.44,112.14
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,29.24,21.11,39.1
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,59.22,23.65,109.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,59.22,23.65,109.36
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,47.16,17.31,87.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,47.16,17.31,87.97
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,38.03,13.84,72.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,38.03,13.84,72.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.75,0.58,0.94
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,51.43,24.3,88.19
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,35.15,11.69,67.81
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.28,12.61,20.39
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Deaths,Rate,1.62,1.26,2.05
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,67.07,36.52,106.44
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,31.79,9.18,62.28
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,35.28,27.33,44.18
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,29.18,8.39,61.75
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,29.18,8.39,61.75
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Deaths,Rate,1.41,0.98,1.92
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.68,17.74,75.21
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,27.29,7.63,55.65
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,14.39,10.1,19.57
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Deaths,Rate,2.46,1.78,3.33
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,58.99,30.88,96.99
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,26.68,7.6,53.44
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,32.33,23.29,43.55
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Deaths,Rate,1.95,1.31,2.68
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,40.1,16.39,71.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,25.94,6.92,51.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,14.16,9.47,19.56
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.18,0.13,0.24
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,105.8,49.35,184.25
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,100.08,45.18,176.66
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,5.72,4.17,7.59
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Deaths,Rate,0.32,0.23,0.43
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,101.7,47.35,177.07
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,94.02,41.76,166.88
URY,Uruguay,Southern Cone,Drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,7.68,5.59,10.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.76,1.49,7.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,3.76,1.49,7.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.08,0.05,0.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,69.84,33.93,118.35
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,63.56,30.21,108.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.27,3.71,9.98
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.21,0.13,0.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,138.17,69.45,235.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,123.27,60.19,212.75
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,14.89,9.26,22.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,10.69,4.23,20.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,10.69,4.23,20.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.33,0.21,0.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,220.25,110.71,375.02
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,196.51,95.95,339.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,23.74,14.76,35.87
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.31,0.19,0.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,251.92,123.31,424.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,228.36,109.36,387.11
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,23.56,13.95,37.47
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.49,0.3,0.73
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,319.74,161.26,543.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,284.72,139.49,490.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,35.01,21.76,52.9
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.66,0.42,0.96
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,384.97,197.76,657.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,338.93,168.47,589.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,46.03,29.28,67.74
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Deaths,Rate,3.89,2.51,5.87
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,554.77,314.44,880.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,300.42,150.58,496.78
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,254.35,163.86,383.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Deaths,Rate,2.09,1.34,3.14
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,302.06,164.64,491.97
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,180.29,86.5,309.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,121.77,78.14,182.82
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Deaths,Rate,1.6,1.03,2.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,312.58,171.27,509.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,216.01,109.29,363.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,96.57,61.98,145.7
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Deaths,Rate,1.71,1.1,2.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,251.3,135.65,412.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,156.68,74.42,271.9
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,94.61,61.24,140.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Deaths,Rate,1.5,0.95,2.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,191.26,97.67,317.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,115.74,49.38,205.29
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,75.52,48.28,111.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Deaths,Rate,1.49,0.93,2.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,155.53,77.55,271.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,87.7,35.16,169.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,67.82,42.39,102.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,28.21,134.28
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,72.53,28.21,134.28
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.14,0.09,0.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.89,24.86,115.71
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,57.85,21.64,108.29
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,5.04,3.22,7.42
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.41,0.26,0.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,70.48,30.12,126.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,55.85,20.77,105.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,14.62,9.36,21.56
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,42.73,14.85,81.18
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,42.73,14.85,81.18
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,33.42,10.75,68.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,33.42,10.75,68.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,31.28,9.8,64.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,31.28,9.8,64.25
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.48,8.55,58.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,28.48,8.55,58.55
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.98,0.67,1.32
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,40.42,17.52,70.56
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,23.73,5.79,47.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,16.7,11.73,22.72
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Deaths,Rate,1.71,1.15,2.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,41.72,18.88,72.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,22.44,5.87,45.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,19.28,13.01,27.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Deaths,Rate,1.38,0.9,2.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,39.43,17.34,69.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,21.19,5.67,42.75
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,18.24,11.67,26.78
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Deaths,Rate,3.48,2.37,4.93
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,47.14,23.4,81.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,21.66,6.28,45.01
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,25.48,17.11,36.06
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.89,0.57,1.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,173.17,90.34,288.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,122.8,58.11,212.97
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,50.37,32.23,75.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Deaths,Rate,0.92,0.59,1.37
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,170.35,88.46,284.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,120.43,56.5,209.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,49.92,31.96,74.88
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.19,1.12,3.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,2.19,1.12,3.76
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.09,0.06,0.13
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,45.53,21.14,82.91
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,38.75,16.4,73.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,6.78,4.74,9.52
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.14,0.1,0.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,94.61,45.46,170.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,84.62,38.55,156.27
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,9.99,6.9,14.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,6.2,3.16,10.66
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,6.2,3.16,10.66
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.22,0.15,0.31
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.35,72.24,270.6
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,134.48,61.27,248.36
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,15.87,10.97,22.24
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.34,0.24,0.48
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,164.45,76.1,300.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,139.06,58.35,264.41
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,25.4,17.75,35.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.32,0.23,0.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.57,104.94,393.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,195.19,88.77,360.84
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,23.39,16.16,32.77
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.3,0.21,0.42
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,270.34,132.52,483.11
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,248.89,117.87,453.08
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,21.46,14.65,30.03
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,244.54,122.01,417.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,244.54,122.01,417.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.21,0.15,0.3
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,170.39,83.95,290.49
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,159.18,76.06,275.05
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,11.21,7.89,15.44
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,194.08,94.28,329.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,194.08,94.28,329.23
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.37,0.27,0.49
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,165.39,82.26,276.39
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,144.93,67.33,248.95
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,20.46,14.93,27.43
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.74,0.52,1.03
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,148.23,75.94,251.15
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,110.74,50.07,198.81
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,37.49,25.88,52.34
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,89.51,40.12,160.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,89.51,40.12,160.65
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.84,0.61,1.12
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,109.56,56.37,182.19
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,75.38,31.55,136.59
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,34.18,24.82,45.61
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.42,0.3,0.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,76.54,35.13,132.74
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,60.13,23.36,110.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,16.41,11.77,22.2
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.38,0.27,0.54
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,72.41,31.74,125.91
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,58.6,22.14,106.58
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,13.81,9.6,19.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,45.28,15.83,86.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,45.28,15.83,86.63
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,37.14,11.54,70.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,37.14,11.54,70.64
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.55,0.42,0.69
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,46.56,20.17,81.99
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,34.71,11.07,67.17
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,11.84,9.09,14.81
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Deaths,Rate,1.2,0.92,1.5
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,57.69,30.37,95.4
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,31.84,10.51,63.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,25.85,19.84,32.32
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,28.93,8.43,58.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,28.93,8.43,58.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Deaths,Rate,0.99,0.67,1.36
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,35.66,13.55,66.22
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,27.02,7.61,54.34
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,8.63,5.93,11.89
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.89,0.64,1.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,37.84,15.73,69.38
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,26.16,7.31,53.53
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,11.66,8.39,15.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Deaths,Rate,2.0,1.32,2.77
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,40.39,16.74,70.83
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,25.86,7.05,50.68
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,14.53,9.68,20.16
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.24,0.17,0.33
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,112.08,54.2,195.07
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,101.01,46.38,179.86
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,11.08,7.82,15.21
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Deaths,Rate,0.33,0.23,0.45
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,106.49,51.03,185.57
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,94.99,42.89,169.85
URY,Uruguay,Southern Cone,Drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,11.5,8.14,15.72
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.0,1.74,11.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.0,1.74,11.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,27.75,13.04,46.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,27.75,13.04,46.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,44.54,20.93,74.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,44.54,20.93,74.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,22.74,6.6,43.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,22.74,6.6,43.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,65.64,30.85,109.85
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,65.64,30.85,109.85
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,106.75,54.09,173.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,106.75,54.09,173.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Deaths,Rate,2.52,1.73,3.61
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,291.58,186.01,434.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,126.8,72.97,199.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,164.78,113.05,235.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Deaths,Rate,1.68,1.13,2.42
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,174.13,104.44,265.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,78.18,39.95,127.51
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,95.95,64.48,138.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Deaths,Rate,1.36,0.9,1.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,179.44,102.98,274.41
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,97.48,48.48,155.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,81.96,54.5,118.43
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Deaths,Rate,1.51,1.02,2.14
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,152.83,89.71,233.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,69.36,33.42,115.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,83.46,56.29,118.46
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Deaths,Rate,1.46,0.96,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,122.01,70.82,191.63
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,48.64,22.6,85.18
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,73.37,48.22,106.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Deaths,Rate,1.44,0.94,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,103.87,58.64,163.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.21,15.67,66.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,65.67,42.97,96.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,31.57,12.96,57.93
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,31.57,12.96,57.93
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Deaths,Rate,0.25,0.17,0.36
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.43,15.43,62.67
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.5,9.46,49.88
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,8.93,5.97,12.79
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Deaths,Rate,0.72,0.49,1.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,52.4,26.07,87.83
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,26.49,8.73,50.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,25.91,17.35,37.14
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.43,6.08,39.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,20.43,6.08,39.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.36,3.79,33.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,15.36,3.79,33.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.04,3.04,31.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.04,3.04,31.08
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.35,2.06,28.47
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.35,2.06,28.47
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,10.27,1.13,22.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.27,1.13,22.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Deaths,Rate,0.8,0.56,1.13
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.5,9.18,35.95
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.94,1.86,21.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,10.57,7.31,14.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Deaths,Rate,2.56,1.78,3.6
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,43.3,25.54,66.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.64,2.22,19.43
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,33.66,23.28,47.27
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.71,2.77,20.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,9.71,2.77,20.8
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Deaths,Rate,0.65,0.44,0.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,78.87,44.73,123.69
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,43.32,20.83,72.59
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,35.55,23.9,51.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Deaths,Rate,0.67,0.45,0.96
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,78.66,44.36,123.81
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,43.2,20.53,72.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,35.45,23.83,50.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.62,2.03,12.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.62,2.03,12.56
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,29.86,13.75,49.89
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,29.86,13.75,49.89
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,47.78,22.01,79.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,47.78,22.01,79.84
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,25.02,7.66,47.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,25.02,7.66,47.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,70.32,32.39,117.5
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,70.32,32.39,117.5
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,113.47,55.95,184.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,113.47,55.95,184.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,141.2,76.72,221.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,141.2,76.72,221.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,97.21,50.33,155.91
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,97.21,50.33,155.91
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,122.31,63.54,189.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,122.31,63.54,189.11
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,93.13,50.13,150.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,93.13,50.13,150.1
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,68.68,33.11,116.68
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,68.68,33.11,116.68
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.36,24.51,93.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.36,24.51,93.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Deaths,Rate,1.71,1.26,2.24
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,117.55,73.72,175.34
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.01,22.26,84.45
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,69.53,51.45,90.88
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Deaths,Rate,0.59,0.44,0.77
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,64.01,35.15,101.82
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,40.06,17.43,70.53
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,23.94,17.72,31.3
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,39.76,17.3,69.48
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,39.76,17.3,69.48
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.64,12.24,56.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,31.64,12.24,56.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,25.54,10.23,46.9
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,25.54,10.23,46.9
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Deaths,Rate,0.6,0.47,0.74
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,36.29,18.56,60.26
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,23.41,8.48,44.32
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,12.87,10.09,15.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Deaths,Rate,1.29,1.02,1.6
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,48.83,28.28,75.86
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,20.93,6.43,41.32
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,27.88,21.86,34.54
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.3,5.96,39.23
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,19.3,5.96,39.23
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Deaths,Rate,1.12,0.8,1.49
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,29.75,13.92,51.21
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,18.25,5.61,36.04
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,11.5,8.31,15.17
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Deaths,Rate,1.99,1.47,2.61
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,44.11,25.19,69.36
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,18.07,5.86,35.27
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,26.04,19.31,34.07
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Deaths,Rate,1.54,1.06,2.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.52,12.71,48.44
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,17.37,5.06,33.52
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,11.15,7.65,14.94
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Deaths,Rate,0.15,0.11,0.19
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,58.41,29.93,94.38
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,53.75,26.46,88.33
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.66,3.47,6.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Deaths,Rate,0.26,0.19,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,58.0,29.65,94.05
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,51.78,25.02,85.98
URY,Uruguay,Southern Cone,Opioid use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,6.22,4.63,8.07
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Deaths,Rate,0.06,0.04,0.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,10.85,4.67,19.47
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,6.42,1.94,12.68
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,4.43,2.73,6.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Deaths,Rate,0.14,0.09,0.21
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.9,20.43,63.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,28.62,13.82,48.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,10.29,6.61,15.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Deaths,Rate,0.23,0.15,0.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,62.02,32.56,101.3
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,45.62,22.03,77.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,16.4,10.54,23.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Deaths,Rate,0.22,0.14,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,40.74,17.54,73.14
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,24.12,7.28,47.62
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,16.62,10.27,25.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Deaths,Rate,0.34,0.22,0.49
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,91.46,48.02,149.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,67.27,32.48,114.07
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,24.19,15.54,35.32
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Deaths,Rate,0.45,0.29,0.63
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,140.24,77.33,222.72
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,108.77,56.72,177.97
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,31.46,20.61,44.75
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Deaths,Rate,2.71,1.84,3.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,307.01,192.97,455.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,129.7,72.69,197.69
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,177.3,120.28,257.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Deaths,Rate,1.39,0.93,2.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,161.48,97.34,245.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,80.59,43.01,128.65
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,80.88,54.33,117.24
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Deaths,Rate,0.98,0.65,1.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,159.91,95.87,242.75
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,101.13,56.68,157.18
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,58.78,39.19,85.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Deaths,Rate,1.1,0.74,1.58
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,132.81,79.69,204.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,71.88,38.67,117.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,60.92,41.02,87.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Deaths,Rate,0.97,0.65,1.4
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,100.5,56.22,156.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,51.34,23.54,85.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,49.17,32.68,70.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Deaths,Rate,0.97,0.63,1.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,82.2,45.6,134.88
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,38.06,16.78,70.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,44.15,28.82,64.32
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,32.65,12.77,59.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,32.65,12.77,59.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Deaths,Rate,0.08,0.05,0.12
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,29.05,11.21,52.95
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.09,9.25,48.7
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,2.96,1.96,4.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Deaths,Rate,0.24,0.16,0.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,33.66,14.41,59.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,25.06,8.72,46.74
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,8.61,5.69,12.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,19.49,5.7,38.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,19.49,5.7,38.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,15.35,3.93,33.51
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,15.35,3.93,33.51
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,14.31,3.61,31.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,14.31,3.61,31.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.96,3.21,28.64
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.96,3.21,28.64
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Deaths,Rate,0.52,0.39,0.67
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.23,7.93,34.09
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.47,1.47,22.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,8.76,6.46,11.66
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Deaths,Rate,0.96,0.67,1.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.7,9.51,36.03
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.94,1.97,21.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,10.74,7.53,14.83
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Deaths,Rate,0.78,0.52,1.16
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,19.92,9.25,34.65
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.44,2.2,19.66
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,10.48,7.01,14.99
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Deaths,Rate,2.03,1.4,2.8
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,24.46,12.81,41.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,9.62,2.61,20.88
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,14.79,10.2,20.55
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Deaths,Rate,0.59,0.39,0.85
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,77.93,44.61,122.12
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,44.44,22.22,73.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,33.49,22.39,48.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Deaths,Rate,0.6,0.4,0.87
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,77.55,44.1,122.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,44.43,21.95,74.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,33.13,22.15,48.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Deaths,Rate,0.07,0.05,0.1
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,12.13,5.98,20.77
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,6.65,2.02,13.28
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,5.48,3.96,7.48
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Deaths,Rate,0.11,0.08,0.15
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,38.44,20.13,65.6
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,30.43,14.43,54.69
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,8.01,5.7,10.92
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Deaths,Rate,0.18,0.12,0.24
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,61.09,31.99,104.26
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,48.36,22.94,86.91
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,12.73,9.05,17.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Deaths,Rate,0.27,0.2,0.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,45.41,22.39,77.74
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,24.89,7.56,49.73
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,20.51,14.83,28.01
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Deaths,Rate,0.26,0.18,0.35
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,90.0,47.13,153.6
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,71.25,33.79,128.04
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,18.75,13.34,25.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Deaths,Rate,0.24,0.17,0.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,132.66,70.8,226.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,115.59,58.89,202.94
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,17.07,11.91,23.23
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,145.15,81.39,236.13
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,145.15,81.39,236.13
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Deaths,Rate,0.17,0.12,0.22
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,107.99,60.08,171.84
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,99.42,53.84,160.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.57,6.24,11.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.44,69.55,198.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,126.44,69.55,198.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Deaths,Rate,0.29,0.21,0.37
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,110.8,63.09,170.5
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,95.07,51.23,150.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,15.73,11.88,20.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Deaths,Rate,0.57,0.4,0.77
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,97.84,57.16,153.97
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,69.27,36.75,115.4
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,28.58,20.41,38.57
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,54.35,26.17,91.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,54.35,26.17,91.42
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Deaths,Rate,0.69,0.52,0.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,76.1,42.94,118.93
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,48.11,22.05,82.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,27.99,20.89,36.39
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Deaths,Rate,0.34,0.25,0.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,52.67,26.75,86.81
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,39.21,16.83,69.02
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,13.46,9.92,17.79
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Deaths,Rate,0.32,0.23,0.43
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,50.04,24.65,83.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,38.66,16.54,67.44
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,11.38,8.11,15.61
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,30.17,11.49,56.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,30.17,11.49,56.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,24.78,8.23,45.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,24.78,8.23,45.36
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Deaths,Rate,0.43,0.34,0.54
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,32.55,15.15,55.04
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,23.18,7.88,43.45
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,9.36,7.27,11.59
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Deaths,Rate,0.94,0.74,1.17
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,41.73,23.33,66.5
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,21.3,7.47,41.2
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,20.43,15.87,25.3
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,19.3,6.21,39.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,19.3,6.21,39.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Deaths,Rate,0.78,0.55,1.05
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,24.85,10.35,44.56
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,17.98,5.48,35.41
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,6.87,4.87,9.15
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Deaths,Rate,0.73,0.54,0.96
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,26.81,12.07,46.71
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,17.39,5.07,34.33
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,9.41,7.0,12.38
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Deaths,Rate,1.56,1.08,2.11
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,28.63,12.95,47.89
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,17.18,5.1,32.52
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,11.45,7.86,15.37
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Deaths,Rate,0.19,0.14,0.25
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,63.37,34.21,103.19
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,54.6,27.83,91.47
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,8.78,6.38,11.72
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Deaths,Rate,0.26,0.19,0.34
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,61.77,32.94,100.98
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,52.65,26.29,88.85
URY,Uruguay,Southern Cone,Opioid use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,9.12,6.64,12.13
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.02,1.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.51,0.02,1.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.19,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.75,0.03,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.75,0.03,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.29,0.0,3.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.29,0.0,3.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Deaths,Rate,0.38,0.22,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,27.9,14.63,47.36
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.91,0.45,6.91
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,24.99,14.18,40.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Deaths,Rate,0.23,0.13,0.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.11,8.58,29.85
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.69,0.76,8.21
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,13.42,7.81,21.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Deaths,Rate,0.21,0.13,0.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,16.66,8.43,29.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.91,0.76,8.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,12.75,7.67,20.43
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Deaths,Rate,0.21,0.12,0.33
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,15.72,7.9,27.91
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,4.13,1.04,9.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,11.58,6.86,18.33
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Deaths,Rate,0.18,0.11,0.28
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.81,6.05,23.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.93,0.77,8.6
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,8.88,5.28,14.43
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Deaths,Rate,0.15,0.08,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.64,4.84,18.97
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.68,0.86,7.56
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.96,3.98,11.4
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.73,0.47,6.3
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.73,0.47,6.3
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,2.34,0.73,4.88
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.52,0.23,3.65
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.81,0.5,1.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Deaths,Rate,0.06,0.04,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,3.59,1.45,6.99
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.22,0.0,3.41
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,2.36,1.45,3.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.21,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.41,0.21,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.58
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Deaths,Rate,0.26,0.15,0.38
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.74,2.27,5.61
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.41,0.23,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,3.34,2.04,5.03
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Deaths,Rate,0.82,0.48,1.22
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,11.01,6.71,16.57
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.22,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,10.64,6.49,16.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.25,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.45,0.25,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.15
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.67,3.24,11.82
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.68,0.33,3.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.99,2.91,8.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Deaths,Rate,0.1,0.06,0.16
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.69,3.25,11.85
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,1.7,0.34,3.84
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Male,All ages,Years of Life Lost (YLLs),Rate,4.98,2.91,8.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.34,0.01,0.89
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.34,0.01,0.89
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.02,1.42
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.54,0.02,1.42
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.18,0.06,0.39
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.39
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.8,0.03,2.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.8,0.03,2.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.0,3.7
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.39,0.0,3.7
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.55,0.89,7.93
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.55,0.89,7.93
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.29,1.66,10.74
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.29,1.66,10.74
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.18,1.55,10.44
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.18,1.55,10.44
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.82,2.09,11.96
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.82,2.09,11.96
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.05,1.91,12.31
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.05,1.91,12.31
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.04,1.97,11.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,6.04,1.97,11.37
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Deaths,Rate,0.16,0.1,0.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,10.78,5.31,18.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.53,1.33,9.5
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.25,3.98,9.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Deaths,Rate,0.05,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,4.54,1.92,8.48
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.38,0.55,5.27
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,2.15,1.37,3.22
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.86,0.0,4.9
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.86,0.0,4.9
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.59,0.29,1.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.59,0.29,1.01
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.51,0.29,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.51,0.29,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Deaths,Rate,0.08,0.06,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,2.28,1.59,3.13
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.49,0.28,0.78
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.8,1.31,2.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Deaths,Rate,0.17,0.13,0.23
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,4.35,3.12,5.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.46,0.28,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,3.9,2.84,5.08
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.27,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.42,0.27,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Deaths,Rate,0.17,0.1,0.26
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,2.23,1.4,3.36
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.49,0.31,0.73
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,1.74,1.09,2.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Deaths,Rate,0.31,0.19,0.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,4.47,2.84,6.71
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.43,0.27,0.66
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,4.04,2.57,6.06
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Deaths,Rate,0.23,0.13,0.35
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.21,1.37,3.34
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.59,0.38,0.88
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,1.62,0.99,2.46
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,2.84,1.0,5.63
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.37,0.69,4.94
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.47,0.31,0.68
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Deaths,Rate,0.03,0.02,0.05
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.0,1.14,5.79
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,2.32,0.69,4.8
URY,Uruguay,Southern Cone,Other drug use disorders,2020,Female,All ages,Years of Life Lost (YLLs),Rate,0.68,0.45,0.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Deaths,Rate,0.01,0.0,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.81,0.43,1.43
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.76,0.41,1.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Deaths,Rate,0.02,0.01,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.98,1.03,3.43
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.32,0.01,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.67,1.02,2.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Deaths,Rate,0.04,0.02,0.06
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.16,1.65,5.47
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.5,0.02,1.33
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.66,1.63,4.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Deaths,Rate,0.04,0.02,0.07
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.05,1.6,5.37
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.2,0.07,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,2.85,1.53,4.95
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Deaths,Rate,0.06,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.66,2.43,8.07
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.74,0.03,1.96
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,3.92,2.4,6.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Deaths,Rate,0.07,0.05,0.1
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,6.21,3.24,10.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.27,0.0,3.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,4.95,3.24,7.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Deaths,Rate,0.41,0.23,0.69
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,30.03,15.63,51.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,2.92,0.54,6.73
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,27.1,15.08,44.94
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Deaths,Rate,0.2,0.11,0.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,15.25,7.51,26.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.63,0.85,7.84
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,11.62,6.66,19.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Deaths,Rate,0.16,0.09,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,13.09,6.56,22.93
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.87,1.03,8.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,9.23,5.53,14.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Deaths,Rate,0.16,0.09,0.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,12.52,6.15,21.81
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.91,1.04,8.19
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,8.61,5.1,13.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Deaths,Rate,0.12,0.07,0.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.87,4.46,18.32
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.86,0.9,8.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.01,3.56,9.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Deaths,Rate,0.1,0.06,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.42,3.47,15.67
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,3.67,0.78,7.89
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,4.75,2.69,7.78
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,2.69,0.49,6.52
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,2.69,0.49,6.52
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,1.75,0.4,3.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,1.47,0.24,3.57
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.27,0.16,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,0.48,4.23
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,1.14,0.0,3.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.79,0.48,1.21
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.22,0.7
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,0.41,0.22,0.7
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.22,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,0.39,0.22,0.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.23,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Deaths,Rate,0.13,0.08,0.18
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,2.66,1.76,3.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,0.39,0.23,0.59
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,2.27,1.5,3.26
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Deaths,Rate,0.29,0.19,0.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,3.6,2.32,5.27
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,0.41,0.26,0.61
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,3.19,2.07,4.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Deaths,Rate,0.26,0.15,0.37
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,3.77,2.35,5.63
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,0.41,0.26,0.6
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,3.36,2.09,5.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Deaths,Rate,0.63,0.44,0.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.12,3.34,7.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,0.44,0.29,0.68
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,4.69,3.09,6.82
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Deaths,Rate,0.09,0.05,0.14
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.22,11.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,1.65,0.36,3.65
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.93,2.86,7.99
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Deaths,Rate,0.09,0.06,0.15
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,6.57,3.21,11.64
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,1.68,0.37,3.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.89,2.84,7.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Deaths,Rate,0.01,0.0,0.01
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.57,0.32,0.93
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.11
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.52,0.3,0.83
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.46,2.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.35,0.01,0.98
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.77,0.45,1.24
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.73,3.53
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.55,0.02,1.56
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.22,0.71,1.97
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.12,1.19,3.49
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.06,0.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,1.94,1.13,3.09
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.6,1.07,5.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.81,0.03,2.3
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.79,1.04,2.9
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Deaths,Rate,0.02,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.07,0.95,6.84
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.42,0.0,4.13
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.65,0.95,2.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.49,0.88,7.8
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.49,0.88,7.8
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Deaths,Rate,0.02,0.01,0.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.02,2.14,11.92
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.24,1.67,10.72
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.78,0.48,1.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.19,1.56,10.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.19,1.56,10.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.28,2.89,13.63
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,5.8,1.97,11.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.47,0.93,2.21
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Deaths,Rate,0.05,0.03,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.58,3.59,16.2
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,6.03,2.06,12.23
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.55,1.53,3.97
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.9,1.99,11.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,5.9,1.99,11.66
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Deaths,Rate,0.06,0.04,0.09
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,7.12,3.0,13.82
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,4.61,1.44,10.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.5,1.56,3.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,3.58,1.32,7.19
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,2.4,0.58,5.39
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,1.18,0.73,1.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,2.82,0.58,6.25
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,1.87,0.0,4.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.96,0.58,1.46
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.29,1.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,0.58,0.29,1.02
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,0.5,0.27,0.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,0.5,0.27,0.79
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Deaths,Rate,0.06,0.05,0.08
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,1.79,1.21,2.45
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,0.48,0.27,0.75
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,1.3,0.94,1.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Deaths,Rate,0.13,0.1,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,2.32,4.42
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,0.45,0.27,0.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,2.84,2.05,3.73
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,0.42,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,0.42,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Deaths,Rate,0.11,0.06,0.18
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,1.5,0.91,2.28
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,0.48,0.29,0.71
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,1.02,0.62,1.56
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Deaths,Rate,0.1,0.06,0.17
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,1.16,2.87
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,0.44,0.25,0.62
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,1.45,0.89,2.22
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Deaths,Rate,0.23,0.13,0.35
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,2.24,1.34,3.4
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,0.56,0.35,0.85
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,1.66,1.0,2.55
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Deaths,Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.0,0.0,0.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Deaths,Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.2,1.21,6.29
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,2.36,0.7,5.0
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,0.84,0.51,1.29
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Deaths,Rate,0.03,0.02,0.04
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,3.23,1.26,6.26
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,2.32,0.7,4.87
URY,Uruguay,Southern Cone,Other drug use disorders,2021,Female,All ages,Years of Life Lost (YLLs),Rate,0.91,0.56,1.39
ARG,Argentina,Southern Cone,,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,353.15,215.78,527.60
ARG,Argentina,Southern Cone,,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,353.15,215.78,527.60
ARG,Argentina,Southern Cone,,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,048.49",578.09,"1,682.93"
ARG,Argentina,Southern Cone,,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,"1,048.49",578.09,"1,682.93"
ARG,Argentina,Southern Cone,,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,389.57",768.65,"2,220.76"
ARG,Argentina,Southern Cone,,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,387.76",766.84,"2,218.95"
ARG,Argentina,Southern Cone,,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,612.27",901.67,"2,571.20"
ARG,Argentina,Southern Cone,,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,610.06",899.46,"2,568.99"
ARG,Argentina,Southern Cone,,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,320.22,203.19,471.07
ARG,Argentina,Southern Cone,,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,320.22,203.19,471.07
ARG,Argentina,Southern Cone,,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,358.80,217.57,537.38
ARG,Argentina,Southern Cone,,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,358.80,217.57,537.38
ARG,Argentina,Southern Cone,,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,662.08,369.30,"1,046.93"
ARG,Argentina,Southern Cone,,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,662.08,369.30,"1,046.93"
ARG,Argentina,Southern Cone,,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,326.06,207.41,480.65
ARG,Argentina,Southern Cone,,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,326.06,207.41,480.65
ARG,Argentina,Southern Cone,,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,889.10,482.89,"1,428.36"
ARG,Argentina,Southern Cone,,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,889.10,482.89,"1,428.36"
ARG,Argentina,Southern Cone,,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,863.89","1,015.56","3,027.12"
ARG,Argentina,Southern Cone,,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,863.89","1,015.56","3,027.12"
ARG,Argentina,Southern Cone,,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,271.33","1,269.49","3,629.91"
ARG,Argentina,Southern Cone,,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,267.63","1,265.79","3,626.21"
ARG,Argentina,Southern Cone,,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,444.57","1,358.06","3,884.28"
ARG,Argentina,Southern Cone,,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,437.16","1,350.65","3,876.87"
ARG,Argentina,Southern Cone,,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,483.10","1,401.48","3,943.22"
ARG,Argentina,Southern Cone,,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,477.47","1,395.85","3,937.59"
ARG,Argentina,Southern Cone,,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,521.54","1,444.80","4,002.02"
ARG,Argentina,Southern Cone,,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,517.69","1,440.94","3,998.17"
ARG,Argentina,Southern Cone,,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,522.00","1,455.75","3,863.41"
ARG,Argentina,Southern Cone,,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,518.19","1,451.94","3,859.60"
ARG,Argentina,Southern Cone,,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,440.68","1,451.99","3,713.63"
ARG,Argentina,Southern Cone,,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,431.58","1,442.89","3,704.52"
ARG,Argentina,Southern Cone,,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,497.58","1,490.89","3,806.68"
ARG,Argentina,Southern Cone,,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,486.06","1,479.37","3,795.16"
ARG,Argentina,Southern Cone,,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,456.07","1,480.35","3,705.46"
ARG,Argentina,Southern Cone,,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,456.07","1,480.35","3,705.46"
ARG,Argentina,Southern Cone,,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,402.08","1,441.62","3,663.60"
ARG,Argentina,Southern Cone,,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,384.60","1,424.13","3,646.11"
ARG,Argentina,Southern Cone,,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,285.85","1,375.38","3,463.01"
ARG,Argentina,Southern Cone,,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,271.45","1,360.98","3,448.61"
ARG,Argentina,Southern Cone,,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,107.34","1,292.67","3,145.35"
ARG,Argentina,Southern Cone,,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,103.52","1,288.85","3,141.53"
ARG,Argentina,Southern Cone,,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,961.18","1,189.54","2,984.75"
ARG,Argentina,Southern Cone,,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"1,951.72","1,180.08","2,975.30"
ARG,Argentina,Southern Cone,,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,958.81","1,176.17","3,004.36"
ARG,Argentina,Southern Cone,,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,947.74","1,165.10","2,993.28"
ARG,Argentina,Southern Cone,,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,787.71","1,080.25","2,769.23"
ARG,Argentina,Southern Cone,,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,773.28","1,065.82","2,754.80"
ARG,Argentina,Southern Cone,,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,624.47",969.48,"2,493.14"
ARG,Argentina,Southern Cone,,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,617.08",962.09,"2,485.76"
ARG,Argentina,Southern Cone,,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,561.27",935.00,"2,388.73"
ARG,Argentina,Southern Cone,,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,551.91",925.64,"2,379.37"
ARG,Argentina,Southern Cone,,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,479.34",890.30,"2,253.37"
ARG,Argentina,Southern Cone,,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,467.43",878.39,"2,241.46"
ARG,Argentina,Southern Cone,,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,335.42",787.20,"2,048.98"
ARG,Argentina,Southern Cone,,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,321.22",773.00,"2,034.79"
ARG,Argentina,Southern Cone,,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,248.18",734.17,"1,938.14"
ARG,Argentina,Southern Cone,,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,229.81",715.80,"1,919.77"
ARG,Argentina,Southern Cone,,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,228.41",727.96,"1,918.47"
ARG,Argentina,Southern Cone,,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,196.95",696.49,"1,887.00"
ARG,Argentina,Southern Cone,,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,065.37",614.73,"1,698.06"
ARG,Argentina,Southern Cone,,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,055.66",605.02,"1,688.36"
ARG,Argentina,Southern Cone,,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,325.55,207.05,479.81
ARG,Argentina,Southern Cone,,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,325.55,207.05,479.81
ARG,Argentina,Southern Cone,,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,932.34","1,128.61","2,991.31"
ARG,Argentina,Southern Cone,,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,925.90","1,122.18","2,984.88"
ARG,Argentina,Southern Cone,,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,939.39","1,133.79","3,000.98"
ARG,Argentina,Southern Cone,,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,932.66","1,127.07","2,994.25"
ARG,Argentina,Southern Cone,,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,190.34,110.13,296.85
ARG,Argentina,Southern Cone,,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,190.34,110.13,296.85
ARG,Argentina,Southern Cone,,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,033.82",542.87,"1,677.88"
ARG,Argentina,Southern Cone,,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,"1,030.37",539.43,"1,674.43"
ARG,Argentina,Southern Cone,,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,581.22",861.97,"2,514.26"
ARG,Argentina,Southern Cone,,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,576.43",857.18,"2,509.48"
ARG,Argentina,Southern Cone,,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,965.65","1,089.11","3,098.09"
ARG,Argentina,Southern Cone,,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"1,960.14","1,083.61","3,092.58"
ARG,Argentina,Southern Cone,,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,151.14,91.95,231.89
ARG,Argentina,Southern Cone,,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,151.14,91.95,231.89
ARG,Argentina,Southern Cone,,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,197.53,113.17,310.00
ARG,Argentina,Southern Cone,,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,197.53,113.17,310.00
ARG,Argentina,Southern Cone,,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,511.59,266.26,838.02
ARG,Argentina,Southern Cone,,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,508.71,263.38,835.14
ARG,Argentina,Southern Cone,,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,155.67,95.68,232.84
ARG,Argentina,Southern Cone,,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,155.67,95.68,232.84
ARG,Argentina,Southern Cone,,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,747.97,381.48,"1,235.44"
ARG,Argentina,Southern Cone,,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,742.92,376.43,"1,230.39"
ARG,Argentina,Southern Cone,,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"2,123.67","1,117.29","3,435.74"
ARG,Argentina,Southern Cone,,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"2,118.64","1,112.26","3,430.70"
ARG,Argentina,Southern Cone,,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,961.25","1,650.86","4,648.36"
ARG,Argentina,Southern Cone,,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"2,953.82","1,643.43","4,640.93"
ARG,Argentina,Southern Cone,,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,263.96","1,842.89","5,085.40"
ARG,Argentina,Southern Cone,,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,255.07","1,834.01","5,076.51"
ARG,Argentina,Southern Cone,,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,391.74","1,925.09","5,271.60"
ARG,Argentina,Southern Cone,,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,383.08","1,916.43","5,262.94"
ARG,Argentina,Southern Cone,,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,518.42","2,006.58","5,456.21"
ARG,Argentina,Southern Cone,,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"3,509.98","1,998.14","5,447.77"
ARG,Argentina,Southern Cone,,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"3,397.34","1,998.83","5,161.79"
ARG,Argentina,Southern Cone,,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"3,393.25","1,994.73","5,157.69"
ARG,Argentina,Southern Cone,,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,192.08","1,911.96","4,805.47"
ARG,Argentina,Southern Cone,,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"3,188.56","1,908.45","4,801.96"
ARG,Argentina,Southern Cone,,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"3,242.94","1,949.05","4,890.13"
ARG,Argentina,Southern Cone,,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"3,239.06","1,945.18","4,886.26"
ARG,Argentina,Southern Cone,,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"3,190.26","1,921.97","4,700.78"
ARG,Argentina,Southern Cone,,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"3,190.26","1,921.97","4,700.78"
ARG,Argentina,Southern Cone,,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"3,109.98","1,863.74","4,717.81"
ARG,Argentina,Southern Cone,,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"3,109.98","1,863.74","4,717.81"
ARG,Argentina,Southern Cone,,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,961.09","1,797.86","4,466.54"
ARG,Argentina,Southern Cone,,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"2,950.55","1,787.32","4,456.01"
ARG,Argentina,Southern Cone,,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,735.79","1,691.08","4,047.78"
ARG,Argentina,Southern Cone,,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"2,728.45","1,683.74","4,040.44"
ARG,Argentina,Southern Cone,,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,516.01","1,526.24","3,766.64"
ARG,Argentina,Southern Cone,,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"2,509.18","1,519.41","3,759.81"
ARG,Argentina,Southern Cone,,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,511.66","1,510.18","3,746.87"
ARG,Argentina,Southern Cone,,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"2,508.16","1,506.68","3,743.36"
ARG,Argentina,Southern Cone,,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,268.70","1,354.58","3,465.64"
ARG,Argentina,Southern Cone,,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,258.85","1,344.74","3,455.80"
ARG,Argentina,Southern Cone,,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,036.86","1,220.40","3,095.24"
ARG,Argentina,Southern Cone,,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,027.41","1,210.94","3,085.78"
ARG,Argentina,Southern Cone,,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,941.87","1,165.87","2,930.42"
ARG,Argentina,Southern Cone,,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,931.07","1,155.07","2,919.62"
ARG,Argentina,Southern Cone,,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,829.44","1,101.34","2,735.34"
ARG,Argentina,Southern Cone,,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,817.04","1,088.94","2,722.95"
ARG,Argentina,Southern Cone,,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,625.90",958.77,"2,460.16"
ARG,Argentina,Southern Cone,,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,622.64",955.51,"2,456.90"
ARG,Argentina,Southern Cone,,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,503.64",880.54,"2,304.01"
ARG,Argentina,Southern Cone,,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,496.00",872.90,"2,296.36"
ARG,Argentina,Southern Cone,,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,481.84",875.20,"2,271.16"
ARG,Argentina,Southern Cone,,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,471.08",864.44,"2,260.40"
ARG,Argentina,Southern Cone,,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,350.41",773.80,"2,113.31"
ARG,Argentina,Southern Cone,,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,339.63",763.02,"2,102.53"
ARG,Argentina,Southern Cone,,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,155.27,95.35,232.76
ARG,Argentina,Southern Cone,,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,155.27,95.35,232.76
ARG,Argentina,Southern Cone,,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,450.49","1,433.02","3,745.63"
ARG,Argentina,Southern Cone,,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,445.23","1,427.76","3,740.37"
ARG,Argentina,Southern Cone,,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,434.23","1,426.36","3,717.13"
ARG,Argentina,Southern Cone,,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,428.69","1,420.82","3,711.59"
ARG,Argentina,Southern Cone,,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,354.59,220.83,533.12
ARG,Argentina,Southern Cone,,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,354.59,220.83,533.12
ARG,Argentina,Southern Cone,,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,076.86",583.13,"1,752.08"
ARG,Argentina,Southern Cone,,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,"1,075.40",581.67,"1,750.61"
ARG,Argentina,Southern Cone,,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,416.42",768.01,"2,309.68"
ARG,Argentina,Southern Cone,,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,415.32",766.91,"2,308.58"
ARG,Argentina,Southern Cone,,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,636.54",890.10,"2,660.82"
ARG,Argentina,Southern Cone,,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,635.66",889.22,"2,659.94"
ARG,Argentina,Southern Cone,,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,322.48,213.05,461.65
ARG,Argentina,Southern Cone,,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,322.48,213.05,461.65
ARG,Argentina,Southern Cone,,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,360.21,223.75,542.35
ARG,Argentina,Southern Cone,,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,360.21,223.75,542.35
ARG,Argentina,Southern Cone,,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,676.58,374.57,"1,090.12"
ARG,Argentina,Southern Cone,,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,674.16,372.14,"1,087.70"
ARG,Argentina,Southern Cone,,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,326.88,205.54,489.40
ARG,Argentina,Southern Cone,,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,326.88,205.54,489.40
ARG,Argentina,Southern Cone,,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,899.12,480.65,"1,475.43"
ARG,Argentina,Southern Cone,,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,895.00,476.52,"1,471.31"
ARG,Argentina,Southern Cone,,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,883.02","1,001.14","3,088.71"
ARG,Argentina,Southern Cone,,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,883.02","1,001.14","3,088.71"
ARG,Argentina,Southern Cone,,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,278.50","1,233.88","3,712.71"
ARG,Argentina,Southern Cone,,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,278.50","1,233.88","3,712.71"
ARG,Argentina,Southern Cone,,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,446.39","1,328.81","4,001.08"
ARG,Argentina,Southern Cone,,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,446.39","1,328.81","4,001.08"
ARG,Argentina,Southern Cone,,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,486.46","1,356.26","4,040.84"
ARG,Argentina,Southern Cone,,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,486.46","1,356.26","4,040.84"
ARG,Argentina,Southern Cone,,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,526.63","1,383.78","4,080.71"
ARG,Argentina,Southern Cone,,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,526.63","1,383.78","4,080.71"
ARG,Argentina,Southern Cone,,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,527.07","1,439.50","3,974.48"
ARG,Argentina,Southern Cone,,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,522.61","1,435.04","3,970.02"
ARG,Argentina,Southern Cone,,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,423.20","1,404.25","3,775.92"
ARG,Argentina,Southern Cone,,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,419.11","1,400.16","3,771.83"
ARG,Argentina,Southern Cone,,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,486.32","1,442.39","3,917.16"
ARG,Argentina,Southern Cone,,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,486.32","1,442.39","3,917.16"
ARG,Argentina,Southern Cone,,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,454.46","1,441.07","3,764.05"
ARG,Argentina,Southern Cone,,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,441.22","1,427.84","3,750.81"
ARG,Argentina,Southern Cone,,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,358.20","1,366.81","3,655.40"
ARG,Argentina,Southern Cone,,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,358.20","1,366.81","3,655.40"
ARG,Argentina,Southern Cone,,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,247.13","1,310.51","3,493.93"
ARG,Argentina,Southern Cone,,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,244.51","1,307.88","3,491.31"
ARG,Argentina,Southern Cone,,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,096.47","1,245.17","3,231.13"
ARG,Argentina,Southern Cone,,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,091.54","1,240.23","3,226.19"
ARG,Argentina,Southern Cone,,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,955.69","1,155.50","3,021.31"
ARG,Argentina,Southern Cone,,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"1,946.42","1,146.23","3,012.04"
ARG,Argentina,Southern Cone,,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,944.68","1,146.99","2,998.75"
ARG,Argentina,Southern Cone,,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,939.18","1,141.49","2,993.25"
ARG,Argentina,Southern Cone,,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,796.38","1,055.68","2,790.69"
ARG,Argentina,Southern Cone,,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,777.63","1,036.93","2,771.94"
ARG,Argentina,Southern Cone,,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,628.02",937.81,"2,553.19"
ARG,Argentina,Southern Cone,,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,624.74",934.53,"2,549.91"
ARG,Argentina,Southern Cone,,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,563.06",903.86,"2,460.27"
ARG,Argentina,Southern Cone,,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,557.76",898.56,"2,454.97"
ARG,Argentina,Southern Cone,,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,479.18",860.02,"2,340.31"
ARG,Argentina,Southern Cone,,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,471.28",852.12,"2,332.40"
ARG,Argentina,Southern Cone,,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,334.26",767.41,"2,074.65"
ARG,Argentina,Southern Cone,,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,329.68",762.82,"2,070.07"
ARG,Argentina,Southern Cone,,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,245.41",714.39,"1,954.82"
ARG,Argentina,Southern Cone,,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,236.94",705.91,"1,946.34"
ARG,Argentina,Southern Cone,,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,215.13",698.33,"1,914.09"
ARG,Argentina,Southern Cone,,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,202.15",685.36,"1,901.12"
ARG,Argentina,Southern Cone,,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,071.83",607.93,"1,720.56"
ARG,Argentina,Southern Cone,,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,060.29",596.39,"1,709.02"
ARG,Argentina,Southern Cone,,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,326.50,206.20,486.97
ARG,Argentina,Southern Cone,,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,326.50,206.20,486.97
ARG,Argentina,Southern Cone,,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,928.86","1,096.50","3,049.60"
ARG,Argentina,Southern Cone,,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,925.29","1,092.94","3,046.04"
ARG,Argentina,Southern Cone,,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,944.78","1,106.47","3,073.02"
ARG,Argentina,Southern Cone,,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,941.00","1,102.69","3,069.24"
ARG,Argentina,Southern Cone,,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,192.46,110.89,301.86
ARG,Argentina,Southern Cone,,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,192.46,110.89,301.86
ARG,Argentina,Southern Cone,,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,070.30",544.56,"1,806.89"
ARG,Argentina,Southern Cone,,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,"1,068.80",543.06,"1,805.39"
ARG,Argentina,Southern Cone,,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,628.53",868.62,"2,680.82"
ARG,Argentina,Southern Cone,,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,626.35",866.43,"2,678.63"
ARG,Argentina,Southern Cone,,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,026.95","1,100.61","3,295.87"
ARG,Argentina,Southern Cone,,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,024.37","1,098.03","3,293.29"
ARG,Argentina,Southern Cone,,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,152.10,94.44,232.58
ARG,Argentina,Southern Cone,,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,152.10,94.44,232.58
ARG,Argentina,Southern Cone,,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,199.64,113.92,314.46
ARG,Argentina,Southern Cone,,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,199.64,113.92,314.46
ARG,Argentina,Southern Cone,,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,526.68,268.06,890.95
ARG,Argentina,Southern Cone,,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,526.68,268.06,890.95
ARG,Argentina,Southern Cone,,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,157.04,95.88,239.56
ARG,Argentina,Southern Cone,,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,157.04,95.88,239.56
ARG,Argentina,Southern Cone,,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,758.02,377.09,"1,298.74"
ARG,Argentina,Southern Cone,,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,758.02,377.09,"1,298.74"
ARG,Argentina,Southern Cone,,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"2,154.64","1,093.79","3,638.04"
ARG,Argentina,Southern Cone,,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"2,150.29","1,089.43","3,633.68"
ARG,Argentina,Southern Cone,,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,018.74","1,649.34","4,888.64"
ARG,Argentina,Southern Cone,,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,014.49","1,645.09","4,884.39"
ARG,Argentina,Southern Cone,,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,314.57","1,847.37","5,320.34"
ARG,Argentina,Southern Cone,,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,310.33","1,843.13","5,316.10"
ARG,Argentina,Southern Cone,,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,468.35","1,938.41","5,539.35"
ARG,Argentina,Southern Cone,,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,464.15","1,934.21","5,535.15"
ARG,Argentina,Southern Cone,,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,621.43","2,029.03","5,757.35"
ARG,Argentina,Southern Cone,,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"3,617.28","2,024.89","5,753.21"
ARG,Argentina,Southern Cone,,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"3,516.32","1,950.75","5,536.39"
ARG,Argentina,Southern Cone,,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"3,516.32","1,950.75","5,536.39"
ARG,Argentina,Southern Cone,,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,269.96","1,876.30","5,042.80"
ARG,Argentina,Southern Cone,,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"3,266.42","1,872.76","5,039.26"
ARG,Argentina,Southern Cone,,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"3,339.00","1,905.86","5,126.16"
ARG,Argentina,Southern Cone,,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"3,339.00","1,905.86","5,126.16"
ARG,Argentina,Southern Cone,,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"3,270.51","1,923.26","4,957.14"
ARG,Argentina,Southern Cone,,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"3,263.21","1,915.96","4,949.85"
ARG,Argentina,Southern Cone,,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"3,166.82","1,842.47","4,864.99"
ARG,Argentina,Southern Cone,,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"3,161.04","1,836.68","4,859.20"
ARG,Argentina,Southern Cone,,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,992.46","1,730.99","4,620.56"
ARG,Argentina,Southern Cone,,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"2,987.07","1,725.60","4,615.17"
ARG,Argentina,Southern Cone,,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,762.28","1,607.91","4,193.74"
ARG,Argentina,Southern Cone,,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"2,757.12","1,602.75","4,188.58"
ARG,Argentina,Southern Cone,,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,540.82","1,479.51","3,911.01"
ARG,Argentina,Southern Cone,,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"2,532.72","1,471.41","3,902.90"
ARG,Argentina,Southern Cone,,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,535.94","1,483.26","3,913.67"
ARG,Argentina,Southern Cone,,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"2,525.15","1,472.48","3,902.89"
ARG,Argentina,Southern Cone,,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,288.59","1,326.20","3,579.41"
ARG,Argentina,Southern Cone,,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,279.93","1,317.54","3,570.76"
ARG,Argentina,Southern Cone,,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,065.27","1,205.09","3,223.21"
ARG,Argentina,Southern Cone,,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,048.22","1,188.05","3,206.17"
ARG,Argentina,Southern Cone,,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,957.16","1,141.58","3,057.87"
ARG,Argentina,Southern Cone,,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,946.53","1,130.96","3,047.25"
ARG,Argentina,Southern Cone,,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,829.95","1,066.85","2,863.32"
ARG,Argentina,Southern Cone,,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,826.88","1,063.79","2,860.26"
ARG,Argentina,Southern Cone,,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,624.53",946.41,"2,556.35"
ARG,Argentina,Southern Cone,,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,621.37",943.25,"2,553.19"
ARG,Argentina,Southern Cone,,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,499.23",867.98,"2,360.84"
ARG,Argentina,Southern Cone,,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,492.92",861.67,"2,354.53"
ARG,Argentina,Southern Cone,,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,483.14",860.91,"2,332.76"
ARG,Argentina,Southern Cone,,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,468.05",845.82,"2,317.67"
ARG,Argentina,Southern Cone,,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,334.26",761.69,"2,106.41"
ARG,Argentina,Southern Cone,,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,332.26",759.69,"2,104.41"
ARG,Argentina,Southern Cone,,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,156.61,95.74,238.95
ARG,Argentina,Southern Cone,,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,156.61,95.74,238.95
ARG,Argentina,Southern Cone,,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,499.08","1,412.11","3,926.82"
ARG,Argentina,Southern Cone,,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,494.92","1,407.95","3,922.66"
ARG,Argentina,Southern Cone,,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,491.83","1,411.48","3,911.20"
ARG,Argentina,Southern Cone,,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,487.29","1,406.95","3,906.66"
BRA,Brazil,Southern Cone,,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,214.00,134.25,317.71
BRA,Brazil,Southern Cone,,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,214.00,134.25,317.71
BRA,Brazil,Southern Cone,,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,837.25,486.40,"1,306.19"
BRA,Brazil,Southern Cone,,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,836.61,485.77,"1,305.55"
BRA,Brazil,Southern Cone,,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,204.41",712.94,"1,865.42"
BRA,Brazil,Southern Cone,,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,203.23",711.76,"1,864.24"
BRA,Brazil,Southern Cone,,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,490.14",894.81,"2,287.25"
BRA,Brazil,Southern Cone,,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,487.32",891.99,"2,284.43"
BRA,Brazil,Southern Cone,,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,186.75,123.03,271.36
BRA,Brazil,Southern Cone,,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,186.75,123.03,271.36
BRA,Brazil,Southern Cone,,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,219.44,137.28,326.69
BRA,Brazil,Southern Cone,,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,219.44,137.28,326.69
BRA,Brazil,Southern Cone,,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,473.76,275.21,739.05
BRA,Brazil,Southern Cone,,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,473.76,275.21,739.05
BRA,Brazil,Southern Cone,,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,191.82,121.48,281.26
BRA,Brazil,Southern Cone,,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,191.82,121.48,281.26
BRA,Brazil,Southern Cone,,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,673.75,383.68,"1,063.34"
BRA,Brazil,Southern Cone,,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,673.75,383.68,"1,063.34"
BRA,Brazil,Southern Cone,,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,589.35",921.45,"2,483.00"
BRA,Brazil,Southern Cone,,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,587.50",919.60,"2,481.14"
BRA,Brazil,Southern Cone,,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,122.68","1,279.33","3,252.41"
BRA,Brazil,Southern Cone,,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,118.15","1,274.80","3,247.88"
BRA,Brazil,Southern Cone,,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,216.88","1,337.63","3,407.52"
BRA,Brazil,Southern Cone,,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,214.20","1,334.95","3,404.85"
BRA,Brazil,Southern Cone,,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,367.68","1,443.74","3,605.86"
BRA,Brazil,Southern Cone,,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,361.92","1,437.97","3,600.09"
BRA,Brazil,Southern Cone,,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,511.07","1,544.63","3,794.45"
BRA,Brazil,Southern Cone,,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,502.38","1,535.94","3,785.75"
BRA,Brazil,Southern Cone,,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,644.32","1,678.90","3,925.25"
BRA,Brazil,Southern Cone,,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,633.06","1,667.65","3,913.99"
BRA,Brazil,Southern Cone,,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,774.14","1,774.02","4,036.28"
BRA,Brazil,Southern Cone,,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,748.22","1,748.09","4,010.35"
BRA,Brazil,Southern Cone,,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,737.90","1,762.10","4,032.74"
BRA,Brazil,Southern Cone,,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,721.32","1,745.52","4,016.16"
BRA,Brazil,Southern Cone,,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,826.20","1,829.94","4,035.41"
BRA,Brazil,Southern Cone,,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,796.59","1,800.34","4,005.80"
BRA,Brazil,Southern Cone,,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,849.78","1,797.15","4,132.60"
BRA,Brazil,Southern Cone,,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,815.76","1,763.13","4,098.57"
BRA,Brazil,Southern Cone,,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,826.76","1,808.74","4,067.77"
BRA,Brazil,Southern Cone,,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,785.08","1,767.06","4,026.09"
BRA,Brazil,Southern Cone,,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,773.60","1,807.35","3,908.58"
BRA,Brazil,Southern Cone,,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,723.16","1,756.90","3,858.14"
BRA,Brazil,Southern Cone,,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,689.56","1,761.21","3,822.70"
BRA,Brazil,Southern Cone,,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"2,633.21","1,704.87","3,766.36"
BRA,Brazil,Southern Cone,,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,708.37","1,786.13","3,824.55"
BRA,Brazil,Southern Cone,,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"2,645.63","1,723.39","3,761.81"
BRA,Brazil,Southern Cone,,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,555.68","1,670.01","3,707.00"
BRA,Brazil,Southern Cone,,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"2,499.30","1,613.63","3,650.62"
BRA,Brazil,Southern Cone,,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,332.46","1,524.87","3,318.04"
BRA,Brazil,Southern Cone,,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"2,267.98","1,460.40","3,253.57"
BRA,Brazil,Southern Cone,,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,221.13","1,461.65","3,155.35"
BRA,Brazil,Southern Cone,,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"2,166.55","1,407.07","3,100.77"
BRA,Brazil,Southern Cone,,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,059.43","1,369.81","2,919.03"
BRA,Brazil,Southern Cone,,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"2,019.22","1,329.60","2,878.82"
BRA,Brazil,Southern Cone,,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,812.89","1,187.29","2,596.14"
BRA,Brazil,Southern Cone,,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,773.57","1,147.97","2,556.82"
BRA,Brazil,Southern Cone,,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,686.45","1,109.07","2,422.69"
BRA,Brazil,Southern Cone,,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,644.53","1,067.14","2,380.77"
BRA,Brazil,Southern Cone,,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,594.39","1,044.14","2,312.92"
BRA,Brazil,Southern Cone,,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,565.02","1,014.77","2,283.56"
BRA,Brazil,Southern Cone,,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,475.90",991.57,"2,107.43"
BRA,Brazil,Southern Cone,,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,406.50",922.18,"2,038.04"
BRA,Brazil,Southern Cone,,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,191.36,121.62,280.37
BRA,Brazil,Southern Cone,,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,191.36,121.62,280.37
BRA,Brazil,Southern Cone,,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,119.52","1,339.73","3,116.67"
BRA,Brazil,Southern Cone,,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,097.64","1,317.85","3,094.78"
BRA,Brazil,Southern Cone,,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,217.16","1,405.79","3,251.04"
BRA,Brazil,Southern Cone,,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,"2,193.01","1,381.65","3,226.89"
BRA,Brazil,Southern Cone,,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,132.27,79.58,199.32
BRA,Brazil,Southern Cone,,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,132.27,79.58,199.32
BRA,Brazil,Southern Cone,,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,896.93,522.85,"1,376.22"
BRA,Brazil,Southern Cone,,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,896.09,522.01,"1,375.38"
BRA,Brazil,Southern Cone,,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,532.75",930.79,"2,313.13"
BRA,Brazil,Southern Cone,,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,530.88",928.93,"2,311.27"
BRA,Brazil,Southern Cone,,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,109.66","1,295.66","3,172.63"
BRA,Brazil,Southern Cone,,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,107.29","1,293.29","3,170.26"
BRA,Brazil,Southern Cone,,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,98.66,62.80,147.86
BRA,Brazil,Southern Cone,,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,98.66,62.80,147.86
BRA,Brazil,Southern Cone,,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,139.41,83.39,210.23
BRA,Brazil,Southern Cone,,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,139.41,83.39,210.23
BRA,Brazil,Southern Cone,,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,417.54,236.96,645.46
BRA,Brazil,Southern Cone,,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,416.77,236.19,644.69
BRA,Brazil,Southern Cone,,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,102.96,63.82,154.55
BRA,Brazil,Southern Cone,,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,102.96,63.82,154.55
BRA,Brazil,Southern Cone,,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,636.15,357.66,987.54
BRA,Brazil,Southern Cone,,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,634.77,356.29,986.16
BRA,Brazil,Southern Cone,,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,876.87","1,104.56","2,872.10"
BRA,Brazil,Southern Cone,,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,875.74","1,103.43","2,870.97"
BRA,Brazil,Southern Cone,,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,144.64","1,941.83","4,719.57"
BRA,Brazil,Southern Cone,,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,141.26","1,938.45","4,716.19"
BRA,Brazil,Southern Cone,,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,276.76","2,049.75","4,883.04"
BRA,Brazil,Southern Cone,,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,272.11","2,045.10","4,878.38"
BRA,Brazil,Southern Cone,,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,720.80","2,322.34","5,559.18"
BRA,Brazil,Southern Cone,,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,716.40","2,317.94","5,554.79"
BRA,Brazil,Southern Cone,,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,137.86","2,578.37","6,194.25"
BRA,Brazil,Southern Cone,,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,133.70","2,574.20","6,190.09"
BRA,Brazil,Southern Cone,,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"4,218.63","2,668.88","6,187.51"
BRA,Brazil,Southern Cone,,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"4,215.41","2,665.65","6,184.28"
BRA,Brazil,Southern Cone,,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,262.56","2,736.80","6,150.76"
BRA,Brazil,Southern Cone,,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"4,250.82","2,725.06","6,139.02"
BRA,Brazil,Southern Cone,,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"4,215.52","2,697.95","6,161.41"
BRA,Brazil,Southern Cone,,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"4,207.91","2,690.34","6,153.81"
BRA,Brazil,Southern Cone,,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"4,315.05","2,794.47","6,136.67"
BRA,Brazil,Southern Cone,,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"4,302.47","2,781.89","6,124.10"
BRA,Brazil,Southern Cone,,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"4,329.85","2,790.24","6,204.03"
BRA,Brazil,Southern Cone,,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"4,315.38","2,775.77","6,189.56"
BRA,Brazil,Southern Cone,,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,230.35","2,731.82","6,052.74"
BRA,Brazil,Southern Cone,,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"4,207.88","2,709.35","6,030.27"
BRA,Brazil,Southern Cone,,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"4,064.33","2,665.17","5,740.35"
BRA,Brazil,Southern Cone,,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"4,037.06","2,637.90","5,713.08"
BRA,Brazil,Southern Cone,,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,862.21","2,549.78","5,453.40"
BRA,Brazil,Southern Cone,,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,827.65","2,515.21","5,418.84"
BRA,Brazil,Southern Cone,,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,875.97","2,563.00","5,454.31"
BRA,Brazil,Southern Cone,,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,841.59","2,528.62","5,419.93"
BRA,Brazil,Southern Cone,,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,591.82","2,389.08","5,091.50"
BRA,Brazil,Southern Cone,,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"3,547.88","2,345.14","5,047.55"
BRA,Brazil,Southern Cone,,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"3,215.58","2,133.69","4,553.11"
BRA,Brazil,Southern Cone,,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"3,176.81","2,094.92","4,514.34"
BRA,Brazil,Southern Cone,,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,067.35","2,042.56","4,335.63"
BRA,Brazil,Southern Cone,,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"3,026.32","2,001.52","4,294.60"
BRA,Brazil,Southern Cone,,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,863.87","1,917.45","4,037.10"
BRA,Brazil,Southern Cone,,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,819.72","1,873.31","3,992.95"
BRA,Brazil,Southern Cone,,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,515.78","1,684.52","3,570.88"
BRA,Brazil,Southern Cone,,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,473.45","1,642.18","3,528.55"
BRA,Brazil,Southern Cone,,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,323.35","1,556.14","3,300.00"
BRA,Brazil,Southern Cone,,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,281.93","1,514.71","3,258.57"
BRA,Brazil,Southern Cone,,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,242.73","1,504.81","3,188.54"
BRA,Brazil,Southern Cone,,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,197.76","1,459.84","3,143.57"
BRA,Brazil,Southern Cone,,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,029.22","1,356.58","2,883.21"
BRA,Brazil,Southern Cone,,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,994.51","1,321.87","2,848.49"
BRA,Brazil,Southern Cone,,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,102.58,63.73,153.96
BRA,Brazil,Southern Cone,,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,102.58,63.73,153.96
BRA,Brazil,Southern Cone,,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"3,107.94","1,985.68","4,515.84"
BRA,Brazil,Southern Cone,,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"3,094.89","1,972.63","4,502.78"
BRA,Brazil,Southern Cone,,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"3,283.24","2,106.31","4,754.93"
BRA,Brazil,Southern Cone,,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"3,267.90","2,090.97","4,739.59"
BRA,Brazil,Southern Cone,,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,215.43,134.19,321.64
BRA,Brazil,Southern Cone,,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,215.43,134.19,321.64
BRA,Brazil,Southern Cone,,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,856.59,494.73,"1,334.93"
BRA,Brazil,Southern Cone,,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,856.27,494.41,"1,334.61"
BRA,Brazil,Southern Cone,,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,226.39",720.93,"1,896.58"
BRA,Brazil,Southern Cone,,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,225.93",720.46,"1,896.11"
BRA,Brazil,Southern Cone,,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,517.44",907.66,"2,334.91"
BRA,Brazil,Southern Cone,,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,515.57",905.78,"2,333.03"
BRA,Brazil,Southern Cone,,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,186.76,121.95,273.22
BRA,Brazil,Southern Cone,,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,186.76,121.95,273.22
BRA,Brazil,Southern Cone,,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,221.10,137.26,331.44
BRA,Brazil,Southern Cone,,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,221.10,137.26,331.44
BRA,Brazil,Southern Cone,,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,485.94,282.26,751.03
BRA,Brazil,Southern Cone,,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,485.94,282.26,751.03
BRA,Brazil,Southern Cone,,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,192.08,121.20,281.08
BRA,Brazil,Southern Cone,,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,192.08,121.20,281.08
BRA,Brazil,Southern Cone,,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,691.92,395.03,"1,077.37"
BRA,Brazil,Southern Cone,,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,691.92,395.03,"1,077.37"
BRA,Brazil,Southern Cone,,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,625.32",933.99,"2,547.20"
BRA,Brazil,Southern Cone,,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,624.40",933.06,"2,546.27"
BRA,Brazil,Southern Cone,,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,160.68","1,296.65","3,323.66"
BRA,Brazil,Southern Cone,,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,157.66","1,293.63","3,320.64"
BRA,Brazil,Southern Cone,,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,251.58","1,348.02","3,453.64"
BRA,Brazil,Southern Cone,,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,250.72","1,347.15","3,452.77"
BRA,Brazil,Southern Cone,,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,406.51","1,463.18","3,680.21"
BRA,Brazil,Southern Cone,,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,402.54","1,459.21","3,676.24"
BRA,Brazil,Southern Cone,,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,552.58","1,571.76","3,893.83"
BRA,Brazil,Southern Cone,,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,545.68","1,564.86","3,886.92"
BRA,Brazil,Southern Cone,,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,721.17","1,714.45","4,055.06"
BRA,Brazil,Southern Cone,,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,715.83","1,709.10","4,049.71"
BRA,Brazil,Southern Cone,,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,864.80","1,822.47","4,179.61"
BRA,Brazil,Southern Cone,,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,837.68","1,795.34","4,152.49"
BRA,Brazil,Southern Cone,,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,839.70","1,819.20","4,186.47"
BRA,Brazil,Southern Cone,,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,821.49","1,800.98","4,168.25"
BRA,Brazil,Southern Cone,,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,927.13","1,876.75","4,193.83"
BRA,Brazil,Southern Cone,,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,892.02","1,841.64","4,158.71"
BRA,Brazil,Southern Cone,,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,940.38","1,855.69","4,267.31"
BRA,Brazil,Southern Cone,,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,902.99","1,818.31","4,229.92"
BRA,Brazil,Southern Cone,,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,904.45","1,851.18","4,203.10"
BRA,Brazil,Southern Cone,,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,861.94","1,808.67","4,160.59"
BRA,Brazil,Southern Cone,,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,839.68","1,853.88","4,001.04"
BRA,Brazil,Southern Cone,,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,788.73","1,802.93","3,950.09"
BRA,Brazil,Southern Cone,,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,754.76","1,803.01","3,925.08"
BRA,Brazil,Southern Cone,,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"2,689.73","1,737.98","3,860.05"
BRA,Brazil,Southern Cone,,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,765.82","1,815.33","3,925.63"
BRA,Brazil,Southern Cone,,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"2,701.24","1,750.75","3,861.05"
BRA,Brazil,Southern Cone,,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,631.72","1,722.48","3,826.17"
BRA,Brazil,Southern Cone,,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"2,547.95","1,638.70","3,742.40"
BRA,Brazil,Southern Cone,,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,374.48","1,545.89","3,384.68"
BRA,Brazil,Southern Cone,,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"2,312.58","1,483.99","3,322.78"
BRA,Brazil,Southern Cone,,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,272.36","1,491.45","3,226.88"
BRA,Brazil,Southern Cone,,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"2,209.58","1,428.68","3,164.11"
BRA,Brazil,Southern Cone,,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,125.87","1,413.36","3,000.53"
BRA,Brazil,Southern Cone,,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"2,061.85","1,349.34","2,936.51"
BRA,Brazil,Southern Cone,,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,848.87","1,215.16","2,640.75"
BRA,Brazil,Southern Cone,,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,812.89","1,179.17","2,604.77"
BRA,Brazil,Southern Cone,,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,723.60","1,129.76","2,471.38"
BRA,Brazil,Southern Cone,,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,681.56","1,087.72","2,429.34"
BRA,Brazil,Southern Cone,,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,643.12","1,062.16","2,376.15"
BRA,Brazil,Southern Cone,,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,600.72","1,019.77","2,333.76"
BRA,Brazil,Southern Cone,,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,501.39",998.75,"2,149.09"
BRA,Brazil,Southern Cone,,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,442.91",940.27,"2,090.60"
BRA,Brazil,Southern Cone,,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,191.60,121.27,280.38
BRA,Brazil,Southern Cone,,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,191.60,121.27,280.38
BRA,Brazil,Southern Cone,,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,175.23","1,369.82","3,205.46"
BRA,Brazil,Southern Cone,,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,151.83","1,346.41","3,182.06"
BRA,Brazil,Southern Cone,,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,280.89","1,441.42","3,351.00"
BRA,Brazil,Southern Cone,,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,"2,254.53","1,415.06","3,324.63"
BRA,Brazil,Southern Cone,,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,134.36,80.74,204.20
BRA,Brazil,Southern Cone,,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,134.36,80.74,204.20
BRA,Brazil,Southern Cone,,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,917.84,539.72,"1,399.99"
BRA,Brazil,Southern Cone,,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,917.84,539.72,"1,399.99"
BRA,Brazil,Southern Cone,,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,548.44",935.47,"2,354.88"
BRA,Brazil,Southern Cone,,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,548.19",935.22,"2,354.63"
BRA,Brazil,Southern Cone,,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,144.09","1,309.84","3,240.66"
BRA,Brazil,Southern Cone,,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,142.58","1,308.33","3,239.15"
BRA,Brazil,Southern Cone,,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,98.53,63.09,149.90
BRA,Brazil,Southern Cone,,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,98.53,63.09,149.90
BRA,Brazil,Southern Cone,,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,141.96,84.80,216.01
BRA,Brazil,Southern Cone,,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,141.96,84.80,216.01
BRA,Brazil,Southern Cone,,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,435.31,250.65,668.60
BRA,Brazil,Southern Cone,,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,435.31,250.65,668.60
BRA,Brazil,Southern Cone,,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,102.74,63.70,154.91
BRA,Brazil,Southern Cone,,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,102.74,63.70,154.91
BRA,Brazil,Southern Cone,,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,663.37,379.58,"1,020.45"
BRA,Brazil,Southern Cone,,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,663.37,379.58,"1,020.45"
BRA,Brazil,Southern Cone,,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,908.26","1,130.79","2,902.95"
BRA,Brazil,Southern Cone,,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,908.26","1,130.79","2,902.95"
BRA,Brazil,Southern Cone,,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,192.31","1,958.48","4,819.17"
BRA,Brazil,Southern Cone,,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,189.89","1,956.06","4,816.75"
BRA,Brazil,Southern Cone,,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,288.58","2,027.55","4,989.87"
BRA,Brazil,Southern Cone,,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,287.65","2,026.62","4,988.94"
BRA,Brazil,Southern Cone,,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,776.06","2,334.76","5,690.32"
BRA,Brazil,Southern Cone,,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,772.54","2,331.25","5,686.80"
BRA,Brazil,Southern Cone,,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,230.18","2,620.96","6,342.84"
BRA,Brazil,Southern Cone,,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,224.25","2,615.03","6,336.91"
BRA,Brazil,Southern Cone,,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"4,447.44","2,778.69","6,575.55"
BRA,Brazil,Southern Cone,,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"4,441.07","2,772.31","6,569.18"
BRA,Brazil,Southern Cone,,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,500.39","2,854.89","6,518.77"
BRA,Brazil,Southern Cone,,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"4,486.29","2,840.80","6,504.68"
BRA,Brazil,Southern Cone,,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"4,502.78","2,838.14","6,578.82"
BRA,Brazil,Southern Cone,,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"4,495.46","2,830.82","6,571.50"
BRA,Brazil,Southern Cone,,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"4,571.06","2,935.17","6,496.96"
BRA,Brazil,Southern Cone,,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"4,556.58","2,920.69","6,482.48"
BRA,Brazil,Southern Cone,,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"4,553.34","2,887.43","6,582.80"
BRA,Brazil,Southern Cone,,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"4,530.55","2,864.63","6,560.00"
BRA,Brazil,Southern Cone,,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,413.62","2,828.28","6,338.52"
BRA,Brazil,Southern Cone,,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"4,393.12","2,807.77","6,318.02"
BRA,Brazil,Southern Cone,,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"4,221.71","2,735.06","5,981.28"
BRA,Brazil,Southern Cone,,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"4,188.15","2,701.50","5,947.72"
BRA,Brazil,Southern Cone,,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,985.08","2,585.79","5,654.19"
BRA,Brazil,Southern Cone,,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,946.29","2,546.99","5,615.39"
BRA,Brazil,Southern Cone,,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,998.36","2,594.25","5,642.60"
BRA,Brazil,Southern Cone,,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,959.13","2,555.02","5,603.38"
BRA,Brazil,Southern Cone,,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,678.25","2,392.12","5,264.81"
BRA,Brazil,Southern Cone,,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"3,633.51","2,347.39","5,220.07"
BRA,Brazil,Southern Cone,,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"3,282.31","2,164.40","4,641.80"
BRA,Brazil,Southern Cone,,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"3,243.09","2,125.18","4,602.58"
BRA,Brazil,Southern Cone,,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,121.14","2,071.88","4,401.83"
BRA,Brazil,Southern Cone,,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"3,083.06","2,033.81","4,363.76"
BRA,Brazil,Southern Cone,,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,903.97","1,947.22","4,078.49"
BRA,Brazil,Southern Cone,,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,867.44","1,910.68","4,041.95"
BRA,Brazil,Southern Cone,,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,550.71","1,701.34","3,608.70"
BRA,Brazil,Southern Cone,,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,506.21","1,656.83","3,564.19"
BRA,Brazil,Southern Cone,,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,348.04","1,566.58","3,335.00"
BRA,Brazil,Southern Cone,,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,307.90","1,526.44","3,294.85"
BRA,Brazil,Southern Cone,,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,249.94","1,492.57","3,221.78"
BRA,Brazil,Southern Cone,,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,219.49","1,462.12","3,191.33"
BRA,Brazil,Southern Cone,,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,049.33","1,380.04","2,905.18"
BRA,Brazil,Southern Cone,,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"2,005.21","1,335.92","2,861.06"
BRA,Brazil,Southern Cone,,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,102.36,63.65,154.46
BRA,Brazil,Southern Cone,,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,102.36,63.65,154.46
BRA,Brazil,Southern Cone,,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"3,226.67","2,040.36","4,706.00"
BRA,Brazil,Southern Cone,,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"3,212.82","2,026.50","4,692.15"
BRA,Brazil,Southern Cone,,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"3,415.98","2,168.67","4,964.14"
BRA,Brazil,Southern Cone,,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"3,399.41","2,152.10","4,947.56"
CHL,Chile,Southern Cone,,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,351.37,223.58,515.22
CHL,Chile,Southern Cone,,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,351.37,223.58,515.22
CHL,Chile,Southern Cone,,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,038.99",565.35,"1,708.32"
CHL,Chile,Southern Cone,,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,"1,038.99",565.35,"1,708.32"
CHL,Chile,Southern Cone,,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,434.81",783.58,"2,350.83"
CHL,Chile,Southern Cone,,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,434.81",783.58,"2,350.83"
CHL,Chile,Southern Cone,,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,725.34",943.12,"2,836.40"
CHL,Chile,Southern Cone,,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,725.34",943.12,"2,836.40"
CHL,Chile,Southern Cone,,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,327.35,214.36,475.43
CHL,Chile,Southern Cone,,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,327.35,214.36,475.43
CHL,Chile,Southern Cone,,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,356.20,225.55,523.48
CHL,Chile,Southern Cone,,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,356.20,225.55,523.48
CHL,Chile,Southern Cone,,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,642.65,362.28,"1,028.26"
CHL,Chile,Southern Cone,,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,642.65,362.28,"1,028.26"
CHL,Chile,Southern Cone,,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,329.76,214.70,478.18
CHL,Chile,Southern Cone,,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,329.76,214.70,478.18
CHL,Chile,Southern Cone,,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,855.80,464.03,"1,403.87"
CHL,Chile,Southern Cone,,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,855.80,464.03,"1,403.87"
CHL,Chile,Southern Cone,,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,864.01",985.89,"3,126.14"
CHL,Chile,Southern Cone,,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,864.01",985.89,"3,126.14"
CHL,Chile,Southern Cone,,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,392.71","1,300.08","3,952.36"
CHL,Chile,Southern Cone,,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,392.71","1,300.08","3,952.36"
CHL,Chile,Southern Cone,,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,560.67","1,404.31","4,178.36"
CHL,Chile,Southern Cone,,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,560.67","1,404.31","4,178.36"
CHL,Chile,Southern Cone,,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,628.71","1,440.33","4,321.17"
CHL,Chile,Southern Cone,,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,628.71","1,440.33","4,321.17"
CHL,Chile,Southern Cone,,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,687.31","1,471.35","4,444.16"
CHL,Chile,Southern Cone,,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,687.31","1,471.35","4,444.16"
CHL,Chile,Southern Cone,,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,626.92","1,517.72","4,194.96"
CHL,Chile,Southern Cone,,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,626.92","1,517.72","4,194.96"
CHL,Chile,Southern Cone,,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,502.34","1,458.77","3,914.51"
CHL,Chile,Southern Cone,,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,501.04","1,457.48","3,913.22"
CHL,Chile,Southern Cone,,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,569.12","1,472.94","4,044.51"
CHL,Chile,Southern Cone,,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,569.12","1,472.94","4,044.51"
CHL,Chile,Southern Cone,,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,522.43","1,492.96","3,851.34"
CHL,Chile,Southern Cone,,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,522.43","1,492.96","3,851.34"
CHL,Chile,Southern Cone,,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,433.33","1,412.36","3,827.17"
CHL,Chile,Southern Cone,,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,433.33","1,412.36","3,827.17"
CHL,Chile,Southern Cone,,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,312.60","1,377.30","3,562.49"
CHL,Chile,Southern Cone,,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,305.29","1,369.99","3,555.18"
CHL,Chile,Southern Cone,,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,171.22","1,312.98","3,336.67"
CHL,Chile,Southern Cone,,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,150.74","1,292.49","3,316.18"
CHL,Chile,Southern Cone,,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,010.31","1,194.28","3,116.91"
CHL,Chile,Southern Cone,,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"2,000.76","1,184.73","3,107.36"
CHL,Chile,Southern Cone,,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,987.65","1,166.76","3,065.79"
CHL,Chile,Southern Cone,,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,987.65","1,166.76","3,065.79"
CHL,Chile,Southern Cone,,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,831.14","1,074.60","2,895.53"
CHL,Chile,Southern Cone,,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,824.51","1,067.98","2,888.91"
CHL,Chile,Southern Cone,,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,670.73","1,006.21","2,596.38"
CHL,Chile,Southern Cone,,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,663.81",999.29,"2,589.46"
CHL,Chile,Southern Cone,,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,622.31",979.06,"2,509.32"
CHL,Chile,Southern Cone,,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,598.28",955.03,"2,485.30"
CHL,Chile,Southern Cone,,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,556.65",942.25,"2,391.28"
CHL,Chile,Southern Cone,,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,509.42",895.02,"2,344.05"
CHL,Chile,Southern Cone,,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,407.76",848.53,"2,186.46"
CHL,Chile,Southern Cone,,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,369.09",809.86,"2,147.79"
CHL,Chile,Southern Cone,,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,276.12",749.48,"2,003.24"
CHL,Chile,Southern Cone,,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,257.02",730.38,"1,984.15"
CHL,Chile,Southern Cone,,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,238.12",713.04,"1,973.58"
CHL,Chile,Southern Cone,,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,238.12",713.04,"1,973.58"
CHL,Chile,Southern Cone,,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,101.63",626.66,"1,735.32"
CHL,Chile,Southern Cone,,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,093.97",618.99,"1,727.67"
CHL,Chile,Southern Cone,,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,329.55,214.68,477.95
CHL,Chile,Southern Cone,,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,329.55,214.68,477.95
CHL,Chile,Southern Cone,,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,985.78","1,137.41","3,156.11"
CHL,Chile,Southern Cone,,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,982.10","1,133.74","3,152.43"
CHL,Chile,Southern Cone,,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,042.91","1,176.57","3,234.92"
CHL,Chile,Southern Cone,,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,"2,038.23","1,171.89","3,230.24"
CHL,Chile,Southern Cone,,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,195.41,114.16,307.67
CHL,Chile,Southern Cone,,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,195.41,114.16,307.67
CHL,Chile,Southern Cone,,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,246.51",651.00,"2,084.29"
CHL,Chile,Southern Cone,,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,"1,246.51",651.00,"2,084.29"
CHL,Chile,Southern Cone,,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,047.62","1,101.84","3,305.06"
CHL,Chile,Southern Cone,,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"2,047.62","1,101.84","3,305.06"
CHL,Chile,Southern Cone,,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,694.26","1,466.13","4,352.42"
CHL,Chile,Southern Cone,,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,691.75","1,463.62","4,349.92"
CHL,Chile,Southern Cone,,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,151.97,94.50,233.15
CHL,Chile,Southern Cone,,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,151.97,94.50,233.15
CHL,Chile,Southern Cone,,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,204.50,117.86,325.09
CHL,Chile,Southern Cone,,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,204.50,117.86,325.09
CHL,Chile,Southern Cone,,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,575.63,298.28,966.62
CHL,Chile,Southern Cone,,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,575.63,298.28,966.62
CHL,Chile,Southern Cone,,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,154.46,97.66,228.41
CHL,Chile,Southern Cone,,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,154.46,97.66,228.41
CHL,Chile,Southern Cone,,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,852.44,432.86,"1,445.10"
CHL,Chile,Southern Cone,,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,852.44,432.86,"1,445.10"
CHL,Chile,Southern Cone,,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"2,629.00","1,374.35","4,393.51"
CHL,Chile,Southern Cone,,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"2,629.00","1,374.35","4,393.51"
CHL,Chile,Southern Cone,,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,986.14","2,176.62","6,420.31"
CHL,Chile,Southern Cone,,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,982.13","2,172.61","6,416.31"
CHL,Chile,Southern Cone,,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"4,319.36","2,380.31","6,766.83"
CHL,Chile,Southern Cone,,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"4,319.36","2,380.31","6,766.83"
CHL,Chile,Southern Cone,,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,586.42","2,531.48","7,316.81"
CHL,Chile,Southern Cone,,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"4,580.64","2,525.70","7,311.02"
CHL,Chile,Southern Cone,,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,814.74","2,660.72","7,786.99"
CHL,Chile,Southern Cone,,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,804.01","2,650.00","7,776.27"
CHL,Chile,Southern Cone,,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"4,565.51","2,592.29","7,277.76"
CHL,Chile,Southern Cone,,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"4,557.01","2,583.79","7,269.27"
CHL,Chile,Southern Cone,,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,226.76","2,415.43","6,627.09"
CHL,Chile,Southern Cone,,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"4,221.88","2,410.54","6,622.21"
CHL,Chile,Southern Cone,,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"4,303.95","2,460.87","6,819.00"
CHL,Chile,Southern Cone,,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"4,296.08","2,453.00","6,811.13"
CHL,Chile,Southern Cone,,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"4,237.73","2,436.23","6,555.02"
CHL,Chile,Southern Cone,,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"4,237.73","2,436.23","6,555.02"
CHL,Chile,Southern Cone,,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"4,099.28","2,340.95","6,372.42"
CHL,Chile,Southern Cone,,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"4,099.28","2,340.95","6,372.42"
CHL,Chile,Southern Cone,,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,835.62","2,196.61","5,935.65"
CHL,Chile,Southern Cone,,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"3,828.36","2,189.35","5,928.39"
CHL,Chile,Southern Cone,,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,499.29","2,028.20","5,397.60"
CHL,Chile,Southern Cone,,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"3,499.29","2,028.20","5,397.60"
CHL,Chile,Southern Cone,,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,207.04","1,862.74","4,994.71"
CHL,Chile,Southern Cone,,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,192.92","1,848.63","4,980.59"
CHL,Chile,Southern Cone,,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,199.83","1,870.70","4,917.35"
CHL,Chile,Southern Cone,,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,174.51","1,845.39","4,892.03"
CHL,Chile,Southern Cone,,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,856.87","1,650.82","4,588.53"
CHL,Chile,Southern Cone,,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,838.17","1,632.11","4,569.83"
CHL,Chile,Southern Cone,,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,557.49","1,479.16","4,071.11"
CHL,Chile,Southern Cone,,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,544.83","1,466.49","4,058.44"
CHL,Chile,Southern Cone,,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,441.69","1,423.05","3,856.30"
CHL,Chile,Southern Cone,,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,422.63","1,403.98","3,837.23"
CHL,Chile,Southern Cone,,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,291.54","1,350.29","3,577.78"
CHL,Chile,Southern Cone,,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,264.18","1,322.93","3,550.41"
CHL,Chile,Southern Cone,,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,021.04","1,192.44","3,271.63"
CHL,Chile,Southern Cone,,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,997.85","1,169.25","3,248.44"
CHL,Chile,Southern Cone,,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,835.38","1,070.96","2,948.31"
CHL,Chile,Southern Cone,,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,826.36","1,061.94","2,939.29"
CHL,Chile,Southern Cone,,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,798.00","1,047.56","2,875.20"
CHL,Chile,Southern Cone,,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,798.00","1,047.56","2,875.20"
CHL,Chile,Southern Cone,,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,648.20",947.60,"2,629.22"
CHL,Chile,Southern Cone,,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,648.20",947.60,"2,629.22"
CHL,Chile,Southern Cone,,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,154.25,97.40,228.82
CHL,Chile,Southern Cone,,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,154.25,97.40,228.82
CHL,Chile,Southern Cone,,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"3,196.04","1,802.33","5,061.78"
CHL,Chile,Southern Cone,,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"3,190.27","1,796.56","5,056.01"
CHL,Chile,Southern Cone,,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"3,280.40","1,860.05","5,184.42"
CHL,Chile,Southern Cone,,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"3,273.30","1,852.95","5,177.32"
CHL,Chile,Southern Cone,,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,351.52,221.95,529.83
CHL,Chile,Southern Cone,,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,351.52,221.95,529.83
CHL,Chile,Southern Cone,,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,037.94",559.76,"1,719.90"
CHL,Chile,Southern Cone,,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,"1,037.94",559.76,"1,719.90"
CHL,Chile,Southern Cone,,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,416.75",775.13,"2,313.10"
CHL,Chile,Southern Cone,,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,416.75",775.13,"2,313.10"
CHL,Chile,Southern Cone,,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,695.76",933.17,"2,764.12"
CHL,Chile,Southern Cone,,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,695.76",933.17,"2,764.12"
CHL,Chile,Southern Cone,,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,328.88,211.14,477.96
CHL,Chile,Southern Cone,,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,328.88,211.14,477.96
CHL,Chile,Southern Cone,,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,356.20,223.44,539.84
CHL,Chile,Southern Cone,,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,356.20,223.44,539.84
CHL,Chile,Southern Cone,,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,641.62,359.04,"1,049.64"
CHL,Chile,Southern Cone,,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,641.62,359.04,"1,049.64"
CHL,Chile,Southern Cone,,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,329.41,215.23,482.84
CHL,Chile,Southern Cone,,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,329.41,215.23,482.84
CHL,Chile,Southern Cone,,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,846.39,456.33,"1,415.40"
CHL,Chile,Southern Cone,,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,846.39,456.33,"1,415.40"
CHL,Chile,Southern Cone,,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,830.36",958.96,"3,065.99"
CHL,Chile,Southern Cone,,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,830.36",958.96,"3,065.99"
CHL,Chile,Southern Cone,,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,336.65","1,280.98","3,809.33"
CHL,Chile,Southern Cone,,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,336.65","1,280.98","3,809.33"
CHL,Chile,Southern Cone,,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,503.42","1,392.93","4,014.77"
CHL,Chile,Southern Cone,,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,503.42","1,392.93","4,014.77"
CHL,Chile,Southern Cone,,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,570.43","1,429.68","4,152.57"
CHL,Chile,Southern Cone,,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,570.43","1,429.68","4,152.57"
CHL,Chile,Southern Cone,,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,628.32","1,461.43","4,271.63"
CHL,Chile,Southern Cone,,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,628.32","1,461.43","4,271.63"
CHL,Chile,Southern Cone,,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,576.27","1,475.92","4,123.56"
CHL,Chile,Southern Cone,,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,576.27","1,475.92","4,123.56"
CHL,Chile,Southern Cone,,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,469.27","1,425.07","3,849.02"
CHL,Chile,Southern Cone,,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,464.89","1,420.68","3,844.64"
CHL,Chile,Southern Cone,,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,532.04","1,438.25","3,933.34"
CHL,Chile,Southern Cone,,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,517.61","1,423.82","3,918.91"
CHL,Chile,Southern Cone,,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,487.88","1,454.06","3,797.75"
CHL,Chile,Southern Cone,,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,487.88","1,454.06","3,797.75"
CHL,Chile,Southern Cone,,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,414.73","1,381.79","3,775.27"
CHL,Chile,Southern Cone,,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,414.73","1,381.79","3,775.27"
CHL,Chile,Southern Cone,,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,293.93","1,357.94","3,537.62"
CHL,Chile,Southern Cone,,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,287.07","1,351.08","3,530.76"
CHL,Chile,Southern Cone,,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,149.95","1,283.71","3,314.58"
CHL,Chile,Southern Cone,,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,130.09","1,263.84","3,294.72"
CHL,Chile,Southern Cone,,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,001.20","1,195.49","3,106.48"
CHL,Chile,Southern Cone,,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"1,981.30","1,175.59","3,086.58"
CHL,Chile,Southern Cone,,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,977.65","1,181.92","3,079.90"
CHL,Chile,Southern Cone,,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,971.07","1,175.35","3,073.32"
CHL,Chile,Southern Cone,,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,840.73","1,099.86","2,874.66"
CHL,Chile,Southern Cone,,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,805.46","1,064.59","2,839.39"
CHL,Chile,Southern Cone,,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,683.25","1,001.22","2,629.81"
CHL,Chile,Southern Cone,,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,655.86",973.83,"2,602.42"
CHL,Chile,Southern Cone,,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,618.15",966.85,"2,518.87"
CHL,Chile,Southern Cone,,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,592.37",941.08,"2,493.09"
CHL,Chile,Southern Cone,,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,531.83",921.29,"2,371.79"
CHL,Chile,Southern Cone,,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,508.20",897.66,"2,348.15"
CHL,Chile,Southern Cone,,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,406.96",839.40,"2,163.58"
CHL,Chile,Southern Cone,,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,371.00",803.44,"2,127.62"
CHL,Chile,Southern Cone,,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,283.31",755.71,"1,993.92"
CHL,Chile,Southern Cone,,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,259.58",731.98,"1,970.20"
CHL,Chile,Southern Cone,,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,250.98",727.36,"1,960.89"
CHL,Chile,Southern Cone,,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,239.20",715.58,"1,949.11"
CHL,Chile,Southern Cone,,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,110.30",645.62,"1,744.30"
CHL,Chile,Southern Cone,,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,094.22",629.53,"1,728.21"
CHL,Chile,Southern Cone,,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,329.35,214.88,482.42
CHL,Chile,Southern Cone,,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,329.35,214.88,482.42
CHL,Chile,Southern Cone,,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,959.47","1,120.15","3,101.17"
CHL,Chile,Southern Cone,,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,953.19","1,113.87","3,094.89"
CHL,Chile,Southern Cone,,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,020.69","1,161.54","3,186.26"
CHL,Chile,Southern Cone,,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,"2,012.59","1,153.45","3,178.17"
CHL,Chile,Southern Cone,,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,193.23,111.40,304.40
CHL,Chile,Southern Cone,,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,193.23,111.40,304.40
CHL,Chile,Southern Cone,,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,238.31",640.61,"2,067.60"
CHL,Chile,Southern Cone,,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,"1,238.31",640.61,"2,067.60"
CHL,Chile,Southern Cone,,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,001.92","1,069.44","3,245.47"
CHL,Chile,Southern Cone,,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"2,001.92","1,069.44","3,245.47"
CHL,Chile,Southern Cone,,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,622.19","1,403.83","4,258.44"
CHL,Chile,Southern Cone,,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,622.19","1,403.83","4,258.44"
CHL,Chile,Southern Cone,,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,151.87,93.86,233.95
CHL,Chile,Southern Cone,,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,151.87,93.86,233.95
CHL,Chile,Southern Cone,,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,201.43,114.11,318.32
CHL,Chile,Southern Cone,,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,201.43,114.11,318.32
CHL,Chile,Southern Cone,,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,569.82,294.01,949.16
CHL,Chile,Southern Cone,,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,569.82,294.01,949.16
CHL,Chile,Southern Cone,,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,154.48,98.89,238.61
CHL,Chile,Southern Cone,,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,154.48,98.89,238.61
CHL,Chile,Southern Cone,,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,834.31,423.17,"1,402.07"
CHL,Chile,Southern Cone,,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,834.31,423.17,"1,402.07"
CHL,Chile,Southern Cone,,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"2,560.97","1,323.34","4,282.87"
CHL,Chile,Southern Cone,,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"2,560.97","1,323.34","4,282.87"
CHL,Chile,Southern Cone,,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,857.11","2,070.22","6,251.58"
CHL,Chile,Southern Cone,,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,857.11","2,070.22","6,251.58"
CHL,Chile,Southern Cone,,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"4,190.52","2,298.53","6,621.44"
CHL,Chile,Southern Cone,,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"4,190.52","2,298.53","6,621.44"
CHL,Chile,Southern Cone,,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,451.05","2,412.47","7,153.73"
CHL,Chile,Southern Cone,,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"4,451.05","2,412.47","7,153.73"
CHL,Chile,Southern Cone,,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,673.96","2,509.96","7,609.15"
CHL,Chile,Southern Cone,,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,673.96","2,509.96","7,609.15"
CHL,Chile,Southern Cone,,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"4,462.14","2,521.26","7,146.76"
CHL,Chile,Southern Cone,,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"4,454.21","2,513.34","7,138.84"
CHL,Chile,Southern Cone,,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,164.94","2,363.12","6,512.91"
CHL,Chile,Southern Cone,,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"4,150.06","2,348.24","6,498.03"
CHL,Chile,Southern Cone,,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"4,240.57","2,404.10","6,694.22"
CHL,Chile,Southern Cone,,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"4,224.92","2,388.45","6,678.58"
CHL,Chile,Southern Cone,,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"4,187.22","2,380.01","6,385.85"
CHL,Chile,Southern Cone,,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"4,170.73","2,363.52","6,369.36"
CHL,Chile,Southern Cone,,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"4,050.45","2,308.19","6,273.53"
CHL,Chile,Southern Cone,,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"4,034.87","2,292.61","6,257.95"
CHL,Chile,Southern Cone,,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,803.96","2,158.28","5,908.48"
CHL,Chile,Southern Cone,,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"3,784.07","2,138.38","5,888.59"
CHL,Chile,Southern Cone,,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,468.50","2,023.77","5,303.34"
CHL,Chile,Southern Cone,,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"3,456.19","2,011.46","5,291.03"
CHL,Chile,Southern Cone,,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,181.73","1,848.51","4,978.89"
CHL,Chile,Southern Cone,,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,161.50","1,828.28","4,958.66"
CHL,Chile,Southern Cone,,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,188.97","1,875.15","4,995.38"
CHL,Chile,Southern Cone,,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,151.70","1,837.87","4,958.10"
CHL,Chile,Southern Cone,,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,827.23","1,606.83","4,568.45"
CHL,Chile,Southern Cone,,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,816.63","1,596.23","4,557.85"
CHL,Chile,Southern Cone,,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,570.67","1,516.33","4,060.05"
CHL,Chile,Southern Cone,,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,519.65","1,465.30","4,009.02"
CHL,Chile,Southern Cone,,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,442.04","1,428.11","3,864.37"
CHL,Chile,Southern Cone,,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,401.53","1,387.59","3,823.85"
CHL,Chile,Southern Cone,,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,278.40","1,315.89","3,615.45"
CHL,Chile,Southern Cone,,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,251.27","1,288.75","3,588.31"
CHL,Chile,Southern Cone,,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,009.61","1,165.91","3,192.81"
CHL,Chile,Southern Cone,,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,988.33","1,144.63","3,171.53"
CHL,Chile,Southern Cone,,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,847.33","1,068.37","2,923.21"
CHL,Chile,Southern Cone,,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,826.90","1,047.95","2,902.79"
CHL,Chile,Southern Cone,,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,822.43","1,055.15","2,881.46"
CHL,Chile,Southern Cone,,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,797.76","1,030.48","2,856.78"
CHL,Chile,Southern Cone,,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,671.16",960.98,"2,630.88"
CHL,Chile,Southern Cone,,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,655.42",945.25,"2,615.15"
CHL,Chile,Southern Cone,,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,154.25,98.47,238.21
CHL,Chile,Southern Cone,,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,154.25,98.47,238.21
CHL,Chile,Southern Cone,,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"3,141.24","1,757.53","4,978.31"
CHL,Chile,Southern Cone,,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"3,130.51","1,746.79","4,967.58"
CHL,Chile,Southern Cone,,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"3,233.35","1,820.82","5,111.47"
CHL,Chile,Southern Cone,,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"3,219.75","1,807.22","5,097.88"
PRY,Paraguay,Southern Cone,,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,212.32,127.51,326.58
PRY,Paraguay,Southern Cone,,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,212.32,127.51,326.58
PRY,Paraguay,Southern Cone,,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,775.13,409.26,"1,290.28"
PRY,Paraguay,Southern Cone,,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,775.13,409.26,"1,290.28"
PRY,Paraguay,Southern Cone,,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,075.33",571.95,"1,790.64"
PRY,Paraguay,Southern Cone,,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,075.33",571.95,"1,790.64"
PRY,Paraguay,Southern Cone,,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,304.61",699.04,"2,174.53"
PRY,Paraguay,Southern Cone,,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,304.61",699.04,"2,174.53"
PRY,Paraguay,Southern Cone,,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,187.24,120.98,286.70
PRY,Paraguay,Southern Cone,,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,187.24,120.98,286.70
PRY,Paraguay,Southern Cone,,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,217.64,129.14,336.94
PRY,Paraguay,Southern Cone,,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,217.64,129.14,336.94
PRY,Paraguay,Southern Cone,,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,459.63,249.29,762.33
PRY,Paraguay,Southern Cone,,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,459.63,249.29,762.33
PRY,Paraguay,Southern Cone,,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,191.50,121.03,285.18
PRY,Paraguay,Southern Cone,,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,191.50,121.03,285.18
PRY,Paraguay,Southern Cone,,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,665.64,351.58,"1,124.48"
PRY,Paraguay,Southern Cone,,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,665.64,351.58,"1,124.48"
PRY,Paraguay,Southern Cone,,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,536.48",793.49,"2,570.68"
PRY,Paraguay,Southern Cone,,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,536.48",793.49,"2,570.68"
PRY,Paraguay,Southern Cone,,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,952.10","1,042.54","3,258.83"
PRY,Paraguay,Southern Cone,,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"1,952.10","1,042.54","3,258.83"
PRY,Paraguay,Southern Cone,,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,063.95","1,107.71","3,438.44"
PRY,Paraguay,Southern Cone,,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,063.95","1,107.71","3,438.44"
PRY,Paraguay,Southern Cone,,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,161.02","1,167.73","3,604.73"
PRY,Paraguay,Southern Cone,,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,161.02","1,167.73","3,604.73"
PRY,Paraguay,Southern Cone,,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,254.70","1,225.67","3,765.23"
PRY,Paraguay,Southern Cone,,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,254.70","1,225.67","3,765.23"
PRY,Paraguay,Southern Cone,,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,378.45","1,342.68","3,869.94"
PRY,Paraguay,Southern Cone,,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,378.45","1,342.68","3,869.94"
PRY,Paraguay,Southern Cone,,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,487.80","1,428.61","3,967.98"
PRY,Paraguay,Southern Cone,,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,480.29","1,421.10","3,960.47"
PRY,Paraguay,Southern Cone,,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,465.11","1,416.07","3,915.13"
PRY,Paraguay,Southern Cone,,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,465.11","1,416.07","3,915.13"
PRY,Paraguay,Southern Cone,,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,535.36","1,479.14","3,988.33"
PRY,Paraguay,Southern Cone,,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,535.36","1,479.14","3,988.33"
PRY,Paraguay,Southern Cone,,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,585.38","1,474.64","4,095.06"
PRY,Paraguay,Southern Cone,,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,562.37","1,451.63","4,072.04"
PRY,Paraguay,Southern Cone,,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,545.13","1,480.93","4,061.41"
PRY,Paraguay,Southern Cone,,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,518.01","1,453.82","4,034.29"
PRY,Paraguay,Southern Cone,,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,464.98","1,474.90","3,838.91"
PRY,Paraguay,Southern Cone,,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,437.13","1,447.06","3,811.07"
PRY,Paraguay,Southern Cone,,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,363.62","1,402.73","3,721.57"
PRY,Paraguay,Southern Cone,,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"2,337.00","1,376.11","3,694.95"
PRY,Paraguay,Southern Cone,,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,332.80","1,373.21","3,673.27"
PRY,Paraguay,Southern Cone,,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"2,332.80","1,373.21","3,673.27"
PRY,Paraguay,Southern Cone,,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,247.60","1,330.15","3,603.95"
PRY,Paraguay,Southern Cone,,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"2,187.62","1,270.17","3,543.98"
PRY,Paraguay,Southern Cone,,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,028.70","1,179.45","3,232.71"
PRY,Paraguay,Southern Cone,,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,994.88","1,145.63","3,198.89"
PRY,Paraguay,Southern Cone,,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,926.78","1,119.87","3,081.76"
PRY,Paraguay,Southern Cone,,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,907.20","1,100.29","3,062.18"
PRY,Paraguay,Southern Cone,,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,786.73","1,038.00","2,874.34"
PRY,Paraguay,Southern Cone,,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,786.73","1,038.00","2,874.34"
PRY,Paraguay,Southern Cone,,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,635.21",951.35,"2,609.38"
PRY,Paraguay,Southern Cone,,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,579.22",895.35,"2,553.39"
PRY,Paraguay,Southern Cone,,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,496.76",854.67,"2,423.93"
PRY,Paraguay,Southern Cone,,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,466.13",824.04,"2,393.30"
PRY,Paraguay,Southern Cone,,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,391.23",774.97,"2,312.36"
PRY,Paraguay,Southern Cone,,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,391.23",774.97,"2,312.36"
PRY,Paraguay,Southern Cone,,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,219.96",672.08,"2,000.30"
PRY,Paraguay,Southern Cone,,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,219.96",672.08,"2,000.30"
PRY,Paraguay,Southern Cone,,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,191.12,121.01,285.33
PRY,Paraguay,Southern Cone,,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,191.12,121.01,285.33
PRY,Paraguay,Southern Cone,,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,916.78","1,085.70","3,092.52"
PRY,Paraguay,Southern Cone,,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,908.05","1,076.97","3,083.79"
PRY,Paraguay,Southern Cone,,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,867.27","1,053.73","3,018.77"
PRY,Paraguay,Southern Cone,,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,860.35","1,046.81","3,011.85"
PRY,Paraguay,Southern Cone,,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,132.45,73.38,216.84
PRY,Paraguay,Southern Cone,,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,132.45,73.38,216.84
PRY,Paraguay,Southern Cone,,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,812.74,419.72,"1,414.20"
PRY,Paraguay,Southern Cone,,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,812.74,419.72,"1,414.20"
PRY,Paraguay,Southern Cone,,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,350.00",718.51,"2,299.08"
PRY,Paraguay,Southern Cone,,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,350.00",718.51,"2,299.08"
PRY,Paraguay,Southern Cone,,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,842.36",987.42,"3,121.29"
PRY,Paraguay,Southern Cone,,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"1,842.36",987.42,"3,121.29"
PRY,Paraguay,Southern Cone,,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,100.43,60.26,158.85
PRY,Paraguay,Southern Cone,,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,100.43,60.26,158.85
PRY,Paraguay,Southern Cone,,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,139.63,76.14,231.54
PRY,Paraguay,Southern Cone,,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,139.63,76.14,231.54
PRY,Paraguay,Southern Cone,,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,398.24,202.66,693.86
PRY,Paraguay,Southern Cone,,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,398.24,202.66,693.86
PRY,Paraguay,Southern Cone,,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,104.21,62.60,158.21
PRY,Paraguay,Southern Cone,,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,104.21,62.60,158.21
PRY,Paraguay,Southern Cone,,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,618.29,310.32,"1,087.23"
PRY,Paraguay,Southern Cone,,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,618.29,310.32,"1,087.23"
PRY,Paraguay,Southern Cone,,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,797.65",932.29,"3,131.32"
PRY,Paraguay,Southern Cone,,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,797.65",932.29,"3,131.32"
PRY,Paraguay,Southern Cone,,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,929.62","1,576.75","4,951.99"
PRY,Paraguay,Southern Cone,,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"2,929.62","1,576.75","4,951.99"
PRY,Paraguay,Southern Cone,,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,111.79","1,698.32","5,200.82"
PRY,Paraguay,Southern Cone,,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,111.79","1,698.32","5,200.82"
PRY,Paraguay,Southern Cone,,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,495.03","1,898.65","5,861.41"
PRY,Paraguay,Southern Cone,,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,495.03","1,898.65","5,861.41"
PRY,Paraguay,Southern Cone,,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,862.49","2,090.74","6,494.79"
PRY,Paraguay,Southern Cone,,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"3,862.49","2,090.74","6,494.79"
PRY,Paraguay,Southern Cone,,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"3,864.55","2,162.48","6,230.45"
PRY,Paraguay,Southern Cone,,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"3,864.55","2,162.48","6,230.45"
PRY,Paraguay,Southern Cone,,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,847.62","2,174.22","6,152.47"
PRY,Paraguay,Southern Cone,,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"3,847.62","2,174.22","6,152.47"
PRY,Paraguay,Southern Cone,,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"3,810.13","2,165.17","6,124.02"
PRY,Paraguay,Southern Cone,,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"3,810.13","2,165.17","6,124.02"
PRY,Paraguay,Southern Cone,,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"3,877.80","2,206.36","6,081.71"
PRY,Paraguay,Southern Cone,,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"3,877.80","2,206.36","6,081.71"
PRY,Paraguay,Southern Cone,,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"3,887.16","2,183.45","6,261.48"
PRY,Paraguay,Southern Cone,,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"3,887.16","2,183.45","6,261.48"
PRY,Paraguay,Southern Cone,,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,790.99","2,153.65","6,036.19"
PRY,Paraguay,Southern Cone,,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"3,790.99","2,153.65","6,036.19"
PRY,Paraguay,Southern Cone,,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,660.71","2,122.69","5,849.35"
PRY,Paraguay,Southern Cone,,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"3,633.80","2,095.78","5,822.44"
PRY,Paraguay,Southern Cone,,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,470.09","2,021.74","5,497.10"
PRY,Paraguay,Southern Cone,,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,451.62","2,003.28","5,478.64"
PRY,Paraguay,Southern Cone,,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,455.46","2,010.95","5,424.90"
PRY,Paraguay,Southern Cone,,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,455.46","2,010.95","5,424.90"
PRY,Paraguay,Southern Cone,,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,213.45","1,889.76","5,081.08"
PRY,Paraguay,Southern Cone,,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"3,183.40","1,859.72","5,051.02"
PRY,Paraguay,Southern Cone,,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,857.49","1,660.56","4,564.84"
PRY,Paraguay,Southern Cone,,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,857.49","1,660.56","4,564.84"
PRY,Paraguay,Southern Cone,,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,724.45","1,595.35","4,325.36"
PRY,Paraguay,Southern Cone,,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,724.45","1,595.35","4,325.36"
PRY,Paraguay,Southern Cone,,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,547.93","1,508.81","4,007.59"
PRY,Paraguay,Southern Cone,,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,547.93","1,508.81","4,007.59"
PRY,Paraguay,Southern Cone,,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,261.62","1,295.22","3,659.18"
PRY,Paraguay,Southern Cone,,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,261.62","1,295.22","3,659.18"
PRY,Paraguay,Southern Cone,,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,091.66","1,197.17","3,386.68"
PRY,Paraguay,Southern Cone,,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,091.66","1,197.17","3,386.68"
PRY,Paraguay,Southern Cone,,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,021.36","1,157.04","3,291.54"
PRY,Paraguay,Southern Cone,,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,021.36","1,157.04","3,291.54"
PRY,Paraguay,Southern Cone,,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,800.33","1,028.56","2,897.19"
PRY,Paraguay,Southern Cone,,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,800.33","1,028.56","2,897.19"
PRY,Paraguay,Southern Cone,,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,103.87,62.39,158.25
PRY,Paraguay,Southern Cone,,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,103.87,62.39,158.25
PRY,Paraguay,Southern Cone,,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,837.38","1,591.80","4,605.54"
PRY,Paraguay,Southern Cone,,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,834.82","1,589.24","4,602.98"
PRY,Paraguay,Southern Cone,,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,778.88","1,555.36","4,518.56"
PRY,Paraguay,Southern Cone,,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,776.68","1,553.16","4,516.36"
PRY,Paraguay,Southern Cone,,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,216.64,130.24,331.15
PRY,Paraguay,Southern Cone,,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,216.64,130.24,331.15
PRY,Paraguay,Southern Cone,,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,821.34,432.93,"1,372.47"
PRY,Paraguay,Southern Cone,,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,821.34,432.93,"1,372.47"
PRY,Paraguay,Southern Cone,,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,139.74",603.90,"1,910.43"
PRY,Paraguay,Southern Cone,,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,139.74",603.90,"1,910.43"
PRY,Paraguay,Southern Cone,,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,383.36",739.11,"2,314.40"
PRY,Paraguay,Southern Cone,,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,383.36",739.11,"2,314.40"
PRY,Paraguay,Southern Cone,,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,187.19,120.35,284.32
PRY,Paraguay,Southern Cone,,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,187.19,120.35,284.32
PRY,Paraguay,Southern Cone,,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,222.96,132.79,343.36
PRY,Paraguay,Southern Cone,,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,222.96,132.79,343.36
PRY,Paraguay,Southern Cone,,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,484.09,260.31,798.38
PRY,Paraguay,Southern Cone,,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,484.09,260.31,798.38
PRY,Paraguay,Southern Cone,,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,191.81,120.01,282.13
PRY,Paraguay,Southern Cone,,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,191.81,120.01,282.13
PRY,Paraguay,Southern Cone,,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,702.64,367.05,"1,179.23"
PRY,Paraguay,Southern Cone,,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,702.64,367.05,"1,179.23"
PRY,Paraguay,Southern Cone,,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,635.38",847.42,"2,762.20"
PRY,Paraguay,Southern Cone,,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,635.38",847.42,"2,762.20"
PRY,Paraguay,Southern Cone,,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,079.39","1,108.51","3,489.52"
PRY,Paraguay,Southern Cone,,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,079.39","1,108.51","3,489.52"
PRY,Paraguay,Southern Cone,,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,203.12","1,174.90","3,707.08"
PRY,Paraguay,Southern Cone,,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,203.12","1,174.90","3,707.08"
PRY,Paraguay,Southern Cone,,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,305.97","1,241.74","3,860.67"
PRY,Paraguay,Southern Cone,,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,305.97","1,241.74","3,860.67"
PRY,Paraguay,Southern Cone,,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,405.41","1,306.35","4,009.15"
PRY,Paraguay,Southern Cone,,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,405.41","1,306.35","4,009.15"
PRY,Paraguay,Southern Cone,,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,515.30","1,404.82","4,080.70"
PRY,Paraguay,Southern Cone,,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,515.30","1,404.82","4,080.70"
PRY,Paraguay,Southern Cone,,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,607.93","1,491.61","4,181.31"
PRY,Paraguay,Southern Cone,,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,603.93","1,487.61","4,177.31"
PRY,Paraguay,Southern Cone,,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,610.07","1,513.60","4,110.94"
PRY,Paraguay,Southern Cone,,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,593.17","1,496.71","4,094.05"
PRY,Paraguay,Southern Cone,,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,659.99","1,527.99","4,236.46"
PRY,Paraguay,Southern Cone,,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,659.99","1,527.99","4,236.46"
PRY,Paraguay,Southern Cone,,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,673.42","1,533.30","4,313.20"
PRY,Paraguay,Southern Cone,,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,673.42","1,533.30","4,313.20"
PRY,Paraguay,Southern Cone,,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,618.04","1,508.78","4,246.32"
PRY,Paraguay,Southern Cone,,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,618.04","1,508.78","4,246.32"
PRY,Paraguay,Southern Cone,,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,512.50","1,484.52","3,998.07"
PRY,Paraguay,Southern Cone,,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,512.50","1,484.52","3,998.07"
PRY,Paraguay,Southern Cone,,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,414.98","1,430.50","3,860.24"
PRY,Paraguay,Southern Cone,,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"2,400.20","1,415.72","3,845.46"
PRY,Paraguay,Southern Cone,,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,397.17","1,423.71","3,814.23"
PRY,Paraguay,Southern Cone,,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"2,397.17","1,423.71","3,814.23"
PRY,Paraguay,Southern Cone,,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,290.75","1,357.63","3,712.26"
PRY,Paraguay,Southern Cone,,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"2,233.96","1,300.83","3,655.47"
PRY,Paraguay,Southern Cone,,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,032.52","1,186.07","3,298.63"
PRY,Paraguay,Southern Cone,,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"2,032.52","1,186.07","3,298.63"
PRY,Paraguay,Southern Cone,,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,940.83","1,128.33","3,136.83"
PRY,Paraguay,Southern Cone,,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,940.83","1,128.33","3,136.83"
PRY,Paraguay,Southern Cone,,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,813.74","1,048.29","2,912.55"
PRY,Paraguay,Southern Cone,,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,813.74","1,048.29","2,912.55"
PRY,Paraguay,Southern Cone,,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,640.23",966.80,"2,609.84"
PRY,Paraguay,Southern Cone,,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,587.04",913.64,"2,556.68"
PRY,Paraguay,Southern Cone,,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,522.18",889.22,"2,441.84"
PRY,Paraguay,Southern Cone,,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,473.56",840.62,"2,393.23"
PRY,Paraguay,Southern Cone,,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,465.88",858.59,"2,376.95"
PRY,Paraguay,Southern Cone,,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,399.10",791.86,"2,310.17"
PRY,Paraguay,Southern Cone,,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,220.10",679.09,"1,984.19"
PRY,Paraguay,Southern Cone,,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,220.10",679.09,"1,984.19"
PRY,Paraguay,Southern Cone,,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,191.39,120.02,282.34
PRY,Paraguay,Southern Cone,,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,191.39,120.02,282.34
PRY,Paraguay,Southern Cone,,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,002.58","1,130.92","3,254.08"
PRY,Paraguay,Southern Cone,,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,997.77","1,126.11","3,249.27"
PRY,Paraguay,Southern Cone,,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,959.23","1,102.40","3,186.75"
PRY,Paraguay,Southern Cone,,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,955.25","1,098.42","3,182.77"
PRY,Paraguay,Southern Cone,,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,137.00,74.77,226.07
PRY,Paraguay,Southern Cone,,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,137.00,74.77,226.07
PRY,Paraguay,Southern Cone,,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,900.53,461.80,"1,570.48"
PRY,Paraguay,Southern Cone,,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,900.53,461.80,"1,570.48"
PRY,Paraguay,Southern Cone,,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,489.72",794.41,"2,516.11"
PRY,Paraguay,Southern Cone,,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,489.72",794.41,"2,516.11"
PRY,Paraguay,Southern Cone,,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,022.28","1,095.99","3,387.10"
PRY,Paraguay,Southern Cone,,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,022.28","1,095.99","3,387.10"
PRY,Paraguay,Southern Cone,,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,101.09,59.32,156.73
PRY,Paraguay,Southern Cone,,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,101.09,59.32,156.73
PRY,Paraguay,Southern Cone,,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,145.26,78.00,242.66
PRY,Paraguay,Southern Cone,,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,145.26,78.00,242.66
PRY,Paraguay,Southern Cone,,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,438.73,220.68,770.16
PRY,Paraguay,Southern Cone,,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,438.73,220.68,770.16
PRY,Paraguay,Southern Cone,,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,104.23,62.08,159.96
PRY,Paraguay,Southern Cone,,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,104.23,62.08,159.96
PRY,Paraguay,Southern Cone,,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,684.26,340.05,"1,211.50"
PRY,Paraguay,Southern Cone,,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,684.26,340.05,"1,211.50"
PRY,Paraguay,Southern Cone,,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,998.31","1,031.36","3,479.83"
PRY,Paraguay,Southern Cone,,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,998.31","1,031.36","3,479.83"
PRY,Paraguay,Southern Cone,,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,227.00","1,759.91","5,382.36"
PRY,Paraguay,Southern Cone,,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,227.00","1,759.91","5,382.36"
PRY,Paraguay,Southern Cone,,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,449.06","1,900.52","5,660.79"
PRY,Paraguay,Southern Cone,,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,449.06","1,900.52","5,660.79"
PRY,Paraguay,Southern Cone,,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,850.09","2,129.36","6,347.15"
PRY,Paraguay,Southern Cone,,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,850.09","2,129.36","6,347.15"
PRY,Paraguay,Southern Cone,,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,235.37","2,349.21","7,006.55"
PRY,Paraguay,Southern Cone,,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,235.37","2,349.21","7,006.55"
PRY,Paraguay,Southern Cone,,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"4,190.77","2,353.46","6,739.79"
PRY,Paraguay,Southern Cone,,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"4,190.77","2,353.46","6,739.79"
PRY,Paraguay,Southern Cone,,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,130.66","2,346.72","6,540.53"
PRY,Paraguay,Southern Cone,,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"4,125.99","2,342.05","6,535.86"
PRY,Paraguay,Southern Cone,,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"4,099.96","2,356.76","6,508.11"
PRY,Paraguay,Southern Cone,,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"4,099.96","2,356.76","6,508.11"
PRY,Paraguay,Southern Cone,,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"4,148.20","2,395.22","6,458.78"
PRY,Paraguay,Southern Cone,,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"4,148.20","2,395.22","6,458.78"
PRY,Paraguay,Southern Cone,,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"4,163.27","2,319.60","6,587.50"
PRY,Paraguay,Southern Cone,,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"4,135.06","2,291.39","6,559.29"
PRY,Paraguay,Southern Cone,,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"4,010.49","2,278.48","6,303.33"
PRY,Paraguay,Southern Cone,,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"4,010.49","2,278.48","6,303.33"
PRY,Paraguay,Southern Cone,,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,816.49","2,240.42","6,011.21"
PRY,Paraguay,Southern Cone,,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"3,816.49","2,240.42","6,011.21"
PRY,Paraguay,Southern Cone,,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,615.71","2,122.51","5,725.89"
PRY,Paraguay,Southern Cone,,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"3,598.11","2,104.91","5,708.30"
PRY,Paraguay,Southern Cone,,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"3,629.07","2,143.96","5,695.06"
PRY,Paraguay,Southern Cone,,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"3,601.43","2,116.32","5,667.42"
PRY,Paraguay,Southern Cone,,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"3,317.91","1,930.27","5,366.23"
PRY,Paraguay,Southern Cone,,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"3,288.50","1,900.86","5,336.83"
PRY,Paraguay,Southern Cone,,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,962.15","1,730.12","4,697.58"
PRY,Paraguay,Southern Cone,,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,928.72","1,696.70","4,664.16"
PRY,Paraguay,Southern Cone,,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,806.48","1,645.66","4,442.32"
PRY,Paraguay,Southern Cone,,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,787.30","1,626.48","4,423.15"
PRY,Paraguay,Southern Cone,,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,596.95","1,531.96","4,098.73"
PRY,Paraguay,Southern Cone,,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,596.95","1,531.96","4,098.73"
PRY,Paraguay,Southern Cone,,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,286.61","1,299.29","3,689.33"
PRY,Paraguay,Southern Cone,,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,286.61","1,299.29","3,689.33"
PRY,Paraguay,Southern Cone,,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,107.04","1,199.31","3,393.44"
PRY,Paraguay,Southern Cone,,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,107.04","1,199.31","3,393.44"
PRY,Paraguay,Southern Cone,,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,032.36","1,158.52","3,269.00"
PRY,Paraguay,Southern Cone,,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,032.36","1,158.52","3,269.00"
PRY,Paraguay,Southern Cone,,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,791.12","1,022.36","2,874.69"
PRY,Paraguay,Southern Cone,,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,791.12","1,022.36","2,874.69"
PRY,Paraguay,Southern Cone,,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,103.95,61.83,159.67
PRY,Paraguay,Southern Cone,,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,103.95,61.83,159.67
PRY,Paraguay,Southern Cone,,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"3,043.39","1,717.59","4,899.90"
PRY,Paraguay,Southern Cone,,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"3,038.19","1,712.39","4,894.70"
PRY,Paraguay,Southern Cone,,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,990.79","1,685.27","4,822.20"
PRY,Paraguay,Southern Cone,,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,986.22","1,680.70","4,817.63"
URY,Uruguay,Southern Cone,,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,348.06,222.18,519.61
URY,Uruguay,Southern Cone,,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,348.06,222.18,519.61
URY,Uruguay,Southern Cone,,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,967.09,537.73,"1,582.64"
URY,Uruguay,Southern Cone,,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,967.09,537.73,"1,582.64"
URY,Uruguay,Southern Cone,,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,283.42",703.07,"2,096.66"
URY,Uruguay,Southern Cone,,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,283.42",703.07,"2,096.66"
URY,Uruguay,Southern Cone,,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,501.44",824.00,"2,461.35"
URY,Uruguay,Southern Cone,,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,501.44",824.00,"2,461.35"
URY,Uruguay,Southern Cone,,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,322.70,208.03,475.59
URY,Uruguay,Southern Cone,,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,322.70,208.03,475.59
URY,Uruguay,Southern Cone,,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,352.63,222.54,528.55
URY,Uruguay,Southern Cone,,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,352.63,222.54,528.55
URY,Uruguay,Southern Cone,,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,619.67,351.40,991.61
URY,Uruguay,Southern Cone,,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,619.67,351.40,991.61
URY,Uruguay,Southern Cone,,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,326.91,221.69,477.45
URY,Uruguay,Southern Cone,,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,326.91,221.69,477.45
URY,Uruguay,Southern Cone,,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,814.75,445.53,"1,329.88"
URY,Uruguay,Southern Cone,,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,814.75,445.53,"1,329.88"
URY,Uruguay,Southern Cone,,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,666.13",908.57,"2,774.20"
URY,Uruguay,Southern Cone,,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,666.13",908.57,"2,774.20"
URY,Uruguay,Southern Cone,,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,049.32","1,116.34","3,375.82"
URY,Uruguay,Southern Cone,,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,049.32","1,116.34","3,375.82"
URY,Uruguay,Southern Cone,,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,165.72","1,164.25","3,530.35"
URY,Uruguay,Southern Cone,,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,165.72","1,164.25","3,530.35"
URY,Uruguay,Southern Cone,,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,230.83","1,214.75","3,660.79"
URY,Uruguay,Southern Cone,,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,230.83","1,214.75","3,660.79"
URY,Uruguay,Southern Cone,,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,293.24","1,263.16","3,785.80"
URY,Uruguay,Southern Cone,,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,293.24","1,263.16","3,785.80"
URY,Uruguay,Southern Cone,,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,498.86","1,498.42","3,935.06"
URY,Uruguay,Southern Cone,,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,321.91","1,321.48","3,758.11"
URY,Uruguay,Southern Cone,,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,331.88","1,369.47","3,657.41"
URY,Uruguay,Southern Cone,,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,272.31","1,309.91","3,597.84"
URY,Uruguay,Southern Cone,,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,323.61","1,329.13","3,716.10"
URY,Uruguay,Southern Cone,,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,323.61","1,329.13","3,716.10"
URY,Uruguay,Southern Cone,,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,307.57","1,340.81","3,584.21"
URY,Uruguay,Southern Cone,,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,307.57","1,340.81","3,584.21"
URY,Uruguay,Southern Cone,,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,302.90","1,345.28","3,587.56"
URY,Uruguay,Southern Cone,,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,246.76","1,289.14","3,531.41"
URY,Uruguay,Southern Cone,,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,195.88","1,314.88","3,405.84"
URY,Uruguay,Southern Cone,,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,145.78","1,264.78","3,355.72"
URY,Uruguay,Southern Cone,,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,114.66","1,293.92","3,244.97"
URY,Uruguay,Southern Cone,,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,015.18","1,194.44","3,145.51"
URY,Uruguay,Southern Cone,,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,968.40","1,194.32","3,050.74"
URY,Uruguay,Southern Cone,,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"1,889.64","1,115.56","2,971.98"
URY,Uruguay,Southern Cone,,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,974.44","1,198.88","3,057.11"
URY,Uruguay,Southern Cone,,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,886.86","1,111.29","2,969.53"
URY,Uruguay,Southern Cone,,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,785.35","1,069.14","2,809.54"
URY,Uruguay,Southern Cone,,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,741.73","1,025.52","2,765.93"
URY,Uruguay,Southern Cone,,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,644.65",992.48,"2,559.05"
URY,Uruguay,Southern Cone,,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,600.01",947.84,"2,514.41"
URY,Uruguay,Southern Cone,,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,584.03",955.03,"2,442.19"
URY,Uruguay,Southern Cone,,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,538.33",909.33,"2,396.50"
URY,Uruguay,Southern Cone,,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,505.87",906.75,"2,291.52"
URY,Uruguay,Southern Cone,,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,458.81",859.68,"2,244.47"
URY,Uruguay,Southern Cone,,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,378.31",832.51,"2,127.22"
URY,Uruguay,Southern Cone,,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,328.55",782.75,"2,077.46"
URY,Uruguay,Southern Cone,,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,250.50",732.09,"1,963.40"
URY,Uruguay,Southern Cone,,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,228.05",709.64,"1,940.95"
URY,Uruguay,Southern Cone,,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,205.16",676.95,"1,919.00"
URY,Uruguay,Southern Cone,,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,205.16",676.95,"1,919.00"
URY,Uruguay,Southern Cone,,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,065.67",612.95,"1,708.19"
URY,Uruguay,Southern Cone,,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,065.67",612.95,"1,708.19"
URY,Uruguay,Southern Cone,,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,326.50,220.46,477.35
URY,Uruguay,Southern Cone,,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,326.50,220.46,477.35
URY,Uruguay,Southern Cone,,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,831.05","1,058.45","2,907.53"
URY,Uruguay,Southern Cone,,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,796.24","1,023.64","2,872.72"
URY,Uruguay,Southern Cone,,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,860.89","1,079.92","2,948.31"
URY,Uruguay,Southern Cone,,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,822.66","1,041.69","2,910.08"
URY,Uruguay,Southern Cone,,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,187.82,110.96,292.70
URY,Uruguay,Southern Cone,,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,187.82,110.96,292.70
URY,Uruguay,Southern Cone,,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,981.94,512.80,"1,654.46"
URY,Uruguay,Southern Cone,,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,981.94,512.80,"1,654.46"
URY,Uruguay,Southern Cone,,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,533.20",822.60,"2,540.39"
URY,Uruguay,Southern Cone,,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,533.20",822.60,"2,540.39"
URY,Uruguay,Southern Cone,,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,957.26","1,053.88","3,222.75"
URY,Uruguay,Southern Cone,,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"1,957.26","1,053.88","3,222.75"
URY,Uruguay,Southern Cone,,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,152.73,94.04,232.10
URY,Uruguay,Southern Cone,,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,152.73,94.04,232.10
URY,Uruguay,Southern Cone,,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,194.48,114.04,304.59
URY,Uruguay,Southern Cone,,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,194.48,114.04,304.59
URY,Uruguay,Southern Cone,,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,486.77,253.32,812.02
URY,Uruguay,Southern Cone,,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,486.77,253.32,812.02
URY,Uruguay,Southern Cone,,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,156.70,96.59,236.90
URY,Uruguay,Southern Cone,,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,156.70,96.59,236.90
URY,Uruguay,Southern Cone,,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,698.56,354.25,"1,179.71"
URY,Uruguay,Southern Cone,,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,698.56,354.25,"1,179.71"
URY,Uruguay,Southern Cone,,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,960.10","1,022.88","3,320.67"
URY,Uruguay,Southern Cone,,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,960.10","1,022.88","3,320.67"
URY,Uruguay,Southern Cone,,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,856.28","1,542.18","4,698.25"
URY,Uruguay,Southern Cone,,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"2,856.28","1,542.18","4,698.25"
URY,Uruguay,Southern Cone,,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,064.41","1,683.11","5,001.15"
URY,Uruguay,Southern Cone,,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,064.41","1,683.11","5,001.15"
URY,Uruguay,Southern Cone,,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,278.93","1,787.09","5,347.95"
URY,Uruguay,Southern Cone,,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,278.93","1,787.09","5,347.95"
URY,Uruguay,Southern Cone,,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,483.29","1,886.15","5,678.31"
URY,Uruguay,Southern Cone,,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"3,483.29","1,886.15","5,678.31"
URY,Uruguay,Southern Cone,,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"3,562.57","2,006.98","5,815.42"
URY,Uruguay,Southern Cone,,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"3,499.93","1,944.34","5,752.78"
URY,Uruguay,Southern Cone,,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,446.42","1,969.88","5,465.21"
URY,Uruguay,Southern Cone,,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"3,400.69","1,924.15","5,419.49"
URY,Uruguay,Southern Cone,,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"3,503.60","2,010.53","5,599.69"
URY,Uruguay,Southern Cone,,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"3,438.12","1,945.06","5,534.22"
URY,Uruguay,Southern Cone,,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"3,499.80","2,027.21","5,511.98"
URY,Uruguay,Southern Cone,,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"3,443.82","1,971.23","5,455.99"
URY,Uruguay,Southern Cone,,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"3,395.75","1,924.77","5,317.25"
URY,Uruguay,Southern Cone,,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"3,395.75","1,924.77","5,317.25"
URY,Uruguay,Southern Cone,,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,252.61","1,874.52","5,030.67"
URY,Uruguay,Southern Cone,,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"3,208.83","1,830.75","4,986.90"
URY,Uruguay,Southern Cone,,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,000.16","1,781.64","4,761.01"
URY,Uruguay,Southern Cone,,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"2,957.71","1,739.18","4,718.56"
URY,Uruguay,Southern Cone,,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,738.18","1,611.59","4,358.82"
URY,Uruguay,Southern Cone,,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"2,723.57","1,596.97","4,344.20"
URY,Uruguay,Southern Cone,,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,720.72","1,596.50","4,319.87"
URY,Uruguay,Southern Cone,,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"2,720.72","1,596.50","4,319.87"
URY,Uruguay,Southern Cone,,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,468.66","1,440.78","3,958.36"
URY,Uruguay,Southern Cone,,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,468.66","1,440.78","3,958.36"
URY,Uruguay,Southern Cone,,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,313.46","1,370.44","3,670.64"
URY,Uruguay,Southern Cone,,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,240.69","1,297.66","3,597.87"
URY,Uruguay,Southern Cone,,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,210.49","1,325.08","3,475.58"
URY,Uruguay,Southern Cone,,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,138.74","1,253.32","3,403.83"
URY,Uruguay,Southern Cone,,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,090.34","1,272.15","3,247.98"
URY,Uruguay,Southern Cone,,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,019.77","1,201.58","3,177.41"
URY,Uruguay,Southern Cone,,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,818.01","1,066.53","2,916.75"
URY,Uruguay,Southern Cone,,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,818.01","1,066.53","2,916.75"
URY,Uruguay,Southern Cone,,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,675.77",962.67,"2,693.55"
URY,Uruguay,Southern Cone,,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,661.38",948.28,"2,679.16"
URY,Uruguay,Southern Cone,,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,690.90",969.35,"2,722.31"
URY,Uruguay,Southern Cone,,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,658.57",937.03,"2,689.99"
URY,Uruguay,Southern Cone,,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,524.52",855.73,"2,452.22"
URY,Uruguay,Southern Cone,,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,510.36",841.57,"2,438.06"
URY,Uruguay,Southern Cone,,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,156.36,96.43,236.55
URY,Uruguay,Southern Cone,,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,156.36,96.43,236.55
URY,Uruguay,Southern Cone,,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,554.62","1,443.90","4,103.19"
URY,Uruguay,Southern Cone,,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,531.66","1,420.93","4,080.22"
URY,Uruguay,Southern Cone,,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,566.56","1,459.37","4,112.48"
URY,Uruguay,Southern Cone,,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,541.75","1,434.56","4,087.68"
URY,Uruguay,Southern Cone,,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,354.10,221.78,531.91
URY,Uruguay,Southern Cone,,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,354.10,221.78,531.91
URY,Uruguay,Southern Cone,,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,062.24",572.42,"1,741.75"
URY,Uruguay,Southern Cone,,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,"1,062.24",572.42,"1,741.75"
URY,Uruguay,Southern Cone,,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,423.09",770.97,"2,337.74"
URY,Uruguay,Southern Cone,,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,"1,423.09",770.97,"2,337.74"
URY,Uruguay,Southern Cone,,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,668.80",909.47,"2,743.09"
URY,Uruguay,Southern Cone,,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,"1,668.80",909.47,"2,743.09"
URY,Uruguay,Southern Cone,,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,324.42,208.23,479.12
URY,Uruguay,Southern Cone,,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,324.42,208.23,479.12
URY,Uruguay,Southern Cone,,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,359.84,223.69,543.57
URY,Uruguay,Southern Cone,,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,359.84,223.69,543.57
URY,Uruguay,Southern Cone,,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,668.35,375.29,"1,075.70"
URY,Uruguay,Southern Cone,,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,668.35,375.29,"1,075.70"
URY,Uruguay,Southern Cone,,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,327.99,213.46,478.21
URY,Uruguay,Southern Cone,,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,327.99,213.46,478.21
URY,Uruguay,Southern Cone,,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,878.68,478.64,"1,438.47"
URY,Uruguay,Southern Cone,,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,878.68,478.64,"1,438.47"
URY,Uruguay,Southern Cone,,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,840.08",960.48,"3,060.27"
URY,Uruguay,Southern Cone,,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,"1,840.08",960.48,"3,060.27"
URY,Uruguay,Southern Cone,,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,279.57","1,234.65","3,762.47"
URY,Uruguay,Southern Cone,,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,"2,279.57","1,234.65","3,762.47"
URY,Uruguay,Southern Cone,,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"2,417.45","1,318.11","3,980.02"
URY,Uruguay,Southern Cone,,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"2,417.45","1,318.11","3,980.02"
URY,Uruguay,Southern Cone,,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,488.22","1,364.81","4,095.85"
URY,Uruguay,Southern Cone,,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,"2,488.22","1,364.81","4,095.85"
URY,Uruguay,Southern Cone,,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,556.28","1,409.72","4,207.25"
URY,Uruguay,Southern Cone,,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,"2,556.28","1,409.72","4,207.25"
URY,Uruguay,Southern Cone,,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"2,630.67","1,536.49","4,170.11"
URY,Uruguay,Southern Cone,,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,"2,541.93","1,447.76","4,081.38"
URY,Uruguay,Southern Cone,,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,497.38","1,461.99","3,918.08"
URY,Uruguay,Southern Cone,,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,"2,440.12","1,404.72","3,860.82"
URY,Uruguay,Southern Cone,,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"2,531.45","1,458.72","4,019.04"
URY,Uruguay,Southern Cone,,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,"2,506.80","1,434.07","3,994.38"
URY,Uruguay,Southern Cone,,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"2,517.47","1,486.27","3,865.91"
URY,Uruguay,Southern Cone,,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,"2,471.77","1,440.57","3,820.21"
URY,Uruguay,Southern Cone,,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"2,443.73","1,426.02","3,827.90"
URY,Uruguay,Southern Cone,,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,"2,387.49","1,369.79","3,771.67"
URY,Uruguay,Southern Cone,,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"2,336.10","1,389.70","3,651.62"
URY,Uruguay,Southern Cone,,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,"2,266.72","1,320.32","3,582.24"
URY,Uruguay,Southern Cone,,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"2,231.25","1,374.67","3,424.73"
URY,Uruguay,Southern Cone,,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,"2,106.83","1,250.24","3,300.30"
URY,Uruguay,Southern Cone,,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,032.53","1,221.37","3,139.69"
URY,Uruguay,Southern Cone,,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,"1,959.31","1,148.15","3,066.46"
URY,Uruguay,Southern Cone,,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,013.50","1,207.82","3,093.91"
URY,Uruguay,Southern Cone,,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,"1,955.46","1,149.77","3,035.86"
URY,Uruguay,Southern Cone,,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,818.68","1,055.12","2,854.17"
URY,Uruguay,Southern Cone,,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,"1,788.76","1,025.21","2,824.25"
URY,Uruguay,Southern Cone,,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,728.96","1,062.26","2,650.66"
URY,Uruguay,Southern Cone,,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,634.45",967.78,"2,556.16"
URY,Uruguay,Southern Cone,,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,657.16","1,018.30","2,551.47"
URY,Uruguay,Southern Cone,,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,568.42",929.58,"2,462.73"
URY,Uruguay,Southern Cone,,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,563.57",960.99,"2,422.18"
URY,Uruguay,Southern Cone,,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,482.33",879.77,"2,340.94"
URY,Uruguay,Southern Cone,,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,354.48",802.15,"2,103.93"
URY,Uruguay,Southern Cone,,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,337.66",785.29,"2,087.08"
URY,Uruguay,Southern Cone,,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,241.47",720.59,"1,961.87"
URY,Uruguay,Southern Cone,,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,230.83",709.94,"1,951.22"
URY,Uruguay,Southern Cone,,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,210.63",688.33,"1,943.83"
URY,Uruguay,Southern Cone,,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,210.63",688.33,"1,943.83"
URY,Uruguay,Southern Cone,,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,070.05",609.86,"1,719.56"
URY,Uruguay,Southern Cone,,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"1,057.19",597.00,"1,706.70"
URY,Uruguay,Southern Cone,,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,327.68,213.01,478.23
URY,Uruguay,Southern Cone,,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,327.68,213.01,478.23
URY,Uruguay,Southern Cone,,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,966.79","1,131.04","3,126.36"
URY,Uruguay,Southern Cone,,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,931.36","1,095.61","3,090.93"
URY,Uruguay,Southern Cone,,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,997.21","1,153.51","3,167.05"
URY,Uruguay,Southern Cone,,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,"1,957.90","1,114.19","3,127.74"
URY,Uruguay,Southern Cone,,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,195.40,113.18,306.89
URY,Uruguay,Southern Cone,,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,195.40,113.18,306.89
URY,Uruguay,Southern Cone,,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,161.73",607.25,"1,948.11"
URY,Uruguay,Southern Cone,,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,"1,161.73",607.25,"1,948.11"
URY,Uruguay,Southern Cone,,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,819.33",988.83,"3,026.09"
URY,Uruguay,Southern Cone,,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,"1,812.60",982.09,"3,019.35"
URY,Uruguay,Southern Cone,,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"2,302.89","1,260.10","3,809.22"
URY,Uruguay,Southern Cone,,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"2,297.62","1,254.84","3,803.96"
URY,Uruguay,Southern Cone,,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,152.55,93.61,232.30
URY,Uruguay,Southern Cone,,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,152.55,93.61,232.30
URY,Uruguay,Southern Cone,,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,203.83,116.90,321.46
URY,Uruguay,Southern Cone,,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,203.83,116.90,321.46
URY,Uruguay,Southern Cone,,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,570.75,297.68,966.84
URY,Uruguay,Southern Cone,,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,570.75,297.68,966.84
URY,Uruguay,Southern Cone,,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,157.03,96.35,240.78
URY,Uruguay,Southern Cone,,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,157.03,96.35,240.78
URY,Uruguay,Southern Cone,,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,819.26,420.12,"1,403.95"
URY,Uruguay,Southern Cone,,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,819.26,420.12,"1,403.95"
URY,Uruguay,Southern Cone,,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"2,307.21","1,205.00","3,855.94"
URY,Uruguay,Southern Cone,,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"2,307.21","1,205.00","3,855.94"
URY,Uruguay,Southern Cone,,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,343.27","1,836.82","5,518.71"
URY,Uruguay,Southern Cone,,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"3,334.90","1,828.45","5,510.35"
URY,Uruguay,Southern Cone,,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"3,623.54","2,035.73","5,983.61"
URY,Uruguay,Southern Cone,,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"3,598.33","2,010.52","5,958.41"
URY,Uruguay,Southern Cone,,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"3,833.56","2,135.81","6,305.60"
URY,Uruguay,Southern Cone,,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"3,821.24","2,123.48","6,293.27"
URY,Uruguay,Southern Cone,,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"4,034.46","2,231.54","6,613.59"
URY,Uruguay,Southern Cone,,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"4,034.46","2,231.54","6,613.59"
URY,Uruguay,Southern Cone,,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"3,981.09","2,265.76","6,401.24"
URY,Uruguay,Southern Cone,,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"3,957.48","2,242.15","6,377.64"
URY,Uruguay,Southern Cone,,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,792.21","2,179.29","6,009.38"
URY,Uruguay,Southern Cone,,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"3,754.36","2,141.44","5,971.53"
URY,Uruguay,Southern Cone,,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"3,894.19","2,243.53","6,293.10"
URY,Uruguay,Southern Cone,,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"3,823.31","2,172.64","6,222.22"
URY,Uruguay,Southern Cone,,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"3,819.47","2,194.56","5,993.79"
URY,Uruguay,Southern Cone,,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"3,798.22","2,173.31","5,972.54"
URY,Uruguay,Southern Cone,,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"3,743.27","2,145.42","5,873.41"
URY,Uruguay,Southern Cone,,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"3,705.78","2,107.92","5,835.92"
URY,Uruguay,Southern Cone,,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"3,495.39","2,033.69","5,422.16"
URY,Uruguay,Southern Cone,,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"3,460.13","1,998.43","5,386.90"
URY,Uruguay,Southern Cone,,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"3,190.21","1,891.04","4,977.15"
URY,Uruguay,Southern Cone,,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"3,173.11","1,873.96","4,960.07"
URY,Uruguay,Southern Cone,,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,936.96","1,737.87","4,640.83"
URY,Uruguay,Southern Cone,,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"2,898.97","1,699.88","4,602.84"
URY,Uruguay,Southern Cone,,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"2,954.41","1,771.47","4,681.39"
URY,Uruguay,Southern Cone,,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"2,899.44","1,716.49","4,626.40"
URY,Uruguay,Southern Cone,,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,643.66","1,535.35","4,232.35"
URY,Uruguay,Southern Cone,,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"2,601.57","1,493.25","4,190.27"
URY,Uruguay,Southern Cone,,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,447.42","1,465.21","3,852.16"
URY,Uruguay,Southern Cone,,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"2,335.17","1,352.96","3,739.91"
URY,Uruguay,Southern Cone,,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,314.53","1,380.16","3,655.70"
URY,Uruguay,Southern Cone,,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"2,224.40","1,290.04","3,565.57"
URY,Uruguay,Southern Cone,,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,157.41","1,279.61","3,423.42"
URY,Uruguay,Southern Cone,,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"2,093.44","1,215.66","3,359.45"
URY,Uruguay,Southern Cone,,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,923.90","1,147.66","3,015.87"
URY,Uruguay,Southern Cone,,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,863.04","1,086.79","2,955.02"
URY,Uruguay,Southern Cone,,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,729.03","1,014.73","2,745.90"
URY,Uruguay,Southern Cone,,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"1,681.39",967.10,"2,698.28"
URY,Uruguay,Southern Cone,,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,736.68","1,023.69","2,769.16"
URY,Uruguay,Southern Cone,,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"1,680.80",967.83,"2,713.28"
URY,Uruguay,Southern Cone,,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,536.93",880.80,"2,469.96"
URY,Uruguay,Southern Cone,,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"1,508.33",852.20,"2,441.37"
URY,Uruguay,Southern Cone,,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,156.71,96.12,239.99
URY,Uruguay,Southern Cone,,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,156.71,96.12,239.99
URY,Uruguay,Southern Cone,,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"2,846.43","1,620.26","4,573.41"
URY,Uruguay,Southern Cone,,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"2,819.58","1,593.41","4,546.56"
URY,Uruguay,Southern Cone,,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,842.39","1,627.93","4,552.89"
URY,Uruguay,Southern Cone,,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"2,809.52","1,595.05","4,520.01"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Deaths,Rate,0.04,0.00,0.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.24,0.00,9.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,3.24,0.00,9.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Deaths,Rate,0.03,0.00,0.08
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,0.00,6.88
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,2.45,0.00,6.88
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Deaths,Rate,0.02,0.00,0.07
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.97,0.00,5.53
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,1.97,0.00,5.53
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Deaths,Rate,0.03,0.00,0.09
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,2.70,0.00,7.58
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,2.70,0.00,7.58
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Deaths,Rate,0.06,0.00,0.16
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,4.71,0.00,13.26
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,4.71,0.00,13.26
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Deaths,Rate,0.06,0.00,0.17
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.74,0.00,13.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,4.74,0.00,13.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Deaths,Rate,0.02,0.00,0.06
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.62,0.00,4.56
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.62,0.00,4.56
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Deaths,Rate,0.12,0.00,0.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,7.66,0.00,21.55
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,7.66,0.00,21.55
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Deaths,Rate,0.11,0.00,0.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.51,1.34,25.90
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.45,1.14,7.21
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,6.06,0.21,18.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Deaths,Rate,0.13,0.00,0.36
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.72,0.00,21.72
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,7.72,0.00,21.72
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Deaths,Rate,0.07,0.00,0.18
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.64,0.00,10.25
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.64,0.00,10.25
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Deaths,Rate,0.14,0.01,0.52
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.61,1.55,31.45
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.58,0.89,5.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,7.03,0.66,26.24
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Deaths,Rate,0.08,0.01,0.27
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.28,6.24,49.59
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.66,5.76,37.12
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.62,0.48,12.46
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Deaths,Rate,0.47,0.07,1.62
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,60.96,23.31,139.52
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,41.75,20.30,73.79
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,19.20,3.01,65.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Deaths,Rate,1.16,0.22,3.62
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,121.60,54.57,251.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,83.16,47.38,130.66
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,38.44,7.19,121.04
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Deaths,Rate,0.62,0.11,2.01
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,100.06,47.90,190.32
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,77.80,43.91,118.32
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,22.26,3.99,72.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Deaths,Rate,2.58,0.51,7.85
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,218.82,99.72,455.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,139.06,83.91,213.01
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,79.76,15.81,242.68
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Deaths,Rate,4.25,0.95,12.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,361.36,175.28,712.25
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,249.98,150.37,378.75
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,111.38,24.91,333.50
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Deaths,Rate,7.86,1.84,23.29
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,533.69,261.60,"1,063.58"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,352.63,219.40,526.98
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,181.05,42.20,536.60
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Deaths,Rate,12.55,2.99,36.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,757.10,373.51,"1,519.06"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,485.71,308.88,719.15
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,271.39,64.62,799.90
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Deaths,Rate,44.65,9.99,133.16
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,710.56",802.78,"3,673.77"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,942.76,631.01,"1,384.18"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,767.81,171.76,"2,289.59"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Deaths,Rate,113.66,26.03,324.14
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,972.95","1,440.50","6,022.15"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,741.41","1,158.10","2,481.82"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,231.54",282.39,"3,540.33"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Deaths,Rate,106.87,25.37,304.41
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"3,257.67","1,546.49","6,629.35"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,859.79","1,214.62","2,647.51"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,397.88",331.86,"3,981.83"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Deaths,Rate,290.40,65.79,814.67
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,620.21","2,832.07","10,835.61"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,504.72","2,352.82","4,900.95"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"2,115.49",479.26,"5,934.66"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Deaths,Rate,4.09,0.92,11.77
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,138.87,65.30,284.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,83.81,53.46,123.17
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,55.07,11.84,160.93
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Deaths,Rate,4.92,1.11,14.14
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,164.94,77.95,336.75
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,99.57,63.75,145.94
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years of Life Lost (YLLs),Rate,65.37,14.20,190.81
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Deaths,Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.84,0.00,2.19
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.84,0.00,2.19
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Deaths,Rate,0.02,0.00,0.05
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.40,0.00,3.66
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.40,0.00,3.66
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Deaths,Rate,0.03,0.00,0.08
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,0.00,5.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.13,0.00,5.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Deaths,Rate,0.06,0.00,0.16
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.23,0.00,11.03
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,4.23,0.00,11.03
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Deaths,Rate,0.06,0.00,0.16
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.11,0.00,10.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,4.11,0.00,10.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Deaths,Rate,0.10,0.00,0.29
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.64,1.89,24.29
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.49,1.70,8.92
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,5.15,0.19,15.37
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Deaths,Rate,0.20,0.00,0.53
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,11.21,0.00,29.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,11.21,0.00,29.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Deaths,Rate,0.14,0.01,0.51
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.17,1.69,31.80
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.20,1.10,6.23
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,6.98,0.59,25.57
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Deaths,Rate,0.08,0.01,0.27
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,26.07,9.12,57.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,22.55,8.67,44.98
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.52,0.46,12.12
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Deaths,Rate,0.45,0.07,1.50
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,75.03,30.52,154.81
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,56.60,27.59,93.87
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,18.42,2.93,60.94
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Deaths,Rate,1.02,0.20,3.23
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,150.10,71.44,286.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,116.25,64.93,178.45
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,33.84,6.51,107.66
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Deaths,Rate,0.49,0.09,1.57
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,127.15,62.11,223.68
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,109.58,58.85,167.71
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,17.57,3.26,55.97
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Deaths,Rate,2.24,0.46,7.02
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,261.00,128.47,504.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,191.87,114.34,287.05
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,69.14,14.12,217.15
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Deaths,Rate,4.58,1.03,13.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,468.92,246.19,874.13
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,348.76,219.32,514.24
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,120.15,26.86,359.89
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Deaths,Rate,8.61,2.06,25.39
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,708.84,364.81,"1,340.19"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,511.30,317.81,757.08
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,197.54,47.01,583.12
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Deaths,Rate,13.37,3.28,39.19
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,992.81,505.22,"1,891.83"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,703.67,434.37,"1,044.50"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,289.14,70.85,847.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Deaths,Rate,39.12,8.86,114.19
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,060.90","1,069.48","3,965.61"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,388.17",917.10,"2,002.09"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,672.72,152.39,"1,963.52"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Deaths,Rate,155.01,36.60,416.52
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,343.46","2,210.12","8,044.26"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,862.27","1,860.76","4,027.44"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"1,481.19",349.36,"4,016.83"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Deaths,Rate,112.22,27.21,301.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"4,166.38","2,080.81","7,707.29"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,698.44","1,724.93","3,767.36"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"1,467.95",355.88,"3,939.93"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Deaths,Rate,364.22,85.81,966.01
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,793.22","3,975.15","14,229.25"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,140.01","3,350.06","7,192.20"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"2,653.21",625.09,"7,037.06"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Deaths,Rate,4.53,1.06,12.41
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,177.73,88.76,334.98
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,120.87,75.98,175.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,56.87,12.78,159.87
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Deaths,Rate,10.48,2.46,28.40
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,347.98,175.47,650.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,234.20,149.24,335.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years of Life Lost (YLLs),Rate,113.78,26.23,314.77
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Deaths,Rate,0.04,0.00,0.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.96,0.00,8.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,2.96,0.00,8.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Deaths,Rate,0.04,0.00,0.11
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.10,0.00,8.72
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,3.10,0.00,8.72
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Deaths,Rate,0.03,0.00,0.09
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.49,0.00,6.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.49,0.00,6.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Deaths,Rate,0.11,0.00,0.30
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,8.55,0.00,24.04
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,8.55,0.00,24.04
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Deaths,Rate,0.05,0.00,0.15
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.10,0.00,11.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,4.10,0.00,11.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Deaths,Rate,0.05,0.00,0.13
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.53,0.00,9.93
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,3.53,0.00,9.93
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Deaths,Rate,0.02,0.00,0.07
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.77,0.00,4.97
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.77,0.00,4.97
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Deaths,Rate,0.21,0.00,0.58
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,13.39,0.00,37.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,13.39,0.00,37.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Deaths,Rate,0.08,0.00,0.23
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,8.10,1.38,20.24
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.57,1.26,6.97
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.53,0.12,13.28
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Deaths,Rate,0.06,0.00,0.17
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.31,0.00,9.32
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.31,0.00,9.32
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.60,0.74,5.43
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.60,0.74,5.43
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Deaths,Rate,0.12,0.02,0.39
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.23,7.23,52.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.99,6.55,34.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,5.25,0.69,17.85
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Deaths,Rate,0.18,0.03,0.62
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,49.29,21.55,99.35
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,41.88,20.37,74.36
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,7.41,1.18,24.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Deaths,Rate,0.66,0.13,2.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,104.19,49.80,199.66
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,82.77,45.69,130.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,21.41,4.11,68.67
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Deaths,Rate,0.31,0.06,1.01
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,88.33,44.34,155.57
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,77.31,42.33,119.55
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,11.01,2.01,36.02
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Deaths,Rate,1.62,0.32,5.12
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,188.74,90.29,370.99
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,138.69,80.29,212.75
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,50.05,10.00,158.24
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Deaths,Rate,4.33,0.94,13.33
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,361.17,175.32,723.23
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,247.70,150.60,373.89
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,113.47,24.72,349.35
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Deaths,Rate,10.27,2.36,30.44
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,584.11,266.46,"1,223.62"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,350.93,213.00,530.93
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,233.18,53.47,692.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Deaths,Rate,17.93,4.19,52.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,871.95,384.14,"1,869.67"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,484.21,293.56,733.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,387.74,90.58,"1,135.97"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Deaths,Rate,46.52,10.48,138.52
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,745.95",795.03,"3,772.38"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,946.07,614.82,"1,390.60"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,799.88,180.20,"2,381.79"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Deaths,Rate,133.62,30.74,376.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"3,120.82","1,458.48","6,401.14"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,741.90","1,141.30","2,489.18"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,378.91",317.18,"3,911.96"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Deaths,Rate,102.59,24.24,282.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"3,212.86","1,540.45","6,342.57"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,870.87","1,223.34","2,652.54"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,341.99",317.11,"3,690.04"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Deaths,Rate,390.53,89.45,"1,093.21"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,344.76","2,960.55","12,900.60"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,499.88","2,308.95","4,936.91"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"2,844.89",651.60,"7,963.69"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Deaths,Rate,4.77,1.09,13.55
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,143.57,65.58,295.91
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,83.82,52.52,123.67
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,59.75,13.06,172.25
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Deaths,Rate,5.81,1.32,16.51
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,172.91,79.22,356.36
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,100.66,63.29,148.16
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years of Life Lost (YLLs),Rate,72.26,15.93,208.20
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Deaths,Rate,0.04,0.00,0.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.02,0.00,7.87
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,3.02,0.00,7.87
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Deaths,Rate,0.03,0.00,0.07
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.27,0.00,5.91
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.27,0.00,5.91
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Deaths,Rate,0.02,0.00,0.06
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,0.00,4.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.81,0.00,4.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Deaths,Rate,0.11,0.00,0.28
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,8.73,0.00,22.78
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,8.73,0.00,22.78
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Deaths,Rate,0.04,0.00,0.10
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.99,0.00,7.79
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.99,0.00,7.79
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Deaths,Rate,0.01,0.00,0.04
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.22,1.74,11.52
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.65,1.69,9.37
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.57,0.05,2.15
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Deaths,Rate,0.06,0.01,0.22
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,6.09,1.34,17.27
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.19,1.09,6.31
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.90,0.26,10.96
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.13,8.50,46.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,23.13,8.50,46.69
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Deaths,Rate,0.06,0.01,0.22
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,60.08,29.98,103.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,57.49,29.56,94.73
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,2.59,0.42,8.81
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Deaths,Rate,0.51,0.10,1.62
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,133.39,70.62,235.82
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,116.32,67.35,181.12
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,17.07,3.27,54.70
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Deaths,Rate,0.76,0.14,2.45
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,135.95,67.59,252.88
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,108.90,62.60,165.14
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,27.05,4.99,87.74
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Deaths,Rate,0.75,0.15,2.35
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,215.88,121.13,371.26
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,192.72,116.42,298.75
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,23.17,4.72,72.50
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Deaths,Rate,3.53,0.81,10.55
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,440.32,244.48,804.72
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,347.73,223.30,528.18
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,92.59,21.17,276.54
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Deaths,Rate,10.15,2.46,29.42
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,736.00,375.61,"1,426.68"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,507.70,320.33,764.46
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,228.30,55.28,662.22
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Deaths,Rate,17.94,4.41,51.61
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,083.92",529.90,"2,158.54"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,695.94,434.49,"1,042.49"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,387.98,95.40,"1,116.04"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Deaths,Rate,43.48,10.22,125.51
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,119.31","1,071.10","4,105.40"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,371.65",895.36,"1,947.24"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,747.66,175.74,"2,158.16"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Deaths,Rate,177.76,43.48,467.95
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,522.51","2,246.73","8,459.71"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,835.44","1,833.44","3,973.15"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"1,687.07",413.29,"4,486.56"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Deaths,Rate,125.10,32.00,329.05
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"4,307.81","2,088.79","8,060.47"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,671.39","1,670.26","3,756.28"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"1,636.41",418.52,"4,304.18"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Deaths,Rate,425.12,103.17,"1,103.44"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,214.94","4,106.46","15,160.30"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,118.09","3,354.90","7,122.11"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"3,096.85",751.56,"8,038.20"
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Deaths,Rate,5.08,1.24,13.61
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,180.50,90.08,340.22
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,120.11,75.65,174.57
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,60.39,14.42,165.65
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Deaths,Rate,12.05,2.94,31.98
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,361.65,180.40,679.32
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,234.94,149.74,336.74
ARG,Argentina,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years of Life Lost (YLLs),Rate,126.71,30.66,342.58
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-4 years,Deaths,Rate,0.50,0.43,0.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,112.77,51.82,210.29
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,67.74,12.56,159.13
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,45.03,39.25,51.15
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-14 years,Deaths,Rate,0.29,0.24,0.35
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,107.87,35.16,228.13
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,82.24,13.96,197.09
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,25.63,21.20,31.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-19 years,Deaths,Rate,0.27,0.22,0.33
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,109.55,34.39,233.36
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,86.54,15.40,205.49
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,23.01,18.99,27.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-24 years,Deaths,Rate,0.34,0.28,0.41
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,116.69,38.56,242.81
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,89.82,16.46,210.39
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,26.87,22.10,32.42
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-27 days,Deaths,Rate,0.04,0.04,0.08
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,39.72,9.56,94.03
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,34.88,5.34,88.61
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,4.84,4.22,5.42
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-4 years,Deaths,Rate,0.41,0.36,0.47
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,109.51,45.86,211.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,72.35,13.46,169.34
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,37.16,32.40,42.22
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-9 years,Deaths,Rate,0.37,0.30,0.45
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,111.83,40.09,226.90
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,79.74,13.80,187.57
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,32.09,26.29,39.33
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-11 months,Deaths,Rate,0.99,0.86,1.12
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,137.21,87.78,214.64
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,46.22,8.45,111.27
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,91.00,79.33,103.37
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,5-9 years,Deaths,Rate,0.33,0.25,0.44
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,113.57,35.77,238.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,85.27,14.05,201.21
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,28.29,21.72,37.17
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-14 years,Deaths,Rate,0.06,0.05,0.07
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,97.40,18.94,234.20
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,92.66,15.18,228.30
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,4.74,3.77,5.90
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-24 years,Deaths,Rate,0.29,0.23,0.34
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,119.05,35.31,254.78
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,98.49,18.55,230.03
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,20.57,16.75,24.75
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-19 years,Deaths,Rate,0.20,0.16,0.24
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,114.72,32.01,249.54
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,99.82,19.85,231.50
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,14.90,12.16,18.04
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-24 years,Deaths,Rate,0.40,0.33,0.48
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,130.31,43.81,265.48
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,101.51,20.31,230.94
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,28.79,23.50,34.54
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,20-24 years,Deaths,Rate,0.61,0.50,0.73
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,145.86,55.58,281.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,103.21,20.76,230.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,42.65,34.82,51.01
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-29 years,Deaths,Rate,0.70,0.59,0.84
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,140.91,54.86,264.08
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,94.94,16.60,208.99
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,45.97,38.26,55.09
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-49 years,Deaths,Rate,0.76,0.64,0.91
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,118.09,48.31,227.94
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,76.33,13.46,178.08
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,41.75,34.86,49.86
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,30-34 years,Deaths,Rate,0.54,0.45,0.64
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,116.56,42.88,242.13
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,84.04,15.80,203.30
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,32.51,27.08,38.83
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,35-39 years,Deaths,Rate,0.63,0.53,0.75
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,108.76,41.64,214.40
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,73.62,12.39,172.60
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,35.14,29.25,41.79
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,40-44 years,Deaths,Rate,0.98,0.82,1.16
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,114.59,51.92,212.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,65.37,10.52,154.40
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,49.22,41.40,58.36
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,45-49 years,Deaths,Rate,1.03,0.86,1.24
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,104.78,50.28,195.64
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,57.72,10.98,138.99
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,47.06,39.29,56.65
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-54 years,Deaths,Rate,1.04,0.87,1.24
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,94.30,44.90,171.30
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,52.03,9.55,120.92
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,42.27,35.35,50.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-64 years,Deaths,Rate,1.22,1.03,1.44
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,100.32,47.13,184.72
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,56.74,10.37,133.20
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,43.58,36.76,51.52
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,55-59 years,Deaths,Rate,1.35,1.15,1.59
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,103.94,50.74,187.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,55.68,9.71,130.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,48.25,41.03,56.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,60-64 years,Deaths,Rate,1.29,1.09,1.52
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,103.52,45.78,197.70
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,63.62,12.11,150.72
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,39.90,33.67,46.98
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-69 years,Deaths,Rate,2.27,1.90,2.69
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,132.95,63.52,242.66
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,73.52,13.60,172.12
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,59.43,49.93,70.54
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-74 years,Deaths,Rate,2.25,1.87,2.69
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,132.02,58.90,247.08
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,77.60,13.58,181.95
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,54.42,45.32,65.13
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,70-74 years,Deaths,Rate,2.22,1.82,2.69
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,130.81,52.90,252.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,82.89,13.56,194.68
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,47.92,39.34,58.12
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75-79 years,Deaths,Rate,1.94,1.62,2.31
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,125.00,45.83,246.35
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,91.69,18.06,206.63
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,33.31,27.76,39.72
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75+ years,Deaths,Rate,4.03,3.29,4.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,142.49,54.60,275.44
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,99.44,19.33,223.52
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,43.05,35.26,51.92
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,80-84 years,Deaths,Rate,2.42,1.94,2.93
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,131.07,44.84,268.74
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,99.43,19.48,230.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,31.64,25.35,38.37
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,85+ years,Deaths,Rate,11.39,9.28,13.84
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,201.18,89.81,355.47
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,118.21,22.18,254.60
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,82.97,67.63,100.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,<1 year,Deaths,Rate,0.90,0.79,1.03
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,128.65,80.91,204.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,45.22,8.18,109.28
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,83.43,72.73,94.77
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,Age-standardized,Deaths,Rate,0.82,0.68,0.98
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,116.44,44.79,230.51
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,80.02,14.48,186.95
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,36.42,30.31,43.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,All ages,Deaths,Rate,0.87,0.72,1.04
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,116.82,45.10,230.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,79.98,14.46,186.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Male,All ages,Years of Life Lost (YLLs),Rate,36.83,30.64,44.08
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-4 years,Deaths,Rate,0.50,0.43,0.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,108.11,51.50,196.74
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,63.22,12.36,145.74
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,44.89,39.14,51.00
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-14 years,Deaths,Rate,0.30,0.25,0.37
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,103.80,36.10,219.04
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,77.35,14.25,186.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,26.45,21.85,32.24
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-19 years,Deaths,Rate,0.29,0.24,0.35
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,105.30,35.31,221.63
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,80.94,15.31,191.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,24.35,20.00,29.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-24 years,Deaths,Rate,0.31,0.26,0.38
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,109.34,36.68,225.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,83.91,15.75,194.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,25.43,20.92,31.01
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-27 days,Deaths,Rate,0.04,0.04,0.04
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,38.80,7.83,98.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,34.86,4.39,94.33
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,3.94,3.45,4.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-4 years,Deaths,Rate,0.45,0.39,0.51
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,107.59,48.57,199.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,67.19,13.36,153.67
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,40.40,35.22,45.89
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-9 years,Deaths,Rate,0.36,0.30,0.44
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,106.35,40.70,214.00
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,74.49,14.30,175.10
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,31.87,26.40,38.89
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-11 months,Deaths,Rate,0.79,0.69,0.90
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,117.53,71.28,190.99
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,44.71,7.79,108.26
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,72.82,63.49,82.73
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,5-9 years,Deaths,Rate,0.30,0.23,0.39
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,105.42,34.77,224.86
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,79.98,15.01,191.23
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,25.45,19.76,33.63
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-14 years,Deaths,Rate,0.13,0.10,0.16
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,98.06,23.00,233.98
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,87.92,15.24,220.84
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,10.15,7.76,13.14
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-24 years,Deaths,Rate,0.26,0.21,0.32
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.11,32.61,234.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,91.89,17.10,211.10
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,19.21,15.51,23.70
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-19 years,Deaths,Rate,0.24,0.19,0.29
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,109.89,32.89,229.61
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,91.98,18.58,207.44
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,17.91,14.31,22.17
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-24 years,Deaths,Rate,0.33,0.27,0.40
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,117.81,37.56,235.22
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,93.94,18.06,206.09
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,23.87,19.50,29.12
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,20-24 years,Deaths,Rate,0.42,0.35,0.51
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,125.66,42.18,240.78
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,95.88,17.54,204.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,29.78,24.64,36.02
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-29 years,Deaths,Rate,0.38,0.31,0.46
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,115.37,37.98,238.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,90.61,17.60,208.56
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,24.76,20.38,29.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-49 years,Deaths,Rate,0.45,0.37,0.54
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,100.17,34.50,205.46
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,74.87,13.65,175.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,25.31,20.85,30.40
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,30-34 years,Deaths,Rate,0.75,0.62,0.89
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.36,51.07,259.93
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,81.15,13.61,206.02
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,45.21,37.47,53.91
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,35-39 years,Deaths,Rate,0.36,0.30,0.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,92.27,28.46,186.64
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,72.15,12.01,162.60
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,20.11,16.45,24.04
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,40-44 years,Deaths,Rate,0.21,0.17,0.25
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,77.64,21.07,166.20
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,67.13,12.37,153.61
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,10.51,8.71,12.59
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,45-49 years,Deaths,Rate,0.54,0.44,0.66
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,83.72,32.29,163.54
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,58.94,12.04,133.28
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,24.78,20.24,30.26
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-54 years,Deaths,Rate,0.46,0.37,0.55
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.21,24.41,140.52
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,51.70,9.35,118.16
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,18.51,15.06,22.37
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-64 years,Deaths,Rate,0.56,0.47,0.66
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,74.04,27.06,150.79
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,54.22,10.47,127.28
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,19.82,16.59,23.51
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,55-59 years,Deaths,Rate,0.59,0.50,0.70
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,73.98,27.98,149.68
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,52.80,9.99,124.71
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,21.18,17.99,24.96
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,60-64 years,Deaths,Rate,0.64,0.54,0.75
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,78.49,29.09,163.78
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,58.64,12.27,140.53
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,19.85,16.82,23.25
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-69 years,Deaths,Rate,1.21,1.03,1.41
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,95.57,37.82,189.06
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,63.81,10.89,152.19
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,31.77,26.93,36.87
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-74 years,Deaths,Rate,1.25,1.03,1.50
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,96.18,36.05,192.26
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,66.09,11.30,156.25
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,30.09,24.76,36.01
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,70-74 years,Deaths,Rate,1.30,1.03,1.62
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,96.91,33.96,196.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,68.80,11.78,161.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,28.11,22.18,35.00
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75-79 years,Deaths,Rate,1.34,1.08,1.65
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,96.15,30.51,196.60
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,73.13,11.95,168.25
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,23.02,18.56,28.35
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75+ years,Deaths,Rate,2.68,2.09,3.29
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,112.59,38.57,222.90
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,82.42,14.79,185.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,30.18,23.78,37.10
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,80-84 years,Deaths,Rate,3.04,2.41,3.71
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,118.20,46.22,226.57
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,78.44,14.72,178.02
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,39.76,31.50,48.55
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,85+ years,Deaths,Rate,4.23,3.22,5.23
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,130.51,42.41,256.90
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,99.73,18.95,218.80
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,30.78,23.47,38.10
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,<1 year,Deaths,Rate,0.72,0.63,0.82
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,110.67,65.75,182.96
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,43.85,7.49,107.05
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,66.83,58.26,75.91
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,Age-standardized,Deaths,Rate,0.51,0.42,0.62
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,100.70,34.77,206.18
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,75.49,13.98,175.76
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,25.21,20.78,30.43
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,All ages,Deaths,Rate,0.61,0.50,0.74
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,100.37,34.62,205.29
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,75.15,13.89,174.82
ARG,Argentina,Southern Cone,Epilepsy,2020,Female,All ages,Years of Life Lost (YLLs),Rate,25.22,20.74,30.47
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-4 years,Deaths,Rate,0.52,0.41,0.65
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,114.53,49.39,204.38
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,67.74,12.48,145.62
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,46.79,36.92,58.76
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-14 years,Deaths,Rate,0.30,0.23,0.38
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,108.46,35.24,223.32
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,82.71,15.16,190.29
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,25.75,20.08,33.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-19 years,Deaths,Rate,0.36,0.29,0.45
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,116.64,39.42,239.55
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,86.79,15.82,202.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,29.85,23.60,37.50
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-24 years,Deaths,Rate,0.49,0.39,0.60
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,127.42,46.84,257.18
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,89.71,16.65,210.32
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,37.71,30.19,46.85
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-27 days,Deaths,Rate,0.08,0.04,0.08
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,41.38,11.12,95.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,35.25,6.00,87.99
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,6.17,5.16,7.10
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-4 years,Deaths,Rate,0.41,0.33,0.52
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,109.18,42.38,200.47
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,72.19,13.20,154.01
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,37.00,29.18,46.46
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-9 years,Deaths,Rate,0.31,0.24,0.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,107.54,35.56,212.49
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,80.15,14.35,177.12
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,27.39,21.21,35.38
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-11 months,Deaths,Rate,1.13,0.89,1.42
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,150.84,91.49,236.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,46.48,9.17,105.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,104.36,82.32,131.06
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,5-9 years,Deaths,Rate,0.24,0.18,0.32
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,106.38,30.77,220.95
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,85.75,15.17,193.37
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,20.63,15.60,27.58
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-14 years,Deaths,Rate,0.16,0.13,0.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,105.35,27.59,242.13
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,92.54,17.47,225.73
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,12.80,10.12,16.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-24 years,Deaths,Rate,0.56,0.46,0.69
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,138.68,51.75,285.68
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,97.65,18.42,235.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,41.03,33.33,50.11
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-19 years,Deaths,Rate,0.56,0.46,0.68
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,141.47,52.12,288.75
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,99.17,17.82,237.70
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,42.30,34.29,51.05
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-24 years,Deaths,Rate,0.77,0.63,0.94
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,156.21,64.46,308.58
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,100.34,18.92,240.75
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,55.87,45.54,67.83
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,20-24 years,Deaths,Rate,0.99,0.81,1.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,170.99,76.83,328.47
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,101.52,20.02,243.80
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,69.47,56.81,84.66
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-29 years,Deaths,Rate,0.96,0.79,1.15
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,156.46,67.68,283.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,94.02,16.19,208.03
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,62.44,51.49,75.17
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-49 years,Deaths,Rate,0.88,0.73,1.05
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,124.61,53.79,230.55
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,75.37,13.01,171.56
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,49.24,40.79,58.99
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,30-34 years,Deaths,Rate,0.84,0.69,1.01
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,132.72,57.46,241.67
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,81.88,15.55,180.88
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,50.84,41.91,60.78
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,35-39 years,Deaths,Rate,0.90,0.75,1.06
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,122.04,52.65,223.98
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,72.40,11.33,165.07
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,49.63,41.31,58.90
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,40-44 years,Deaths,Rate,0.81,0.67,0.96
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,106.14,45.17,199.88
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,65.38,11.26,151.24
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,40.76,33.91,48.63
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,45-49 years,Deaths,Rate,0.86,0.72,1.05
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,97.27,42.38,191.06
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,57.95,9.67,143.37
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,39.31,32.70,47.69
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-54 years,Deaths,Rate,0.79,0.65,0.95
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,84.18,37.28,156.41
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,52.10,10.74,118.01
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,32.08,26.54,38.39
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-64 years,Deaths,Rate,0.91,0.76,1.08
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,89.05,37.98,164.45
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,56.26,10.58,125.64
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,32.78,27.40,38.81
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,55-59 years,Deaths,Rate,1.06,0.89,1.24
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,93.10,41.05,169.74
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,55.36,9.33,125.49
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,37.74,31.72,44.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,60-64 years,Deaths,Rate,0.91,0.76,1.08
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,90.47,35.41,168.35
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,62.35,11.77,135.10
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,28.12,23.65,33.25
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-69 years,Deaths,Rate,1.25,1.04,1.50
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,107.01,41.11,205.82
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,74.18,13.76,166.59
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,32.84,27.36,39.22
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-74 years,Deaths,Rate,1.50,1.24,1.81
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,113.14,44.53,217.67
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,77.38,15.03,174.58
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,35.76,29.50,43.10
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,70-74 years,Deaths,Rate,1.83,1.49,2.22
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,121.04,48.94,232.98
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,81.52,16.68,184.89
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,39.52,32.26,48.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75-79 years,Deaths,Rate,3.99,3.32,4.84
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,156.94,74.00,277.07
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,88.23,17.00,193.95
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,68.71,57.01,83.12
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75+ years,Deaths,Rate,4.42,3.60,5.37
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,155.79,66.97,285.55
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,97.33,19.19,214.51
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,58.46,47.78,71.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,80-84 years,Deaths,Rate,3.79,3.01,4.64
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,147.62,59.33,279.32
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,98.08,19.90,218.62
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,49.54,39.43,60.70
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,85+ years,Deaths,Rate,6.34,5.11,7.73
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,164.68,60.72,315.13
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,118.49,23.51,258.83
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,46.19,37.20,56.30
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,<1 year,Deaths,Rate,1.04,0.82,1.30
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,141.25,84.44,223.88
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,45.50,8.89,103.69
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,95.75,75.55,120.19
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,Age-standardized,Deaths,Rate,0.86,0.70,1.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,121.29,48.71,233.46
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,79.42,14.48,182.59
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,41.87,34.23,50.87
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,All ages,Deaths,Rate,0.90,0.74,1.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,121.17,48.70,233.13
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,79.36,14.48,182.37
ARG,Argentina,Southern Cone,Epilepsy,2021,Male,All ages,Years of Life Lost (YLLs),Rate,41.82,34.22,50.76
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-4 years,Deaths,Rate,0.45,0.36,0.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,102.58,45.24,188.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,61.47,12.80,136.94
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,41.11,32.44,51.63
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-14 years,Deaths,Rate,0.35,0.27,0.45
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,107.16,38.39,220.61
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,77.21,15.13,181.70
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,29.95,23.25,38.91
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-19 years,Deaths,Rate,0.42,0.33,0.53
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,115.32,42.54,234.19
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,81.07,15.69,190.32
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,34.25,26.86,43.87
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-24 years,Deaths,Rate,0.55,0.44,0.68
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,126.44,49.71,249.52
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,83.94,15.78,196.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,42.51,33.93,53.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-27 days,Deaths,Rate,0.04,0.04,0.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,38.14,9.18,88.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,33.12,5.01,82.67
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,5.01,4.16,5.77
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-4 years,Deaths,Rate,0.37,0.29,0.47
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,98.90,40.16,187.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,65.37,13.71,145.15
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,33.53,26.45,42.11
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-9 years,Deaths,Rate,0.41,0.32,0.53
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,109.71,42.58,215.61
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,74.27,15.12,169.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,35.44,27.46,46.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-11 months,Deaths,Rate,0.93,0.74,1.17
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,128.86,76.42,205.23
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,42.84,8.57,97.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,86.02,67.86,108.03
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,5-9 years,Deaths,Rate,0.43,0.33,0.58
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,117.35,44.30,235.66
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,80.56,16.12,186.56
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,36.80,28.17,49.10
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-14 years,Deaths,Rate,0.16,0.13,0.22
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,100.70,26.37,233.06
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,87.49,16.15,215.67
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,13.22,10.22,17.39
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-24 years,Deaths,Rate,0.62,0.50,0.76
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.74,52.95,272.54
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,91.82,16.55,217.33
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,44.92,36.39,55.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-19 years,Deaths,Rate,0.63,0.50,0.78
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,139.95,55.10,275.21
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,92.73,17.35,216.36
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,47.22,37.75,58.85
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-24 years,Deaths,Rate,0.85,0.69,1.04
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,155.49,66.77,293.07
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,94.07,16.76,218.20
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,61.42,50.01,74.88
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,20-24 years,Deaths,Rate,1.07,0.89,1.29
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,170.96,78.39,310.86
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,95.40,16.17,220.02
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,75.56,62.22,90.83
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-29 years,Deaths,Rate,0.75,0.62,0.91
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,137.99,54.68,256.88
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,88.90,14.45,197.42
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,49.09,40.23,59.46
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-49 years,Deaths,Rate,0.54,0.45,0.66
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,104.80,38.77,207.49
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,73.64,13.20,169.81
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,31.16,25.57,37.68
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,30-34 years,Deaths,Rate,0.64,0.53,0.77
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,117.83,47.21,228.24
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,79.21,15.47,181.65
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,38.62,31.74,46.59
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,35-39 years,Deaths,Rate,0.33,0.27,0.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,90.55,29.66,184.40
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,72.08,14.50,162.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,18.47,15.16,22.31
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,40-44 years,Deaths,Rate,0.58,0.48,0.70
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,95.05,35.42,201.54
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,65.75,11.25,166.27
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,29.29,24.16,35.27
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,45-49 years,Deaths,Rate,0.36,0.29,0.44
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,74.80,22.87,153.69
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,58.43,9.58,133.69
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,16.38,13.30,20.01
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-54 years,Deaths,Rate,0.58,0.47,0.70
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,75.36,27.34,152.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,51.87,8.21,123.55
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,23.49,19.13,28.55
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-64 years,Deaths,Rate,0.55,0.45,0.65
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,72.69,25.06,148.30
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,53.16,8.85,125.00
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,19.53,16.21,23.31
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,55-59 years,Deaths,Rate,0.40,0.34,0.48
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,66.00,19.20,135.64
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,51.59,7.11,118.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,14.41,12.09,17.07
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,60-64 years,Deaths,Rate,0.66,0.56,0.77
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,76.81,28.72,157.53
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,56.35,11.48,133.60
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,20.46,17.24,23.93
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-69 years,Deaths,Rate,1.21,1.03,1.41
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,94.96,38.53,178.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,63.32,11.61,141.54
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,31.64,26.93,37.03
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-74 years,Deaths,Rate,1.38,1.14,1.65
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,98.12,40.02,183.02
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,65.32,12.76,143.77
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,32.81,27.26,39.25
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,70-74 years,Deaths,Rate,1.58,1.28,1.94
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,101.85,41.78,188.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,67.67,14.13,146.39
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,34.18,27.65,41.87
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75-79 years,Deaths,Rate,1.49,1.21,1.83
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,98.39,34.07,191.44
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,72.76,13.33,160.00
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,25.62,20.74,31.45
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75+ years,Deaths,Rate,2.52,1.94,3.12
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,108.23,36.20,214.45
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,81.53,15.40,181.46
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,26.70,20.80,32.99
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,80-84 years,Deaths,Rate,1.27,0.99,1.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,93.55,27.10,195.09
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,76.89,14.12,174.61
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,16.67,12.98,20.47
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,85+ years,Deaths,Rate,5.27,3.95,6.57
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,137.30,48.48,267.28
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,98.91,19.69,219.41
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,38.39,28.79,47.87
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,<1 year,Deaths,Rate,0.86,0.68,1.07
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,120.97,70.58,195.08
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,41.99,8.26,95.94
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,78.98,62.32,99.14
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,Age-standardized,Deaths,Rate,0.64,0.52,0.78
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,109.17,41.53,215.53
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,74.77,13.70,173.18
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,34.40,27.83,42.35
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,All ages,Deaths,Rate,0.73,0.59,0.90
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,107.97,40.81,213.26
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,74.41,13.64,172.01
ARG,Argentina,Southern Cone,Epilepsy,2021,Female,All ages,Years of Life Lost (YLLs),Rate,33.56,27.16,41.24
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.07,0.03,0.13
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.07,0.03,0.13
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.11,0.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.24,0.11,0.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.30,0.93
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.58,0.30,0.93
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.08,0.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.19,0.08,0.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.51,1.54
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.96,0.51,1.54
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.38,1.23
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.74,0.38,1.23
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.73,2.16
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.35,0.73,2.16
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.96,1.07,3.08
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.96,1.07,3.08
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Deaths,Rate,0.12,0.09,0.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,11.76,8.24,15.77
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,4.04,2.29,6.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,7.71,5.95,9.72
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Deaths,Rate,0.15,0.11,0.19
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,16.56,10.44,24.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,8.89,4.60,14.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,7.67,5.84,9.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.04,4.23,10.36
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,7.04,4.23,10.36
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Deaths,Rate,0.07,0.05,0.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,13.67,8.49,19.98
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.00,5.74,15.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.67,2.76,4.86
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Deaths,Rate,0.28,0.21,0.37
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,26.16,16.08,39.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,12.01,5.32,20.80
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,14.16,10.77,18.53
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Deaths,Rate,0.32,0.24,0.41
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,27.32,17.04,42.32
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.74,5.94,23.48
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,14.58,11.10,18.85
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Deaths,Rate,0.38,0.28,0.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,28.94,17.69,44.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,13.46,6.28,23.55
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,15.47,11.41,20.78
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Deaths,Rate,0.56,0.43,0.72
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,32.55,20.86,48.31
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,13.12,6.06,23.25
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,19.43,14.80,25.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Deaths,Rate,0.42,0.32,0.53
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,28.18,17.72,42.74
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,13.23,6.36,23.73
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,14.95,11.36,19.02
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Deaths,Rate,0.94,0.74,1.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.81,28.21,59.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,12.59,5.47,22.37
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,29.21,22.75,36.98
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Deaths,Rate,0.71,0.53,0.93
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,30.65,19.50,45.89
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,11.96,5.58,21.62
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,18.70,13.92,24.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Deaths,Rate,0.81,0.60,1.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.61,19.57,45.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,11.31,5.13,20.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,19.31,14.44,25.07
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Deaths,Rate,0.93,0.70,1.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.57,19.67,44.31
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,10.47,4.56,18.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,20.10,15.12,26.11
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Deaths,Rate,0.84,0.62,1.08
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,23.65,14.45,36.35
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,9.28,3.75,17.71
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,14.37,10.70,18.64
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Deaths,Rate,0.99,0.75,1.27
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,22.45,14.76,32.55
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,8.62,4.34,14.69
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,13.82,10.43,17.86
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Deaths,Rate,1.46,1.12,1.89
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.82,19.92,37.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.71,5.31,12.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,19.11,14.62,24.69
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Deaths,Rate,0.68,0.51,0.85
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.81,8.10,16.72
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,6.90,4.35,10.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,4.91,3.75,6.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Deaths,Rate,0.20,0.15,0.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.72,8.07,18.87
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,6.02,2.98,10.19
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,6.70,5.09,8.67
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,All ages,Deaths,Rate,0.22,0.17,0.28
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,13.43,8.53,19.90
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,6.26,3.09,10.63
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years of Life Lost (YLLs),Rate,7.17,5.44,9.27
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.35,0.17,0.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.35,0.17,0.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.50,1.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.92,0.50,1.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.06
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.11,0.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.26,0.11,0.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.53,0.84,2.42
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.53,0.84,2.42
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.58,1.86
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.14,0.58,1.86
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,1.21,3.43
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.18,1.21,3.43
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.21,1.83,5.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.21,1.83,5.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,6.48,3.76,9.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,6.48,3.76,9.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Deaths,Rate,0.20,0.16,0.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,21.87,13.39,33.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.72,5.57,20.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,10.16,7.82,12.99
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Deaths,Rate,0.19,0.15,0.24
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,21.59,12.69,33.76
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.83,3.61,19.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,11.76,9.08,14.76
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Deaths,Rate,0.14,0.10,0.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,20.51,12.16,32.63
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,12.97,6.42,22.96
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,7.54,5.73,9.66
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Deaths,Rate,0.07,0.05,0.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,18.54,9.40,29.80
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,15.02,6.68,25.36
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,3.52,2.71,4.44
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Deaths,Rate,0.70,0.54,0.91
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,47.50,32.67,67.99
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,15.51,8.00,26.66
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,31.99,24.67,41.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Deaths,Rate,0.09,0.07,0.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,19.14,10.29,31.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,15.42,7.47,26.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,3.72,2.82,4.76
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Deaths,Rate,0.40,0.30,0.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.29,17.30,42.27
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.86,7.09,25.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,13.43,10.21,17.10
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Deaths,Rate,0.50,0.38,0.62
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.69,20.62,47.75
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.96,7.08,25.60
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,17.73,13.54,22.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Deaths,Rate,0.64,0.49,0.83
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.03,21.75,49.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,14.10,6.67,23.30
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,19.93,15.08,25.79
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Deaths,Rate,0.36,0.27,0.47
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,22.42,12.88,34.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,12.85,5.79,22.54
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,9.57,7.09,12.30
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Deaths,Rate,0.60,0.45,0.78
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,26.15,15.89,39.65
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,12.34,5.55,21.65
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,13.81,10.33,18.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Deaths,Rate,0.87,0.65,1.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.56,19.44,45.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.74,5.27,20.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,18.82,14.17,24.75
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Deaths,Rate,0.38,0.29,0.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,17.07,9.65,28.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.46,4.75,19.37
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,6.60,4.91,8.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Deaths,Rate,0.16,0.12,0.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,12.06,6.48,20.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.31,4.43,16.83
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,2.75,2.04,3.68
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,8.95,3.70,17.52
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,8.95,3.70,17.52
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.01,4.72,12.49
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,8.01,4.72,12.49
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Deaths,Rate,0.16,0.12,0.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,13.61,8.25,20.70
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,7.46,3.56,12.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,6.14,4.69,7.87
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,All ages,Deaths,Rate,0.18,0.14,0.23
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,14.57,8.83,22.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,7.98,3.80,13.74
ARG,Argentina,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years of Life Lost (YLLs),Rate,6.59,5.03,8.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.12,0.41
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.24,0.12,0.41
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.31,0.94
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.58,0.31,0.94
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.08,0.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.19,0.08,0.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.95,0.51,1.54
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.95,0.51,1.54
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.39,1.25
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.74,0.39,1.25
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.35,0.73,2.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.35,0.73,2.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,1.07,3.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.95,1.07,3.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Deaths,Rate,0.07,0.05,0.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,8.46,5.68,11.70
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,4.00,2.27,6.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,4.46,3.42,5.70
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Deaths,Rate,0.09,0.07,0.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.38,7.95,20.67
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,8.63,4.37,14.45
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.76,3.58,6.22
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Deaths,Rate,0.06,0.05,0.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,10.79,7.05,15.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,6.88,4.18,10.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,3.91,2.87,5.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,12.88,8.17,19.07
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,9.57,5.69,14.75
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.31,2.48,4.32
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Deaths,Rate,0.09,0.07,0.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.05,7.97,27.60
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,11.26,4.33,21.31
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,4.80,3.63,6.29
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Deaths,Rate,0.17,0.13,0.23
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.54,11.75,32.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.68,5.81,22.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,7.86,5.94,10.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Deaths,Rate,0.24,0.18,0.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,22.95,13.26,36.53
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,13.07,5.96,23.24
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,9.87,7.30,13.29
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Deaths,Rate,0.34,0.26,0.45
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,24.78,14.88,38.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,12.81,5.86,22.62
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,11.98,9.03,15.64
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Deaths,Rate,0.31,0.23,0.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,24.03,14.15,37.13
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,13.02,5.91,22.87
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,11.00,8.24,14.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Deaths,Rate,0.51,0.39,0.65
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,27.86,17.68,41.64
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,12.24,5.66,21.60
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,15.63,12.02,20.04
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Deaths,Rate,0.50,0.37,0.66
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,24.62,14.69,38.01
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,11.48,5.07,20.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,13.14,9.62,17.42
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Deaths,Rate,0.44,0.33,0.58
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,21.84,12.90,34.16
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,10.99,4.91,19.82
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,10.85,7.99,14.34
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Deaths,Rate,0.37,0.27,0.48
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,18.26,10.58,29.19
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,10.35,4.70,18.83
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,7.90,5.88,10.36
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Deaths,Rate,0.80,0.59,1.04
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,22.68,13.74,34.83
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,8.94,3.57,16.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,13.74,10.17,17.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Deaths,Rate,0.55,0.41,0.71
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.19,10.84,25.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,8.40,4.30,14.47
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,8.79,6.55,11.45
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Deaths,Rate,0.50,0.38,0.64
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,15.08,10.50,21.52
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,8.59,5.57,13.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,6.49,4.94,8.43
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.80,4.24,10.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,6.80,4.24,10.46
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Deaths,Rate,0.12,0.09,0.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.97,5.95,15.42
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,5.85,2.85,10.02
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,4.12,3.09,5.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,All ages,Deaths,Rate,0.13,0.10,0.17
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.56,6.30,16.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,6.14,2.99,10.55
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.41,3.31,5.78
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.18
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.18
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.36,0.19,0.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.36,0.19,0.59
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.76,1.18,2.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.94,0.52,1.48
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.83,0.66,1.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.03
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.06
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.11,0.45
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.27,0.11,0.45
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Deaths,Rate,0.02,0.02,0.02
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.90,1.94,4.11
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.53,0.85,2.41
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,1.37,1.09,1.70
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.15,0.62,1.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.15,0.62,1.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Deaths,Rate,0.03,0.02,0.04
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.27,2.90,6.02
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.19,1.23,3.43
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.08,1.66,2.58
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Deaths,Rate,0.06,0.05,0.07
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.37,5.16,10.18
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.23,1.84,5.02
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,4.15,3.32,5.16
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,6.49,3.79,9.63
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,6.49,3.79,9.63
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Deaths,Rate,0.18,0.14,0.24
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.39,12.21,31.89
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,11.66,5.52,20.51
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.74,6.69,11.39
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,9.71,3.43,18.75
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,9.71,3.43,18.75
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Deaths,Rate,0.07,0.05,0.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,16.78,8.75,27.61
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,13.13,6.00,22.87
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,3.65,2.75,4.74
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Deaths,Rate,0.29,0.22,0.37
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,29.33,18.50,43.90
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,14.86,7.41,25.33
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,14.47,11.09,18.58
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Deaths,Rate,0.65,0.50,0.86
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,44.83,30.27,67.14
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,15.18,7.50,28.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,29.66,22.77,38.98
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Deaths,Rate,0.13,0.09,0.16
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,20.62,11.92,32.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,15.47,8.08,25.58
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,5.16,3.84,6.63
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Deaths,Rate,0.31,0.23,0.40
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,25.50,15.31,38.66
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,14.71,7.18,24.90
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,10.79,8.13,13.76
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Deaths,Rate,0.45,0.34,0.57
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.91,19.19,45.32
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.74,6.91,25.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,16.18,12.28,20.23
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Deaths,Rate,0.37,0.28,0.49
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,25.34,15.06,38.98
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,13.79,6.42,23.90
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,11.55,8.65,15.09
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Deaths,Rate,0.87,0.64,1.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,35.56,22.69,53.52
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,12.83,5.91,24.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,22.73,16.78,29.39
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Deaths,Rate,0.86,0.65,1.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,32.95,21.18,49.47
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,12.21,5.64,22.36
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,20.75,15.54,27.11
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Deaths,Rate,0.85,0.65,1.13
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.89,19.41,44.71
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.47,5.32,20.29
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,18.41,14.09,24.42
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Deaths,Rate,1.29,0.96,1.73
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,32.40,21.26,47.49
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.25,4.84,17.66
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,22.14,16.42,29.82
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Deaths,Rate,0.95,0.71,1.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,23.16,15.27,33.41
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.43,5.07,15.15
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,13.73,10.20,18.26
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Deaths,Rate,0.86,0.65,1.12
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,21.07,14.32,28.92
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,9.76,5.85,14.27
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,11.32,8.48,14.64
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Deaths,Rate,0.55,0.40,0.71
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,11.91,7.56,17.58
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.92,4.63,12.39
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,3.99,2.94,5.20
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Deaths,Rate,0.18,0.14,0.24
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,13.75,8.39,21.05
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,7.42,3.58,12.85
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,6.33,4.81,8.21
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,All ages,Deaths,Rate,0.24,0.18,0.31
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,15.28,9.40,23.30
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.00,3.87,13.84
ARG,Argentina,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years of Life Lost (YLLs),Rate,7.29,5.53,9.46
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-4 years,Deaths,Rate,1.45,1.15,1.80
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,212.84,120.39,353.30
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,81.02,15.54,189.68
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,131.81,104.85,163.62
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-14 years,Deaths,Rate,1.65,1.32,2.03
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,355.78,137.47,762.89
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,216.23,25.68,590.37
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,139.55,111.79,172.51
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-19 years,Deaths,Rate,1.91,1.54,2.34
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,454.87,163.24,988.88
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,299.24,37.87,798.40
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,155.63,125.37,190.48
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-24 years,Deaths,Rate,2.20,1.79,2.66
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,532.93,187.25,"1,163.36"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,361.30,47.92,954.95
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,171.63,139.32,208.41
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-27 days,Deaths,Rate,0.54,0.43,0.70
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,105.64,46.65,206.21
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,55.63,8.59,141.14
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,50.01,38.01,65.07
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-4 years,Deaths,Rate,0.85,0.71,1.02
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,162.71,79.89,292.43
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,86.09,16.59,200.72
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,76.62,63.30,91.72
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-9 years,Deaths,Rate,1.19,0.95,1.48
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,235.91,102.14,476.48
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,132.88,19.94,348.09
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,103.03,82.20,128.39
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-11 months,Deaths,Rate,4.72,3.62,6.05
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,491.53,344.31,693.30
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,56.33,10.59,135.26
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,435.20,333.72,558.04
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,5-9 years,Deaths,Rate,1.44,1.13,1.83
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,290.71,118.80,614.25
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,167.90,22.45,458.41
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,122.81,96.35,155.84
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-14 years,Deaths,Rate,2.05,1.67,2.47
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,556.91,172.80,"1,299.96"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,392.76,38.50,"1,101.84"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,164.15,134.30,198.11
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-24 years,Deaths,Rate,2.71,2.22,3.24
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,721.18,232.90,"1,617.09"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,519.51,67.31,"1,375.73"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,201.67,165.58,241.37
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-19 years,Deaths,Rate,2.73,2.22,3.27
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,761.36,242.96,"1,687.90"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,556.01,75.57,"1,441.84"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,205.34,167.39,246.07
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-24 years,Deaths,Rate,3.05,2.51,3.64
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,806.55,264.13,"1,781.93"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,585.39,82.29,"1,518.08"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,221.16,181.84,263.85
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,20-24 years,Deaths,Rate,3.37,2.79,4.01
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,851.63,285.25,"1,875.72"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,614.69,88.99,"1,594.13"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,236.94,196.26,281.59
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-29 years,Deaths,Rate,3.06,2.55,3.63
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,830.35,253.67,"1,799.56"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,630.75,86.91,"1,562.32"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,199.59,166.76,237.24
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-49 years,Deaths,Rate,3.25,2.66,4.02
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,856.88,285.42,"1,831.82"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,678.33,139.21,"1,612.05"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,178.55,146.21,219.76
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,30-34 years,Deaths,Rate,2.65,2.19,3.19
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,817.75,245.87,"1,814.02"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,657.54,113.95,"1,621.30"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,160.21,131.92,192.73
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,35-39 years,Deaths,Rate,2.45,2.03,2.93
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,830.88,258.80,"1,801.00"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,695.13,146.41,"1,638.53"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,135.76,112.39,162.47
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,40-44 years,Deaths,Rate,3.98,3.27,4.86
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,918.90,341.82,"1,921.26"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,718.13,177.06,"1,676.36"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,200.78,164.75,244.90
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,45-49 years,Deaths,Rate,4.38,3.43,5.95
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,901.07,344.47,"1,830.42"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,701.58,188.40,"1,559.73"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,199.49,156.07,270.69
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-54 years,Deaths,Rate,6.73,4.71,11.03
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,940.24,386.83,"1,898.21"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,666.88,195.64,"1,450.40"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,273.36,191.19,447.81
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-64 years,Deaths,Rate,10.68,6.62,19.83
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,045.87",456.23,"2,114.91"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,675.81,224.79,"1,432.91"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,370.05,231.44,682.00
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,55-59 years,Deaths,Rate,9.99,6.25,18.63
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,017.29",440.19,"2,064.69"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,660.35,216.83,"1,398.93"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,356.94,223.36,665.76
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,60-64 years,Deaths,Rate,16.21,9.35,31.77
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,205.20",557.83,"2,432.37"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,703.92,268.84,"1,449.94"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,501.28,288.99,982.43
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-69 years,Deaths,Rate,25.33,14.76,49.64
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,469.81",745.92,"2,835.91"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,805.90,359.12,"1,534.95"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,663.92,386.80,"1,300.97"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-74 years,Deaths,Rate,34.63,20.79,66.69
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,728.16",925.63,"3,246.73"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,913.73,437.80,"1,676.14"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,814.43,487.83,"1,570.60"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,70-74 years,Deaths,Rate,46.69,28.62,88.80
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,063.09","1,158.59","3,779.34"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,053.52",539.80,"1,859.18"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,009.57",618.79,"1,920.15"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75-79 years,Deaths,Rate,107.18,64.26,207.71
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,426.98","2,039.23","6,153.21"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,584.09",934.31,"2,581.74"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,842.89","1,104.92","3,571.47"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75+ years,Deaths,Rate,216.18,103.66,473.93
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,875.08","2,745.25","8,940.52"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,415.18","1,488.90","3,708.77"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"2,459.90","1,256.35","5,231.75"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,80-84 years,Deaths,Rate,207.66,107.32,439.85
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,297.91","2,987.37","9,688.98"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,581.57","1,583.58","3,935.43"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"2,716.34","1,403.79","5,753.56"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,85+ years,Deaths,Rate,492.22,193.76,"1,167.13"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,773.83","4,106.97","14,613.82"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,188.17","2,695.47","6,111.64"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"3,585.66","1,411.50","8,502.18"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,<1 year,Deaths,Rate,4.35,3.33,5.59
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,457.64,318.18,650.53
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,56.27,10.42,135.78
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,401.38,307.76,514.76
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Deaths,Rate,11.93,6.83,23.17
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,909.03,373.91,"1,867.99"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,605.76,168.04,"1,369.05"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,303.27,205.87,498.94
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,All ages,Deaths,Rate,13.73,7.74,27.05
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,956.03,401.00,"1,953.59"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,629.01,183.06,"1,403.18"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Male,All ages,Years of Life Lost (YLLs),Rate,327.02,217.94,550.41
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-4 years,Deaths,Rate,1.41,1.12,1.75
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,204.31,117.47,332.93
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,75.72,15.28,173.85
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,128.59,102.19,159.09
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-14 years,Deaths,Rate,1.59,1.25,2.01
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,406.72,134.56,904.36
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,271.58,28.40,733.57
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,135.14,106.16,170.80
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-19 years,Deaths,Rate,1.52,1.20,1.91
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,535.28,145.44,"1,234.14"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,409.16,45.84,"1,075.64"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,126.12,99.60,158.50
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-24 years,Deaths,Rate,1.64,1.31,2.04
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,648.94,162.56,"1,497.04"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,518.34,58.29,"1,334.24"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,130.60,104.27,162.80
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-27 days,Deaths,Rate,0.57,0.45,0.74
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,108.07,47.00,217.95
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,55.61,7.05,150.56
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,52.50,39.95,67.39
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-4 years,Deaths,Rate,0.88,0.72,1.05
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,159.16,81.41,276.84
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,80.05,16.46,182.22
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,79.10,64.94,94.62
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-9 years,Deaths,Rate,1.33,1.06,1.68
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,257.30,112.30,522.97
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,142.13,20.60,377.97
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,115.17,91.70,145.00
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-11 months,Deaths,Rate,4.34,3.33,5.55
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,454.61,316.78,643.42
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,54.52,9.77,131.36
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,400.09,307.01,512.06
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,5-9 years,Deaths,Rate,1.67,1.31,2.15
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,331.17,135.55,708.22
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,188.86,23.72,525.31
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,142.31,111.83,182.92
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-14 years,Deaths,Rate,1.67,1.30,2.11
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,675.46,149.61,"1,645.27"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,541.58,45.61,"1,476.03"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,133.88,104.00,169.24
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-24 years,Deaths,Rate,1.70,1.37,2.09
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,902.79,186.47,"2,146.48"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,775.68,84.20,"1,989.57"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,127.11,102.27,156.91
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-19 years,Deaths,Rate,1.31,1.06,1.60
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,930.47,178.88,"2,247.90"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,832.10,99.42,"2,127.19"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,98.37,79.46,120.71
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-24 years,Deaths,Rate,1.71,1.41,2.09
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,019.63",205.42,"2,404.08"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,895.99,104.04,"2,253.51"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,123.64,101.38,150.57
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,20-24 years,Deaths,Rate,2.12,1.75,2.56
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,108.03",231.72,"2,558.91"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,959.34,108.61,"2,378.74"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,148.70,123.11,180.17
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-29 years,Deaths,Rate,1.51,1.25,1.83
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,089.67",207.74,"2,529.28"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,990.78,126.25,"2,409.72"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,98.89,81.49,119.56
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-49 years,Deaths,Rate,2.30,1.83,2.95
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,179.75",302.09,"2,594.85"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,056.47",203.35,"2,437.86"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,123.28,98.74,156.99
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,30-34 years,Deaths,Rate,1.91,1.58,2.28
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,147.30",255.58,"2,592.35"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,031.86",160.10,"2,454.98"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,115.44,95.48,137.36
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,35-39 years,Deaths,Rate,2.22,1.81,2.68
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,206.89",326.63,"2,573.96"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,083.88",226.58,"2,425.41"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,123.01,100.05,148.55
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,40-44 years,Deaths,Rate,1.80,1.47,2.22
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,209.24",334.56,"2,661.48"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,118.26",260.19,"2,549.43"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,90.98,74.37,112.05
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,45-49 years,Deaths,Rate,4.43,3.33,6.39
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,269.75",414.46,"2,631.07"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,068.13",263.14,"2,340.41"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,201.62,151.33,290.66
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-54 years,Deaths,Rate,4.18,2.64,7.68
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,166.58",370.59,"2,493.14"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,996.64,263.56,"2,181.30"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,169.94,107.03,311.84
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-64 years,Deaths,Rate,6.84,3.57,14.84
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,206.06",416.26,"2,570.77"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,971.07,292.01,"2,066.11"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,234.99,124.24,504.66
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,55-59 years,Deaths,Rate,5.62,3.01,11.91
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,155.51",381.61,"2,447.04"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,954.58,274.08,"2,021.23"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,200.93,107.53,425.80
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,60-64 years,Deaths,Rate,11.20,5.24,26.23
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,306.03",506.11,"2,793.63"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,959.60,344.04,"1,982.56"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,346.42,162.07,811.07
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-69 years,Deaths,Rate,15.15,6.62,36.02
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,431.94",617.36,"2,925.96"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,034.88",443.88,"1,982.00"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,397.06,173.48,943.96
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-74 years,Deaths,Rate,23.91,10.47,56.89
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,717.02",778.05,"3,475.27"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,162.28",535.23,"2,155.68"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,554.74,242.81,"1,319.59"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,70-74 years,Deaths,Rate,34.29,15.02,81.59
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,054.44",968.23,"4,125.44"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,313.07",643.36,"2,361.25"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,741.37,324.88,"1,764.19"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75-79 years,Deaths,Rate,73.22,29.80,177.30
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,240.77","1,657.90","6,314.05"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,981.83","1,145.41","3,265.32"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"1,258.94",512.49,"3,048.74"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75+ years,Deaths,Rate,220.04,69.36,547.20
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,650.80","2,825.22","10,670.77"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,452.58","2,094.73","5,246.24"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"2,198.21",730.49,"5,424.53"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,80-84 years,Deaths,Rate,172.65,60.21,416.22
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,565.59","2,760.05","10,460.71"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,307.28","1,972.54","5,016.32"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"2,258.31",787.51,"5,444.39"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,85+ years,Deaths,Rate,478.24,135.28,"1,209.31"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,190.64","4,563.86","17,126.35"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,706.85","3,578.39","8,316.93"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"3,483.79",985.47,"8,809.42"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,<1 year,Deaths,Rate,4.01,3.07,5.13
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,424.44,293.29,606.38
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,54.61,9.53,133.03
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,369.82,283.75,473.35
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Deaths,Rate,9.33,4.06,20.87
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,100.74",350.55,"2,375.49"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,880.29,220.91,"1,965.51"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,220.45,129.64,409.98
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,All ages,Deaths,Rate,17.86,6.73,42.20
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,300.98",457.95,"2,744.36"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,997.86,303.50,"2,121.53"
ARG,Argentina,Southern Cone,Neurological conditions,2020,Female,All ages,Years of Life Lost (YLLs),Rate,303.11,154.46,622.83
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-4 years,Deaths,Rate,1.56,1.17,2.04
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,222.87,121.85,359.44
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,80.79,15.38,173.49
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,142.08,106.47,185.95
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-14 years,Deaths,Rate,2.12,1.66,2.69
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,398.25,166.72,801.53
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,219.78,26.97,574.78
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,178.47,139.75,226.74
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-19 years,Deaths,Rate,2.43,1.93,3.02
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,500.15,195.50,"1,041.30"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,303.06,39.15,795.38
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,197.09,156.35,245.92
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-24 years,Deaths,Rate,2.50,2.01,3.09
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,561.08,206.56,"1,199.54"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,364.06,48.95,955.34
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,197.02,157.61,244.20
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-27 days,Deaths,Rate,0.68,0.46,0.93
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,119.44,54.44,226.75
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,56.13,9.55,140.02
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,63.31,44.93,86.68
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-4 years,Deaths,Rate,0.85,0.67,1.06
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,162.08,76.50,277.88
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,85.65,16.22,182.49
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,76.43,60.28,95.40
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-9 years,Deaths,Rate,1.46,1.14,1.88
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,261.42,118.71,490.60
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,134.99,20.67,328.38
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,126.43,98.04,162.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-11 months,Deaths,Rate,5.52,3.96,7.50
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,565.76,376.72,818.91
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,56.51,11.34,127.46
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,509.25,365.37,691.45
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,5-9 years,Deaths,Rate,1.90,1.46,2.45
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,331.29,148.40,640.23
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,169.69,23.80,431.01
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,161.59,124.60,209.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-14 years,Deaths,Rate,2.83,2.29,3.49
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,618.35,224.24,"1,348.70"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,391.17,40.22,"1,068.76"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,227.19,184.02,279.94
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-24 years,Deaths,Rate,3.00,2.45,3.63
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,742.88,252.30,"1,647.07"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,516.99,67.82,"1,373.17"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,225.88,184.48,273.90
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-19 years,Deaths,Rate,3.37,2.75,4.04
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,809.26,282.81,"1,768.60"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,555.69,76.12,"1,464.53"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,253.57,206.69,304.08
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-24 years,Deaths,Rate,3.08,2.53,3.71
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,808.35,267.05,"1,803.96"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,583.16,82.32,"1,533.24"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,225.20,184.73,270.72
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,20-24 years,Deaths,Rate,2.80,2.32,3.38
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,807.45,251.26,"1,839.41"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,610.70,88.55,"1,602.14"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,196.75,162.71,237.28
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-29 years,Deaths,Rate,2.81,2.33,3.35
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,813.49,238.57,"1,813.56"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,630.13,86.25,"1,595.08"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,183.36,152.32,218.48
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-49 years,Deaths,Rate,2.91,2.36,3.62
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,838.69,273.71,"1,806.08"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,677.19,142.22,"1,606.53"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,161.50,131.49,199.55
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,30-34 years,Deaths,Rate,2.73,2.23,3.30
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,819.08,248.81,"1,814.02"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,654.31,114.07,"1,614.76"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,164.77,134.75,199.26
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,35-39 years,Deaths,Rate,2.85,2.36,3.41
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,851.90,280.31,"1,817.39"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,694.17,149.72,"1,628.68"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,157.73,130.59,188.71
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,40-44 years,Deaths,Rate,2.60,2.11,3.20
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,847.81,289.64,"1,803.93"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,716.67,182.99,"1,642.48"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,131.14,106.65,161.45
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,45-49 years,Deaths,Rate,3.70,2.85,5.09
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,869.89,324.43,"1,775.59"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,701.60,194.51,"1,543.82"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,168.29,129.91,231.77
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-54 years,Deaths,Rate,4.33,2.97,7.19
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,844.13,317.80,"1,735.80"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,668.36,197.03,"1,443.80"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,175.78,120.77,292.00
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-64 years,Deaths,Rate,8.71,5.21,16.87
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,972.60,400.69,"1,991.62"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,673.66,220.37,"1,416.60"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,298.94,180.32,575.02
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,55-59 years,Deaths,Rate,8.96,5.45,17.24
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,978.54,406.81,"2,017.43"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,658.18,212.19,"1,401.31"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,320.36,194.62,616.12
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,60-64 years,Deaths,Rate,13.75,7.66,28.27
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,122.56",494.91,"2,274.68"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,697.36,257.92,"1,400.47"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,425.21,236.98,874.20
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-69 years,Deaths,Rate,22.65,12.73,46.32
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,391.10",686.56,"2,730.78"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,797.61,352.83,"1,516.89"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,593.49,333.73,"1,213.88"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-74 years,Deaths,Rate,34.47,20.10,68.13
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,704.00",888.13,"3,249.75"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,900.07,420.59,"1,657.00"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,803.93,467.54,"1,592.76"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,70-74 years,Deaths,Rate,49.75,29.61,96.28
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,107.99","1,148.38","3,919.81"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,032.36",508.08,"1,837.89"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,075.63",640.31,"2,081.92"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75-79 years,Deaths,Rate,107.76,62.79,212.92
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,395.14","1,955.07","6,204.87"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,542.17",875.37,"2,543.81"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,852.96","1,079.70","3,661.06"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75+ years,Deaths,Rate,236.10,108.90,523.17
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,983.50","2,717.27","9,298.53"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,362.75","1,428.06","3,665.49"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"2,620.75","1,289.21","5,633.04"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,80-84 years,Deaths,Rate,214.95,108.19,449.37
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,342.92","2,963.96","9,753.15"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,531.17","1,548.75","3,875.11"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"2,811.75","1,415.21","5,878.03"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,85+ years,Deaths,Rate,579.52,222.44,"1,385.88"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,346.35","4,224.87","16,199.16"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,124.71","2,604.43","6,103.45"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"4,221.63","1,620.45","10,095.71"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,<1 year,Deaths,Rate,5.10,3.65,6.93
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,526.63,348.47,767.00
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,56.48,11.19,128.57
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,470.15,337.28,638.43
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Deaths,Rate,12.28,6.76,24.43
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,905.08,367.24,"1,864.77"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,602.47,166.03,"1,358.91"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,302.61,201.21,505.86
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,All ages,Deaths,Rate,14.33,7.75,28.90
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,957.41,395.57,"1,963.33"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,629.25,181.98,"1,400.59"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Male,All ages,Years of Life Lost (YLLs),Rate,328.17,213.59,562.73
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-4 years,Deaths,Rate,1.41,1.05,1.83
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,201.83,111.25,328.46
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,73.39,15.66,162.32
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,128.44,95.60,166.13
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-14 years,Deaths,Rate,1.56,1.20,2.01
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,407.51,130.85,921.89
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,275.82,29.47,752.12
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,131.69,101.38,169.77
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-19 years,Deaths,Rate,1.75,1.37,2.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,558.30,157.92,"1,293.03"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,415.56,46.41,"1,111.43"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,142.74,111.51,181.60
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-24 years,Deaths,Rate,1.88,1.49,2.35
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,672.11,176.96,"1,539.60"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,524.54,60.19,"1,354.03"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,147.58,116.77,185.56
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-27 days,Deaths,Rate,0.72,0.49,0.98
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,118.97,54.65,222.68
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,52.73,7.97,131.46
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,66.25,46.64,91.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-4 years,Deaths,Rate,0.73,0.58,0.91
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,143.53,68.86,252.43
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,77.64,16.70,170.98
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,65.89,52.16,81.46
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-9 years,Deaths,Rate,1.06,0.82,1.35
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,235.64,92.73,502.37
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,144.13,21.38,385.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,91.51,71.34,117.15
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-11 months,Deaths,Rate,5.17,3.66,6.90
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,528.45,348.44,754.19
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,52.14,10.69,117.96
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,476.31,337.75,636.22
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,5-9 years,Deaths,Rate,1.29,1.00,1.67
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,300.80,109.61,679.17
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,191.17,24.70,536.77
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,109.63,84.92,142.39
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-14 years,Deaths,Rate,1.96,1.54,2.50
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,695.98,169.69,"1,687.35"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,538.84,46.39,"1,486.34"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,157.13,123.29,201.01
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-24 years,Deaths,Rate,2.22,1.79,2.75
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,942.52,220.17,"2,202.34"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,775.92,85.92,"1,995.84"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,166.60,134.25,206.50
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-19 years,Deaths,Rate,2.34,1.89,2.89
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,013.70",239.67,"2,413.96"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,837.60,97.57,"2,196.65"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,176.11,142.10,217.32
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-24 years,Deaths,Rate,2.36,1.92,2.88
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,070.79",246.44,"2,470.30"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,899.28,106.48,"2,260.94"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,171.52,139.96,209.36
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,20-24 years,Deaths,Rate,2.38,1.96,2.87
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,127.63",253.18,"2,526.39"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,960.67,115.35,"2,324.95"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,166.95,137.82,201.44
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-29 years,Deaths,Rate,2.10,1.72,2.56
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,132.20",229.88,"2,593.02"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,994.78,117.49,"2,425.86"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,137.42,112.39,167.16
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-49 years,Deaths,Rate,2.37,1.89,3.03
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,186.62",304.71,"2,605.82"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,056.55",200.42,"2,441.17"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,130.08,104.28,164.64
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,30-34 years,Deaths,Rate,1.98,1.62,2.38
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,150.10",260.79,"2,564.79"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,030.78",162.84,"2,421.25"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,119.32,97.96,143.55
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,35-39 years,Deaths,Rate,2.15,1.74,2.61
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,201.26",321.86,"2,605.78"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,082.39",225.36,"2,461.23"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,118.87,96.50,144.56
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,40-44 years,Deaths,Rate,2.73,2.22,3.42
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,254.79",364.56,"2,727.08"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,116.89",252.62,"2,554.76"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,137.90,111.94,172.32
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,45-49 years,Deaths,Rate,3.03,2.24,4.43
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,205.29",364.42,"2,534.50"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,067.41",262.39,"2,333.13"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,137.88,102.03,201.36
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-54 years,Deaths,Rate,3.19,1.97,6.03
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,128.40",340.29,"2,432.49"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,999.03,260.16,"2,187.44"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,129.37,80.14,245.05
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-64 years,Deaths,Rate,5.19,2.65,11.46
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,149.02",383.67,"2,451.69"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,969.73,290.95,"2,059.64"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,179.29,92.71,392.05
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,55-59 years,Deaths,Rate,4.76,2.47,10.39
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,120.32",370.11,"2,391.38"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,950.19,281.79,"2,020.04"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,170.13,88.32,371.33
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,60-64 years,Deaths,Rate,7.99,3.62,18.93
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,203.88",448.68,"2,538.93"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,956.70,336.62,"1,953.66"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,247.18,112.06,585.27
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-69 years,Deaths,Rate,13.46,5.77,32.40
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,381.49",594.15,"2,843.40"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,028.74",442.99,"1,994.29"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,352.75,151.17,849.11
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-74 years,Deaths,Rate,25.62,10.96,61.02
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,742.49",787.65,"3,551.40"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,155.21",536.27,"2,151.56"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,587.28,251.39,"1,399.84"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,70-74 years,Deaths,Rate,39.92,17.08,94.71
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,167.27","1,015.34","4,384.48"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,304.02",646.03,"2,336.62"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,863.25,369.31,"2,047.86"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75-79 years,Deaths,Rate,81.94,33.13,198.54
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,375.98","1,687.91","6,575.34"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,966.96","1,118.26","3,161.48"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"1,409.02",569.65,"3,413.86"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75+ years,Deaths,Rate,246.13,78.01,603.76
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,886.02","2,890.23","11,154.31"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,431.80","2,071.27","5,167.74"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"2,454.21",818.96,"5,986.58"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,80-84 years,Deaths,Rate,189.80,66.90,451.81
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,770.03","2,805.88","10,884.56"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,287.38","1,930.81","4,974.62"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"2,482.65",875.07,"5,909.94"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,85+ years,Deaths,Rate,540.47,154.14,"1,343.20"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,633.33","4,714.29","18,049.12"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,696.18","3,591.41","8,264.30"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"3,937.15","1,122.88","9,784.82"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,<1 year,Deaths,Rate,4.78,3.39,6.41
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,492.85,322.89,707.97
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,52.20,10.45,119.14
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,440.65,312.44,588.84
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Deaths,Rate,10.00,4.29,22.27
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,110.86",355.05,"2,393.00"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,879.58,219.59,"1,965.74"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,231.29,135.46,427.26
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,All ages,Deaths,Rate,19.70,7.33,46.20
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,326.92",467.37,"2,795.18"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,002.68",304.10,"2,130.99"
ARG,Argentina,Southern Cone,Neurological conditions,2021,Female,All ages,Years of Life Lost (YLLs),Rate,324.25,163.27,664.18
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-24 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.60,0.97
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.76,0.59,0.95
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-24 years,Deaths,Rate,0.02,0.01,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,1.00,1.62
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,1.27,1.00,1.60
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-24 years,Deaths,Rate,0.03,0.02,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.95,1.51,2.46
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,1.93,1.51,2.43
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,20-24 years,Deaths,Rate,0.05,0.04,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.90,3.03,4.92
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.86,3.02,4.85
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.02,0.49
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.21,0.02,0.49
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-49 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.47,1.27,4.23
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,1.86,0.73,3.56
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.60,0.55,0.67
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.60,0.15,1.26
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.60,0.15,1.26
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.58,2.41
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.31,0.58,2.41
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.64,1.37,4.70
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.64,1.37,4.70
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,45-49 years,Deaths,Rate,0.08,0.07,0.09
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.05,5.11,14.68
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.45,1.83,10.69
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,3.61,3.29,3.99
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-54 years,Deaths,Rate,0.19,0.18,0.20
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,18.98,11.84,29.27
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,11.32,4.74,21.02
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,7.66,7.10,8.25
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-64 years,Deaths,Rate,0.77,0.70,0.84
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,51.63,34.60,73.18
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.16,11.31,45.54
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,25.47,23.29,27.64
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,55-59 years,Deaths,Rate,0.62,0.57,0.67
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,45.56,29.14,67.12
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,23.37,8.73,43.11
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,22.20,20.41,24.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,60-64 years,Deaths,Rate,1.64,1.49,1.78
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,97.78,68.15,132.90
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,47.16,22.12,77.83
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,50.61,46.03,55.07
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-69 years,Deaths,Rate,4.94,4.53,5.33
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,219.96,171.55,282.37
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,90.39,52.92,142.80
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,129.57,118.63,139.57
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-74 years,Deaths,Rate,8.10,7.44,8.75
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,309.17,247.10,384.62
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,121.13,74.51,181.58
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,188.04,172.59,203.04
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,70-74 years,Deaths,Rate,12.20,11.22,13.20
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,424.82,345.04,517.17
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,160.98,102.50,231.86
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,263.84,242.54,285.31
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75-79 years,Deaths,Rate,28.68,26.26,30.88
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,762.99,636.40,899.59
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,269.80,184.84,368.59
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,493.20,451.56,531.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75+ years,Deaths,Rate,48.17,43.56,52.29
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,891.21,740.16,"1,052.02"
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,313.15,214.82,425.82
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,578.06,525.34,626.20
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,80-84 years,Deaths,Rate,49.92,45.72,54.14
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,018.97",850.26,"1,196.82"
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,366.01,252.21,488.56
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,652.96,598.05,708.26
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,85+ years,Deaths,Rate,92.81,82.32,101.44
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,018.38",833.45,"1,213.39"
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,342.30,233.80,474.42
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,676.08,599.65,738.97
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Deaths,Rate,2.00,1.82,2.17
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,51.15,40.59,63.51
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.92,12.15,29.66
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,31.23,28.45,33.86
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,All ages,Deaths,Rate,2.41,2.19,2.62
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,60.85,48.48,75.26
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,23.53,14.48,34.82
ARG,Argentina,Southern Cone,Parkinson disease,2020,Male,All ages,Years of Life Lost (YLLs),Rate,37.31,34.00,40.44
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.05
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.05
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.01,0.36
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.14,0.01,0.36
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.44,1.71,3.39
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.09,0.48,1.90
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.36,1.23,1.49
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.08,0.90
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.39,0.08,0.90
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,35-39 years,Deaths,Rate,0.07,0.06,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.54,3.67,5.62
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.81,0.31,1.51
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,3.72,3.35,4.11
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.52,0.66,2.64
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.52,0.66,2.64
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,45-49 years,Deaths,Rate,0.08,0.07,0.08
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.49,4.77,8.57
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.98,1.56,4.74
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.51,3.21,3.83
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-54 years,Deaths,Rate,0.27,0.25,0.29
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,16.64,12.18,24.28
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.62,1.99,12.30
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,11.02,10.20,11.98
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-64 years,Deaths,Rate,0.56,0.51,0.60
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,31.41,22.70,43.33
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,12.96,5.65,23.28
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,18.46,17.06,20.05
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,55-59 years,Deaths,Rate,0.20,0.18,0.21
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,18.72,12.18,28.37
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.71,5.70,20.79
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,7.01,6.47,7.58
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,60-64 years,Deaths,Rate,1.27,1.18,1.38
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.09,46.16,81.36
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,22.71,9.78,38.56
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,39.38,36.38,42.80
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-69 years,Deaths,Rate,2.04,1.89,2.21
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,99.06,75.05,130.80
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,45.48,25.59,72.95
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,53.58,49.46,57.85
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-74 years,Deaths,Rate,3.45,3.17,3.75
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,141.47,109.67,181.36
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,61.76,36.52,94.81
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,79.71,73.14,86.55
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,70-74 years,Deaths,Rate,5.12,4.68,5.57
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,191.67,150.64,241.21
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,81.03,49.46,120.68
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,110.64,101.17,120.52
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75-79 years,Deaths,Rate,13.47,12.07,14.86
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,367.28,295.38,455.35
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,135.66,87.87,199.83
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,231.62,207.52,255.52
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75+ years,Deaths,Rate,26.44,22.48,29.30
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,455.65,351.67,566.09
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,164.43,101.01,243.84
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,291.22,250.66,322.25
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,80-84 years,Deaths,Rate,25.35,21.83,27.97
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,520.34,400.69,643.40
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,188.69,115.08,277.55
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,331.65,285.61,365.84
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,85+ years,Deaths,Rate,46.11,38.06,51.33
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,517.12,382.94,646.91
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,181.21,105.67,272.95
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,335.91,277.28,373.96
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Deaths,Rate,0.98,0.86,1.08
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.68,19.64,32.89
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.12,5.80,15.83
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,15.55,13.84,17.06
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,All ages,Deaths,Rate,1.99,1.72,2.20
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,44.14,33.82,56.00
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,17.02,9.95,26.16
ARG,Argentina,Southern Cone,Parkinson disease,2020,Female,All ages,Years of Life Lost (YLLs),Rate,27.12,23.87,29.83
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.20,0.01,0.48
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.20,0.01,0.48
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-49 years,Deaths,Rate,0.02,0.02,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.94,1.52,4.96
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,1.81,0.66,3.50
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.13,0.86,1.46
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.13,1.26
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.56,0.13,1.26
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,35-39 years,Deaths,Rate,0.06,0.04,0.08
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.57,2.95,6.70
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.26,0.53,2.29
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.31,2.43,4.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,40-44 years,Deaths,Rate,0.05,0.04,0.06
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.96,3.14,7.53
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.56,1.26,4.57
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.40,1.89,2.96
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.25,1.66,10.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.25,1.66,10.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-54 years,Deaths,Rate,0.18,0.17,0.20
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,18.09,11.47,27.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,10.68,4.66,19.39
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,7.40,6.81,8.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-64 years,Deaths,Rate,0.69,0.63,0.75
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,47.56,31.87,68.53
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,24.41,10.77,43.30
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,23.15,21.10,25.23
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,55-59 years,Deaths,Rate,0.77,0.71,0.84
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,49.47,33.19,71.86
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,21.97,7.95,41.89
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,27.50,25.24,29.97
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,60-64 years,Deaths,Rate,1.21,1.10,1.32
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,81.37,55.26,114.94
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,43.87,21.34,74.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,37.50,33.92,40.95
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-69 years,Deaths,Rate,3.97,3.62,4.31
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,186.46,142.96,238.04
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,82.35,48.00,125.17
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,104.11,94.96,112.87
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-74 years,Deaths,Rate,7.15,6.56,7.75
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,273.28,213.78,339.56
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,108.38,62.51,160.93
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,164.89,151.27,178.63
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,70-74 years,Deaths,Rate,11.26,10.36,12.19
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,385.36,305.22,470.63
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,142.00,81.24,207.10
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,243.36,223.97,263.53
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75-79 years,Deaths,Rate,31.17,28.28,33.75
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,766.24,636.50,921.23
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,230.28,150.18,340.98
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,535.96,486.32,580.25
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75+ years,Deaths,Rate,58.38,52.32,63.83
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,962.85,804.40,"1,153.04"
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,264.18,174.69,390.87
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,698.67,629.71,762.18
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,80-84 years,Deaths,Rate,69.71,63.53,76.17
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,220.78","1,038.70","1,450.99"
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,308.92,207.65,454.59
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,911.87,831.06,996.41
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,85+ years,Deaths,Rate,108.59,94.98,119.62
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,074.02",879.27,"1,292.94"
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,282.98,187.38,421.54
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,791.04,691.88,871.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Deaths,Rate,2.26,2.03,2.47
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,50.88,40.38,63.60
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,17.52,10.21,27.20
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,33.36,30.17,36.40
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,All ages,Deaths,Rate,2.75,2.48,3.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,61.26,48.81,76.29
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,20.88,12.28,32.24
ARG,Argentina,Southern Cone,Parkinson disease,2021,Male,All ages,Years of Life Lost (YLLs),Rate,40.38,36.53,44.05
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.06
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.06
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.01,0.39
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.14,0.01,0.39
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-49 years,Deaths,Rate,0.01,0.01,0.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.69,0.98,2.64
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.12,0.49,1.99
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.57,0.49,0.65
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.40,0.08,0.99
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.40,0.08,0.99
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.84,0.31,1.58
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.84,0.31,1.58
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,40-44 years,Deaths,Rate,0.06,0.05,0.07
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,4.48,3.25,6.06
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.58,0.74,2.73
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,2.90,2.50,3.32
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.03,1.52,4.84
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.03,1.52,4.84
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.77,2.04,11.54
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.77,2.04,11.54
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-64 years,Deaths,Rate,0.22,0.21,0.24
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,20.28,11.50,31.78
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,13.12,4.93,23.99
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,7.16,6.57,7.79
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,55-59 years,Deaths,Rate,0.15,0.14,0.16
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,17.38,10.24,26.19
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.98,5.28,20.32
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,5.41,4.96,5.87
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,60-64 years,Deaths,Rate,0.56,0.52,0.61
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,40.26,23.86,61.33
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,22.90,7.91,42.41
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,17.36,15.95,18.92
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-69 years,Deaths,Rate,1.44,1.33,1.57
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,82.18,58.34,113.27
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,44.33,23.58,72.26
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,37.86,34.76,41.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-74 years,Deaths,Rate,3.75,3.42,4.07
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,145.76,112.62,185.84
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,61.09,35.31,94.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,84.66,77.31,91.84
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,70-74 years,Deaths,Rate,6.46,5.89,7.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,220.56,176.50,271.24
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,80.83,49.13,119.59
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,139.74,127.38,151.65
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75-79 years,Deaths,Rate,13.83,12.40,15.20
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,376.91,298.80,456.53
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,139.11,85.67,195.25
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,237.80,213.13,261.28
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75+ years,Deaths,Rate,29.56,24.81,32.90
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,498.01,382.24,610.48
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,172.75,105.55,249.48
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,325.26,276.68,361.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,80-84 years,Deaths,Rate,31.06,26.31,34.45
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,604.83,467.12,737.26
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,198.60,122.95,286.59
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,406.22,344.17,450.67
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,85+ years,Deaths,Rate,50.79,41.25,56.93
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,565.31,417.22,705.16
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,195.29,116.76,290.45
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,370.02,300.46,414.71
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Deaths,Rate,1.03,0.89,1.14
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,25.30,18.86,32.47
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.35,5.76,16.01
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,14.95,13.10,16.46
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,All ages,Deaths,Rate,2.18,1.85,2.42
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,45.74,34.47,57.80
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,17.71,10.16,26.86
ARG,Argentina,Southern Cone,Parkinson disease,2021,Female,All ages,Years of Life Lost (YLLs),Rate,28.03,24.31,30.94
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.46,0.00,4.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,1.46,0.00,4.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.00,3.68
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.31,0.00,3.68
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.23,0.00,6.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.23,0.00,6.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.00,3.90
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,1.39,0.00,3.90
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,2.48,0.00,6.97
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,2.48,0.00,6.97
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Deaths,Rate,0.02,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.85,0.00,5.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,1.85,0.00,5.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Deaths,Rate,0.04,0.00,0.11
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.83,0.00,7.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.83,0.00,7.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Deaths,Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.89,0.00,2.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.89,0.00,2.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Deaths,Rate,0.05,0.00,0.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,0.00,9.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,3.27,0.00,9.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Deaths,Rate,0.08,0.00,0.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.54,0.00,15.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,5.54,0.00,15.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Deaths,Rate,0.03,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,2.11,0.00,5.94
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.11,0.00,5.94
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Deaths,Rate,0.12,0.01,0.39
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.53,2.69,28.19
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,4.57,2.23,8.33
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.97,0.46,19.86
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Deaths,Rate,0.03,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,1.84,0.00,5.19
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.84,0.00,5.19
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Deaths,Rate,0.10,0.00,0.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.55,0.00,15.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,5.55,0.00,15.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Deaths,Rate,0.19,0.02,0.69
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.79,2.08,41.49
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.45,1.21,6.59
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,9.34,0.87,34.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Deaths,Rate,0.27,0.04,0.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,35.34,13.38,84.66
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,22.83,11.67,41.32
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,12.51,1.71,43.34
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Deaths,Rate,0.47,0.07,1.61
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,78.80,39.24,159.57
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,59.88,36.26,94.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,18.92,2.98,65.30
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Deaths,Rate,2.00,0.39,6.15
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,197.39,93.53,398.36
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,131.15,80.87,194.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,66.24,12.66,204.16
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Deaths,Rate,1.55,0.29,4.94
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,178.40,84.85,356.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,123.15,74.49,179.65
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,55.25,10.36,176.57
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Deaths,Rate,4.59,0.91,13.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,377.10,175.80,765.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,235.01,147.54,343.90
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,142.09,28.26,421.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Deaths,Rate,13.46,3.04,39.75
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,774.67,347.69,"1,653.10"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,422.03,267.93,611.42
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,352.64,79.76,"1,041.68"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Deaths,Rate,24.60,5.85,70.89
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,136.80",496.93,"2,467.64"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,568.33,362.14,826.92
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,568.47,134.79,"1,640.72"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Deaths,Rate,40.79,9.93,116.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,662.80",713.70,"3,650.80"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,780.83,498.99,"1,139.96"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,881.97,214.71,"2,510.85"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Deaths,Rate,112.91,26.56,333.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,332.30","1,381.61","7,717.31"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,390.74",924.85,"1,984.29"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,941.56",456.76,"5,733.03"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Deaths,Rate,416.76,100.91,"1,131.32"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,328.67","2,439.78","14,453.27"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,167.47","1,437.71","3,038.62"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"4,161.19","1,002.07","11,414.64"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Deaths,Rate,317.29,75.99,849.59
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,601.09","2,584.45","14,533.22"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,450.70","1,590.50","3,420.05"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"4,150.39",993.95,"11,113.17"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Deaths,Rate,"1,436.13",351.25,"3,841.01"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"14,374.57","5,203.65","33,393.17"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,912.85","2,644.90","5,412.60"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"10,461.73","2,558.75","27,980.56"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Deaths,Rate,15.34,3.69,41.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,292.54,117.04,656.61
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,117.16,75.87,167.85
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,175.38,41.17,488.76
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Deaths,Rate,13.74,3.30,37.68
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,282.45,114.13,631.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,117.01,75.50,168.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years of Life Lost (YLLs),Rate,165.44,38.63,463.39
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Deaths,Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.77,0.00,2.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.77,0.00,2.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Deaths,Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.00,3.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,1.31,0.00,3.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,0.00,4.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,1.57,0.00,4.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Deaths,Rate,0.03,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.25,0.00,5.85
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,2.25,0.00,5.85
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Deaths,Rate,0.03,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.52,0.00,6.55
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.52,0.00,6.55
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Deaths,Rate,0.04,0.00,0.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,0.00,7.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,2.79,0.00,7.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Deaths,Rate,0.04,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.64,0.00,6.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,2.64,0.00,6.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Deaths,Rate,0.04,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.50,0.00,6.50
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.50,0.00,6.50
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Deaths,Rate,0.02,0.00,0.06
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.61,0.00,4.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.61,0.00,4.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Deaths,Rate,0.09,0.01,0.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.70,2.90,23.11
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.30,2.58,9.04
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,4.40,0.32,14.06
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Deaths,Rate,0.02,0.00,0.06
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.00,3.60
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.38,0.00,3.60
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Deaths,Rate,0.10,0.00,0.25
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.30,0.00,13.79
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,5.30,0.00,13.79
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Deaths,Rate,0.09,0.01,0.34
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.61,1.87,24.74
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.00,1.43,7.48
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,4.60,0.44,17.26
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Deaths,Rate,0.22,0.03,0.76
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,35.63,14.44,77.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,25.72,13.09,43.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,9.92,1.34,34.75
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Deaths,Rate,0.45,0.07,1.53
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,86.66,41.97,169.46
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.48,39.05,107.17
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,18.18,2.91,62.29
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Deaths,Rate,1.64,0.32,5.01
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,212.04,108.24,399.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,157.61,97.65,232.59
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,54.42,10.60,167.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Deaths,Rate,1.29,0.24,4.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,192.54,101.76,357.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,146.49,93.03,211.68
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,46.05,8.73,145.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Deaths,Rate,3.55,0.73,10.49
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,392.68,199.21,739.20
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,282.81,176.76,414.93
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,109.87,22.45,324.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Deaths,Rate,10.28,2.38,30.02
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,773.01,393.58,"1,510.31"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,503.59,331.08,723.53
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,269.42,62.50,786.77
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Deaths,Rate,20.41,5.10,57.70
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,148.17",558.69,"2,312.64"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,679.52,442.17,985.45
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,468.64,116.51,"1,327.19"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Deaths,Rate,34.32,8.82,95.69
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,663.16",785.33,"3,414.05"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,921.03,594.67,"1,344.99"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,742.13,190.66,"2,069.05"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Deaths,Rate,100.13,24.23,283.60
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,336.22","1,499.73","7,135.24"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,614.42","1,083.03","2,258.85"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"1,721.81",416.71,"4,876.39"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Deaths,Rate,493.80,126.85,"1,258.68"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,280.01","2,956.37","15,590.39"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,695.57","1,787.14","3,760.23"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"4,584.44","1,169.23","11,830.16"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Deaths,Rate,294.80,74.88,758.38
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,685.50","2,833.34","13,917.41"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,829.27","1,853.82","3,997.28"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"3,856.23",979.52,"9,920.13"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Deaths,Rate,"1,588.17",412.25,"3,979.37"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"16,349.58","6,175.52","35,574.12"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"4,780.28","3,172.43","6,585.67"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"11,569.29","3,003.08","28,988.46"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Deaths,Rate,15.60,3.98,40.25
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,306.89,132.05,643.37
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,138.53,90.18,197.52
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,168.36,41.87,445.85
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Deaths,Rate,21.34,5.45,54.93
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,405.33,173.76,850.50
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,180.42,117.58,256.88
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years of Life Lost (YLLs),Rate,224.91,56.18,593.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Deaths,Rate,0.03,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.09,0.00,5.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,2.09,0.00,5.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Deaths,Rate,0.02,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.99,0.00,5.61
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,1.99,0.00,5.61
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.23,0.00,6.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,2.23,0.00,6.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,1.38,0.00,3.89
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,1.38,0.00,3.89
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,2.46,0.00,6.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,2.46,0.00,6.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Deaths,Rate,0.05,0.00,0.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,3.70,0.00,10.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,3.70,0.00,10.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Deaths,Rate,0.04,0.00,0.11
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.82,0.00,7.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,2.82,0.00,7.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Deaths,Rate,0.02,0.00,0.06
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.74,0.00,4.89
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,1.74,0.00,4.89
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Deaths,Rate,0.03,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,0.00,6.82
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,2.42,0.00,6.82
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Deaths,Rate,0.04,0.00,0.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.07,0.00,8.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,3.07,0.00,8.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Deaths,Rate,0.03,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,2.01,0.00,5.64
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.01,0.00,5.64
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Deaths,Rate,0.11,0.01,0.38
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.30,2.75,27.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,4.62,2.27,8.39
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,5.68,0.47,18.81
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Deaths,Rate,0.05,0.00,0.14
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.94,0.00,8.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,2.94,0.00,8.27
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Deaths,Rate,0.06,0.00,0.17
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,0.00,9.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,3.34,0.00,9.41
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Deaths,Rate,0.15,0.01,0.54
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.81,1.86,33.69
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.45,1.18,6.59
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,7.36,0.68,27.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Deaths,Rate,0.32,0.04,1.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,37.16,13.76,90.55
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,22.77,11.81,41.02
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,14.39,1.95,49.54
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Deaths,Rate,0.33,0.05,1.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,73.26,38.34,139.59
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,59.85,36.26,94.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,13.41,2.09,45.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Deaths,Rate,1.96,0.38,5.96
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,196.14,92.36,393.20
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,131.76,79.82,196.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,64.38,12.54,196.29
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Deaths,Rate,1.48,0.28,4.79
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,175.71,81.57,351.92
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,122.64,71.62,180.75
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,53.07,9.95,171.17
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Deaths,Rate,4.65,0.94,13.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,379.50,175.12,770.54
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,235.67,145.98,349.21
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,143.83,29.15,421.33
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Deaths,Rate,13.72,3.09,40.57
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,788.48,354.97,"1,681.22"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,428.80,274.05,618.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,359.69,80.92,"1,063.22"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Deaths,Rate,24.85,5.88,71.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,154.65",506.96,"2,502.04"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,580.24,371.46,844.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,574.42,135.50,"1,657.47"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Deaths,Rate,40.81,9.89,116.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,679.91",725.00,"3,679.48"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,797.47,511.19,"1,169.59"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,882.44,213.80,"2,509.88"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Deaths,Rate,116.32,27.02,335.37
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,412.47","1,403.01","7,752.58"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,412.28",938.36,"1,985.94"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"2,000.19",464.65,"5,766.64"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Deaths,Rate,423.57,102.84,"1,144.49"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,403.18","2,471.49","14,526.14"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,197.02","1,455.40","3,070.80"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"4,206.16","1,016.09","11,455.33"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Deaths,Rate,303.83,74.41,810.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,453.87","2,584.94","14,095.49"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,479.54","1,611.64","3,493.51"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"3,974.33",973.30,"10,601.98"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Deaths,Rate,"1,478.76",361.45,"3,953.35"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"14,717.94","5,288.69","34,235.40"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,945.64","2,655.64","5,436.52"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"10,772.30","2,633.05","28,798.88"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Deaths,Rate,15.54,3.75,42.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,294.98,118.16,658.60
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,118.53,76.60,169.76
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,176.46,41.56,488.83
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Deaths,Rate,14.34,3.45,39.15
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,293.20,118.64,651.91
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,121.83,78.46,175.04
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years of Life Lost (YLLs),Rate,171.36,40.18,476.87
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Deaths,Rate,0.02,0.00,0.05
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,0.00,4.14
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,1.59,0.00,4.14
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Deaths,Rate,0.03,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,0.00,5.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,2.15,0.00,5.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.24,0.00,5.84
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,2.24,0.00,5.84
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Deaths,Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,1.40,0.00,3.64
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,1.40,0.00,3.64
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Deaths,Rate,0.03,0.00,0.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,2.48,0.00,6.47
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,2.48,0.00,6.47
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Deaths,Rate,0.03,0.00,0.07
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,2.22,0.00,5.78
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,2.22,0.00,5.78
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Deaths,Rate,0.04,0.00,0.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.83,0.00,7.38
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,2.83,0.00,7.38
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Deaths,Rate,0.05,0.00,0.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.72,0.00,9.69
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,3.72,0.00,9.69
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Deaths,Rate,0.04,0.00,0.11
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.11,0.00,8.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,3.11,0.00,8.10
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Deaths,Rate,0.04,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.54,0.00,6.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,2.54,0.00,6.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Deaths,Rate,0.05,0.00,0.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.19,0.00,8.32
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,3.19,0.00,8.32
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Deaths,Rate,0.10,0.01,0.33
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.58,3.02,25.97
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,5.34,2.60,9.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,5.25,0.41,16.84
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Deaths,Rate,0.04,0.00,0.09
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.20,0.00,5.73
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,2.20,0.00,5.73
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Deaths,Rate,0.06,0.00,0.15
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.29,0.00,8.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,3.29,0.00,8.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Deaths,Rate,0.14,0.01,0.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,10.94,2.04,33.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.97,1.38,7.43
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,6.97,0.66,25.79
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Deaths,Rate,0.25,0.03,0.86
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,37.08,14.65,82.22
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,25.54,13.08,42.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,11.53,1.57,39.28
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Deaths,Rate,0.36,0.06,1.24
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,83.11,42.82,157.51
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,68.54,40.51,106.95
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,14.57,2.32,50.55
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Deaths,Rate,1.56,0.31,4.82
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,211.66,108.36,394.01
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,160.08,98.23,234.33
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,51.57,10.13,159.68
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Deaths,Rate,1.21,0.23,3.88
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,189.84,101.04,351.40
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,146.76,92.86,212.63
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,43.08,8.18,138.78
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Deaths,Rate,3.46,0.71,10.29
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,395.29,197.57,734.72
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,288.29,175.56,416.39
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,107.00,22.02,318.34
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Deaths,Rate,10.30,2.37,29.80
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,799.76,407.89,"1,548.65"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,529.73,345.89,767.66
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,270.03,62.00,780.99
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Deaths,Rate,20.97,5.23,58.62
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,199.45",586.09,"2,394.03"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,718.85,466.71,"1,048.04"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,480.60,119.38,"1,345.99"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Deaths,Rate,35.35,9.10,97.46
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,738.01",826.21,"3,533.15"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,973.68,629.51,"1,425.85"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,764.34,196.70,"2,107.30"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Deaths,Rate,108.71,26.75,304.08
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,525.70","1,580.98","7,553.60"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,656.47","1,120.93","2,325.03"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"1,869.23",460.05,"5,228.57"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Deaths,Rate,524.62,136.21,"1,310.33"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,577.47","3,055.00","16,124.09"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,706.72","1,798.35","3,774.71"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"4,870.75","1,256.65","12,349.38"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Deaths,Rate,305.32,78.66,780.13
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,824.75","2,883.24","14,190.04"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,830.98","1,854.32","3,985.46"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"3,993.77","1,028.92","10,204.58"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Deaths,Rate,"1,714.67",449.18,"4,188.97"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,272.34","6,441.93","37,100.15"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"4,781.55","3,169.82","6,584.81"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"12,490.79","3,272.11","30,515.34"
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Deaths,Rate,16.65,4.29,42.12
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,319.70,136.73,666.30
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,141.34,91.97,201.58
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,178.36,44.76,464.72
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Deaths,Rate,23.15,5.97,58.43
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,431.53,184.08,899.65
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,188.49,122.77,268.48
BRA,Brazil,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years of Life Lost (YLLs),Rate,243.04,61.30,631.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-4 years,Deaths,Rate,1.38,1.16,1.61
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,225.64,164.03,306.96
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,99.99,58.70,160.93
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,125.65,105.33,146.03
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-14 years,Deaths,Rate,0.78,0.63,0.92
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,182.93,115.91,273.08
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,114.56,60.40,192.36
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,68.38,55.51,80.72
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-19 years,Deaths,Rate,0.77,0.64,0.90
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,184.05,117.03,277.71
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,119.14,62.90,201.99
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,64.91,54.13,75.72
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-24 years,Deaths,Rate,0.86,0.74,0.98
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,190.91,123.06,284.83
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,122.21,64.12,206.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,68.70,58.95,78.83
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-27 days,Deaths,Rate,0.22,0.18,0.26
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,96.60,56.82,156.29
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,76.42,39.83,132.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,20.18,16.99,23.90
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-4 years,Deaths,Rate,1.00,0.84,1.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,194.09,137.25,270.75
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,103.94,61.69,165.99
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,90.14,75.56,104.76
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-9 years,Deaths,Rate,0.73,0.58,0.88
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,175.62,111.46,258.56
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,110.98,60.47,180.89
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,64.64,50.99,77.68
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-11 months,Deaths,Rate,3.24,2.71,3.76
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,382.57,296.97,487.26
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,84.27,46.93,140.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,298.30,250.05,346.65
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,5-9 years,Deaths,Rate,0.52,0.37,0.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,161.09,91.18,248.97
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,116.51,59.52,192.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,44.58,31.66,56.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-14 years,Deaths,Rate,0.46,0.39,0.53
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,163.60,94.26,264.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,126.50,62.87,222.04
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,37.11,31.39,42.34
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-24 years,Deaths,Rate,0.80,0.73,0.89
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,189.67,120.58,289.21
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,130.61,67.15,223.61
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,59.06,53.43,65.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-19 years,Deaths,Rate,0.74,0.67,0.82
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,187.14,120.09,290.47
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,131.80,69.80,228.54
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,55.34,50.29,61.94
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-24 years,Deaths,Rate,0.96,0.88,1.06
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,201.64,132.67,300.62
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,132.50,69.11,224.33
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,69.15,63.56,76.29
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,20-24 years,Deaths,Rate,1.17,1.08,1.28
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,215.44,144.62,310.27
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,133.16,68.46,220.34
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,82.27,76.17,89.94
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-29 years,Deaths,Rate,1.25,1.18,1.32
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,207.94,143.36,289.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,126.29,66.23,203.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,81.64,77.13,86.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-49 years,Deaths,Rate,2.29,2.17,2.41
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,236.65,173.66,321.41
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,115.82,59.02,194.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,120.83,114.63,127.24
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,30-34 years,Deaths,Rate,1.31,1.24,1.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,195.10,131.66,283.07
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,115.83,56.61,199.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,79.26,75.05,84.06
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,35-39 years,Deaths,Rate,2.06,1.96,2.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,226.92,165.50,310.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,112.74,57.05,190.43
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,114.18,108.45,120.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,40-44 years,Deaths,Rate,3.02,2.88,3.16
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,264.39,203.55,350.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,112.21,58.44,190.70
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,152.18,145.11,159.31
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,45-49 years,Deaths,Rate,4.25,4.02,4.48
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,304.21,239.28,389.83
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,110.98,56.36,185.96
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,193.23,182.91,203.87
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-54 years,Deaths,Rate,4.44,4.19,4.67
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,292.49,226.14,377.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,112.33,56.09,188.03
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,180.16,170.05,189.62
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-64 years,Deaths,Rate,4.71,4.42,4.98
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,295.45,223.88,394.11
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,125.21,64.10,214.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,170.24,159.78,180.09
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,55-59 years,Deaths,Rate,5.19,4.87,5.50
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,309.50,237.54,410.84
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,123.90,63.44,214.22
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,185.60,174.11,196.62
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,60-64 years,Deaths,Rate,4.48,4.17,4.77
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,282.31,204.32,395.57
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,143.83,75.50,248.13
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,138.48,128.82,147.43
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-69 years,Deaths,Rate,5.20,4.89,5.53
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,300.96,215.63,430.37
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,164.59,87.52,285.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,136.37,128.11,145.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-74 years,Deaths,Rate,5.55,5.18,5.93
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,304.49,216.71,432.52
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,170.28,91.44,289.16
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,134.21,125.27,143.35
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,70-74 years,Deaths,Rate,6.06,5.60,6.52
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,309.62,218.28,435.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,178.55,97.14,294.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,131.08,121.15,140.97
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75-79 years,Deaths,Rate,7.90,7.20,8.57
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,329.32,228.94,469.74
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,193.40,105.11,322.35
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,135.92,123.83,147.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75+ years,Deaths,Rate,13.33,11.67,14.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,365.80,252.54,513.88
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,206.87,111.78,340.23
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,158.93,140.76,173.65
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,80-84 years,Deaths,Rate,12.30,10.87,13.47
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,370.80,253.89,513.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,209.90,111.70,337.52
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,160.90,142.18,176.14
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,85+ years,Deaths,Rate,30.33,25.59,33.50
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,461.07,317.16,639.20
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,240.15,130.76,395.18
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,220.92,186.40,244.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,<1 year,Deaths,Rate,2.96,2.48,3.44
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,356.83,275.36,457.46
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,83.57,46.29,139.86
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,273.26,229.07,317.60
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,Age-standardized,Deaths,Rate,2.52,2.32,2.72
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,232.25,163.22,326.77
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,125.13,65.08,210.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,107.12,98.14,116.11
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,All ages,Deaths,Rate,2.64,2.43,2.83
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,236.34,167.32,331.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,125.41,65.09,211.33
BRA,Brazil,Southern Cone,Epilepsy,2020,Male,All ages,Years of Life Lost (YLLs),Rate,110.93,102.23,119.67
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-4 years,Deaths,Rate,0.98,0.82,1.14
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,170.36,121.71,234.80
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,81.10,46.88,131.06
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,89.26,74.82,103.74
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-14 years,Deaths,Rate,0.53,0.43,0.62
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,141.86,87.43,219.84
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,95.66,49.37,165.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,46.20,38.06,54.46
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-19 years,Deaths,Rate,0.54,0.46,0.62
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,144.86,90.26,223.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,99.32,51.70,170.85
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,45.55,38.57,52.54
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-24 years,Deaths,Rate,0.57,0.49,0.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,147.18,92.63,225.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,101.39,53.07,173.63
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,45.79,39.56,52.04
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-27 days,Deaths,Rate,0.31,0.26,0.37
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,88.08,54.71,139.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,59.29,30.47,104.91
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,28.78,24.23,34.09
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-4 years,Deaths,Rate,0.71,0.59,0.82
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,148.35,102.68,209.73
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,84.91,49.50,136.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,63.44,53.18,73.73
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-9 years,Deaths,Rate,0.48,0.39,0.58
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,135.19,83.44,206.53
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,92.58,49.35,155.40
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,42.61,34.10,51.14
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-11 months,Deaths,Rate,2.31,1.94,2.68
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,278.81,215.04,358.54
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,65.85,36.52,111.05
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,212.96,178.52,247.49
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,5-9 years,Deaths,Rate,0.31,0.22,0.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,124.85,68.32,204.02
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,98.61,49.23,170.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,26.24,19.10,33.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-14 years,Deaths,Rate,0.31,0.27,0.35
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,131.37,73.49,221.05
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,106.62,51.86,192.86
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,24.74,21.63,28.19
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-24 years,Deaths,Rate,0.53,0.48,0.57
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,147.10,91.40,229.54
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,108.26,56.08,187.17
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,38.85,35.32,42.37
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-19 years,Deaths,Rate,0.58,0.53,0.63
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,153.09,98.04,233.12
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,109.34,58.10,185.82
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,43.76,39.95,47.30
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-24 years,Deaths,Rate,0.62,0.57,0.67
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,154.26,99.54,233.40
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,109.00,58.00,184.58
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,45.26,41.54,48.82
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,20-24 years,Deaths,Rate,0.66,0.61,0.71
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,155.35,100.95,233.66
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,108.68,57.91,183.41
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,46.67,43.04,50.25
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-29 years,Deaths,Rate,0.67,0.63,0.71
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,144.94,91.34,213.07
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,101.30,50.43,166.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,43.63,40.91,46.43
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-49 years,Deaths,Rate,0.84,0.79,0.89
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,137.68,88.71,203.08
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,92.16,45.81,154.77
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,45.53,42.91,48.31
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,30-34 years,Deaths,Rate,0.55,0.52,0.58
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,126.02,75.12,193.11
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,92.78,43.78,157.93
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,33.24,31.33,35.18
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,35-39 years,Deaths,Rate,0.83,0.78,0.87
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,135.05,87.44,200.51
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,89.33,44.34,152.12
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,45.72,43.10,48.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,40-44 years,Deaths,Rate,1.03,0.98,1.09
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,140.98,94.13,205.07
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,88.96,44.93,150.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,52.02,49.20,55.07
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,45-49 years,Deaths,Rate,1.21,1.14,1.29
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,142.77,97.42,204.35
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,87.85,45.64,145.82
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,54.92,51.78,58.53
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-54 years,Deaths,Rate,1.14,1.06,1.22
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,135.60,87.90,197.14
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,89.44,44.79,147.69
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,46.16,43.11,49.45
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-64 years,Deaths,Rate,1.59,1.48,1.71
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,157.02,103.15,232.99
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,100.85,51.01,172.77
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,56.17,52.14,60.22
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,55-59 years,Deaths,Rate,1.77,1.65,1.90
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,161.77,107.52,240.87
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,98.47,48.63,173.04
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,63.31,58.89,67.83
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,60-64 years,Deaths,Rate,1.95,1.80,2.10
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,178.35,117.17,268.79
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,118.01,61.64,204.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,60.34,55.53,64.79
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-69 years,Deaths,Rate,2.07,1.90,2.23
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,192.52,123.44,297.51
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,138.31,73.57,238.95
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,54.21,49.87,58.55
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-74 years,Deaths,Rate,2.75,2.51,2.98
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,209.92,137.16,319.59
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,145.02,77.84,249.20
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,64.90,59.32,70.39
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,70-74 years,Deaths,Rate,3.68,3.34,4.01
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,233.81,155.99,349.91
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,154.23,83.70,263.26
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,79.58,72.29,86.64
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75-79 years,Deaths,Rate,4.67,4.08,5.13
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,248.39,157.69,366.65
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,168.03,87.51,278.45
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,80.36,70.18,88.19
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75+ years,Deaths,Rate,7.97,6.46,9.01
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,272.48,170.47,401.49
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,181.43,95.02,299.37
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,91.05,75.45,102.11
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,80-84 years,Deaths,Rate,6.36,5.31,7.12
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,265.09,164.41,389.69
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,181.91,94.96,296.50
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,83.18,69.46,93.19
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,85+ years,Deaths,Rate,17.04,12.99,19.68
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,332.98,205.47,490.47
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,208.87,110.85,347.10
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,124.11,94.63,143.36
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,<1 year,Deaths,Rate,2.13,1.79,2.48
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,261.91,200.83,339.08
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,65.27,35.99,110.51
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,196.64,164.84,228.57
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,Age-standardized,Deaths,Rate,1.13,1.01,1.24
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,152.02,97.18,228.52
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,102.44,52.61,174.00
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,49.58,44.57,54.52
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,All ages,Deaths,Rate,1.28,1.14,1.40
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,154.37,98.94,231.57
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,103.89,53.30,176.38
BRA,Brazil,Southern Cone,Epilepsy,2020,Female,All ages,Years of Life Lost (YLLs),Rate,50.48,45.64,55.19
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-4 years,Deaths,Rate,1.35,1.09,1.64
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,219.74,152.27,310.72
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,97.53,53.44,161.76
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,122.21,98.84,148.96
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-14 years,Deaths,Rate,0.70,0.55,0.85
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,175.48,106.32,274.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,114.10,57.71,200.15
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,61.38,48.61,74.53
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-19 years,Deaths,Rate,0.72,0.60,0.85
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,179.37,109.62,281.58
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,118.82,59.78,209.66
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,60.54,49.85,71.92
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-24 years,Deaths,Rate,0.77,0.65,0.89
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,183.51,112.83,285.13
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,121.77,60.60,213.01
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,61.74,52.23,72.12
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-27 days,Deaths,Rate,0.21,0.17,0.27
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,93.54,53.89,160.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,73.70,37.75,135.61
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,19.84,16.14,24.79
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-4 years,Deaths,Rate,0.99,0.80,1.21
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,190.48,127.94,274.00
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,101.54,56.01,165.59
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,88.94,71.93,108.41
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-9 years,Deaths,Rate,0.63,0.48,0.78
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,165.71,100.88,258.76
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,110.22,58.10,190.30
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,55.49,42.77,68.46
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-11 months,Deaths,Rate,3.10,2.51,3.78
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,367.47,274.48,495.32
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,81.38,43.10,146.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,286.09,231.38,348.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,5-9 years,Deaths,Rate,0.35,0.24,0.44
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,146.45,79.82,246.91
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,116.98,59.73,209.52
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,29.47,20.09,37.39
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-14 years,Deaths,Rate,0.44,0.36,0.51
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,162.14,88.87,267.90
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,126.96,59.76,227.28
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,35.19,29.11,40.61
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-24 years,Deaths,Rate,0.73,0.65,0.81
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,184.19,111.29,289.33
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,130.47,62.99,229.36
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,53.72,48.30,59.98
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-19 years,Deaths,Rate,0.77,0.71,0.86
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,190.14,118.78,300.68
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,131.92,65.51,236.01
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,58.22,53.27,64.67
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-24 years,Deaths,Rate,0.86,0.79,0.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.31,121.59,299.18
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,132.08,64.48,230.31
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,62.23,57.11,68.87
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,20-24 years,Deaths,Rate,0.94,0.86,1.04
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,198.25,124.23,297.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,132.24,63.51,224.93
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,66.01,60.73,72.83
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-29 years,Deaths,Rate,1.05,1.00,1.11
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,193.58,123.46,278.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,124.70,58.40,205.88
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,68.89,65.06,72.81
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-49 years,Deaths,Rate,2.23,2.09,2.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,231.80,165.86,316.94
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,114.41,55.79,192.11
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,117.38,110.07,124.83
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,30-34 years,Deaths,Rate,1.40,1.32,1.50
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,200.12,133.36,291.16
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,115.42,53.92,200.52
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,84.69,79.45,90.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,35-39 years,Deaths,Rate,1.89,1.77,2.02
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,216.18,155.91,296.06
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,111.32,57.70,184.02
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,104.86,98.21,112.04
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,40-44 years,Deaths,Rate,3.16,2.97,3.34
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,269.65,204.60,354.65
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,110.19,54.70,186.20
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,159.47,149.90,168.45
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,45-49 years,Deaths,Rate,4.01,3.74,4.28
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,292.09,224.22,376.78
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,109.50,53.84,182.10
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,182.60,170.38,194.67
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-54 years,Deaths,Rate,4.74,4.43,5.07
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,304.80,233.69,405.29
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,112.24,53.74,199.47
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,192.55,179.95,205.82
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-64 years,Deaths,Rate,5.06,4.72,5.42
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,308.17,232.02,420.45
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,125.43,61.78,225.06
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,182.74,170.25,195.39
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,55-59 years,Deaths,Rate,5.51,5.14,5.88
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,320.77,245.19,432.00
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,123.78,61.39,221.82
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,197.00,183.80,210.18
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,60-64 years,Deaths,Rate,4.95,4.58,5.31
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,297.46,214.14,426.25
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,144.46,72.63,262.03
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,153.00,141.50,164.22
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-69 years,Deaths,Rate,5.71,5.30,6.14
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,315.47,222.50,452.37
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,165.70,83.63,291.57
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,149.77,138.86,160.79
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-74 years,Deaths,Rate,6.00,5.52,6.47
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,317.17,221.04,456.17
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,172.10,87.33,299.73
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,145.08,133.72,156.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,70-74 years,Deaths,Rate,6.40,5.84,6.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,319.62,218.96,461.62
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,181.28,92.62,311.44
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,138.35,126.34,150.18
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75-79 years,Deaths,Rate,9.32,8.41,10.21
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,357.49,246.28,509.60
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,197.18,101.75,334.03
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,160.30,144.53,175.58
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75+ years,Deaths,Rate,13.84,11.96,15.27
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,376.34,252.12,538.48
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,211.95,108.03,357.42
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,164.39,144.09,181.06
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,80-84 years,Deaths,Rate,9.13,8.01,10.08
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,334.69,213.94,490.52
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,215.27,109.22,358.68
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,119.42,104.72,131.84
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,85+ years,Deaths,Rate,34.08,28.30,37.84
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,496.29,329.94,696.70
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,248.05,123.77,421.06
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,248.24,206.17,275.64
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,<1 year,Deaths,Rate,2.84,2.30,3.47
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,342.85,254.65,465.22
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,80.69,42.62,145.64
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,262.16,212.03,319.58
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,Age-standardized,Deaths,Rate,2.55,2.31,2.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,229.97,157.28,330.91
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,124.71,61.76,215.58
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,105.26,95.52,115.33
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,All ages,Deaths,Rate,2.71,2.47,2.93
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,235.40,162.59,336.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,125.17,61.92,216.30
BRA,Brazil,Southern Cone,Epilepsy,2021,Male,All ages,Years of Life Lost (YLLs),Rate,110.24,100.67,120.10
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-4 years,Deaths,Rate,0.94,0.76,1.14
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,168.14,115.14,241.65
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,83.07,46.34,137.96
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,85.07,68.80,103.70
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-14 years,Deaths,Rate,0.54,0.43,0.66
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,145.88,87.80,232.98
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,98.60,50.09,175.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,47.28,37.71,57.55
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-19 years,Deaths,Rate,0.54,0.45,0.64
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,147.55,88.90,236.11
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,102.21,51.48,182.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,45.34,37.42,53.73
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-24 years,Deaths,Rate,0.53,0.45,0.61
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,146.97,87.63,237.20
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,104.16,51.62,187.22
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,42.81,36.01,49.98
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-27 days,Deaths,Rate,0.30,0.25,0.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,87.90,52.64,147.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,59.57,29.60,112.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,28.34,23.04,35.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-4 years,Deaths,Rate,0.68,0.55,0.82
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,147.74,98.23,216.71
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,87.08,49.17,142.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,60.66,49.06,73.94
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-9 years,Deaths,Rate,0.48,0.37,0.60
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,138.17,83.56,217.10
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,95.57,50.74,164.11
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,42.60,32.82,52.99
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-11 months,Deaths,Rate,2.20,1.78,2.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,270.13,199.32,365.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,66.86,34.93,118.20
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,203.27,164.39,247.75
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,5-9 years,Deaths,Rate,0.33,0.24,0.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,130.72,72.15,217.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,102.17,51.95,180.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,28.55,20.20,36.71
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-14 years,Deaths,Rate,0.37,0.32,0.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,139.74,77.34,240.10
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,109.78,51.80,205.67
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,29.96,25.54,34.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-24 years,Deaths,Rate,0.46,0.42,0.51
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,145.70,84.26,241.97
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,111.00,53.08,203.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,34.70,31.18,38.19
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-19 years,Deaths,Rate,0.53,0.49,0.57
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,152.15,91.93,244.74
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,112.15,55.30,201.58
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,39.99,36.63,43.16
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-24 years,Deaths,Rate,0.51,0.46,0.55
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,148.41,87.41,242.81
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,111.56,53.66,202.91
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,36.85,33.74,39.91
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,20-24 years,Deaths,Rate,0.48,0.44,0.52
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,144.93,83.19,241.02
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,111.00,52.14,204.15
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,33.93,31.05,36.87
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-29 years,Deaths,Rate,0.59,0.55,0.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,141.28,83.89,217.18
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,102.97,48.28,176.03
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,38.31,35.60,41.15
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-49 years,Deaths,Rate,0.86,0.80,0.92
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,138.45,87.27,206.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,92.47,44.54,157.33
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,45.98,42.73,49.30
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,30-34 years,Deaths,Rate,0.53,0.50,0.57
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,125.93,73.35,198.43
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,93.68,43.33,163.97
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,32.25,30.02,34.47
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,35-39 years,Deaths,Rate,0.89,0.83,0.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,138.48,89.49,202.86
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,89.06,43.60,150.23
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,49.43,45.89,52.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,40-44 years,Deaths,Rate,1.04,0.97,1.12
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,141.05,93.31,207.57
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,88.41,44.20,151.24
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,52.64,49.10,56.34
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,45-49 years,Deaths,Rate,1.30,1.20,1.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,146.83,97.85,207.66
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,87.80,43.21,143.74
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,59.03,54.64,63.92
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-54 years,Deaths,Rate,1.53,1.42,1.65
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,152.12,99.88,225.83
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,89.96,42.19,158.96
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,62.15,57.69,66.87
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-64 years,Deaths,Rate,1.65,1.52,1.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,161.28,104.35,246.36
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,102.04,49.62,182.52
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,59.24,54.73,63.84
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,55-59 years,Deaths,Rate,1.80,1.67,1.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,164.77,108.55,250.31
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,100.33,49.01,180.76
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,64.44,59.55,69.54
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,60-64 years,Deaths,Rate,1.61,1.47,1.73
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,168.54,104.98,267.06
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,118.90,59.47,213.57
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,49.64,45.50,53.50
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-69 years,Deaths,Rate,2.73,2.49,2.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,210.11,137.73,320.18
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,138.65,72.52,242.80
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,71.46,65.21,77.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-74 years,Deaths,Rate,3.05,2.76,3.32
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,217.69,139.78,329.42
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,144.58,73.47,249.86
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,73.11,66.31,79.55
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,70-74 years,Deaths,Rate,3.48,3.14,3.81
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,227.89,142.55,341.86
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,152.57,74.76,259.38
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,75.32,67.79,82.48
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75-79 years,Deaths,Rate,5.63,4.89,6.21
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,262.44,169.53,391.44
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,165.60,85.46,284.60
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,96.85,84.07,106.84
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75+ years,Deaths,Rate,9.16,7.39,10.40
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,286.09,180.05,424.48
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,178.63,91.51,303.46
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,107.46,88.54,121.02
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,80-84 years,Deaths,Rate,8.08,6.67,9.11
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,284.74,180.24,416.00
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,179.01,93.02,296.80
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,105.72,87.22,119.20
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,85+ years,Deaths,Rate,18.19,13.71,21.12
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,338.50,202.27,506.75
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,205.97,102.36,352.91
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,132.53,99.91,153.84
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,<1 year,Deaths,Rate,2.04,1.65,2.48
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,253.99,186.33,346.63
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,66.21,34.45,117.69
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,187.78,151.88,228.95
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,Age-standardized,Deaths,Rate,1.18,1.04,1.31
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,153.79,95.34,237.90
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,103.81,51.10,182.12
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,49.99,44.25,55.77
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,All ages,Deaths,Rate,1.36,1.20,1.51
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,156.67,97.64,241.17
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,105.21,51.74,184.20
BRA,Brazil,Southern Cone,Epilepsy,2021,Female,All ages,Years of Life Lost (YLLs),Rate,51.47,45.89,56.97
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.07
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.07
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.12,0.05,0.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.12,0.05,0.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.15,0.48
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.28,0.15,0.48
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.03,0.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.03,0.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.23,0.77
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.45,0.23,0.77
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.35,0.17,0.61
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.35,0.17,0.61
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.32,1.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.62,0.32,1.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.47,1.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.87,0.47,1.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.55,3.54,5.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.74,0.97,2.73
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,2.81,2.57,3.08
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.17,6.81,12.23
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,5.09,3.13,7.70
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.08,3.68,4.53
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Deaths,Rate,0.03,0.03,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,4.97,3.54,7.05
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.13,1.87,5.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.84,1.67,2.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Deaths,Rate,0.03,0.03,0.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,6.87,4.70,9.60
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,5.02,3.02,7.56
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.85,1.68,2.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Deaths,Rate,0.12,0.11,0.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.15,9.85,17.43
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.15,4.44,10.78
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.00,5.40,6.65
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Deaths,Rate,0.20,0.18,0.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,18.41,14.08,23.91
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,9.38,5.99,13.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,9.03,8.09,10.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Deaths,Rate,0.16,0.14,0.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,17.89,13.31,23.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,11.59,7.70,16.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,6.31,5.61,7.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Deaths,Rate,0.27,0.24,0.30
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,21.71,16.59,27.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,12.35,8.21,17.39
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.36,8.38,10.41
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Deaths,Rate,0.27,0.24,0.30
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,22.33,17.13,28.47
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,12.78,8.58,17.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,9.55,8.55,10.62
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Deaths,Rate,0.43,0.38,0.47
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.02,20.27,32.67
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,12.84,8.44,18.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,13.18,11.82,14.62
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Deaths,Rate,0.53,0.47,0.59
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,26.54,20.68,33.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,12.66,8.25,18.14
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,13.87,12.43,15.54
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Deaths,Rate,0.50,0.45,0.56
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,24.70,19.16,31.51
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,12.48,8.23,17.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,12.22,10.93,13.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Deaths,Rate,0.45,0.40,0.51
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,22.02,16.95,28.38
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.21,8.20,17.30
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,9.81,8.75,11.08
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Deaths,Rate,0.55,0.49,0.62
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,20.84,15.92,26.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,11.31,7.51,16.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,9.53,8.41,10.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Deaths,Rate,0.51,0.45,0.57
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,18.29,13.74,23.66
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.44,6.86,14.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,7.85,6.89,8.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Deaths,Rate,0.75,0.65,0.84
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,19.83,15.05,25.14
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.04,6.56,14.21
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,9.79,8.49,10.93
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,8.63,5.47,12.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.63,5.47,12.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Deaths,Rate,0.11,0.09,0.12
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.09,6.09,10.57
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,4.53,2.90,6.61
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.56,3.19,3.96
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,All ages,Deaths,Rate,0.12,0.10,0.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,8.96,6.75,11.70
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,5.01,3.21,7.30
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years of Life Lost (YLLs),Rate,3.96,3.54,4.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.44,0.36,0.54
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.06,0.02,0.11
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.38,0.34,0.43
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.49,0.35,0.67
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.20,0.10,0.35
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.28,0.25,0.32
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Deaths,Rate,0.01,0.00,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.92,0.64,1.29
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.28,0.84
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.40,0.36,0.45
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Deaths,Rate,0.01,0.01,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,1.28,1.05,1.54
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.15,0.06,0.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,1.12,0.98,1.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.47,1.02,2.05
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.82,0.44,1.34
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.65,0.58,0.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.60,0.31,1.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.60,0.31,1.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.55,1.01,2.29
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,1.13,0.61,1.82
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.43,0.40,0.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.45,1.66,3.48
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.61,0.89,2.58
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.83,0.77,0.90
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.90,3.35,6.86
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.29,1.90,5.06
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.61,1.44,1.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Deaths,Rate,0.11,0.10,0.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.25,10.47,18.97
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.49,5.27,12.61
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,5.76,5.20,6.36
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Deaths,Rate,0.05,0.04,0.05
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,8.52,6.03,11.84
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.75,3.50,8.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,2.77,2.53,3.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Deaths,Rate,0.11,0.10,0.12
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,14.62,10.70,19.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.66,5.37,13.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,5.96,5.33,6.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Deaths,Rate,0.09,0.08,0.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.03,11.14,21.79
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,11.42,6.98,16.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,4.60,4.15,5.07
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Deaths,Rate,0.33,0.30,0.37
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,29.51,23.02,37.34
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,14.31,9.25,20.65
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,15.20,13.77,16.69
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Deaths,Rate,0.24,0.22,0.26
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,26.51,19.76,34.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.77,10.98,23.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,9.74,8.78,10.73
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Deaths,Rate,0.44,0.39,0.48
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,32.86,25.45,41.38
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,17.60,11.75,24.47
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,15.26,13.70,16.91
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Deaths,Rate,0.57,0.51,0.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,38.38,30.37,47.38
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,18.12,12.11,24.99
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,20.26,18.26,22.39
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Deaths,Rate,0.53,0.47,0.59
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.34,26.80,43.34
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,18.02,12.28,25.12
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,16.32,14.52,18.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Deaths,Rate,0.38,0.33,0.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,27.69,20.55,36.31
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,17.66,11.82,24.90
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,10.03,8.73,11.41
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Deaths,Rate,0.47,0.41,0.53
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.66,21.64,37.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,17.40,11.80,24.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,11.25,9.83,12.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Deaths,Rate,0.60,0.52,0.67
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,29.99,23.13,38.34
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,17.05,11.78,23.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,12.94,11.34,14.50
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Deaths,Rate,0.82,0.71,0.92
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,30.08,22.50,38.45
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,15.97,10.37,22.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,14.11,12.12,15.83
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Deaths,Rate,0.88,0.72,1.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,26.20,19.20,33.95
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.69,9.63,20.86
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,11.52,9.56,13.09
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Deaths,Rate,0.72,0.59,0.82
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,23.82,17.35,31.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.40,9.59,20.43
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,9.41,7.76,10.75
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Deaths,Rate,1.22,0.91,1.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,21.32,14.78,28.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,12.39,8.15,17.76
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,8.93,6.63,10.51
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Deaths,Rate,0.15,0.13,0.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.02,9.02,15.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.88,4.43,9.92
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,5.14,4.59,5.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,All ages,Deaths,Rate,0.18,0.16,0.21
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,14.07,10.58,18.26
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,8.03,5.19,11.54
BRA,Brazil,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years of Life Lost (YLLs),Rate,6.04,5.38,6.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.07
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.07
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.12,0.06,0.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.12,0.06,0.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.29,0.15,0.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.29,0.15,0.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.24,0.78
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.24,0.78
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.36,0.17,0.62
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.36,0.17,0.62
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.33,1.06
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.63,0.33,1.06
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.88,0.48,1.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.88,0.48,1.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,2.42,1.58,3.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.75,0.97,2.76
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.67,0.61,0.74
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.07,6.63,12.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,5.16,3.15,7.74
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.91,3.48,4.37
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,4.34,2.93,6.36
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,3.16,1.88,5.05
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.18,1.05,1.31
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Deaths,Rate,0.10,0.09,0.11
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.66,8.01,14.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,5.08,3.01,7.83
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,5.57,4.99,6.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Deaths,Rate,0.12,0.11,0.14
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.32,9.90,17.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,7.19,4.44,10.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,6.13,5.45,6.83
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,15.97,11.73,21.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,9.43,5.98,13.77
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.54,5.75,7.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Deaths,Rate,0.26,0.23,0.30
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,22.43,17.01,28.67
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,11.70,7.54,16.53
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,10.73,9.47,12.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Deaths,Rate,0.32,0.28,0.36
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,23.84,18.29,30.34
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,12.42,8.20,17.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,11.42,10.09,12.94
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Deaths,Rate,0.31,0.28,0.36
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,24.03,18.52,30.23
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,12.83,8.65,17.52
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,11.20,9.87,12.70
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Deaths,Rate,0.41,0.36,0.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,25.44,19.66,32.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,12.87,8.51,18.38
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,12.57,11.16,14.25
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Deaths,Rate,0.36,0.32,0.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,21.98,16.65,27.93
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,12.58,8.35,17.33
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,9.40,8.30,10.60
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Deaths,Rate,0.46,0.40,0.52
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.32,17.91,29.50
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,12.44,8.33,17.17
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,10.88,9.58,12.33
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Deaths,Rate,0.60,0.53,0.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,25.23,19.73,31.76
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.25,8.30,16.95
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,12.99,11.43,14.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Deaths,Rate,0.61,0.53,0.69
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,21.81,16.58,28.20
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,11.36,7.48,16.31
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,10.45,9.10,11.89
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Deaths,Rate,0.75,0.63,0.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,20.11,15.09,25.84
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,10.50,6.85,14.93
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,9.61,8.23,10.90
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Deaths,Rate,0.60,0.52,0.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,17.98,13.42,23.08
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,10.13,6.65,14.20
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,7.85,6.77,8.88
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Deaths,Rate,1.38,1.12,1.56
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,18.74,13.59,23.64
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,8.66,5.43,12.24
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,10.08,8.16,11.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Deaths,Rate,0.12,0.10,0.13
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.30,6.21,10.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,4.55,2.90,6.58
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.75,3.31,4.23
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,All ages,Deaths,Rate,0.13,0.11,0.15
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.34,7.00,12.14
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,5.10,3.26,7.37
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years of Life Lost (YLLs),Rate,4.24,3.75,4.78
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.06,0.02,0.11
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.06,0.02,0.11
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.31,0.64
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.20,0.10,0.35
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.25,0.21,0.29
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.09,0.78,1.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.52,0.28,0.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.57,0.51,0.64
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.06,0.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.15,0.06,0.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.74,1.25,2.37
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.83,0.44,1.35
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.91,0.81,1.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.54,1.11,2.11
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.61,0.31,1.01
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.93,0.80,1.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.46,1.80,3.33
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,1.13,0.61,1.84
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,1.32,1.18,1.49
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.32,2.44,4.47
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.62,0.89,2.61
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,1.69,1.54,1.86
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.89,3.30,6.85
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.29,1.89,5.04
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,1.59,1.41,1.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Deaths,Rate,0.09,0.08,0.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.24,9.62,17.81
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,8.51,5.39,12.50
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,4.74,4.22,5.31
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Deaths,Rate,0.02,0.02,0.03
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.21,4.85,10.35
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.75,3.53,8.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.46,1.32,1.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Deaths,Rate,0.08,0.07,0.09
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,13.29,9.50,18.12
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,8.69,5.43,12.90
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,4.61,4.07,5.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Deaths,Rate,0.16,0.15,0.18
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,19.62,14.68,25.91
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,11.39,7.34,16.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,8.23,7.34,9.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Deaths,Rate,0.18,0.16,0.20
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.52,16.78,29.43
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,14.19,9.31,20.14
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,8.33,7.48,9.29
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Deaths,Rate,0.31,0.28,0.35
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,29.38,22.57,37.22
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.72,11.23,23.12
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,12.67,11.33,14.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Deaths,Rate,0.35,0.31,0.40
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,30.19,23.04,38.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,17.55,11.81,24.26
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,12.64,11.23,14.19
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Deaths,Rate,0.37,0.33,0.41
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,31.12,23.48,39.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,18.04,11.87,24.94
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,13.08,11.62,14.74
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Deaths,Rate,0.39,0.34,0.44
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,30.10,23.11,38.55
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,18.01,12.45,24.87
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,12.09,10.66,13.68
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Deaths,Rate,0.69,0.59,0.79
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,35.61,27.22,44.74
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,17.61,11.78,23.94
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,18.00,15.44,20.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Deaths,Rate,0.66,0.57,0.76
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,33.54,25.73,42.41
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,17.41,11.81,23.88
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.13,13.92,18.52
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Deaths,Rate,0.63,0.55,0.71
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,30.75,23.72,39.26
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,17.14,11.86,23.80
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.61,11.86,15.46
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Deaths,Rate,0.85,0.71,0.97
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,30.44,23.21,38.70
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,15.89,10.95,22.10
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,14.55,12.26,16.60
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Deaths,Rate,0.92,0.73,1.06
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,26.26,19.36,33.72
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,14.65,9.92,20.32
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,11.61,9.43,13.39
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Deaths,Rate,0.54,0.44,0.63
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,21.51,15.28,27.98
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,14.40,9.55,19.77
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,7.11,5.73,8.21
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Deaths,Rate,1.58,1.16,1.87
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,23.83,16.70,30.92
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,12.33,8.23,17.27
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,11.51,8.46,13.64
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Deaths,Rate,0.14,0.13,0.16
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,11.61,8.66,15.15
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.86,4.48,9.79
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.75,4.18,5.36
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,All ages,Deaths,Rate,0.18,0.16,0.20
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,13.79,10.30,17.94
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.11,5.32,11.53
BRA,Brazil,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years of Life Lost (YLLs),Rate,5.67,4.98,6.41
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-4 years,Deaths,Rate,2.14,1.61,2.77
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,314.38,216.05,445.13
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,119.60,70.16,192.66
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,194.79,145.89,252.47
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-14 years,Deaths,Rate,2.40,1.88,2.92
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,666.30,243.90,"1,370.51"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,462.20,84.60,"1,121.79"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,204.10,159.30,248.72
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-19 years,Deaths,Rate,2.73,2.27,3.20
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,835.65,281.57,"1,757.17"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,613.19,97.88,"1,495.07"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,222.46,183.69,262.10
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-24 years,Deaths,Rate,3.03,2.61,3.47
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,924.93,309.12,"1,952.27"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,687.81,106.59,"1,679.20"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,237.12,202.53,273.07
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-27 days,Deaths,Rate,0.49,0.39,0.61
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,167.29,99.52,267.34
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,121.80,63.52,210.92
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,45.49,36.00,56.42
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-4 years,Deaths,Rate,1.38,1.04,1.78
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,247.57,166.07,357.21
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,123.33,73.19,197.07
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,124.24,92.88,160.14
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-9 years,Deaths,Rate,1.85,1.35,2.34
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,398.58,196.11,701.28
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,237.85,78.65,498.48
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,160.73,117.46,202.80
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-11 months,Deaths,Rate,5.77,4.33,7.52
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,634.18,455.89,864.41
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,102.32,56.99,170.73
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,531.86,398.90,693.68
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,5-9 years,Deaths,Rate,2.22,1.60,2.77
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,517.34,219.74,971.87
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,327.91,82.95,735.52
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,189.43,136.79,236.35
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-14 years,Deaths,Rate,2.83,2.42,3.20
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,146.20",293.94,"2,639.18"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,918.95,99.94,"2,381.98"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,227.25,194.00,257.20
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-24 years,Deaths,Rate,3.55,3.22,3.90
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,232.77",364.41,"2,704.28"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,968.34,124.75,"2,413.78"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,264.43,239.66,290.51
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-19 years,Deaths,Rate,3.63,3.33,3.97
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,302.63",385.45,"2,823.42"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"1,029.54",134.52,"2,524.42"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,273.09,250.93,299.00
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-24 years,Deaths,Rate,3.88,3.59,4.21
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,272.53",396.78,"2,734.19"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,991.03,136.15,"2,428.38"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,281.51,260.63,305.80
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,20-24 years,Deaths,Rate,4.12,3.84,4.44
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,243.92",407.56,"2,649.34"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,954.41,137.70,"2,337.07"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,289.51,269.86,312.28
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-29 years,Deaths,Rate,3.35,3.17,3.54
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,093.65",342.96,"2,275.25"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,874.78,136.13,"2,044.11"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,218.87,206.83,231.14
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-49 years,Deaths,Rate,5.90,5.48,6.54
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,138.41",459.11,"2,242.38"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,827.20,169.50,"1,899.26"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,311.21,289.60,343.12
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,30-34 years,Deaths,Rate,3.43,3.24,3.65
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,035.96",335.23,"2,173.31"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,828.91,139.81,"1,953.01"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,207.05,195.42,220.30
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,35-39 years,Deaths,Rate,5.01,4.75,5.30
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,090.35",435.26,"2,147.49"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,812.65,172.44,"1,853.77"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,277.70,262.83,293.72
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,40-44 years,Deaths,Rate,7.72,7.25,8.32
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,203.86",559.87,"2,301.78"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,814.76,194.25,"1,882.40"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,389.09,365.62,419.39
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,45-49 years,Deaths,Rate,11.15,10.01,13.37
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,306.67",670.82,"2,339.61"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,799.32,215.53,"1,731.35"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,507.35,455.29,608.27
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-54 years,Deaths,Rate,13.86,10.98,20.98
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,347.88",688.97,"2,506.31"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,785.03,243.17,"1,654.31"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,562.85,445.80,852.00
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-64 years,Deaths,Rate,19.89,12.54,37.80
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,525.13",748.35,"2,978.17"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,827.77,300.19,"1,672.16"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,697.36,448.15,"1,306.01"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,55-59 years,Deaths,Rate,19.47,12.53,36.99
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,510.19",739.34,"2,976.19"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,814.30,291.66,"1,653.99"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,695.89,447.68,"1,322.20"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,60-64 years,Deaths,Rate,28.36,14.61,60.99
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,777.45",837.73,"3,603.92"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,900.61,385.89,"1,717.79"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,876.84,451.84,"1,886.13"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-69 years,Deaths,Rate,44.48,21.62,100.72
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,235.78","1,090.44","4,594.40"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,070.00",523.79,"1,954.78"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,"1,165.78",566.65,"2,639.62"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-74 years,Deaths,Rate,62.89,30.85,140.16
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,691.36","1,350.26","5,443.97"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,210.64",624.48,"2,139.90"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,"1,480.72",725.78,"3,304.07"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,70-74 years,Deaths,Rate,89.64,44.26,197.44
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,353.11","1,727.67","6,678.01"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,414.91",770.75,"2,408.79"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,938.19",956.92,"4,269.21"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75-79 years,Deaths,Rate,189.86,93.40,426.86
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,300.02","2,831.48","10,551.14"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"2,035.47","1,225.43","3,211.39"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"3,264.55","1,606.04","7,339.75"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75+ years,Deaths,Rate,566.11,219.56,"1,324.64"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,689.19","4,147.99","17,826.97"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,812.19","1,742.14","4,250.19"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"5,877.01","2,405.85","13,576.78"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,80-84 years,Deaths,Rate,452.23,189.67,"1,008.41"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"9,023.52","4,385.49","17,821.89"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"3,108.01","1,904.46","4,631.27"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"5,915.51","2,481.03","13,190.62"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,85+ years,Deaths,Rate,"1,813.48",624.54,"4,372.26"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,747.94","7,494.54","38,431.25"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,537.32","2,944.98","6,580.75"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"13,210.62","4,549.57","31,850.50"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,<1 year,Deaths,Rate,5.29,3.99,6.88
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,592.16,423.81,810.67
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,104.07,57.58,174.35
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,488.08,366.23,636.32
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Deaths,Rate,27.83,13.43,59.59
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,408.13",593.50,"2,853.40"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,839.69,232.11,"1,834.85"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,568.44,361.38,"1,018.56"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,All ages,Deaths,Rate,26.36,13.11,55.78
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,424.62",605.14,"2,879.45"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,853.94,237.58,"1,862.36"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Male,All ages,Years of Life Lost (YLLs),Rate,570.68,367.55,"1,017.10"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-4 years,Deaths,Rate,1.61,1.22,2.07
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,243.69,167.07,345.18
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,96.97,56.05,156.57
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,146.73,111.01,188.61
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-14 years,Deaths,Rate,1.78,1.45,2.17
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,837.00,197.14,"1,870.66"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,685.86,75.08,"1,685.83"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,151.14,122.06,184.83
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-19 years,Deaths,Rate,1.96,1.66,2.30
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,083.36",229.81,"2,451.70"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,923.64,95.50,"2,263.35"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,159.72,134.31,188.35
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-24 years,Deaths,Rate,2.08,1.80,2.39
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,198.70",250.52,"2,717.63"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"1,035.44",109.89,"2,528.75"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,163.25,140.63,188.89
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-27 days,Deaths,Rate,0.50,0.40,0.62
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,140.53,85.21,224.23
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,94.54,48.65,167.17
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,45.98,36.55,57.07
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-4 years,Deaths,Rate,1.05,0.80,1.34
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,195.10,130.94,281.73
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,100.74,58.77,161.11
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,94.36,72.17,120.63
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-9 years,Deaths,Rate,1.26,0.95,1.61
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,410.85,147.95,830.30
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,301.34,65.03,690.67
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,109.51,82.91,139.63
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-11 months,Deaths,Rate,4.29,3.20,5.55
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,475.47,339.85,646.48
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,79.98,44.36,134.83
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,395.49,295.49,511.65
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,5-9 years,Deaths,Rate,1.42,1.07,1.81
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,580.42,161.31,"1,261.45"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,459.00,69.96,"1,106.89"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,121.42,91.35,154.57
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-14 years,Deaths,Rate,2.30,2.02,2.63
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,650.15",260.58,"3,912.22"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,465.89",98.12,"3,701.51"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,184.26,162.46,210.71
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-24 years,Deaths,Rate,2.41,2.20,2.66
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,670.13",302.43,"3,864.53"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"1,489.25",138.02,"3,665.12"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,180.88,164.41,199.41
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-19 years,Deaths,Rate,2.43,2.23,2.63
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,759.11",319.42,"4,045.46"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"1,575.86",151.51,"3,847.48"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,183.25,167.91,197.98
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-24 years,Deaths,Rate,2.47,2.28,2.67
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,679.22",321.45,"3,842.85"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,499.87",156.15,"3,648.58"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,179.35,165.30,194.28
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,20-24 years,Deaths,Rate,2.50,2.32,2.71
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,604.18",323.35,"3,652.55"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,428.49",160.51,"3,461.76"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,175.68,162.84,190.80
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-29 years,Deaths,Rate,2.20,2.06,2.36
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,464.71",287.03,"3,307.53"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,320.99",152.63,"3,153.28"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,143.71,134.41,154.25
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-49 years,Deaths,Rate,3.25,2.94,3.88
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,490.83",370.97,"3,203.10"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,317.27",213.40,"2,998.62"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,173.57,157.56,204.49
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,30-34 years,Deaths,Rate,2.13,2.00,2.32
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,427.00",294.87,"3,149.62"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,298.30",174.23,"3,009.75"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,128.70,120.64,139.87
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,35-39 years,Deaths,Rate,2.95,2.75,3.26
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,482.16",368.00,"3,161.26"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,318.62",215.57,"2,980.77"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,163.54,152.43,180.48
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,40-44 years,Deaths,Rate,3.82,3.53,4.38
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,542.47",429.91,"3,226.95"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,349.69",251.88,"3,006.20"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,192.79,178.02,220.75
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,45-49 years,Deaths,Rate,5.55,4.66,7.71
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,550.17",496.80,"3,170.43"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,297.62",284.89,"2,819.36"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,252.55,211.91,351.07
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-54 years,Deaths,Rate,6.41,4.29,12.22
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,496.06",482.05,"3,115.97"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,235.60",307.95,"2,619.58"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,260.46,174.09,496.39
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-64 years,Deaths,Rate,10.49,5.21,23.83
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,595.51",556.45,"3,378.51"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,230.03",371.03,"2,556.35"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,365.48,185.42,822.15
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,55-59 years,Deaths,Rate,11.08,5.54,25.46
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,602.10",557.52,"3,447.05"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,206.04",359.47,"2,537.06"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,396.06,198.04,909.99
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,60-64 years,Deaths,Rate,14.92,5.98,36.49
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,712.79",648.75,"3,627.87"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,251.30",463.95,"2,499.58"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,461.49,184.80,"1,128.29"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-69 years,Deaths,Rate,26.28,10.07,66.03
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,077.80",890.99,"4,350.76"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,389.17",626.96,"2,620.28"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,688.63,264.02,"1,730.48"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-74 years,Deaths,Rate,40.62,15.96,99.54
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,479.11","1,113.03","5,133.29"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,531.03",741.10,"2,805.83"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,948.08,371.93,"2,327.46"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,70-74 years,Deaths,Rate,60.32,24.05,145.54
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,030.01","1,417.83","6,207.50"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,725.76",897.78,"3,060.55"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,304.25",520.06,"3,146.95"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75-79 years,Deaths,Rate,142.41,54.35,348.31
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"4,820.48","2,315.38","9,766.57"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,371.80","1,380.92","3,777.40"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,448.68",934.46,"5,989.17"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75+ years,Deaths,Rate,584.15,188.31,"1,389.26"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,005.65","3,942.58","18,490.14"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,434.77","2,094.36","5,219.29"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"5,570.88","1,848.22","13,270.85"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,80-84 years,Deaths,Rate,369.04,126.35,864.63
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,392.82","3,819.47","16,761.88"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,565.50","2,166.73","5,451.99"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"4,827.32","1,652.74","11,309.89"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,85+ years,Deaths,Rate,"1,801.11",552.91,"4,280.94"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"18,605.87","7,519.26","39,111.23"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,485.39","3,491.49","7,925.92"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"13,120.48","4,027.77","31,185.30"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,<1 year,Deaths,Rate,3.95,2.97,5.10
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,445.78,317.28,609.05
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,81.27,44.74,137.70
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,364.51,272.54,471.36
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Deaths,Rate,22.48,8.80,51.04
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,633.45",485.34,"3,524.91"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,240.53",271.43,"2,750.14"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,392.92,213.91,774.77
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,All ages,Deaths,Rate,29.66,11.16,68.19
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,770.30",550.70,"3,798.35"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,302.31",312.93,"2,836.11"
BRA,Brazil,Southern Cone,Neurological conditions,2020,Female,All ages,Years of Life Lost (YLLs),Rate,467.99,237.77,962.24
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-4 years,Deaths,Rate,2.09,1.54,2.75
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,306.49,203.45,443.15
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,116.33,63.85,192.91
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,190.17,139.61,250.24
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-14 years,Deaths,Rate,2.33,1.78,2.86
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,662.54,232.51,"1,379.16"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,464.36,81.86,"1,134.68"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,198.18,150.65,244.47
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-19 years,Deaths,Rate,2.86,2.37,3.36
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,847.58,284.95,"1,785.09"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,615.34,94.26,"1,510.97"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,232.24,190.69,274.12
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-24 years,Deaths,Rate,3.09,2.64,3.56
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,932.34,307.23,"1,971.26"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,690.78,102.51,"1,691.72"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,241.56,204.72,279.54
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-27 days,Deaths,Rate,0.48,0.38,0.61
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,162.35,95.38,272.54
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,117.32,60.16,215.87
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,45.03,35.21,56.67
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-4 years,Deaths,Rate,1.37,0.99,1.81
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,243.32,155.44,357.90
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,120.14,66.43,195.74
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,123.17,89.01,162.16
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-9 years,Deaths,Rate,1.95,1.38,2.48
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,407.72,196.01,734.06
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,238.50,76.17,518.69
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,169.22,119.84,215.37
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-11 months,Deaths,Rate,5.58,4.16,7.34
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,612.78,436.10,854.15
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,98.58,52.26,177.58
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,514.20,383.84,676.57
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,5-9 years,Deaths,Rate,2.41,1.69,3.01
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,535.59,227.57,"1,026.63"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,330.55,83.75,769.87
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,205.04,143.82,256.76
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-14 years,Deaths,Rate,2.48,2.09,2.83
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,124.36",264.86,"2,611.66"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,925.34,97.04,"2,384.72"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,199.02,167.82,226.94
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-24 years,Deaths,Rate,3.60,3.27,3.96
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,241.51",362.80,"2,718.69"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,973.34,119.83,"2,423.37"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,268.17,242.96,295.32
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-19 years,Deaths,Rate,4.34,4.01,4.73
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,360.55",430.34,"2,910.47"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"1,033.90",128.65,"2,554.15"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,326.65,301.69,356.32
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-24 years,Deaths,Rate,4.12,3.81,4.49
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,295.30",407.77,"2,767.83"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,995.39,130.30,"2,441.11"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,299.92,277.47,326.72
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,20-24 years,Deaths,Rate,3.91,3.62,4.25
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,233.79",386.49,"2,633.36"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,959.08,131.85,"2,334.55"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,274.71,254.63,298.81
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-29 years,Deaths,Rate,3.80,3.58,4.04
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,127.94",360.02,"2,397.51"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,879.64,126.05,"2,133.70"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,248.30,233.97,263.81
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-49 years,Deaths,Rate,6.01,5.51,6.71
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,152.61",457.28,"2,294.44"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,834.63,164.69,"1,940.97"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,317.98,292.59,353.47
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,30-34 years,Deaths,Rate,3.46,3.23,3.72
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,042.80",330.60,"2,230.76"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,834.05,135.48,"2,006.34"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,208.75,195.12,224.42
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,35-39 years,Deaths,Rate,4.98,4.65,5.36
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,096.01",429.37,"2,174.39"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,819.98,171.77,"1,877.70"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,276.03,257.60,296.69
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,40-44 years,Deaths,Rate,8.01,7.42,8.74
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,228.04",562.62,"2,346.27"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,823.94,188.61,"1,905.29"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,404.10,374.01,440.98
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,45-49 years,Deaths,Rate,10.71,9.48,12.91
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,299.07",641.81,"2,336.93"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,811.61,210.46,"1,749.29"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,487.46,431.35,587.63
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-54 years,Deaths,Rate,15.54,12.15,23.56
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,432.58",735.16,"2,636.78"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,801.41,241.82,"1,680.22"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,631.17,493.34,956.56
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-64 years,Deaths,Rate,21.15,13.20,40.21
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,586.13",771.58,"3,097.72"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,842.36,298.23,"1,704.28"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,743.77,473.36,"1,393.44"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,55-59 years,Deaths,Rate,20.59,13.07,39.59
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,563.82",756.60,"3,094.51"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,827.92,289.47,"1,679.65"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,735.89,467.14,"1,414.86"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,60-64 years,Deaths,Rate,29.07,14.71,62.51
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,811.40",836.59,"3,697.73"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,912.58,381.66,"1,764.84"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,898.82,454.94,"1,932.89"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-69 years,Deaths,Rate,50.09,23.67,114.75
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,399.24","1,149.35","4,975.34"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,"1,086.39",528.91,"1,968.00"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,"1,312.85",620.44,"3,007.34"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-74 years,Deaths,Rate,67.28,32.18,151.48
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,823.00","1,392.54","5,770.80"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,232.90",632.70,"2,185.26"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,"1,590.10",759.84,"3,585.54"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,70-74 years,Deaths,Rate,91.93,44.39,204.18
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,430.87","1,741.37","6,911.86"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,443.06",781.57,"2,496.91"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,987.81",959.80,"4,414.95"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75-79 years,Deaths,Rate,203.30,97.68,453.10
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,563.65","2,914.11","11,048.34"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"2,068.01","1,234.52","3,257.39"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"3,495.64","1,679.59","7,790.95"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75+ years,Deaths,Rate,586.65,223.33,"1,377.31"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,934.07","4,201.49","18,393.69"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,853.78","1,757.43","4,322.13"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"6,080.29","2,444.06","14,071.55"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,80-84 years,Deaths,Rate,442.86,183.23,993.77
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,942.77","4,322.09","17,744.89"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"3,149.89","1,925.39","4,745.78"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"5,792.87","2,396.70","12,999.10"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,85+ years,Deaths,Rate,"1,894.24",640.59,"4,588.99"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"18,382.38","7,621.76","40,059.15"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,583.42","2,955.29","6,629.82"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"13,798.96","4,666.47","33,429.34"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,<1 year,Deaths,Rate,5.12,3.84,6.71
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,572.29,405.47,801.87
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,100.26,52.97,181.03
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,472.03,352.50,620.85
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Deaths,Rate,28.90,13.72,62.19
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,438.09",598.39,"2,929.93"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,847.80,229.00,"1,864.56"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,590.29,369.40,"1,065.37"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,All ages,Deaths,Rate,28.10,13.68,59.90
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,468.52",617.57,"2,983.33"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,865.85,237.60,"1,896.01"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Male,All ages,Years of Life Lost (YLLs),Rate,602.67,379.97,"1,087.32"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-4 years,Deaths,Rate,1.55,1.18,2.00
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,239.68,162.04,346.97
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,99.03,55.26,164.50
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,140.65,106.78,182.47
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-14 years,Deaths,Rate,1.89,1.50,2.30
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,839.69,203.97,"1,917.76"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,679.63,76.90,"1,722.33"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,160.06,127.07,195.43
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-19 years,Deaths,Rate,2.01,1.67,2.36
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,079.38",232.31,"2,485.99"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,915.18,96.27,"2,292.01"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,164.20,136.04,193.97
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-24 years,Deaths,Rate,2.09,1.77,2.41
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,192.93",248.53,"2,748.82"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,"1,028.31",109.44,"2,557.73"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,164.62,139.09,191.09
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-27 days,Deaths,Rate,0.49,0.38,0.62
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,140.30,82.61,236.10
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,94.86,47.09,178.95
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,45.44,35.52,57.16
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-4 years,Deaths,Rate,1.01,0.77,1.30
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,193.81,127.70,285.58
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,103.02,58.23,168.80
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,90.78,69.47,116.78
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-9 years,Deaths,Rate,1.50,1.12,1.89
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,431.74,164.23,867.85
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,302.02,67.34,704.00
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,129.72,96.89,163.85
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-11 months,Deaths,Rate,4.12,3.10,5.40
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,461.19,328.33,641.23
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,81.01,42.36,143.21
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,380.18,285.97,498.03
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,5-9 years,Deaths,Rate,1.88,1.39,2.35
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,616.71,192.63,"1,320.51"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,456.73,74.43,"1,120.06"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,159.98,118.21,200.45
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-14 years,Deaths,Rate,2.22,1.93,2.53
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,625.80",254.73,"3,988.99"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,447.32",99.78,"3,786.24"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,178.48,154.94,202.75
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-24 years,Deaths,Rate,2.31,2.07,2.54
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,651.39",291.24,"3,896.76"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"1,478.27",136.20,"3,706.00"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,173.12,155.04,190.76
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-19 years,Deaths,Rate,2.33,2.14,2.52
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,740.77",310.53,"4,053.98"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"1,565.15",149.73,"3,864.05"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,175.62,160.80,189.94
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-24 years,Deaths,Rate,2.35,2.13,2.55
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,663.03",307.84,"3,854.83"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,492.34",152.76,"3,669.52"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,170.69,155.09,185.31
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,20-24 years,Deaths,Rate,2.36,2.13,2.58
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,590.61",305.34,"3,669.31"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,424.52",155.58,"3,488.31"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,166.09,149.76,181.00
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-29 years,Deaths,Rate,2.24,2.04,2.43
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,466.60",284.45,"3,289.33"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,320.15",151.04,"3,130.69"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,146.45,133.41,158.64
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-49 years,Deaths,Rate,3.40,2.98,3.99
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,507.19",372.21,"3,226.14"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,326.35",212.70,"3,016.08"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,180.84,159.51,210.06
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,30-34 years,Deaths,Rate,2.21,2.01,2.39
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,439.21",293.74,"3,148.06"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,305.92",172.54,"3,003.72"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,133.29,121.20,144.35
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,35-39 years,Deaths,Rate,3.15,2.85,3.42
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,503.67",375.79,"3,208.11"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,329.18",218.06,"3,018.69"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,174.49,157.73,189.43
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,40-44 years,Deaths,Rate,4.00,3.58,4.49
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,563.84",432.37,"3,330.82"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,362.35",251.97,"3,104.27"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,201.49,180.40,226.56
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,45-49 years,Deaths,Rate,5.70,4.67,7.71
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,572.88",491.18,"3,148.98"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,313.28",278.86,"2,797.95"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,259.60,212.33,351.03
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-54 years,Deaths,Rate,7.72,5.07,14.49
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,569.63",513.81,"3,243.57"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,256.02",307.81,"2,655.00"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,313.62,206.00,588.57
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-64 years,Deaths,Rate,11.05,5.47,24.99
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,637.66",568.61,"3,438.39"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,251.55",372.96,"2,574.32"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,386.12,195.64,864.06
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,55-59 years,Deaths,Rate,10.56,5.25,24.39
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,603.92",554.67,"3,430.33"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,226.53",367.06,"2,558.70"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,377.39,187.60,871.63
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,60-64 years,Deaths,Rate,15.70,6.22,38.63
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,760.61",652.28,"3,687.66"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,275.07",460.06,"2,493.09"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,485.54,192.22,"1,194.58"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-69 years,Deaths,Rate,29.27,11.04,73.04
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,198.55",932.72,"4,604.72"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,431.38",643.29,"2,690.51"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,767.17,289.43,"1,914.21"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-74 years,Deaths,Rate,42.84,16.67,104.23
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,589.66","1,155.51","5,335.73"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,586.23",766.05,"2,889.78"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,"1,003.43",389.46,"2,445.95"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,70-74 years,Deaths,Rate,61.13,24.24,146.26
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,116.67","1,455.71","6,320.73"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,794.87",931.47,"3,158.28"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,321.79",524.24,"3,162.45"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75-79 years,Deaths,Rate,155.16,59.20,376.37
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,096.57","2,445.98","10,365.13"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,428.64","1,428.12","3,893.44"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,667.93","1,017.86","6,471.69"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75+ years,Deaths,Rate,617.99,199.40,"1,445.57"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,365.64","4,073.25","19,148.41"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,460.72","2,111.95","5,274.67"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"5,904.92","1,961.30","13,873.75"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,80-84 years,Deaths,Rate,382.32,130.82,893.32
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,584.00","3,884.96","17,151.13"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,582.98","2,173.75","5,465.97"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"5,001.01","1,711.21","11,685.16"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,85+ years,Deaths,Rate,"1,930.81",593.21,"4,489.01"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"19,564.79","7,810.49","40,666.16"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,499.47","3,489.12","7,965.12"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"14,065.32","4,321.37","32,701.04"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,<1 year,Deaths,Rate,3.80,2.87,4.96
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,432.77,306.57,605.36
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,82.23,42.78,146.37
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,350.54,263.80,458.99
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Deaths,Rate,23.85,9.24,53.46
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,660.20",493.18,"3,587.07"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,247.53",273.08,"2,777.50"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,412.66,220.09,809.57
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,All ages,Deaths,Rate,32.00,11.93,72.63
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,815.01",566.92,"3,890.58"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,315.55",319.16,"2,867.03"
BRA,Brazil,Southern Cone,Neurological conditions,2021,Female,All ages,Years of Life Lost (YLLs),Rate,499.46,247.75,"1,023.54"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.32,0.00,0.37
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.32,0.00,0.37
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.23,0.00,0.27
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.23,0.00,0.27
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-24 years,Deaths,Rate,0.01,0.00,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.33,0.62
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.53,0.32,0.59
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-14 years,Deaths,Rate,0.01,0.00,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.93,0.00,1.09
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.93,0.00,1.09
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.53,0.99
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.85,0.52,0.96
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-24 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.84,0.77,0.95
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.05
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.81,0.76,0.89
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,20-24 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.64,1.49,1.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.05,0.01,0.11
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,1.58,1.48,1.74
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-29 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.08,0.74,1.50
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.38,0.10,0.74
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.70,0.64,0.77
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-49 years,Deaths,Rate,0.06,0.06,0.06
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.09,5.25,9.52
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,4.10,2.40,6.37
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.00,2.85,3.15
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,30-34 years,Deaths,Rate,0.03,0.03,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,3.01,2.27,3.94
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,1.17,0.52,2.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.84,1.74,1.94
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,35-39 years,Deaths,Rate,0.04,0.04,0.05
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,5.48,3.98,7.40
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.01,1.69,4.73
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,2.47,2.29,2.67
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,40-44 years,Deaths,Rate,0.04,0.04,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.03,5.24,11.82
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,6.03,3.36,9.68
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,2.00,1.88,2.14
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,45-49 years,Deaths,Rate,0.20,0.19,0.20
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,20.50,16.09,26.29
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,11.46,7.36,16.97
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,9.03,8.73,9.32
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-54 years,Deaths,Rate,0.24,0.23,0.25
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,27.98,20.93,38.10
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,18.17,11.45,27.98
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,9.81,9.48,10.12
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-64 years,Deaths,Rate,1.08,1.04,1.11
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,63.18,52.06,77.43
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,27.64,17.78,40.61
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,35.54,34.28,36.82
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,55-59 years,Deaths,Rate,0.86,0.83,0.89
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,58.12,47.14,71.05
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,27.44,17.49,39.41
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,30.69,29.65,31.64
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,60-64 years,Deaths,Rate,2.44,2.35,2.53
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,115.83,99.15,137.14
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,40.41,26.48,58.75
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,75.42,72.67,78.39
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-69 years,Deaths,Rate,5.57,5.32,5.79
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,209.20,179.44,239.27
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,63.12,39.99,87.48
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,146.08,139.45,151.80
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-74 years,Deaths,Rate,10.48,9.98,10.88
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,318.47,279.24,359.16
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,76.78,49.08,108.16
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,241.69,230.16,250.99
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,70-74 years,Deaths,Rate,17.60,16.74,18.27
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,477.19,424.20,533.30
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,96.63,62.27,138.21
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,380.56,361.93,395.08
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75-79 years,Deaths,Rate,35.76,33.35,37.21
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,754.01,668.92,835.83
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,139.15,95.53,196.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,614.86,573.38,639.81
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75+ years,Deaths,Rate,82.78,72.76,88.05
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,066.23",917.04,"1,182.53"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,147.86,98.60,210.83
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,918.37,818.44,971.71
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,80-84 years,Deaths,Rate,76.47,68.02,80.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,167.40","1,000.73","1,297.40"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,167.18,110.97,239.81
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,000.22",889.76,"1,057.59"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,85+ years,Deaths,Rate,226.02,191.91,243.49
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,788.09","1,485.47","1,980.10"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,141.59,87.49,206.34
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,646.50","1,397.98","1,773.75"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Deaths,Rate,3.39,3.03,3.59
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,61.30,52.29,69.87
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,13.69,8.81,19.81
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,47.61,43.48,50.06
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,All ages,Deaths,Rate,3.17,2.84,3.35
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,61.62,52.57,70.48
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,14.54,9.34,21.05
BRA,Brazil,Southern Cone,Parkinson disease,2020,Male,All ages,Years of Life Lost (YLLs),Rate,47.08,43.22,49.43
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-29 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.81,1.38
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.25,0.04,0.53
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.81,0.77,0.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-49 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.98,2.73,5.61
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.69,1.49,4.26
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.29,1.24,1.35
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,30-34 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.62,2.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.77,0.29,1.42
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,1.38,1.33,1.43
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.94,1.03,3.19
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,1.94,1.03,3.19
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,40-44 years,Deaths,Rate,0.03,0.02,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,3.48,7.88
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.01,2.22,6.51
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,1.32,1.26,1.38
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,45-49 years,Deaths,Rate,0.07,0.07,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.53,7.53,14.19
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,7.22,4.34,10.78
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.30,3.19,3.41
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-54 years,Deaths,Rate,0.19,0.19,0.20
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,19.86,14.40,26.76
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,12.07,6.86,18.70
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,7.79,7.54,8.06
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-64 years,Deaths,Rate,0.49,0.47,0.51
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.64,26.64,44.50
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,18.04,10.81,27.22
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,16.60,15.83,17.28
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,55-59 years,Deaths,Rate,0.48,0.46,0.50
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,34.65,26.92,44.87
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,17.46,10.40,27.02
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,17.19,16.52,17.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,60-64 years,Deaths,Rate,0.87,0.82,0.91
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,53.22,41.69,66.38
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.22,16.26,38.17
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,26.99,25.43,28.21
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-69 years,Deaths,Rate,2.30,2.13,2.40
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,103.49,84.15,123.21
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,43.32,28.28,60.27
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,60.16,55.87,62.94
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-74 years,Deaths,Rate,4.28,3.92,4.49
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,152.64,125.55,179.81
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,54.00,35.23,76.28
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,98.64,90.33,103.53
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,70-74 years,Deaths,Rate,7.00,6.36,7.36
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,220.11,182.39,257.51
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,68.65,44.77,98.26
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,151.46,137.62,159.24
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75-79 years,Deaths,Rate,17.08,15.07,18.08
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,393.35,327.34,451.34
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,99.64,68.21,140.42
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,293.71,259.12,310.91
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75+ years,Deaths,Rate,47.28,37.81,52.34
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,607.83,478.12,705.94
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,115.84,76.65,166.33
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,491.99,401.47,539.61
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,80-84 years,Deaths,Rate,38.46,31.58,41.92
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,629.63,495.14,732.24
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,126.58,82.01,183.85
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,503.04,413.13,548.39
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,85+ years,Deaths,Rate,122.52,93.90,138.23
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,027.80",771.08,"1,203.88"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,135.25,87.07,196.89
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,892.55,684.02,"1,006.99"
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Deaths,Rate,1.68,1.39,1.84
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,32.15,25.39,38.38
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.66,6.11,14.13
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,22.49,19.27,24.25
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,All ages,Deaths,Rate,2.26,1.85,2.48
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,41.55,32.79,49.50
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,12.18,7.73,17.79
BRA,Brazil,Southern Cone,Parkinson disease,2020,Female,All ages,Years of Life Lost (YLLs),Rate,29.36,25.06,31.72
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.06
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.06,0.01,0.11
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.06,0.01,0.11
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.09,0.75
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.38,0.09,0.75
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-49 years,Deaths,Rate,0.05,0.05,0.06
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.82,4.94,9.40
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,4.25,2.51,6.66
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.57,2.43,2.73
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,30-34 years,Deaths,Rate,0.03,0.03,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.95,2.21,3.90
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,1.18,0.54,2.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,1.76,1.67,1.87
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,35-39 years,Deaths,Rate,0.03,0.03,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.74,3.29,6.61
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,3.07,1.75,4.77
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,1.67,1.54,1.83
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,40-44 years,Deaths,Rate,0.06,0.06,0.07
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.21,6.29,13.33
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,6.15,3.45,10.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,3.06,2.85,3.30
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,45-49 years,Deaths,Rate,0.16,0.15,0.17
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,19.09,14.52,25.37
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,11.90,7.66,17.85
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,7.19,6.86,7.52
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-54 years,Deaths,Rate,0.40,0.38,0.41
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,35.21,26.81,46.08
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,19.12,11.45,29.24
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,16.09,15.36,16.84
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-64 years,Deaths,Rate,1.12,1.06,1.17
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,66.23,53.24,81.53
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,28.69,17.63,42.11
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,37.54,35.61,39.42
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,55-59 years,Deaths,Rate,0.98,0.93,1.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,63.38,50.61,78.26
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,28.46,17.39,41.68
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,34.92,33.22,36.58
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,60-64 years,Deaths,Rate,2.21,2.09,2.33
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,109.76,90.57,131.29
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,41.34,25.90,59.27
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,68.42,64.67,72.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-69 years,Deaths,Rate,6.43,6.06,6.76
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,233.05,199.83,268.32
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,64.58,41.12,91.23
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,168.47,158.71,177.09
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-74 years,Deaths,Rate,10.33,9.71,10.85
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,319.18,276.53,364.91
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,78.52,50.13,112.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,240.66,226.41,252.89
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,70-74 years,Deaths,Rate,15.92,14.96,16.72
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,442.74,386.55,503.48
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,98.52,63.05,141.85
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,344.22,323.51,361.62
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75-79 years,Deaths,Rate,39.29,36.49,41.30
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,817.90,724.23,906.86
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,142.33,96.78,196.70
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,675.57,627.45,710.16
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75+ years,Deaths,Rate,86.83,75.60,93.17
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,122.84",960.21,"1,250.53"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,151.72,101.44,213.47
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,971.12,858.77,"1,037.06"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,80-84 years,Deaths,Rate,79.46,70.04,84.92
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,211.37","1,030.75","1,355.81"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,171.95,114.55,245.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,039.42",916.21,"1,110.77"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,85+ years,Deaths,Rate,232.13,194.35,252.06
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,836.57","1,509.24","2,045.99"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,145.58,93.47,209.78
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,690.99","1,415.77","1,836.21"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Deaths,Rate,3.50,3.09,3.74
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,62.99,53.23,72.33
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,14.06,8.95,20.36
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,48.93,44.28,51.97
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,All ages,Deaths,Rate,3.37,2.99,3.60
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,65.14,55.03,75.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,15.31,9.72,22.17
BRA,Brazil,Southern Cone,Parkinson disease,2021,Male,All ages,Years of Life Lost (YLLs),Rate,49.83,45.31,52.86
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.28,0.05,0.58
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.28,0.05,0.58
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-49 years,Deaths,Rate,0.04,0.04,0.04
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,4.70,3.32,6.48
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.82,1.54,4.51
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.88,1.78,1.97
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,30-34 years,Deaths,Rate,0.01,0.01,0.01
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,1.57,1.03,2.34
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.84,0.33,1.57
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.73,0.69,0.77
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,35-39 years,Deaths,Rate,0.02,0.02,0.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,3.34,2.31,4.65
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,2.03,1.06,3.27
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,1.32,1.25,1.38
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,40-44 years,Deaths,Rate,0.08,0.07,0.08
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,7.93,5.84,10.66
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,4.13,2.25,6.64
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,3.80,3.59,4.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,45-49 years,Deaths,Rate,0.08,0.08,0.09
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.33,8.06,15.50
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,7.48,4.40,11.49
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,3.84,3.66,4.02
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-54 years,Deaths,Rate,0.16,0.15,0.16
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,18.69,13.10,25.20
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,12.36,7.06,18.55
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.33,6.04,6.65
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-64 years,Deaths,Rate,0.58,0.54,0.61
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,38.26,29.64,48.63
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,19.16,11.75,28.52
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,19.09,17.89,20.11
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,55-59 years,Deaths,Rate,0.38,0.36,0.40
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,32.25,24.43,41.79
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,18.58,11.46,27.44
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,13.67,12.97,14.35
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,60-64 years,Deaths,Rate,1.33,1.24,1.40
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,69.33,56.05,85.43
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,28.23,17.85,42.06
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,41.11,38.20,43.37
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-69 years,Deaths,Rate,2.72,2.51,2.88
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,118.80,96.41,142.23
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,47.44,30.74,66.86
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,71.36,65.67,75.37
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-74 years,Deaths,Rate,4.41,4.02,4.68
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,162.23,132.35,193.35
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,59.63,38.81,84.70
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,102.60,93.54,108.65
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,70-74 years,Deaths,Rate,6.69,6.06,7.10
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,220.76,180.78,262.23
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,76.06,49.68,108.73
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,144.69,131.10,153.50
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75-79 years,Deaths,Rate,17.92,15.70,19.07
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,419.28,344.16,484.38
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,111.18,74.13,156.47
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,308.10,270.02,327.91
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75+ years,Deaths,Rate,46.49,37.09,51.84
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,620.58,485.14,724.95
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,129.16,84.96,182.43
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,491.42,400.18,542.52
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,80-84 years,Deaths,Rate,38.88,31.88,42.71
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,650.41,509.62,756.79
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,141.82,92.65,198.18
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,508.59,416.97,558.61
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,85+ years,Deaths,Rate,118.02,89.97,134.43
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,010.02",752.94,"1,195.60"
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,150.25,97.54,216.34
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,859.77,655.40,979.26
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Deaths,Rate,1.69,1.39,1.87
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,33.73,26.51,40.47
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.53,6.68,15.28
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,23.20,19.83,25.19
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,All ages,Deaths,Rate,2.31,1.89,2.55
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,44.61,35.07,53.42
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,13.63,8.67,19.73
BRA,Brazil,Southern Cone,Parkinson disease,2021,Female,All ages,Years of Life Lost (YLLs),Rate,30.98,26.40,33.69
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Deaths,Rate,0.06,0.01,0.19
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.21,1.55,15.68
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.62,1.21,7.03
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,2.59,0.34,8.65
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.63,0.77,5.31
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.63,0.77,5.31
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Deaths,Rate,0.32,0.04,1.07
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.37,7.96,83.10
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.75,6.01,34.20
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,14.62,1.95,48.90
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Deaths,Rate,0.51,0.08,1.71
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,63.67,25.63,145.72
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,43.18,22.47,76.35
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,20.48,3.16,69.37
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Deaths,Rate,1.62,0.31,5.07
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,138.01,58.45,302.29
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,84.51,48.29,134.37
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,53.50,10.15,167.92
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Deaths,Rate,0.92,0.17,3.02
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,113.98,50.03,237.15
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,80.96,43.92,129.27
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,33.03,6.11,107.88
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Deaths,Rate,3.86,0.77,11.74
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,260.67,110.06,577.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,141.37,86.31,214.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,119.31,23.75,363.11
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Deaths,Rate,12.41,2.83,37.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,578.96,228.75,"1,347.09"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,253.70,154.62,377.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,325.26,74.13,969.79
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Deaths,Rate,22.60,5.31,67.22
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,877.38,336.77,"2,084.10"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,356.05,214.39,532.99
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,521.33,122.38,"1,551.11"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Deaths,Rate,36.41,8.69,108.19
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,282.03",483.25,"3,083.47"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,494.83,295.44,744.11
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,787.20,187.80,"2,339.36"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Deaths,Rate,110.77,24.53,333.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,858.74","1,041.72","7,114.14"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,954.03,619.96,"1,381.18"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,904.72",421.76,"5,732.96"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Deaths,Rate,362.38,82.79,998.36
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,519.06","2,080.94","12,730.73"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,923.44","1,260.24","2,717.20"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"3,595.62",820.70,"10,013.53"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Deaths,Rate,280.50,65.64,763.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,548.41","2,062.54","12,607.82"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,879.38","1,203.89","2,621.90"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"3,669.04",858.64,"9,985.93"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Deaths,Rate,862.72,196.69,"2,340.72"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,842.78","3,802.20","22,058.83"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,558.12","2,369.35","5,007.42"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"6,284.65","1,432.85","17,051.40"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Deaths,Rate,11.11,2.54,31.09
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,222.27,84.45,516.25
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,85.12,53.34,124.59
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,137.15,31.11,391.66
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Deaths,Rate,18.04,4.12,50.16
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,333.95,127.14,772.33
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,126.76,80.05,184.49
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years of Life Lost (YLLs),Rate,207.19,47.08,587.84
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Deaths,Rate,0.05,0.00,0.12
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,3.47,0.00,9.04
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,3.47,0.00,9.04
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Deaths,Rate,0.07,0.00,0.18
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.17,0.00,13.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,5.17,0.00,13.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Deaths,Rate,0.11,0.00,0.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.26,0.00,21.53
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,8.26,0.00,21.53
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Deaths,Rate,0.18,0.00,0.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,13.32,0.00,34.68
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,13.32,0.00,34.68
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Deaths,Rate,0.16,0.00,0.43
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.92,0.00,31.05
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,11.92,0.00,31.05
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Deaths,Rate,0.15,0.00,0.40
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,10.73,0.00,27.94
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,10.73,0.00,27.94
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Deaths,Rate,0.03,0.00,0.10
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.13,1.81,14.85
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.68,1.68,9.59
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,1.45,0.13,5.26
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Deaths,Rate,0.16,0.01,0.56
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,11.04,1.79,34.87
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.22,1.11,6.52
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,7.81,0.68,28.35
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.76,8.21,46.72
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,22.76,8.21,46.72
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Deaths,Rate,0.33,0.05,1.09
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,72.53,33.16,140.05
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,59.15,31.05,95.80
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,13.37,2.12,44.25
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Deaths,Rate,1.62,0.32,4.86
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,171.54,79.54,341.26
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,118.88,69.20,182.73
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,52.66,10.34,158.53
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Deaths,Rate,0.89,0.17,2.72
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,144.30,69.96,269.47
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,112.65,63.91,172.08
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,31.65,6.05,97.40
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Deaths,Rate,4.03,0.82,11.90
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,323.88,147.28,669.47
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,199.19,121.99,301.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,124.70,25.29,368.07
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Deaths,Rate,9.42,2.16,27.62
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,608.23,290.57,"1,240.72"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,361.28,233.84,516.81
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,246.95,56.73,723.91
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Deaths,Rate,20.20,4.93,57.91
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,979.42,445.82,"2,069.97"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,518.31,333.64,746.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,461.11,112.18,"1,323.67"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Deaths,Rate,34.17,8.51,97.18
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,460.71",647.13,"3,145.21"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,721.92,463.05,"1,043.87"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,738.79,184.08,"2,101.33"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Deaths,Rate,119.58,28.00,340.03
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,470.59","1,390.91","7,847.25"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,414.43",909.39,"2,000.43"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,056.16",481.52,"5,846.82"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Deaths,Rate,499.96,120.67,"1,309.38"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,606.51","3,063.22","16,352.85"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,001.32","1,948.81","4,217.37"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"4,605.19","1,114.41","12,135.47"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Deaths,Rate,307.78,78.10,788.42
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,748.87","2,757.43","14,151.80"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,722.86","1,735.82","3,838.71"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"4,026.00","1,021.61","10,313.09"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Deaths,Rate,"1,113.04",266.39,"2,898.37"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"13,220.08","5,297.98","28,270.82"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,111.93","3,357.40","7,157.13"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"8,108.15","1,940.58","21,113.69"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Deaths,Rate,12.96,3.12,34.44
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,274.93,113.80,588.66
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,122.64,77.75,176.53
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,152.29,36.05,412.13
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Deaths,Rate,31.91,7.69,84.08
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,566.53,233.04,"1,211.74"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,242.89,155.58,346.56
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years of Life Lost (YLLs),Rate,323.64,77.46,865.18
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Deaths,Rate,0.11,0.00,0.31
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.25,0.00,26.02
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,9.25,0.00,26.02
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Deaths,Rate,0.08,0.00,0.23
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,6.86,0.00,19.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,6.86,0.00,19.30
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Deaths,Rate,0.06,0.00,0.18
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.28,0.00,14.85
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,5.28,0.00,14.85
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Deaths,Rate,0.09,0.00,0.27
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,8.07,0.00,22.71
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,8.07,0.00,22.71
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Deaths,Rate,0.16,0.00,0.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,13.86,0.00,39.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,13.86,0.00,39.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Deaths,Rate,0.16,0.00,0.44
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,12.69,0.00,35.71
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,12.69,0.00,35.71
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Deaths,Rate,0.05,0.00,0.14
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,4.01,0.00,11.28
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,4.01,0.00,11.28
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Deaths,Rate,0.05,0.00,0.15
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.81,1.31,16.22
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.64,1.31,7.28
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.18,0.00,8.94
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Deaths,Rate,0.24,0.00,0.67
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,14.43,0.00,40.59
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,14.43,0.00,40.59
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.58,0.76,5.39
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.58,0.76,5.39
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.95,6.66,35.69
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.95,6.66,35.69
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Deaths,Rate,0.82,0.13,2.74
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,76.11,27.13,186.51
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,43.01,21.98,75.31
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,33.10,5.14,111.20
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Deaths,Rate,2.20,0.42,7.02
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,158.71,62.65,371.49
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,84.66,48.63,134.60
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,74.04,14.01,236.89
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Deaths,Rate,1.84,0.34,6.07
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,145.81,57.59,339.32
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,80.08,45.57,122.31
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,65.73,12.02,217.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Deaths,Rate,4.37,0.89,13.52
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,277.66,113.24,641.66
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,142.45,85.75,223.45
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,135.21,27.49,418.21
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Deaths,Rate,9.20,2.05,26.73
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,496.62,209.62,"1,068.42"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,255.57,155.88,367.96
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,241.05,53.75,700.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Deaths,Rate,23.73,5.62,69.13
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,895.35,346.52,"2,097.45"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,358.24,219.53,532.83
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,537.11,126.99,"1,564.62"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Deaths,Rate,42.99,10.36,125.35
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,423.99",528.01,"3,461.75"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,494.36,303.92,751.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,929.62,224.09,"2,710.34"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Deaths,Rate,123.38,27.55,359.93
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,078.86","1,097.88","7,579.77"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,957.32,624.14,"1,390.77"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"2,121.54",473.75,"6,188.99"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Deaths,Rate,436.51,101.64,"1,206.91"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,210.22","2,259.27","14,698.18"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,921.12","1,264.31","2,747.12"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"4,289.10",994.96,"11,951.06"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Deaths,Rate,337.74,79.53,939.19
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,314.90","2,278.72","15,000.16"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,897.11","1,238.35","2,714.97"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"4,417.80","1,040.37","12,285.19"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Deaths,Rate,"1,070.19",250.19,"2,921.48"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"11,364.35","4,191.85","26,345.58"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,568.39","2,369.28","5,063.52"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"7,795.95","1,822.58","21,282.06"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Deaths,Rate,13.30,3.08,37.17
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,248.21,90.63,588.33
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,85.44,54.01,125.89
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,162.77,36.62,462.44
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Deaths,Rate,21.90,5.08,60.96
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,378.18,138.88,893.57
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,129.17,82.17,189.36
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years of Life Lost (YLLs),Rate,249.01,56.71,704.21
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Deaths,Rate,0.10,0.01,0.34
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.33,2.34,24.53
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.59,1.73,8.88
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,4.74,0.61,15.65
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.18,1.03,6.32
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.18,1.03,6.32
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Deaths,Rate,0.58,0.08,1.93
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,48.92,12.04,130.83
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,22.39,8.60,43.17
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,26.53,3.44,87.66
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Deaths,Rate,0.30,0.05,1.01
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,70.41,31.63,136.60
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,58.10,29.72,95.73
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,12.31,1.92,40.87
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Deaths,Rate,1.78,0.34,5.42
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,176.96,79.52,363.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,118.13,68.34,183.43
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,58.83,11.18,179.98
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Deaths,Rate,1.74,0.31,5.41
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,173.57,75.60,365.09
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,111.44,64.40,171.67
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,62.13,11.20,193.42
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Deaths,Rate,3.60,0.72,10.76
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,309.46,141.76,635.46
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,198.17,119.41,302.59
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,111.29,22.35,332.87
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Deaths,Rate,8.37,1.92,24.25
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,578.18,278.17,"1,150.46"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,358.76,227.85,514.87
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,219.41,50.32,635.60
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Deaths,Rate,21.40,5.27,60.60
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,999.19,449.25,"2,111.96"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,515.02,330.39,739.49
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,484.17,118.86,"1,372.47"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Deaths,Rate,37.97,9.53,106.83
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,534.73",666.88,"3,335.02"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,713.77,460.84,"1,025.21"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,820.96,206.05,"2,309.81"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Deaths,Rate,119.64,28.71,343.24
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,451.22","1,409.44","7,860.21"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,394.06",915.76,"1,958.30"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,057.16",493.68,"5,901.91"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Deaths,Rate,718.21,175.86,"1,876.80"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,271.34","3,497.77","20,728.66"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,946.94","1,946.24","4,103.37"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"6,324.40","1,551.53","16,625.30"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Deaths,Rate,385.45,97.62,993.93
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"7,726.80","3,028.43","16,717.08"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,684.94","1,751.44","3,715.85"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"5,041.86","1,276.99","13,001.22"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Deaths,Rate,"1,732.18",422.06,"4,500.64"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,680.07","6,442.14","39,832.31"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,061.73","3,367.57","7,046.61"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"12,618.33","3,074.57","32,785.71"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Deaths,Rate,17.67,4.32,46.72
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,312.32,124.03,687.97
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,121.24,77.70,173.40
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,191.08,46.33,514.57
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Deaths,Rate,45.91,11.22,120.50
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,680.50,264.32,"1,507.39"
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,243.61,157.91,345.28
CHL,Chile,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years of Life Lost (YLLs),Rate,436.89,106.41,"1,162.11"
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-4 years,Deaths,Rate,0.71,0.48,1.00
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,155.33,65.11,292.98
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,91.09,21.15,202.62
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,64.24,43.96,90.36
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-14 years,Deaths,Rate,0.51,0.37,0.69
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,152.86,55.19,319.27
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,109.22,23.64,259.98
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,43.63,31.55,59.28
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-19 years,Deaths,Rate,0.64,0.48,0.83
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,169.20,64.16,350.80
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,117.28,24.77,282.78
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,51.92,39.38,68.02
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-24 years,Deaths,Rate,0.66,0.51,0.84
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,177.31,65.82,367.20
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,125.72,26.11,301.00
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,51.58,39.71,66.20
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-27 days,Deaths,Rate,0.45,0.34,0.56
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,104.05,41.69,208.55
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,65.49,13.63,158.37
CHL,Chile,Southern Cone,Epilepsy,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,38.56,27.94,50.18
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-4 years,Deaths,Rate,0.54,0.37,0.76
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,143.77,55.60,278.54
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,95.04,22.28,209.96
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,48.72,33.32,68.58
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-9 years,Deaths,Rate,0.42,0.30,0.57
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,140.82,49.63,295.06
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,103.83,23.11,244.85
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,36.99,26.52,50.21
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-11 months,Deaths,Rate,1.55,1.07,2.18
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,217.25,114.32,372.23
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,73.96,16.32,170.53
CHL,Chile,Southern Cone,Epilepsy,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,143.30,98.00,201.69
CHL,Chile,Southern Cone,Epilepsy,2020,Male,5-9 years,Deaths,Rate,0.33,0.25,0.43
CHL,Chile,Southern Cone,Epilepsy,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,138.62,45.18,307.36
CHL,Chile,Southern Cone,Epilepsy,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,110.36,23.72,270.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,28.26,21.46,36.54
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-14 years,Deaths,Rate,0.50,0.38,0.67
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,165.10,56.20,355.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,124.89,25.86,302.15
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,40.21,30.35,53.67
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-24 years,Deaths,Rate,0.74,0.59,0.92
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,195.79,72.52,407.31
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,140.48,28.28,338.67
CHL,Chile,Southern Cone,Epilepsy,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,55.31,44.24,68.63
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-19 years,Deaths,Rate,1.00,0.82,1.23
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,215.69,89.66,440.49
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,140.20,28.00,347.61
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,75.49,61.66,92.88
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-24 years,Deaths,Rate,0.85,0.69,1.03
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,209.48,79.81,430.29
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,147.44,29.37,354.98
CHL,Chile,Southern Cone,Epilepsy,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,62.05,50.44,75.31
CHL,Chile,Southern Cone,Epilepsy,2020,Male,20-24 years,Deaths,Rate,0.72,0.58,0.86
CHL,Chile,Southern Cone,Epilepsy,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,204.14,71.32,421.50
CHL,Chile,Southern Cone,Epilepsy,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,153.67,30.55,361.32
CHL,Chile,Southern Cone,Epilepsy,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,50.47,40.77,60.18
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-29 years,Deaths,Rate,1.12,0.93,1.34
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,221.94,91.73,439.50
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,148.95,31.14,352.23
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,72.99,60.59,87.27
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-49 years,Deaths,Rate,1.38,1.16,1.62
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,200.30,89.62,372.83
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,125.09,26.46,284.21
CHL,Chile,Southern Cone,Epilepsy,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,75.21,63.16,88.63
CHL,Chile,Southern Cone,Epilepsy,2020,Male,30-34 years,Deaths,Rate,0.75,0.63,0.89
CHL,Chile,Southern Cone,Epilepsy,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,179.20,65.78,360.73
CHL,Chile,Southern Cone,Epilepsy,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,133.92,27.51,306.96
CHL,Chile,Southern Cone,Epilepsy,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,45.28,38.28,53.78
CHL,Chile,Southern Cone,Epilepsy,2020,Male,35-39 years,Deaths,Rate,1.61,1.36,1.87
CHL,Chile,Southern Cone,Epilepsy,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,208.97,100.98,372.26
CHL,Chile,Southern Cone,Epilepsy,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,120.03,25.83,268.48
CHL,Chile,Southern Cone,Epilepsy,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,88.93,75.15,103.79
CHL,Chile,Southern Cone,Epilepsy,2020,Male,40-44 years,Deaths,Rate,2.27,1.92,2.64
CHL,Chile,Southern Cone,Epilepsy,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,224.01,120.42,373.98
CHL,Chile,Southern Cone,Epilepsy,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,109.48,23.45,240.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,114.54,96.96,133.15
CHL,Chile,Southern Cone,Epilepsy,2020,Male,45-49 years,Deaths,Rate,1.29,1.06,1.54
CHL,Chile,Southern Cone,Epilepsy,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,164.58,71.50,303.17
CHL,Chile,Southern Cone,Epilepsy,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,106.10,23.10,233.31
CHL,Chile,Southern Cone,Epilepsy,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,58.48,48.40,69.86
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-54 years,Deaths,Rate,3.36,2.85,3.93
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,245.08,141.07,420.72
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,108.53,25.19,261.24
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,136.55,115.88,159.47
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-64 years,Deaths,Rate,3.99,3.40,4.67
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,260.53,147.01,444.60
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,118.92,26.21,279.30
CHL,Chile,Southern Cone,Epilepsy,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,141.61,120.79,165.30
CHL,Chile,Southern Cone,Epilepsy,2020,Male,55-59 years,Deaths,Rate,3.70,3.24,4.22
CHL,Chile,Southern Cone,Epilepsy,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,249.14,139.55,427.64
CHL,Chile,Southern Cone,Epilepsy,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,117.04,23.87,276.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,132.10,115.68,150.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,60-64 years,Deaths,Rate,5.14,4.30,6.13
CHL,Chile,Southern Cone,Epilepsy,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,293.43,163.20,494.68
CHL,Chile,Southern Cone,Epilepsy,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,134.35,30.23,305.21
CHL,Chile,Southern Cone,Epilepsy,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,159.07,132.97,189.47
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-69 years,Deaths,Rate,6.60,5.58,7.82
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,325.61,181.19,551.50
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,152.60,34.91,346.50
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,173.01,146.28,205.01
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-74 years,Deaths,Rate,5.35,4.50,6.37
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,291.86,148.74,523.46
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,158.87,36.73,365.15
CHL,Chile,Southern Cone,Epilepsy,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,132.99,112.01,158.31
CHL,Chile,Southern Cone,Epilepsy,2020,Male,70-74 years,Deaths,Rate,3.64,3.03,4.39
CHL,Chile,Southern Cone,Epilepsy,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,246.10,104.75,485.43
CHL,Chile,Southern Cone,Epilepsy,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,167.38,39.21,390.44
CHL,Chile,Southern Cone,Epilepsy,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,78.72,65.54,94.99
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75-79 years,Deaths,Rate,9.56,7.93,11.56
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,349.45,181.59,617.04
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,185.08,45.24,418.34
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,164.37,136.36,198.70
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75+ years,Deaths,Rate,11.09,8.95,13.49
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,334.65,156.05,614.72
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,201.83,48.06,453.26
CHL,Chile,Southern Cone,Epilepsy,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,132.83,107.99,161.46
CHL,Chile,Southern Cone,Epilepsy,2020,Male,80-84 years,Deaths,Rate,6.14,4.88,7.57
CHL,Chile,Southern Cone,Epilepsy,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,282.23,112.38,551.88
CHL,Chile,Southern Cone,Epilepsy,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,201.97,48.62,452.80
CHL,Chile,Southern Cone,Epilepsy,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,80.26,63.76,99.09
CHL,Chile,Southern Cone,Epilepsy,2020,Male,85+ years,Deaths,Rate,18.94,15.01,23.04
CHL,Chile,Southern Cone,Epilepsy,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,367.04,161.38,678.79
CHL,Chile,Southern Cone,Epilepsy,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,229.09,52.06,510.94
CHL,Chile,Southern Cone,Epilepsy,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,137.96,109.32,167.84
CHL,Chile,Southern Cone,Epilepsy,2020,Male,<1 year,Deaths,Rate,1.46,0.99,2.04
CHL,Chile,Southern Cone,Epilepsy,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,207.50,108.05,358.11
CHL,Chile,Southern Cone,Epilepsy,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,73.24,16.09,169.48
CHL,Chile,Southern Cone,Epilepsy,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,134.26,91.96,188.64
CHL,Chile,Southern Cone,Epilepsy,2020,Male,Age-standardized,Deaths,Rate,1.90,1.58,2.28
CHL,Chile,Southern Cone,Epilepsy,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,206.56,92.19,393.18
CHL,Chile,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,127.55,27.31,297.55
CHL,Chile,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,79.02,64.88,95.63
CHL,Chile,Southern Cone,Epilepsy,2020,Male,All ages,Deaths,Rate,2.30,1.91,2.75
CHL,Chile,Southern Cone,Epilepsy,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,215.48,98.72,404.73
CHL,Chile,Southern Cone,Epilepsy,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,130.05,27.99,302.19
CHL,Chile,Southern Cone,Epilepsy,2020,Male,All ages,Years of Life Lost (YLLs),Rate,85.43,70.73,102.53
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-4 years,Deaths,Rate,0.52,0.36,0.73
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,133.64,51.57,267.58
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,86.63,19.40,201.46
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,47.01,32.17,66.13
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-14 years,Deaths,Rate,0.28,0.20,0.38
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,125.53,38.49,280.62
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,101.65,21.25,248.14
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,23.89,17.24,32.48
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-19 years,Deaths,Rate,0.39,0.30,0.50
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,139.27,46.62,302.69
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,107.72,22.76,261.74
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,31.55,23.86,40.95
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-24 years,Deaths,Rate,0.44,0.34,0.56
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,147.45,50.07,316.14
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,113.25,23.83,272.63
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,34.20,26.24,43.51
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-27 days,Deaths,Rate,0.35,0.23,0.35
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,93.10,33.06,200.45
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,65.88,13.43,165.05
CHL,Chile,Southern Cone,Epilepsy,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,27.22,19.74,35.39
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-4 years,Deaths,Rate,0.50,0.34,0.70
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,134.39,50.41,270.05
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,89.82,19.94,207.32
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,44.57,30.48,62.73
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-9 years,Deaths,Rate,0.21,0.14,0.30
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,116.80,34.30,267.22
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,97.76,21.28,240.42
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,19.04,13.02,26.80
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-11 months,Deaths,Rate,0.66,0.45,0.93
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,133.77,59.02,261.66
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,72.79,17.32,175.83
CHL,Chile,Southern Cone,Epilepsy,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,60.98,41.70,85.83
CHL,Chile,Southern Cone,Epilepsy,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Epilepsy,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,103.69,22.28,265.10
CHL,Chile,Southern Cone,Epilepsy,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,103.69,22.28,265.10
CHL,Chile,Southern Cone,Epilepsy,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-14 years,Deaths,Rate,0.33,0.26,0.43
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,140.33,42.90,308.65
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,113.55,21.93,274.28
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,26.78,20.97,34.37
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-24 years,Deaths,Rate,0.56,0.44,0.68
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,165.12,58.36,346.03
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,123.85,25.58,295.33
CHL,Chile,Southern Cone,Epilepsy,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,41.27,32.79,50.70
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-19 years,Deaths,Rate,0.71,0.57,0.86
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,178.21,69.67,365.28
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,124.95,27.04,300.33
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,53.26,42.62,64.95
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-24 years,Deaths,Rate,0.65,0.52,0.80
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,176.09,65.20,362.56
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,128.41,27.19,304.64
CHL,Chile,Southern Cone,Epilepsy,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,47.68,38.01,57.92
CHL,Chile,Southern Cone,Epilepsy,2020,Female,20-24 years,Deaths,Rate,0.61,0.49,0.74
CHL,Chile,Southern Cone,Epilepsy,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,174.28,61.38,360.24
CHL,Chile,Southern Cone,Epilepsy,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,131.37,27.32,308.33
CHL,Chile,Southern Cone,Epilepsy,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,42.91,34.07,51.91
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-29 years,Deaths,Rate,0.91,0.74,1.12
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,188.19,76.50,379.51
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,128.71,28.26,306.59
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,59.48,48.24,72.92
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-49 years,Deaths,Rate,0.66,0.54,0.80
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,148.07,54.50,302.62
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,111.66,24.69,258.33
CHL,Chile,Southern Cone,Epilepsy,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,36.41,29.81,44.29
CHL,Chile,Southern Cone,Epilepsy,2020,Female,30-34 years,Deaths,Rate,0.26,0.21,0.32
CHL,Chile,Southern Cone,Epilepsy,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,132.27,40.14,293.03
CHL,Chile,Southern Cone,Epilepsy,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,116.53,27.38,273.80
CHL,Chile,Southern Cone,Epilepsy,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,15.74,12.76,19.23
CHL,Chile,Southern Cone,Epilepsy,2020,Female,35-39 years,Deaths,Rate,0.60,0.49,0.73
CHL,Chile,Southern Cone,Epilepsy,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,142.12,49.33,285.18
CHL,Chile,Southern Cone,Epilepsy,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,109.04,22.50,244.66
CHL,Chile,Southern Cone,Epilepsy,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,33.07,26.83,40.51
CHL,Chile,Southern Cone,Epilepsy,2020,Female,40-44 years,Deaths,Rate,0.31,0.26,0.37
CHL,Chile,Southern Cone,Epilepsy,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,118.89,36.92,258.68
CHL,Chile,Southern Cone,Epilepsy,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,103.26,23.91,240.20
CHL,Chile,Southern Cone,Epilepsy,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,15.63,13.01,18.48
CHL,Chile,Southern Cone,Epilepsy,2020,Female,45-49 years,Deaths,Rate,1.28,1.06,1.54
CHL,Chile,Southern Cone,Epilepsy,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,154.42,68.59,283.98
CHL,Chile,Southern Cone,Epilepsy,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,96.33,20.27,213.90
CHL,Chile,Southern Cone,Epilepsy,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,58.09,48.32,70.08
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-54 years,Deaths,Rate,1.98,1.62,2.38
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,171.25,88.00,310.02
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,91.02,22.04,213.30
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,80.24,65.96,96.72
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-64 years,Deaths,Rate,1.92,1.60,2.29
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,165.41,79.49,305.37
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,95.93,21.72,222.38
CHL,Chile,Southern Cone,Epilepsy,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,69.48,57.77,82.99
CHL,Chile,Southern Cone,Epilepsy,2020,Female,55-59 years,Deaths,Rate,1.95,1.62,2.32
CHL,Chile,Southern Cone,Epilepsy,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,164.33,78.53,300.25
CHL,Chile,Southern Cone,Epilepsy,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,94.70,20.56,217.23
CHL,Chile,Southern Cone,Epilepsy,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,69.63,57.97,83.02
CHL,Chile,Southern Cone,Epilepsy,2020,Female,60-64 years,Deaths,Rate,1.82,1.54,2.14
CHL,Chile,Southern Cone,Epilepsy,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,159.47,70.16,305.49
CHL,Chile,Southern Cone,Epilepsy,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,103.36,22.65,239.36
CHL,Chile,Southern Cone,Epilepsy,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,56.11,47.51,66.13
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-69 years,Deaths,Rate,2.17,1.83,2.57
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,170.82,76.04,320.22
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,113.83,27.96,252.83
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,56.99,48.09,67.39
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-74 years,Deaths,Rate,2.33,1.93,2.80
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,173.90,74.37,332.61
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,117.90,27.81,265.45
CHL,Chile,Southern Cone,Epilepsy,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,56.00,46.56,67.17
CHL,Chile,Southern Cone,Epilepsy,2020,Female,70-74 years,Deaths,Rate,2.53,2.06,3.09
CHL,Chile,Southern Cone,Epilepsy,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,177.89,72.20,348.69
CHL,Chile,Southern Cone,Epilepsy,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,123.17,27.61,281.81
CHL,Chile,Southern Cone,Epilepsy,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,54.72,44.59,66.88
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75-79 years,Deaths,Rate,5.39,4.34,6.64
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,225.89,107.11,425.92
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,133.13,32.51,311.76
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,92.76,74.59,114.16
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75+ years,Deaths,Rate,7.92,6.03,9.86
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,237.78,105.37,449.20
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,149.03,36.99,339.14
CHL,Chile,Southern Cone,Epilepsy,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,88.74,68.39,110.07
CHL,Chile,Southern Cone,Epilepsy,2020,Female,80-84 years,Deaths,Rate,6.25,4.73,7.76
CHL,Chile,Southern Cone,Epilepsy,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,226.46,96.84,423.78
CHL,Chile,Southern Cone,Epilepsy,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,144.63,34.99,322.24
CHL,Chile,Southern Cone,Epilepsy,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,81.83,61.85,101.54
CHL,Chile,Southern Cone,Epilepsy,2020,Female,85+ years,Deaths,Rate,12.34,9.15,15.45
CHL,Chile,Southern Cone,Epilepsy,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,261.47,110.62,498.40
CHL,Chile,Southern Cone,Epilepsy,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,171.56,43.97,385.88
CHL,Chile,Southern Cone,Epilepsy,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,89.91,66.65,112.52
CHL,Chile,Southern Cone,Epilepsy,2020,Female,<1 year,Deaths,Rate,0.63,0.43,0.88
CHL,Chile,Southern Cone,Epilepsy,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,130.28,56.80,256.41
CHL,Chile,Southern Cone,Epilepsy,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,72.19,16.98,174.90
CHL,Chile,Southern Cone,Epilepsy,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,58.07,39.81,81.50
CHL,Chile,Southern Cone,Epilepsy,2020,Female,Age-standardized,Deaths,Rate,1.02,0.82,1.24
CHL,Chile,Southern Cone,Epilepsy,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,153.35,58.31,313.07
CHL,Chile,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,110.85,24.29,260.63
CHL,Chile,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,42.50,34.02,52.44
CHL,Chile,Southern Cone,Epilepsy,2020,Female,All ages,Deaths,Rate,1.38,1.10,1.68
CHL,Chile,Southern Cone,Epilepsy,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,158.30,62.08,318.51
CHL,Chile,Southern Cone,Epilepsy,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,112.13,24.87,261.95
CHL,Chile,Southern Cone,Epilepsy,2020,Female,All ages,Years of Life Lost (YLLs),Rate,46.18,37.20,56.56
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-4 years,Deaths,Rate,0.72,0.47,1.08
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,159.02,63.64,328.85
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,93.97,20.94,230.80
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,65.05,42.70,98.05
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-14 years,Deaths,Rate,0.49,0.35,0.70
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,154.91,52.65,338.05
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,112.70,22.89,278.28
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,42.21,29.76,59.77
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-19 years,Deaths,Rate,0.59,0.44,0.80
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,168.53,60.76,357.93
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,120.06,24.79,292.53
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,48.47,35.97,65.40
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-24 years,Deaths,Rate,0.61,0.46,0.79
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,175.18,62.51,374.49
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,127.34,26.35,311.46
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,47.84,36.17,63.03
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-27 days,Deaths,Rate,0.49,0.37,0.61
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,114.07,42.96,246.51
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,69.40,12.24,186.53
CHL,Chile,Southern Cone,Epilepsy,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,44.68,30.72,60.10
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-4 years,Deaths,Rate,0.53,0.35,0.80
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,145.09,53.05,310.76
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,97.63,21.90,239.13
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,47.46,31.14,71.63
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-9 years,Deaths,Rate,0.32,0.21,0.46
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,135.12,42.01,308.81
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,107.23,23.04,268.43
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,27.90,18.97,40.38
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-11 months,Deaths,Rate,1.72,1.13,2.58
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,235.46,120.55,430.48
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,77.29,16.77,191.79
CHL,Chile,Southern Cone,Epilepsy,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,158.16,103.77,238.67
CHL,Chile,Southern Cone,Epilepsy,2021,Male,5-9 years,Deaths,Rate,0.16,0.12,0.21
CHL,Chile,Southern Cone,Epilepsy,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,127.97,34.09,307.41
CHL,Chile,Southern Cone,Epilepsy,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,114.11,23.85,289.46
CHL,Chile,Southern Cone,Epilepsy,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,13.86,10.23,17.95
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-14 years,Deaths,Rate,0.63,0.48,0.85
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,178.41,61.72,376.88
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,127.64,23.62,308.52
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,50.76,38.10,68.37
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-24 years,Deaths,Rate,0.72,0.57,0.90
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,194.65,71.23,408.39
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,140.76,28.63,340.71
CHL,Chile,Southern Cone,Epilepsy,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,53.89,42.60,67.68
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-19 years,Deaths,Rate,0.88,0.71,1.08
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,207.60,84.02,414.98
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,141.18,30.23,333.41
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,66.42,53.78,81.57
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-24 years,Deaths,Rate,0.76,0.61,0.92
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,202.14,75.62,422.94
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,146.81,30.94,355.58
CHL,Chile,Southern Cone,Epilepsy,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,55.33,44.68,67.37
CHL,Chile,Southern Cone,Epilepsy,2021,Male,20-24 years,Deaths,Rate,0.65,0.52,0.78
CHL,Chile,Southern Cone,Epilepsy,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,197.43,68.37,429.83
CHL,Chile,Southern Cone,Epilepsy,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,151.68,31.56,374.73
CHL,Chile,Southern Cone,Epilepsy,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,45.75,36.82,55.09
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-29 years,Deaths,Rate,0.72,0.59,0.87
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,194.24,72.52,411.05
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,147.26,34.15,354.14
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,46.99,38.36,56.92
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-49 years,Deaths,Rate,1.61,1.34,1.92
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,210.35,95.04,402.86
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,125.20,24.12,301.13
CHL,Chile,Southern Cone,Epilepsy,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,85.15,70.92,101.73
CHL,Chile,Southern Cone,Epilepsy,2021,Male,30-34 years,Deaths,Rate,1.43,1.21,1.72
CHL,Chile,Southern Cone,Epilepsy,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,220.79,99.62,424.87
CHL,Chile,Southern Cone,Epilepsy,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,134.23,26.78,321.01
CHL,Chile,Southern Cone,Epilepsy,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,86.56,72.84,103.86
CHL,Chile,Southern Cone,Epilepsy,2021,Male,35-39 years,Deaths,Rate,1.54,1.29,1.79
CHL,Chile,Southern Cone,Epilepsy,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,207.04,90.65,391.22
CHL,Chile,Southern Cone,Epilepsy,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,122.00,19.17,291.94
CHL,Chile,Southern Cone,Epilepsy,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,85.03,71.47,99.29
CHL,Chile,Southern Cone,Epilepsy,2021,Male,40-44 years,Deaths,Rate,1.18,1.00,1.41
CHL,Chile,Southern Cone,Epilepsy,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,170.75,68.68,342.66
CHL,Chile,Southern Cone,Epilepsy,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,111.04,18.45,271.55
CHL,Chile,Southern Cone,Epilepsy,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,59.70,50.23,71.12
CHL,Chile,Southern Cone,Epilepsy,2021,Male,45-49 years,Deaths,Rate,3.47,2.86,4.17
CHL,Chile,Southern Cone,Epilepsy,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,262.69,150.00,441.55
CHL,Chile,Southern Cone,Epilepsy,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,104.96,19.90,251.81
CHL,Chile,Southern Cone,Epilepsy,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,157.72,130.10,189.75
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-54 years,Deaths,Rate,4.08,3.45,4.79
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,270.88,160.54,446.27
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,105.38,20.63,251.83
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,165.51,139.91,194.45
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-64 years,Deaths,Rate,4.15,3.52,4.86
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,263.96,148.34,443.08
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,114.87,21.68,268.50
CHL,Chile,Southern Cone,Epilepsy,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,149.09,126.65,174.58
CHL,Chile,Southern Cone,Epilepsy,2021,Male,55-59 years,Deaths,Rate,3.86,3.36,4.44
CHL,Chile,Southern Cone,Epilepsy,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,250.94,141.58,415.86
CHL,Chile,Southern Cone,Epilepsy,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,112.89,21.52,257.08
CHL,Chile,Southern Cone,Epilepsy,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,138.04,120.06,158.78
CHL,Chile,Southern Cone,Epilepsy,2021,Male,60-64 years,Deaths,Rate,4.56,3.80,5.42
CHL,Chile,Southern Cone,Epilepsy,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,270.21,140.71,470.34
CHL,Chile,Southern Cone,Epilepsy,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,129.12,23.19,302.65
CHL,Chile,Southern Cone,Epilepsy,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,141.09,117.51,167.68
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-69 years,Deaths,Rate,3.55,2.99,4.22
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,240.96,106.34,443.05
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,147.83,27.94,332.49
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,93.13,78.40,110.56
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-74 years,Deaths,Rate,4.22,3.52,5.06
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,254.61,112.92,482.08
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,154.09,29.03,361.69
CHL,Chile,Southern Cone,Epilepsy,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,100.51,83.89,120.39
CHL,Chile,Southern Cone,Epilepsy,2021,Male,70-74 years,Deaths,Rate,5.10,4.22,6.17
CHL,Chile,Southern Cone,Epilepsy,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,272.70,121.64,533.83
CHL,Chile,Southern Cone,Epilepsy,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,162.40,30.47,400.41
CHL,Chile,Southern Cone,Epilepsy,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,110.29,91.17,133.42
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75-79 years,Deaths,Rate,11.50,9.47,14.07
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,379.31,201.32,661.19
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,181.54,38.59,419.25
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,197.77,162.73,241.94
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75+ years,Deaths,Rate,11.80,9.53,14.45
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,352.42,168.03,646.85
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,199.00,43.66,458.79
CHL,Chile,Southern Cone,Epilepsy,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,153.41,124.37,188.06
CHL,Chile,Southern Cone,Epilepsy,2021,Male,80-84 years,Deaths,Rate,9.91,7.82,12.29
CHL,Chile,Southern Cone,Epilepsy,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,327.89,147.27,625.19
CHL,Chile,Southern Cone,Epilepsy,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,198.30,44.95,464.38
CHL,Chile,Southern Cone,Epilepsy,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,129.59,102.32,160.80
CHL,Chile,Southern Cone,Epilepsy,2021,Male,85+ years,Deaths,Rate,14.36,11.49,17.42
CHL,Chile,Southern Cone,Epilepsy,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,333.72,134.52,646.17
CHL,Chile,Southern Cone,Epilepsy,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,229.12,50.82,519.24
CHL,Chile,Southern Cone,Epilepsy,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,104.59,83.70,126.93
CHL,Chile,Southern Cone,Epilepsy,2021,Male,<1 year,Deaths,Rate,1.61,1.05,2.42
CHL,Chile,Southern Cone,Epilepsy,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,225.00,113.87,414.63
CHL,Chile,Southern Cone,Epilepsy,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,76.60,16.38,191.34
CHL,Chile,Southern Cone,Epilepsy,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,148.39,97.49,223.29
CHL,Chile,Southern Cone,Epilepsy,2021,Male,Age-standardized,Deaths,Rate,1.96,1.61,2.37
CHL,Chile,Southern Cone,Epilepsy,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,208.46,91.40,405.89
CHL,Chile,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,127.46,25.41,306.63
CHL,Chile,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,81.01,65.99,99.27
CHL,Chile,Southern Cone,Epilepsy,2021,Male,All ages,Deaths,Rate,2.38,1.96,2.86
CHL,Chile,Southern Cone,Epilepsy,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,217.90,98.34,417.46
CHL,Chile,Southern Cone,Epilepsy,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,129.55,25.66,310.37
CHL,Chile,Southern Cone,Epilepsy,2021,Male,All ages,Years of Life Lost (YLLs),Rate,88.35,72.68,107.09
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-4 years,Deaths,Rate,0.55,0.36,0.83
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,137.34,50.06,281.37
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,87.44,17.30,206.15
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,49.90,32.76,75.22
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-14 years,Deaths,Rate,0.23,0.16,0.34
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,124.63,36.32,284.00
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,103.93,22.24,253.56
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,20.71,14.08,30.44
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-19 years,Deaths,Rate,0.30,0.22,0.41
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,134.28,41.08,299.16
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,109.27,22.80,264.70
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,25.01,18.28,34.46
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-24 years,Deaths,Rate,0.26,0.20,0.36
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,136.55,39.13,310.31
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,115.09,23.30,281.09
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,21.45,15.83,29.22
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-27 days,Deaths,Rate,0.38,0.26,0.51
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,100.01,34.19,225.89
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,65.95,10.88,180.17
CHL,Chile,Southern Cone,Epilepsy,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,34.06,23.43,45.72
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-4 years,Deaths,Rate,0.50,0.33,0.75
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,135.22,47.31,280.15
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,90.56,18.00,212.74
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,44.67,29.31,67.41
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-9 years,Deaths,Rate,0.32,0.22,0.46
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,127.60,39.49,285.04
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,99.69,20.36,244.21
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,27.91,19.13,40.82
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-11 months,Deaths,Rate,0.85,0.56,1.28
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,151.83,65.84,292.93
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,73.22,14.27,174.31
CHL,Chile,Southern Cone,Epilepsy,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,78.60,51.57,118.61
CHL,Chile,Southern Cone,Epilepsy,2021,Female,5-9 years,Deaths,Rate,0.19,0.14,0.26
CHL,Chile,Southern Cone,Epilepsy,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,122.13,33.88,288.54
CHL,Chile,Southern Cone,Epilepsy,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,106.25,22.05,266.80
CHL,Chile,Southern Cone,Epilepsy,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,15.88,11.83,21.74
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,116.03,26.75,281.72
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,116.03,26.75,281.72
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-24 years,Deaths,Rate,0.21,0.17,0.26
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,140.89,37.79,325.17
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,125.50,25.35,306.24
CHL,Chile,Southern Cone,Epilepsy,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,15.39,12.44,18.93
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-19 years,Deaths,Rate,0.50,0.40,0.61
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,161.92,54.70,342.61
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,124.59,24.40,296.63
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,37.32,30.30,45.98
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-24 years,Deaths,Rate,0.30,0.25,0.37
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,152.29,42.85,345.08
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,129.84,24.71,317.47
CHL,Chile,Southern Cone,Epilepsy,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,22.44,18.14,27.60
CHL,Chile,Southern Cone,Epilepsy,2021,Female,20-24 years,Deaths,Rate,0.14,0.11,0.17
CHL,Chile,Southern Cone,Epilepsy,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,144.04,32.71,347.18
CHL,Chile,Southern Cone,Epilepsy,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,134.34,24.97,335.31
CHL,Chile,Southern Cone,Epilepsy,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,9.71,7.74,11.88
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-29 years,Deaths,Rate,0.73,0.59,0.90
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,175.86,63.66,358.01
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,128.30,25.15,299.28
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,47.56,38.51,58.73
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-49 years,Deaths,Rate,0.93,0.76,1.13
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,161.25,61.01,326.54
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,111.89,20.49,266.43
CHL,Chile,Southern Cone,Epilepsy,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,49.36,40.52,60.11
CHL,Chile,Southern Cone,Epilepsy,2021,Female,30-34 years,Deaths,Rate,0.78,0.63,0.94
CHL,Chile,Southern Cone,Epilepsy,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,165.25,60.50,342.38
CHL,Chile,Southern Cone,Epilepsy,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,118.31,22.33,285.47
CHL,Chile,Southern Cone,Epilepsy,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,46.94,38.18,56.90
CHL,Chile,Southern Cone,Epilepsy,2021,Female,35-39 years,Deaths,Rate,0.45,0.36,0.54
CHL,Chile,Southern Cone,Epilepsy,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,134.17,39.85,298.53
CHL,Chile,Southern Cone,Epilepsy,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,109.43,19.84,268.37
CHL,Chile,Southern Cone,Epilepsy,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,24.73,20.01,30.16
CHL,Chile,Southern Cone,Epilepsy,2021,Female,40-44 years,Deaths,Rate,0.77,0.64,0.92
CHL,Chile,Southern Cone,Epilepsy,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,141.79,49.85,290.57
CHL,Chile,Southern Cone,Epilepsy,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,102.84,17.35,244.05
CHL,Chile,Southern Cone,Epilepsy,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,38.96,32.51,46.52
CHL,Chile,Southern Cone,Epilepsy,2021,Female,45-49 years,Deaths,Rate,2.04,1.69,2.49
CHL,Chile,Southern Cone,Epilepsy,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,188.99,93.63,337.46
CHL,Chile,Southern Cone,Epilepsy,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,96.15,16.57,224.14
CHL,Chile,Southern Cone,Epilepsy,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,92.84,77.06,113.32
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-54 years,Deaths,Rate,1.51,1.25,1.82
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,152.21,69.89,305.16
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,90.67,18.99,231.06
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,61.54,50.89,74.11
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-64 years,Deaths,Rate,1.59,1.33,1.90
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,152.50,67.38,300.05
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,95.42,19.80,231.97
CHL,Chile,Southern Cone,Epilepsy,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,57.08,47.58,68.08
CHL,Chile,Southern Cone,Epilepsy,2021,Female,55-59 years,Deaths,Rate,1.56,1.30,1.85
CHL,Chile,Southern Cone,Epilepsy,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,149.37,67.15,298.59
CHL,Chile,Southern Cone,Epilepsy,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,93.45,20.62,232.34
CHL,Chile,Southern Cone,Epilepsy,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,55.91,46.52,66.26
CHL,Chile,Southern Cone,Epilepsy,2021,Female,60-64 years,Deaths,Rate,1.71,1.45,2.03
CHL,Chile,Southern Cone,Epilepsy,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,156.37,64.61,295.53
CHL,Chile,Southern Cone,Epilepsy,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,103.37,19.85,232.67
CHL,Chile,Southern Cone,Epilepsy,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,53.00,44.76,62.86
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-69 years,Deaths,Rate,2.14,1.80,2.54
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,168.58,70.69,318.98
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,112.45,23.56,252.53
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,56.13,47.12,66.45
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-74 years,Deaths,Rate,2.72,2.25,3.27
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,180.71,76.82,348.40
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,116.44,23.61,271.09
CHL,Chile,Southern Cone,Epilepsy,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,64.27,53.20,77.30
CHL,Chile,Southern Cone,Epilepsy,2021,Female,70-74 years,Deaths,Rate,3.45,2.82,4.21
CHL,Chile,Southern Cone,Epilepsy,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,196.15,84.62,385.82
CHL,Chile,Southern Cone,Epilepsy,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,121.52,23.68,294.71
CHL,Chile,Southern Cone,Epilepsy,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,74.63,60.94,91.11
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75-79 years,Deaths,Rate,7.01,5.67,8.60
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,250.23,122.07,457.69
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,129.64,24.58,309.84
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,120.59,97.48,147.85
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75+ years,Deaths,Rate,8.28,6.34,10.27
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,244.25,104.88,468.11
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,146.28,28.75,346.90
CHL,Chile,Southern Cone,Epilepsy,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,97.97,76.14,121.21
CHL,Chile,Southern Cone,Epilepsy,2021,Female,80-84 years,Deaths,Rate,6.29,4.76,7.85
CHL,Chile,Southern Cone,Epilepsy,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,223.89,90.04,428.15
CHL,Chile,Southern Cone,Epilepsy,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,141.64,27.77,325.48
CHL,Chile,Southern Cone,Epilepsy,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,82.25,62.27,102.67
CHL,Chile,Southern Cone,Epilepsy,2021,Female,85+ years,Deaths,Rate,11.52,8.52,14.37
CHL,Chile,Southern Cone,Epilepsy,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,254.43,96.70,515.08
CHL,Chile,Southern Cone,Epilepsy,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,170.51,34.65,410.38
CHL,Chile,Southern Cone,Epilepsy,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,83.91,62.05,104.70
CHL,Chile,Southern Cone,Epilepsy,2021,Female,<1 year,Deaths,Rate,0.81,0.54,1.22
CHL,Chile,Southern Cone,Epilepsy,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,147.38,63.14,287.18
CHL,Chile,Southern Cone,Epilepsy,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,72.60,13.98,174.82
CHL,Chile,Southern Cone,Epilepsy,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,74.78,49.16,112.37
CHL,Chile,Southern Cone,Epilepsy,2021,Female,Age-standardized,Deaths,Rate,1.03,0.83,1.27
CHL,Chile,Southern Cone,Epilepsy,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,152.70,54.89,320.06
CHL,Chile,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,111.42,21.88,268.44
CHL,Chile,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,41.28,33.01,51.62
CHL,Chile,Southern Cone,Epilepsy,2021,Female,All ages,Deaths,Rate,1.43,1.15,1.75
CHL,Chile,Southern Cone,Epilepsy,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,158.65,59.30,327.19
CHL,Chile,Southern Cone,Epilepsy,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,112.42,21.99,270.14
CHL,Chile,Southern Cone,Epilepsy,2021,Female,All ages,Years of Life Lost (YLLs),Rate,46.23,37.30,57.05
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.14
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.14
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.12,0.42
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.25,0.12,0.42
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.61,0.33,0.99
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.61,0.33,0.99
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.05
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.05
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.20,0.08,0.35
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.20,0.08,0.35
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.97,0.52,1.57
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.97,0.52,1.57
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.73,0.38,1.21
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.73,0.38,1.21
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.31,0.71,2.11
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.31,0.71,2.11
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.81,1.00,2.89
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.81,1.00,2.89
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.40,2.02,5.17
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,3.40,2.02,5.17
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Deaths,Rate,0.06,0.04,0.07
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.73,6.50,13.97
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,6.73,4.21,10.08
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.01,2.29,3.89
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.47,3.51,7.96
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,5.47,3.51,7.96
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Deaths,Rate,0.15,0.11,0.19
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,15.53,10.94,21.01
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,7.44,4.81,10.52
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,8.08,6.13,10.49
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Deaths,Rate,0.15,0.12,0.19
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,16.39,11.26,23.61
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.75,5.42,13.76
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,7.64,5.84,9.85
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.55,5.89,14.52
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,9.55,5.89,14.52
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Deaths,Rate,0.34,0.25,0.44
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,23.50,14.04,35.94
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.85,3.99,17.96
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,13.66,10.05,17.97
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Deaths,Rate,0.44,0.33,0.57
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,25.17,15.91,36.98
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,9.85,4.49,17.02
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,15.32,11.42,19.96
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Deaths,Rate,0.37,0.28,0.48
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,22.84,13.51,34.49
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,9.63,3.67,17.22
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,13.21,9.84,17.27
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Deaths,Rate,0.64,0.48,0.83
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,29.99,21.08,41.19
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,10.11,6.08,15.59
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,19.88,14.99,25.60
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Deaths,Rate,0.27,0.19,0.34
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,16.30,10.94,23.13
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,9.38,5.83,14.16
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,6.92,5.10,8.97
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Deaths,Rate,0.31,0.22,0.40
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,16.49,11.07,23.52
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.17,5.69,13.99
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,7.32,5.39,9.54
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Deaths,Rate,0.36,0.27,0.48
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,16.75,11.26,24.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.88,5.49,13.76
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,7.87,5.77,10.31
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Deaths,Rate,1.13,0.85,1.47
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,27.70,19.55,37.88
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,8.36,4.98,12.64
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,19.34,14.57,25.24
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Deaths,Rate,0.75,0.56,0.97
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,19.59,13.63,27.11
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,7.74,4.75,11.69
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,11.85,8.89,15.42
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Deaths,Rate,0.87,0.65,1.13
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,19.02,13.13,26.34
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,7.56,4.61,11.54
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,11.46,8.51,14.79
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.91,4.50,10.32
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,6.91,4.50,10.32
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,8.59,5.60,12.45
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,4.66,2.65,7.34
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.93,2.95,5.11
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,All ages,Deaths,Rate,0.15,0.11,0.20
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,10.27,6.71,14.88
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,5.45,3.10,8.60
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years of Life Lost (YLLs),Rate,4.82,3.61,6.27
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.17
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.17
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.19,0.61
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.37,0.19,0.61
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.98,0.56,1.56
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.98,0.56,1.56
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.12,0.45
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.27,0.12,0.45
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.56,0.89,2.48
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.56,0.89,2.48
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.13,0.61,1.86
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.13,0.61,1.86
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.13,1.23,3.37
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.13,1.23,3.37
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.00,1.76,4.66
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.00,1.76,4.66
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.64,3.38,8.26
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,5.64,3.38,8.26
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Deaths,Rate,0.06,0.04,0.07
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.75,7.11,20.62
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,9.85,4.89,16.92
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,2.90,2.21,3.70
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,8.60,5.14,12.84
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,8.60,5.14,12.84
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.61,4.12,20.39
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.61,4.12,20.39
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Deaths,Rate,0.31,0.24,0.40
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,27.91,17.97,42.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,12.28,6.02,22.14
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,15.63,11.94,19.93
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.21,6.13,23.31
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,13.21,6.13,23.31
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,13.19,5.94,23.59
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,13.19,5.94,23.59
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Deaths,Rate,0.12,0.09,0.15
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.04,8.87,28.43
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,13.05,5.83,23.37
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,3.99,3.04,5.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Deaths,Rate,0.18,0.14,0.22
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,19.50,10.71,31.73
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,13.17,5.84,23.73
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,6.33,4.86,8.01
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Deaths,Rate,0.20,0.15,0.26
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.98,10.39,30.62
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.74,5.69,22.70
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,6.23,4.70,7.92
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Deaths,Rate,0.72,0.54,0.95
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,31.36,20.00,47.12
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,12.37,5.87,22.19
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,19.00,14.13,24.93
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Deaths,Rate,0.68,0.51,0.89
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,28.55,17.91,43.10
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,11.87,5.50,21.29
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.68,12.41,21.81
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Deaths,Rate,0.63,0.47,0.82
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,24.90,15.19,37.89
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.22,5.02,20.13
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.68,10.17,17.76
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Deaths,Rate,0.45,0.33,0.60
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,18.01,9.86,29.35
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.28,4.19,18.98
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,7.73,5.67,10.36
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Deaths,Rate,0.53,0.38,0.70
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,17.34,10.06,27.18
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.73,4.55,17.12
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,7.61,5.52,10.06
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Deaths,Rate,1.25,0.90,1.64
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,25.92,15.58,39.76
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,9.55,3.81,18.33
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,16.36,11.77,21.43
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.23,5.59,13.88
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,9.23,5.59,13.88
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Deaths,Rate,0.09,0.07,0.12
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,9.21,5.16,14.83
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.53,3.14,11.37
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,2.68,2.02,3.45
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,All ages,Deaths,Rate,0.13,0.09,0.16
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,11.27,6.35,18.07
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,7.75,3.71,13.53
CHL,Chile,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years of Life Lost (YLLs),Rate,3.52,2.64,4.54
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.14
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.14
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.12,0.43
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.25,0.12,0.43
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.60,0.32,0.98
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.60,0.32,0.98
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.05
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.05
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.20,0.09,0.35
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.20,0.09,0.35
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.96,0.51,1.55
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.96,0.51,1.55
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.38,1.26
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.74,0.38,1.26
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.30,0.71,2.11
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.30,0.71,2.11
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.79,0.99,2.84
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,1.79,0.99,2.84
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.35,1.98,5.11
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,3.35,1.98,5.11
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Deaths,Rate,0.03,0.02,0.04
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.84,5.01,11.62
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,6.63,4.10,10.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.21,0.91,1.61
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.33,3.38,7.86
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,5.33,3.38,7.86
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.26,4.69,10.38
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,7.26,4.69,10.38
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,8.63,5.06,13.28
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,8.63,5.06,13.28
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Deaths,Rate,0.15,0.11,0.20
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,16.40,11.11,24.05
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,9.55,5.95,14.90
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.86,5.16,9.15
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,9.89,6.27,15.50
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,9.89,6.27,15.50
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Deaths,Rate,0.12,0.09,0.16
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.23,8.67,21.75
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,9.80,5.39,15.96
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,4.43,3.27,5.79
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Deaths,Rate,0.37,0.27,0.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,22.74,13.33,35.05
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,9.60,3.63,17.87
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,13.15,9.71,17.18
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,9.93,6.32,14.33
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,9.93,6.32,14.33
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Deaths,Rate,0.21,0.15,0.28
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,14.89,10.08,22.01
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,9.41,6.04,14.79
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,5.48,4.05,7.22
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Deaths,Rate,0.28,0.20,0.36
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,15.68,10.59,22.65
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,9.17,5.80,14.09
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,6.51,4.79,8.56
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Deaths,Rate,0.37,0.27,0.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,16.73,11.26,23.50
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,8.85,5.48,13.15
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,7.88,5.78,10.34
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,8.14,4.97,12.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,8.14,4.97,12.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,7.61,4.70,11.68
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,7.61,4.70,11.68
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,7.50,4.47,11.58
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,7.50,4.47,11.58
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,6.85,4.49,10.44
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,6.85,4.49,10.44
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Deaths,Rate,0.04,0.03,0.05
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,5.96,3.75,8.94
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,4.61,2.75,7.16
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,1.35,1.00,1.78
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,All ages,Deaths,Rate,0.05,0.04,0.07
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,7.16,4.52,10.73
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,5.46,3.25,8.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years of Life Lost (YLLs),Rate,1.71,1.27,2.25
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.05,0.18
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.05,0.18
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.20,0.64
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.37,0.20,0.64
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.56,1.59
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.99,0.56,1.59
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.06
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.06
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.27,0.13,0.46
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.27,0.13,0.46
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.56,0.89,2.51
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.56,0.89,2.51
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.14,0.63,1.94
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.14,0.63,1.94
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.15,1.24,3.44
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.15,1.24,3.44
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.02,1.75,4.73
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.02,1.75,4.73
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,5.66,3.39,8.32
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,5.66,3.39,8.32
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,9.82,4.68,16.83
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,9.82,4.68,16.83
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,8.63,4.90,13.40
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,8.63,4.90,13.40
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,10.60,4.32,20.38
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,10.60,4.32,20.38
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,12.05,4.89,21.52
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,12.05,4.89,21.52
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.18,6.15,22.56
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,13.18,6.15,22.56
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Deaths,Rate,0.15,0.11,0.20
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,19.08,10.84,30.39
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,12.93,6.24,22.48
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,6.15,4.61,7.91
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Deaths,Rate,0.11,0.08,0.14
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,16.62,8.85,27.25
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,12.80,5.98,22.34
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,3.82,2.86,4.90
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,13.03,5.66,22.36
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,13.03,5.66,22.36
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Deaths,Rate,0.17,0.13,0.22
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,17.69,10.02,28.95
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.38,6.03,22.16
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,5.30,3.98,6.79
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Deaths,Rate,0.39,0.28,0.51
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,22.11,12.94,34.33
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,11.90,5.48,20.96
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,10.21,7.46,13.37
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Deaths,Rate,0.49,0.36,0.65
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,23.31,14.00,36.14
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,11.62,5.43,20.79
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,11.69,8.57,15.35
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Deaths,Rate,0.63,0.46,0.83
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,24.84,15.34,38.45
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.27,5.37,20.56
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,13.57,9.97,17.88
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Deaths,Rate,0.41,0.30,0.56
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,17.37,9.65,27.40
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.28,4.51,17.74
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,7.09,5.14,9.66
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Deaths,Rate,0.57,0.41,0.76
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,16.49,9.72,25.46
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.68,4.83,16.39
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,6.81,4.90,9.07
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Deaths,Rate,0.63,0.45,0.83
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,17.69,10.14,28.15
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,9.46,4.28,17.30
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,8.23,5.86,10.85
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Deaths,Rate,0.72,0.52,0.94
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,14.40,9.45,20.80
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,9.15,5.68,13.98
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,5.25,3.77,6.83
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Deaths,Rate,0.06,0.04,0.07
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,7.82,4.09,12.91
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,6.47,3.09,11.15
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,1.35,0.99,1.76
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,All ages,Deaths,Rate,0.09,0.07,0.12
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.77,5.19,16.02
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,7.75,3.70,13.37
CHL,Chile,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years of Life Lost (YLLs),Rate,2.02,1.49,2.65
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-4 years,Deaths,Rate,1.51,1.13,1.93
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,246.28,127.95,418.03
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,109.15,25.93,241.67
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,137.13,102.02,176.36
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-14 years,Deaths,Rate,1.90,1.48,2.41
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,401.35,162.89,842.57
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,240.95,38.36,638.91
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,160.40,124.53,203.66
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-19 years,Deaths,Rate,2.23,1.77,2.77
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,506.03,194.05,"1,083.26"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,325.57,51.17,857.93
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,180.46,142.88,225.33
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-24 years,Deaths,Rate,2.41,1.93,2.97
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,583.19,213.04,"1,260.75"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,395.36,62.79,"1,029.05"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,187.83,150.25,231.71
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-27 days,Deaths,Rate,2.46,1.90,3.13
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,329.36,194.24,541.15
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,104.38,21.79,252.02
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,224.97,172.45,289.13
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-4 years,Deaths,Rate,0.98,0.78,1.22
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,201.31,97.06,357.55
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,113.13,27.21,248.56
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,88.17,69.85,108.99
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-9 years,Deaths,Rate,1.37,1.08,1.71
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,280.13,125.72,559.61
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,161.40,31.94,411.39
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,118.73,93.78,148.22
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-11 months,Deaths,Rate,4.02,2.75,5.40
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,460.59,274.30,705.10
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,89.94,20.02,206.66
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,370.65,254.28,498.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,5-9 years,Deaths,Rate,1.66,1.31,2.08
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,338.79,147.05,709.96
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,197.32,35.46,532.56
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,141.46,111.59,177.41
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-14 years,Deaths,Rate,2.51,1.98,3.19
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,609.09,211.48,"1,371.84"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,407.76,52.86,"1,116.05"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,201.33,158.62,255.79
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-24 years,Deaths,Rate,2.90,2.36,3.54
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,756.65,258.20,"1,675.58"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,539.70,81.96,"1,410.92"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,216.95,176.24,264.66
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-19 years,Deaths,Rate,3.15,2.59,3.81
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,803.79,282.68,"1,767.88"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,566.28,87.58,"1,480.92"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,237.52,195.09,286.96
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-24 years,Deaths,Rate,3.08,2.53,3.70
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,822.52,279.05,"1,811.17"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,598.59,94.94,"1,542.55"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,223.93,184.11,268.62
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,20-24 years,Deaths,Rate,3.02,2.49,3.60
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,838.64,275.93,"1,848.45"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,626.42,101.29,"1,595.62"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,212.22,174.64,252.83
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-29 years,Deaths,Rate,3.73,3.12,4.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,889.27,306.92,"1,918.97"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,645.70,103.19,"1,629.24"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,243.57,203.73,289.73
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-49 years,Deaths,Rate,4.60,3.80,5.58
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,935.25,357.88,"1,906.67"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,687.74,152.64,"1,607.11"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,247.51,205.24,299.57
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,30-34 years,Deaths,Rate,1.75,1.47,2.09
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,775.02,217.75,"1,756.13"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,669.26,129.22,"1,630.24"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,105.75,88.53,125.89
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,35-39 years,Deaths,Rate,5.55,4.67,6.52
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,009.09",422.17,"1,988.39"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,701.52,163.65,"1,627.48"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,307.56,258.52,360.91
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,40-44 years,Deaths,Rate,5.91,4.95,7.04
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,018.83",433.87,"1,954.03"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,720.75,184.45,"1,599.17"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,298.08,249.42,354.86
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,45-49 years,Deaths,Rate,6.76,5.39,8.79
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,020.98",443.68,"1,936.02"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,713.61,198.32,"1,536.22"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,307.37,245.36,399.81
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-54 years,Deaths,Rate,12.29,9.15,18.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,189.62",580.08,"2,252.98"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,690.74,208.50,"1,504.32"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,498.89,371.59,748.65
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-64 years,Deaths,Rate,18.49,12.09,32.64
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,356.96",666.96,"2,636.37"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,710.15,239.53,"1,505.92"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,646.81,427.43,"1,130.45"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,55-59 years,Deaths,Rate,19.06,12.62,33.78
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,375.59",680.81,"2,714.09"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,694.55,229.66,"1,506.71"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,681.04,451.15,"1,207.38"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,60-64 years,Deaths,Rate,25.74,15.24,49.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,548.99",761.82,"3,035.82"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,752.95,290.54,"1,507.03"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,796.04,471.28,"1,528.80"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-69 years,Deaths,Rate,42.01,24.33,82.81
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,978.12","1,019.68","3,810.49"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,877.03,382.11,"1,640.11"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,"1,101.08",637.58,"2,170.38"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-74 years,Deaths,Rate,58.81,34.68,115.34
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,374.15","1,271.46","4,526.92"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,991.62,457.30,"1,814.49"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,"1,382.53",814.17,"2,712.43"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,70-74 years,Deaths,Rate,81.59,48.73,159.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,911.18","1,612.87","5,498.39"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,147.00",559.25,"2,050.94"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,764.17","1,053.62","3,447.45"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75-79 years,Deaths,Rate,191.79,115.12,375.37
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,008.67","2,934.71","9,288.47"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,710.90",955.26,"2,833.95"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"3,297.77","1,979.44","6,454.52"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75+ years,Deaths,Rate,494.58,225.58,"1,073.35"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,878.80","4,140.76","15,108.04"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,758.31","1,644.31","4,273.58"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"5,120.49","2,496.44","10,834.46"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,80-84 years,Deaths,Rate,404.13,208.26,817.75
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,051.96","4,351.86","14,940.96"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,765.68","1,627.70","4,244.23"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"5,286.28","2,724.16","10,696.73"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,85+ years,Deaths,Rate,"1,087.99",425.13,"2,492.07"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"12,390.76","5,887.32","24,816.18"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,465.15","2,790.35","6,662.21"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"7,925.62","3,096.97","18,153.97"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,<1 year,Deaths,Rate,3.88,2.72,5.18
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,449.27,267.40,690.96
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,91.19,20.17,210.57
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,358.09,247.22,480.39
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Deaths,Rate,21.66,11.92,42.51
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,105.80",493.13,"2,217.76"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,631.56,182.63,"1,410.85"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,474.25,310.50,806.92
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,All ages,Deaths,Rate,31.92,16.67,64.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,301.87",596.02,"2,590.93"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,708.22,225.73,"1,531.20"
CHL,Chile,Southern Cone,Neurological conditions,2020,Male,All ages,Years of Life Lost (YLLs),Rate,593.65,370.29,"1,059.72"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-4 years,Deaths,Rate,1.17,0.89,1.60
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,210.52,105.02,386.70
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,103.85,23.72,240.25
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,106.67,81.30,146.46
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-14 years,Deaths,Rate,0.93,0.72,1.23
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,399.85,98.31,973.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,320.75,36.97,868.90
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,79.10,61.35,104.54
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-19 years,Deaths,Rate,1.20,0.94,1.52
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,576.99,130.55,"1,378.29"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,480.33,54.40,"1,254.62"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,96.66,76.15,123.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-24 years,Deaths,Rate,1.49,1.18,1.86
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,730.70,161.16,"1,724.44"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,616.51,70.62,"1,581.25"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,114.18,90.54,143.18
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-27 days,Deaths,Rate,2.22,1.52,2.92
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,311.18,164.47,528.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,105.01,21.38,263.06
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,206.17,143.09,265.63
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-4 years,Deaths,Rate,0.86,0.68,1.07
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,184.19,85.33,341.57
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,106.91,24.26,245.21
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,77.27,61.07,96.36
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-9 years,Deaths,Rate,0.46,0.36,0.58
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,218.13,61.24,526.82
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,177.39,29.38,474.92
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,40.75,31.86,51.91
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-11 months,Deaths,Rate,2.63,1.91,4.15
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,331.46,196.94,596.84
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,88.56,21.29,213.50
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,242.90,175.65,383.32
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,5-9 years,Deaths,Rate,0.16,0.12,0.22
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,243.45,43.27,664.99
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,229.95,33.20,646.24
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,13.50,10.07,18.75
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-14 years,Deaths,Rate,1.50,1.19,1.91
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,736.26,148.38,"1,835.67"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,615.73,53.16,"1,682.42"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,120.53,95.22,153.26
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-24 years,Deaths,Rate,2.00,1.60,2.44
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,032.20",214.19,"2,439.07"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,884.28,95.76,"2,257.78"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,147.92,118.43,181.29
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-19 years,Deaths,Rate,1.95,1.57,2.36
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,079.30",221.96,"2,526.35"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,932.84,103.82,"2,348.40"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,146.46,118.14,177.95
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-24 years,Deaths,Rate,2.21,1.78,2.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,163.10",243.30,"2,705.97"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,003.07",114.60,"2,512.27"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,160.03,128.70,193.69
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,20-24 years,Deaths,Rate,2.44,1.96,2.95
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,234.74",261.54,"2,859.53"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,063.11",123.82,"2,652.38"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,171.63,137.72,207.15
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-29 years,Deaths,Rate,1.82,1.49,2.24
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,217.59",232.58,"2,894.94"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,098.63",135.58,"2,748.64"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,118.96,97.00,146.29
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-49 years,Deaths,Rate,2.44,1.93,3.23
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,292.34",318.09,"2,865.40"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,163.69",215.85,"2,696.98"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,128.64,102.24,168.42
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,30-34 years,Deaths,Rate,1.30,1.07,1.59
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,218.50",257.09,"2,815.22"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,139.82",192.78,"2,719.37"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,78.69,64.31,95.85
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,35-39 years,Deaths,Rate,1.64,1.33,2.04
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,281.29",305.39,"2,815.49"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,190.34",231.78,"2,702.68"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,90.95,73.60,112.81
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,40-44 years,Deaths,Rate,2.32,1.91,2.84
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,343.33",362.03,"2,904.78"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,226.11",265.66,"2,761.62"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,117.22,96.37,143.16
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,45-49 years,Deaths,Rate,5.59,4.22,8.14
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,433.07",465.73,"2,903.77"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,178.92",273.67,"2,533.20"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,254.15,192.06,370.56
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-54 years,Deaths,Rate,7.41,4.78,13.47
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,405.27",460.33,"2,964.83"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,104.38",266.24,"2,417.75"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,300.90,194.10,547.07
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-64 years,Deaths,Rate,9.95,5.36,20.53
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,424.38",495.30,"3,006.37"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,075.75",304.47,"2,293.85"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,348.63,190.83,712.52
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,55-59 years,Deaths,Rate,9.03,4.96,18.53
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,380.43",471.54,"2,958.98"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,057.59",294.23,"2,296.66"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,322.83,177.31,662.32
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,60-64 years,Deaths,Rate,14.11,6.54,31.45
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,497.71",565.15,"3,111.11"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,061.27",362.97,"2,138.74"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,436.44,202.18,972.37
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-69 years,Deaths,Rate,23.92,10.80,55.38
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,760.56",760.82,"3,629.97"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,133.68",477.85,"2,178.69"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,626.88,282.98,"1,451.28"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-74 years,Deaths,Rate,39.40,17.36,91.72
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,171.42",972.81,"4,462.73"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,257.53",569.52,"2,336.04"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,913.89,403.28,"2,126.69"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,70-74 years,Deaths,Rate,59.48,25.87,138.86
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,704.16","1,247.67","5,542.53"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,418.12",688.39,"2,540.07"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,286.04",559.28,"3,002.46"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75-79 years,Deaths,Rate,170.83,69.56,405.45
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,047.69","2,364.65","10,422.61"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,110.32","1,168.67","3,450.96"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,937.37","1,195.99","6,971.65"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75+ years,Deaths,Rate,593.60,184.09,"1,448.28"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,332.41","4,070.51","19,236.08"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,710.81","2,237.34","5,643.04"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"5,621.60","1,833.17","13,593.04"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,80-84 years,Deaths,Rate,391.61,137.30,907.04
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,580.06","3,844.81","17,149.67"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,457.54","2,048.77","5,285.07"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"5,122.51","1,796.04","11,864.60"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,85+ years,Deaths,Rate,"1,265.08",359.23,"3,141.34"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"15,031.63","6,276.45","31,419.45"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,815.96","3,659.59","8,535.77"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"9,215.66","2,616.86","22,883.68"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,<1 year,Deaths,Rate,2.60,1.86,3.98
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,329.72,194.15,590.99
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,89.97,21.31,217.76
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,239.75,172.85,373.22
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Deaths,Rate,19.01,7.36,43.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,307.68",405.90,"2,863.40"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,971.45,234.67,"2,180.72"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,336.23,171.22,682.68
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,All ages,Deaths,Rate,41.82,14.43,99.47
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,688.26",575.38,"3,635.07"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,135.01",334.09,"2,421.55"
CHL,Chile,Southern Cone,Neurological conditions,2020,Female,All ages,Years of Life Lost (YLLs),Rate,553.25,241.30,"1,213.51"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-4 years,Deaths,Rate,1.59,1.16,2.08
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,256.50,130.45,464.28
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,112.31,25.55,274.68
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,144.19,104.90,189.60
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-14 years,Deaths,Rate,2.31,1.78,2.96
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,442.09,186.92,913.39
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,248.13,37.71,665.28
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,193.96,149.21,248.11
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-19 years,Deaths,Rate,2.69,2.12,3.37
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,548.35,222.79,"1,155.74"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,330.95,52.16,882.83
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,217.41,170.63,272.91
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-24 years,Deaths,Rate,2.94,2.34,3.64
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,626.97,245.11,"1,339.07"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,398.52,63.79,"1,055.61"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,228.45,181.32,283.46
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-27 days,Deaths,Rate,2.82,2.08,3.67
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,374.29,215.79,642.59
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,110.53,19.46,297.06
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,263.89,196.33,345.53
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-4 years,Deaths,Rate,0.97,0.75,1.22
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,202.53,94.06,391.85
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,115.92,26.62,282.43
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,86.61,67.44,109.42
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-9 years,Deaths,Rate,1.44,1.12,1.82
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,291.63,128.53,602.53
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,166.68,31.97,445.06
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,124.95,96.56,157.47
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-11 months,Deaths,Rate,4.68,3.15,6.40
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,525.27,311.08,823.13
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,93.77,20.57,232.42
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,431.50,290.51,590.72
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,5-9 years,Deaths,Rate,1.79,1.38,2.25
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,355.56,153.26,753.68
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,203.10,35.81,561.74
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,152.46,117.45,191.93
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-14 years,Deaths,Rate,3.48,2.74,4.43
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,691.28,270.12,"1,466.44"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,412.08,50.25,"1,110.71"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,279.20,219.87,355.73
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-24 years,Deaths,Rate,3.68,2.98,4.51
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,815.45,305.94,"1,766.50"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,539.60,83.24,"1,428.06"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,275.85,222.70,338.44
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-19 years,Deaths,Rate,3.78,3.08,4.57
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,853.19,325.69,"1,850.96"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,568.53,93.61,"1,506.89"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,284.66,232.08,344.07
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-24 years,Deaths,Rate,3.78,3.09,4.55
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,872.79,322.49,"1,905.06"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,598.49,98.48,"1,574.61"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,274.30,224.01,330.46
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,20-24 years,Deaths,Rate,3.78,3.09,4.53
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,889.73,319.72,"1,951.81"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,624.37,102.68,"1,633.11"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,265.36,217.04,318.70
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-29 years,Deaths,Rate,2.88,2.37,3.46
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,832.01,260.50,"1,824.84"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,644.06,105.42,"1,599.09"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,187.95,155.07,225.76
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-49 years,Deaths,Rate,4.10,3.36,5.04
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,907.98,333.15,"1,885.89"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,687.65,152.03,"1,615.73"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,220.33,181.12,270.16
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,30-34 years,Deaths,Rate,3.47,2.89,4.16
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,877.13,303.79,"1,915.54"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,667.96,129.34,"1,664.43"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,209.18,174.45,251.11
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,35-39 years,Deaths,Rate,3.45,2.89,4.06
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,894.03,321.69,"1,834.65"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,702.71,161.48,"1,609.72"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,191.33,160.21,224.93
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,40-44 years,Deaths,Rate,3.70,3.08,4.47
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,908.51,332.67,"1,871.45"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,721.94,177.55,"1,645.91"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,186.57,155.13,225.54
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,45-49 years,Deaths,Rate,7.54,6.00,9.83
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,056.31",473.72,"1,998.00"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,713.44,200.87,"1,550.68"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,342.88,272.84,447.33
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-54 years,Deaths,Rate,13.21,9.83,19.78
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,225.09",616.54,"2,298.94"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,688.84,217.33,"1,495.84"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,536.25,399.21,803.10
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-64 years,Deaths,Rate,19.34,12.65,34.24
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,383.48",688.68,"2,668.24"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,704.84,240.28,"1,480.03"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,678.64,448.40,"1,188.21"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,55-59 years,Deaths,Rate,20.41,13.52,36.08
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,418.16",711.94,"2,738.65"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,688.50,228.62,"1,449.25"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,729.66,483.32,"1,289.40"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,60-64 years,Deaths,Rate,25.86,15.21,50.36
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,543.32",752.90,"3,052.91"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,743.79,282.63,"1,495.46"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,799.53,470.28,"1,557.45"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-69 years,Deaths,Rate,33.24,19.01,64.75
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,732.67",878.31,"3,328.92"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,861.60,380.05,"1,631.87"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,871.06,498.26,"1,697.05"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-74 years,Deaths,Rate,57.01,33.46,110.61
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,288.25","1,222.74","4,352.10"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,968.60,449.52,"1,791.15"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,"1,319.65",773.23,"2,560.95"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,70-74 years,Deaths,Rate,88.54,52.62,171.41
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,024.85","1,679.40","5,708.63"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,110.46",541.62,"2,002.33"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,914.39","1,137.78","3,706.31"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75-79 years,Deaths,Rate,205.46,122.51,395.64
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,185.43","3,021.06","9,541.91"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,652.53",914.49,"2,738.93"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"3,532.90","2,106.57","6,802.98"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75+ years,Deaths,Rate,577.32,261.76,"1,264.45"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,579.99","4,444.24","16,784.34"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,670.56","1,590.48","4,177.31"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"5,909.43","2,853.76","12,607.03"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,80-84 years,Deaths,Rate,476.43,242.64,986.39
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,921.29","4,771.19","17,111.03"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,689.25","1,597.24","4,208.43"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"6,232.04","3,173.95","12,902.60"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,85+ years,Deaths,Rate,"1,312.06",516.71,"3,026.95"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"13,920.70","6,484.31","28,613.58"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,362.81","2,720.27","6,563.20"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"9,557.89","3,764.03","22,050.38"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,<1 year,Deaths,Rate,4.52,3.10,6.14
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,512.27,302.88,807.58
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,95.21,20.47,237.98
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,417.07,282.41,569.60
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Deaths,Rate,23.99,12.93,47.77
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,132.67",506.25,"2,283.61"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,628.44,181.10,"1,416.80"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,504.23,325.15,866.80
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,All ages,Deaths,Rate,36.16,18.53,74.33
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,347.14",617.27,"2,698.16"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,706.88,225.49,"1,538.77"
CHL,Chile,Southern Cone,Neurological conditions,2021,Male,All ages,Years of Life Lost (YLLs),Rate,640.26,391.78,"1,159.39"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-4 years,Deaths,Rate,1.33,1.00,1.83
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,225.34,111.80,413.61
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,104.53,21.24,245.77
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,120.81,90.56,167.85
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-14 years,Deaths,Rate,1.62,1.25,2.14
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,465.28,145.13,"1,065.53"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,328.39,39.59,884.10
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,136.89,105.54,181.42
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-19 years,Deaths,Rate,1.80,1.41,2.32
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,630.90,171.47,"1,462.15"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,484.37,56.60,"1,272.47"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,146.54,114.86,189.68
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-24 years,Deaths,Rate,1.70,1.34,2.17
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,755.11,179.21,"1,783.37"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,620.05,73.04,"1,610.26"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,135.06,106.17,173.11
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-27 days,Deaths,Rate,2.82,2.05,3.71
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,368.80,207.06,631.56
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,105.00,17.29,286.59
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,263.79,189.78,344.98
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-4 years,Deaths,Rate,0.87,0.69,1.10
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,186.11,83.59,350.53
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,107.53,22.01,251.69
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,78.58,61.58,98.85
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-9 years,Deaths,Rate,1.23,0.95,1.61
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,287.63,110.78,624.25
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,180.83,28.54,485.26
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,106.79,82.24,138.99
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-11 months,Deaths,Rate,3.55,2.52,5.53
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,415.92,249.60,721.28
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,88.87,17.61,211.15
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,327.05,231.99,510.12
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,5-9 years,Deaths,Rate,1.49,1.14,1.97
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,360.51,130.30,820.76
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,233.46,33.24,652.95
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,127.05,97.07,167.81
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-14 years,Deaths,Rate,2.01,1.58,2.58
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,781.07,189.28,"1,883.27"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,620.16,62.08,"1,676.24"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,160.90,127.20,207.04
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-24 years,Deaths,Rate,1.87,1.50,2.33
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,025.92",213.25,"2,465.32"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,884.40,99.91,"2,289.08"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,141.52,113.35,176.24
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-19 years,Deaths,Rate,2.31,1.88,2.83
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,105.60",246.94,"2,598.93"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,931.42,105.36,"2,385.59"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,174.18,141.58,213.34
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-24 years,Deaths,Rate,1.81,1.46,2.21
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,138.12",224.24,"2,732.04"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,005.49",117.24,"2,569.91"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,132.63,107.00,162.13
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,20-24 years,Deaths,Rate,1.38,1.10,1.68
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,165.94",204.82,"2,845.93"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,068.85",127.41,"2,727.62"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,97.08,77.41,118.31
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-29 years,Deaths,Rate,1.82,1.48,2.24
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,215.55",231.92,"2,854.61"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,096.65",135.38,"2,708.62"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,118.90,96.54,145.99
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-49 years,Deaths,Rate,3.12,2.49,4.00
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,329.79",341.15,"2,890.91"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,161.84",206.84,"2,677.53"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,167.95,134.32,213.38
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,30-34 years,Deaths,Rate,3.11,2.54,3.76
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,327.18",325.24,"2,895.39"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,139.43",172.20,"2,668.79"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,187.75,153.04,226.60
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,35-39 years,Deaths,Rate,2.38,1.92,2.91
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,320.72",335.25,"2,898.68"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,188.81",228.88,"2,737.43"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,131.91,106.37,161.24
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,40-44 years,Deaths,Rate,3.55,2.91,4.37
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,400.30",398.49,"2,940.29"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,221.10",251.57,"2,719.92"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,179.19,146.92,220.38
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,45-49 years,Deaths,Rate,5.10,3.86,7.26
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,409.19",440.87,"2,869.69"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,177.09",265.29,"2,539.35"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,232.10,175.58,330.34
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-54 years,Deaths,Rate,6.52,4.22,11.57
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,363.98",445.24,"2,830.66"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,099.36",273.87,"2,360.93"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,264.61,171.37,469.73
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-64 years,Deaths,Rate,9.89,5.26,20.51
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,415.11",493.22,"2,981.23"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,069.86",306.83,"2,272.11"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,345.25,186.39,709.12
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,55-59 years,Deaths,Rate,10.26,5.54,21.12
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,417.99",496.71,"3,039.18"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,051.44",298.68,"2,284.30"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,366.55,198.03,754.89
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,60-64 years,Deaths,Rate,13.54,6.19,30.61
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,473.63",547.25,"3,097.79"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,054.97",355.83,"2,151.11"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,418.66,191.43,946.68
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-69 years,Deaths,Rate,22.00,9.81,50.62
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,706.02",724.03,"3,491.75"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,129.43",466.99,"2,164.95"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,576.59,257.04,"1,326.80"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-74 years,Deaths,Rate,42.84,18.70,99.20
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,237.63",995.90,"4,609.13"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,254.86",566.44,"2,334.10"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,982.77,429.46,"2,275.03"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,70-74 years,Deaths,Rate,69.34,30.01,161.00
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,913.84","1,341.74","6,030.47"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,414.41",692.94,"2,549.27"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,499.43",648.79,"3,481.20"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75-79 years,Deaths,Rate,169.14,69.40,405.40
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,006.68","2,373.14","10,390.14"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,098.29","1,179.89","3,419.32"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"2,908.40","1,193.25","6,970.81"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75+ years,Deaths,Rate,833.25,256.43,"2,039.42"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"11,175.28","4,650.21","23,800.44"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,679.40","2,244.27","5,574.93"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"7,495.88","2,405.94","18,225.51"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,80-84 years,Deaths,Rate,471.59,164.32,"1,100.16"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"9,616.04","4,224.29","19,609.64"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,447.37","2,074.90","5,218.88"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"6,168.67","2,149.39","14,390.76"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,85+ years,Deaths,Rate,"1,951.76",563.10,"4,833.88"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"20,020.78","7,787.07","43,717.30"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,802.86","3,685.06","8,504.01"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"14,217.91","4,102.01","35,213.30"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,<1 year,Deaths,Rate,3.49,2.48,5.30
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,411.88,245.95,713.58
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,90.26,17.58,217.61
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,321.63,228.38,495.97
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Deaths,Rate,24.58,9.23,56.96
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,374.91",437.02,"3,000.16"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,970.46,233.12,"2,179.04"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,404.45,203.90,821.12
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,All ages,Deaths,Rate,57.73,19.42,138.21
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,840.15",633.16,"3,976.98"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,138.64",336.13,"2,424.19"
CHL,Chile,Southern Cone,Neurological conditions,2021,Female,All ages,Years of Life Lost (YLLs),Rate,701.51,297.03,"1,552.79"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.07
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.01,0.46
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.19,0.01,0.46
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-49 years,Deaths,Rate,0.03,0.03,0.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.17,1.90,4.99
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,1.88,0.72,3.59
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.29,1.18,1.40
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.56,0.12,1.20
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.56,0.12,1.20
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.26,0.49,2.27
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.26,0.49,2.27
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.63,1.31,4.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.63,1.31,4.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,45-49 years,Deaths,Rate,0.16,0.15,0.17
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.85,8.69,18.58
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.54,2.00,10.66
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,7.31,6.69,7.92
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-54 years,Deaths,Rate,0.67,0.62,0.73
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.07,30.45,50.47
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,11.76,5.16,20.82
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,27.31,25.29,29.65
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-64 years,Deaths,Rate,1.62,1.48,1.77
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,82.98,63.75,109.48
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,27.70,13.11,49.07
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,55.28,50.64,60.41
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,55-59 years,Deaths,Rate,1.66,1.52,1.82
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,84.62,64.90,110.44
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,25.17,10.62,45.42
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,59.44,54.27,65.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,60-64 years,Deaths,Rate,2.79,2.55,3.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,137.14,104.91,183.68
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,50.98,26.12,89.35
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,86.17,78.79,94.33
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-69 years,Deaths,Rate,5.28,4.82,5.76
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,238.35,186.77,301.95
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,99.95,60.35,151.12
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,138.41,126.42,150.82
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-74 years,Deaths,Rate,10.15,9.36,10.90
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,366.19,297.01,444.43
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,132.83,81.79,193.54
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,233.36,215.22,250.88
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,70-74 years,Deaths,Rate,16.75,15.52,17.88
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,539.52,446.51,637.63
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,177.41,110.87,251.07
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,362.11,335.63,386.55
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75-79 years,Deaths,Rate,42.74,39.66,45.74
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,039.96",872.67,"1,240.81"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,305.15,190.71,454.36
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,734.81,681.96,786.44
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75+ years,Deaths,Rate,81.59,72.03,88.88
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,318.14","1,073.99","1,579.88"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,386.68,241.10,569.26
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,931.46,832.90,"1,010.62"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,80-84 years,Deaths,Rate,89.41,80.21,97.13
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,609.36","1,325.87","1,917.30"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,439.85,276.67,646.73
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,169.51","1,049.20","1,270.56"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,85+ years,Deaths,Rate,136.77,116.19,150.59
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,459.09","1,131.61","1,770.66"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,462.74,285.17,673.70
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,996.34,846.44,"1,096.95"
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Deaths,Rate,3.08,2.76,3.35
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,70.82,57.04,86.86
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.78,13.44,34.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,48.04,43.60,52.01
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,All ages,Deaths,Rate,4.64,4.14,5.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,100.08,80.52,122.52
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,32.10,19.05,48.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Male,All ages,Years of Life Lost (YLLs),Rate,67.99,61.47,73.67
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.01
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.01
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.01,0.35
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.14,0.01,0.35
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.47,1.91
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.07,0.47,1.91
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.08,0.88
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.38,0.08,0.88
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.78,0.24,1.48
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.78,0.24,1.48
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.48,0.68,2.57
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.48,0.68,2.57
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.97,1.52,4.87
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.97,1.52,4.87
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,5.69,1.90,11.52
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.69,1.90,11.52
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-64 years,Deaths,Rate,0.42,0.38,0.46
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,26.74,17.14,39.69
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,13.19,4.77,24.96
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,13.55,12.36,14.73
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,55-59 years,Deaths,Rate,0.35,0.33,0.38
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,24.82,15.14,38.32
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,12.16,3.55,24.59
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,12.66,11.60,13.73
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,60-64 years,Deaths,Rate,1.01,0.92,1.10
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,54.74,38.08,75.78
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,23.56,9.68,41.86
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,31.17,28.39,33.92
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-69 years,Deaths,Rate,1.69,1.56,1.83
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,89.43,63.66,121.33
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,45.10,22.78,73.28
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,44.33,40.88,48.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-74 years,Deaths,Rate,4.12,3.77,4.45
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,155.00,119.52,195.57
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,61.47,34.07,94.52
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,93.53,85.45,101.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,70-74 years,Deaths,Rate,7.28,6.62,7.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,240.03,191.94,291.83
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,82.69,48.71,122.06
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,157.34,143.23,169.77
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75-79 years,Deaths,Rate,24.72,22.03,26.93
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,578.29,477.18,678.06
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,153.15,98.35,215.09
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,425.15,378.83,462.97
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75+ years,Deaths,Rate,51.26,41.82,57.20
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,749.53,588.41,889.74
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,200.17,132.04,279.83
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,549.36,456.37,609.92
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,80-84 years,Deaths,Rate,49.42,40.94,54.85
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,874.20,687.35,"1,036.55"
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,227.75,151.84,319.10
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,646.45,535.50,717.45
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,85+ years,Deaths,Rate,84.15,65.93,94.92
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,845.12,635.14,"1,014.14"
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,232.10,154.88,322.67
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,613.01,480.26,691.47
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Deaths,Rate,1.62,1.37,1.80
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,33.90,26.03,42.06
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,11.14,6.39,17.05
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,22.75,19.63,25.01
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,All ages,Deaths,Rate,3.47,2.87,3.86
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,62.08,47.75,76.21
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,19.48,11.57,29.19
CHL,Chile,Southern Cone,Parkinson disease,2020,Female,All ages,Years of Life Lost (YLLs),Rate,42.60,36.18,47.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.04
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.04
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.07
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.01,0.46
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.19,0.01,0.46
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-49 years,Deaths,Rate,0.03,0.02,0.03
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.02,1.83,4.80
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,1.82,0.72,3.48
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,1.21,1.11,1.32
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.54,0.14,1.15
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.54,0.14,1.15
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.22,0.50,2.18
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.22,0.50,2.18
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.53,1.30,4.48
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.53,1.30,4.48
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,45-49 years,Deaths,Rate,0.15,0.14,0.16
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.21,8.26,18.08
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.35,1.97,10.58
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,6.86,6.29,7.49
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-54 years,Deaths,Rate,0.33,0.30,0.36
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,24.57,17.62,34.92
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,11.33,5.37,20.51
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,13.24,12.26,14.41
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-64 years,Deaths,Rate,1.05,0.96,1.15
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,62.31,44.50,85.34
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.88,12.11,46.59
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,35.43,32.39,38.76
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,55-59 years,Deaths,Rate,1.10,1.00,1.21
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,64.23,46.50,88.63
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,24.79,10.61,45.40
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,39.44,35.90,43.23
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,60-64 years,Deaths,Rate,1.90,1.74,2.08
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,107.70,76.09,145.13
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,48.91,22.34,80.82
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,58.79,53.75,64.31
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-69 years,Deaths,Rate,4.81,4.38,5.25
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,212.91,167.22,269.52
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,86.91,52.37,131.95
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,126.00,114.85,137.58
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-74 years,Deaths,Rate,10.89,10.04,11.68
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,361.13,297.80,432.08
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,113.17,69.31,165.75
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,247.96,228.49,266.32
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,70-74 years,Deaths,Rate,18.95,17.53,20.21
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,557.64,470.92,647.59
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,147.98,91.76,210.57
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,409.66,379.16,437.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75-79 years,Deaths,Rate,40.25,37.27,43.23
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,941.51,792.95,"1,098.67"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,249.31,152.11,355.35
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,692.20,640.84,743.32
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75+ years,Deaths,Rate,89.22,78.36,97.48
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,290.16","1,063.65","1,512.49"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,305.87,188.50,441.03
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,984.30,875.15,"1,071.46"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,80-84 years,Deaths,Rate,93.66,83.59,101.96
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,576.72","1,313.52","1,836.72"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,351.51,220.08,503.07
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,225.20","1,093.44","1,333.65"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,85+ years,Deaths,Rate,166.77,141.80,183.89
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,566.43","1,248.52","1,857.61"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,351.59,215.51,518.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,214.85","1,032.99","1,339.59"
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Deaths,Rate,3.23,2.88,3.51
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,66.51,53.80,80.45
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,19.25,11.11,29.21
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,47.26,42.69,51.24
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,All ages,Deaths,Rate,5.02,4.45,5.47
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,96.73,78.30,116.65
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,27.47,15.97,41.49
CHL,Chile,Southern Cone,Parkinson disease,2021,Male,All ages,Years of Life Lost (YLLs),Rate,69.26,62.33,75.16
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.01
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.01
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.05
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.05
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.01,0.34
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.14,0.01,0.34
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,1.08,0.47,1.89
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.08,0.47,1.89
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.38,0.08,0.86
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.38,0.08,0.86
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.80,0.28,1.45
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.80,0.28,1.45
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.51,0.69,2.64
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.51,0.69,2.64
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.94,1.51,4.73
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,2.94,1.51,4.73
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-54 years,Deaths,Rate,0.45,0.42,0.49
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,24.07,19.21,30.76
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,5.61,2.12,10.78
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,18.46,17.09,19.98
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-64 years,Deaths,Rate,0.61,0.56,0.67
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,34.97,25.22,48.76
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,13.01,5.10,24.90
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,21.95,20.11,23.86
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,55-59 years,Deaths,Rate,0.87,0.79,0.95
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,42.56,32.03,58.05
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,11.50,3.67,24.25
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,31.06,28.37,33.81
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,60-64 years,Deaths,Rate,0.51,0.47,0.56
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,39.57,24.79,60.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,23.67,10.32,42.68
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,15.90,14.46,17.34
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-69 years,Deaths,Rate,2.73,2.51,2.96
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,119.25,91.92,153.56
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,47.81,26.18,76.02
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,71.44,65.74,77.54
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-74 years,Deaths,Rate,6.64,6.05,7.19
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,216.42,176.95,264.14
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,65.94,39.66,101.13
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,150.49,137.28,163.01
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,70-74 years,Deaths,Rate,11.61,10.56,12.57
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,340.02,285.11,404.81
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,88.99,56.81,133.07
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,251.04,228.29,271.73
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75-79 years,Deaths,Rate,23.51,20.96,25.70
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,572.35,471.43,677.40
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,168.02,110.98,235.57
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,404.34,360.45,441.83
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75+ years,Deaths,Rate,69.58,56.17,77.96
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,909.68,711.29,"1,082.89"
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,227.20,151.32,321.60
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,682.48,559.98,761.29
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,80-84 years,Deaths,Rate,51.56,42.41,57.29
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,933.89,730.61,"1,115.72"
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,259.45,175.92,366.36
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,674.44,554.69,749.35
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,85+ years,Deaths,Rate,141.11,110.83,159.29
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,299.50",986.67,"1,548.28"
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,271.57,179.31,387.92
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"1,027.93",807.36,"1,160.36"
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Deaths,Rate,2.14,1.79,2.38
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,41.56,32.66,50.94
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.10,7.28,18.49
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,29.46,25.38,32.45
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,All ages,Deaths,Rate,4.89,4.01,5.45
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,79.38,62.17,96.51
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,21.83,13.48,32.81
CHL,Chile,Southern Cone,Parkinson disease,2021,Female,All ages,Years of Life Lost (YLLs),Rate,57.55,48.69,63.70
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.22,1.15,6.43
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.22,1.15,6.43
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.02,0.98,6.10
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,3.02,0.98,6.10
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,19.55,7.09,39.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,19.55,7.09,39.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,51.46,27.79,86.58
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,51.46,27.79,86.58
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Deaths,Rate,0.76,0.15,2.41
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,134.23,68.02,245.52
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,110.64,63.34,170.89
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,23.59,4.68,74.63
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,107.59,61.81,161.19
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,107.59,61.81,161.19
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Deaths,Rate,2.95,0.58,9.34
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,297.60,138.51,603.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,206.24,120.39,314.21
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,91.35,18.12,288.94
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Deaths,Rate,2.62,0.55,7.83
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,437.00,245.90,745.16
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,368.31,231.47,540.13
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,68.68,14.43,205.02
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Deaths,Rate,11.04,2.58,32.83
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,749.58,372.20,"1,476.47"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,504.06,314.98,745.89
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,245.52,57.22,730.58
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Deaths,Rate,22.60,5.37,67.19
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,179.07",545.75,"2,481.29"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,690.57,429.72,"1,028.60"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,488.50,116.02,"1,452.69"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Deaths,Rate,36.39,8.09,104.86
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,903.35",986.11,"3,649.65"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,277.88",847.21,"1,846.88"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,625.47,138.90,"1,802.77"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Deaths,Rate,72.09,16.65,198.20
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,902.08","1,553.50","5,272.50"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,026.93","1,352.84","2,849.65"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,875.15,200.64,"2,422.84"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Deaths,Rate,91.02,21.18,244.45
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"3,519.85","1,837.32","6,410.99"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,329.11","1,559.93","3,213.11"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,190.73",277.33,"3,197.89"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Deaths,Rate,158.17,37.30,429.03
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,153.43","2,951.71","8,691.63"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,001.51","2,680.24","5,566.03"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,151.92",271.47,"3,125.60"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Deaths,Rate,3.07,0.71,8.60
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,152.74,79.71,282.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,108.87,69.69,157.75
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,43.87,10.02,125.23
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Deaths,Rate,1.81,0.42,5.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,97.08,50.26,181.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,69.32,43.95,101.23
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years of Life Lost (YLLs),Rate,27.76,6.32,79.77
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.99,1.50,7.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,3.99,1.50,7.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.73,1.06,7.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.73,1.06,7.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.90,9.41,48.01
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,23.90,9.41,48.01
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,61.16,31.44,103.29
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,61.16,31.44,103.29
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Deaths,Rate,0.54,0.11,1.66
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,155.16,81.39,267.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,137.14,77.87,211.54
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,18.01,3.52,55.59
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Deaths,Rate,0.80,0.15,2.51
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,161.09,80.28,296.88
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,132.44,75.01,207.32
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,28.65,5.27,89.55
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Deaths,Rate,0.98,0.21,2.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,283.35,155.01,465.55
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,253.01,148.65,373.40
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,30.34,6.35,92.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Deaths,Rate,3.90,0.84,11.11
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,555.32,317.04,965.85
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,452.89,295.02,674.74
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,102.43,22.02,291.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Deaths,Rate,8.76,2.10,24.68
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,818.92,447.14,"1,479.53"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,619.11,399.46,916.82
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,199.81,47.68,562.72
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Deaths,Rate,15.22,3.78,42.69
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,168.69",619.78,"2,161.13"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,839.66,538.05,"1,238.04"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,329.03,81.73,923.10
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Deaths,Rate,39.44,9.35,105.88
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,189.05","1,179.20","3,939.59"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,510.89","1,018.39","2,119.05"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,678.16,160.81,"1,820.51"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Deaths,Rate,99.53,24.17,254.56
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"3,761.13","1,987.17","6,598.18"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,634.15","1,716.07","3,680.58"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"1,126.99",271.10,"2,917.61"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Deaths,Rate,127.12,30.00,331.59
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"4,386.33","2,133.05","8,157.12"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,723.48","1,740.62","3,819.77"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"1,662.90",392.42,"4,337.39"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Deaths,Rate,199.03,49.94,489.60
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,487.85","3,612.25","10,569.92"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,038.03","3,248.60","7,003.24"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"1,449.82",363.65,"3,566.67"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Deaths,Rate,3.54,0.85,9.23
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,179.44,95.07,317.22
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,132.07,83.81,190.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,47.37,11.25,126.27
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Deaths,Rate,3.00,0.73,7.81
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,151.40,80.32,267.14
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,111.76,70.90,161.53
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years of Life Lost (YLLs),Rate,39.65,9.42,105.61
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Deaths,Rate,0.11,0.00,0.30
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,9.23,0.00,25.97
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,9.23,0.00,25.97
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Deaths,Rate,0.08,0.00,0.23
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,7.10,0.00,19.99
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,7.10,0.00,19.99
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Deaths,Rate,0.07,0.00,0.19
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.74,0.00,16.14
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,5.74,0.00,16.14
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Deaths,Rate,0.17,0.00,0.49
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,14.92,0.00,41.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,14.92,0.00,41.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Deaths,Rate,0.32,0.00,0.90
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,27.41,0.00,77.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,27.41,0.00,77.12
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Deaths,Rate,0.21,0.00,0.58
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,13.51,0.00,38.02
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,13.51,0.00,38.02
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Deaths,Rate,0.05,0.00,0.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.62,1.21,15.61
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.20,1.21,5.99
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,3.42,0.00,9.63
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.95,0.95,6.07
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.95,0.95,6.07
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,19.57,7.60,35.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,19.57,7.60,35.98
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,51.68,25.70,86.62
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,51.68,25.70,86.62
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Deaths,Rate,0.27,0.05,0.87
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,120.97,66.67,203.04
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,111.23,65.00,172.03
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,9.74,1.67,31.01
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Deaths,Rate,0.79,0.14,2.52
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,135.74,66.34,251.22
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,107.50,61.49,161.33
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,28.24,4.84,89.90
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,206.44,129.22,315.71
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,206.44,129.22,315.71
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Deaths,Rate,1.22,0.25,3.73
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,400.12,235.49,628.41
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,368.18,228.81,530.78
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,31.94,6.69,97.63
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Deaths,Rate,4.69,1.07,13.86
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,607.85,339.86,"1,054.51"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,503.13,315.98,744.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,104.73,23.87,309.56
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Deaths,Rate,9.52,2.20,27.90
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,895.79,484.52,"1,645.16"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,690.19,436.82,"1,041.82"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,205.62,47.70,603.34
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Deaths,Rate,40.21,8.99,117.56
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,964.67",987.92,"3,844.36"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,273.41",833.42,"1,822.78"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,691.26,154.51,"2,021.58"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Deaths,Rate,70.15,16.20,191.71
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,881.29","1,514.68","5,238.34"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,013.90","1,315.71","2,839.75"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,867.41,198.96,"2,398.59"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Deaths,Rate,81.64,19.04,214.97
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"3,396.89","1,752.43","6,092.37"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,328.81","1,503.22","3,280.28"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,068.14",249.15,"2,812.09"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Deaths,Rate,151.83,35.73,403.45
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,084.59","2,887.28","8,462.07"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,978.44","2,627.25","5,523.25"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,106.15",260.03,"2,938.82"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Deaths,Rate,2.64,0.60,7.27
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,146.11,76.68,262.60
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,108.65,68.94,157.62
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,37.47,7.74,104.97
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Deaths,Rate,1.53,0.34,4.23
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,93.58,48.05,170.33
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,68.92,43.37,100.75
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years of Life Lost (YLLs),Rate,24.66,4.68,69.58
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.87,1.36,7.47
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,3.87,1.36,7.47
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.71,1.27,7.24
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.71,1.27,7.24
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,23.17,8.19,44.61
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,23.17,8.19,44.61
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,60.77,32.00,97.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,60.77,32.00,97.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Deaths,Rate,0.53,0.10,1.62
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,156.32,85.27,265.54
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,138.58,81.91,211.43
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,17.73,3.36,54.11
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Deaths,Rate,0.78,0.14,2.45
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,159.69,81.96,287.78
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,131.84,77.01,200.15
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,27.85,4.94,87.63
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Deaths,Rate,0.96,0.19,2.81
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,285.63,163.99,472.66
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,256.00,157.94,385.63
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,29.63,6.04,87.02
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Deaths,Rate,7.71,1.69,21.66
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,657.34,335.72,"1,264.88"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,455.26,291.40,696.91
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,202.08,44.32,567.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Deaths,Rate,11.37,2.65,31.95
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,883.07,461.47,"1,670.05"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,616.95,399.72,922.13
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,266.12,61.74,747.92
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Deaths,Rate,16.30,3.93,45.79
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,186.93",630.73,"2,215.44"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,834.60,545.54,"1,225.28"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,352.33,85.19,990.16
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Deaths,Rate,44.11,10.66,120.40
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"2,239.65","1,167.88","4,145.62"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,481.26",984.75,"2,075.43"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,758.38,183.14,"2,070.16"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Deaths,Rate,122.95,29.87,311.89
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"3,984.30","2,028.82","7,212.04"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"2,592.66","1,693.13","3,638.90"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"1,391.65",335.70,"3,573.12"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Deaths,Rate,168.80,39.75,428.45
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"4,900.05","2,255.78","9,411.52"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,692.19","1,735.90","3,807.00"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"2,207.82",519.88,"5,604.52"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Deaths,Rate,244.52,61.21,600.37
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,804.44","3,715.36","11,395.29"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,023.43","3,269.56","7,021.62"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"1,781.06",445.85,"4,373.68"
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Deaths,Rate,4.42,1.06,11.41
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,190.26,97.84,346.37
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,131.22,83.86,190.26
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,59.05,13.99,156.11
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Deaths,Rate,3.73,0.90,9.64
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,161.02,82.96,292.59
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,111.49,71.23,161.62
PRY,Paraguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years of Life Lost (YLLs),Rate,49.54,11.73,130.97
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Deaths,Rate,2.93,1.15,7.03
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,345.27,124.66,804.98
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,80.02,20.44,168.14
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,265.25,104.22,636.84
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Deaths,Rate,1.31,0.57,2.92
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,226.34,78.09,495.42
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,109.74,27.41,234.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,116.59,50.68,261.17
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Deaths,Rate,1.13,0.51,2.43
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,219.98,73.84,476.18
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,121.50,29.51,261.92
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,98.49,44.33,214.26
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Deaths,Rate,1.03,0.49,2.14
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.70,72.77,468.45
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,130.77,32.04,282.89
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,87.93,40.73,185.55
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Deaths,Rate,0.31,0.16,1.09
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,82.16,20.11,210.15
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,47.55,9.51,116.30
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,34.61,10.76,93.85
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Deaths,Rate,2.37,0.93,5.69
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,298.67,105.96,689.94
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,86.00,22.35,179.51
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,212.67,83.61,510.43
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Deaths,Rate,1.24,0.52,2.84
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,211.17,71.21,471.50
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,100.87,25.03,217.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,110.30,46.18,254.17
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Deaths,Rate,5.63,2.21,13.50
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,575.98,217.11,"1,368.95"
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,57.07,13.13,123.54
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,518.90,203.98,"1,245.43"
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Deaths,Rate,0.27,0.17,0.42
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,136.69,41.62,285.53
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,113.53,27.30,249.52
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,23.15,14.32,36.01
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Deaths,Rate,0.59,0.35,0.91
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,186.58,63.97,366.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,139.68,35.50,293.45
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,46.89,28.47,73.26
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Deaths,Rate,0.58,0.34,0.89
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,199.73,64.10,405.39
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,156.38,38.19,338.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,43.35,25.92,66.60
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Deaths,Rate,0.52,0.31,0.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,199.05,59.85,412.83
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,160.20,36.41,353.07
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,38.85,23.43,59.76
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Deaths,Rate,0.57,0.34,0.87
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,206.35,64.17,424.82
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,164.77,39.54,361.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,41.57,24.63,63.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Deaths,Rate,0.63,0.37,0.95
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,213.39,68.34,436.40
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,169.19,42.55,369.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,44.20,25.79,66.62
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Deaths,Rate,2.21,1.42,3.35
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,304.17,132.39,571.71
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,160.13,39.48,353.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,144.04,92.91,218.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Deaths,Rate,1.56,0.99,2.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,220.67,87.30,416.92
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,132.24,30.73,284.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,88.42,56.57,132.36
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Deaths,Rate,0.86,0.55,1.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,193.55,64.94,379.59
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,141.46,31.70,303.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,52.09,33.24,75.66
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Deaths,Rate,1.13,0.73,1.66
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,185.99,67.78,354.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,123.61,27.69,263.17
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,62.38,40.09,91.62
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Deaths,Rate,1.37,0.88,2.04
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,179.58,69.05,336.90
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,110.55,24.82,234.16
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,69.03,44.23,102.74
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Deaths,Rate,2.38,1.49,3.60
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,211.44,92.11,379.11
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,102.98,24.28,215.32
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,108.46,67.83,163.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Deaths,Rate,1.37,0.80,2.11
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,154.62,56.94,308.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,98.94,24.49,222.62
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,55.69,32.45,85.71
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Deaths,Rate,1.84,1.03,2.83
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,172.14,62.57,333.22
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,107.22,26.17,233.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,64.92,36.41,99.49
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Deaths,Rate,1.59,0.89,2.39
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,162.47,57.35,308.76
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,105.66,25.79,223.60
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,56.81,31.57,85.16
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Deaths,Rate,2.91,1.58,4.52
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,212.07,78.19,404.14
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,122.10,29.27,264.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,89.96,48.94,139.81
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Deaths,Rate,3.86,2.03,5.98
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,244.04,91.20,462.95
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,142.57,37.90,306.28
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,101.45,53.32,156.69
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Deaths,Rate,3.94,2.08,6.10
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,245.41,90.44,465.22
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,149.84,40.07,317.53
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,95.57,50.38,147.69
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Deaths,Rate,4.05,2.15,6.26
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,247.30,89.40,468.32
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,159.82,43.06,333.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,87.48,46.34,135.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Deaths,Rate,3.25,1.80,5.02
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,226.49,74.79,434.28
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,170.50,43.90,347.71
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,55.99,30.88,86.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75+ years,Deaths,Rate,3.31,1.81,5.22
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,229.38,73.62,443.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,178.76,45.98,364.36
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,50.62,27.64,79.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Deaths,Rate,5.28,2.84,8.52
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,246.83,84.04,471.30
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,177.84,46.96,360.12
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,68.99,37.08,111.18
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,208.06,51.21,427.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,208.06,51.21,427.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,<1 year,Deaths,Rate,5.14,2.02,12.37
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,530.84,199.12,"1,263.05"
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,56.20,12.80,122.88
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,474.63,186.32,"1,140.17"
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Deaths,Rate,1.54,0.86,2.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,212.88,76.70,426.35
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,130.15,31.50,280.06
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,82.73,45.20,146.29
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,All ages,Deaths,Rate,1.46,0.81,2.49
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,215.35,77.42,434.52
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,130.23,31.47,280.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Male,All ages,Years of Life Lost (YLLs),Rate,85.12,45.95,153.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Deaths,Rate,1.87,0.73,4.49
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,236.96,83.17,551.29
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,67.59,16.64,144.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,169.37,66.52,406.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Deaths,Rate,0.94,0.43,2.04
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,173.12,58.71,374.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,90.53,21.75,194.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,82.59,36.95,180.01
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Deaths,Rate,0.90,0.42,1.83
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,174.52,58.74,367.95
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,98.23,23.13,210.08
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,76.29,35.61,157.86
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Deaths,Rate,0.72,0.34,1.47
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,165.50,53.41,354.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,104.16,24.78,227.40
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,61.34,28.63,126.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Deaths,Rate,0.33,0.17,1.16
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,81.17,19.42,206.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,42.99,7.64,102.58
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,38.18,11.79,103.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Deaths,Rate,1.55,0.61,3.71
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,210.90,72.44,485.84
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,72.25,17.93,153.06
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,138.65,54.51,332.78
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Deaths,Rate,0.71,0.28,1.70
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,148.30,46.63,331.14
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,84.56,21.58,178.15
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,63.74,25.06,152.99
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Deaths,Rate,3.44,1.34,8.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,366.44,136.44,871.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,49.64,11.89,111.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,316.80,124.55,760.38
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,95.04,24.68,199.51
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,95.04,24.68,199.51
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Deaths,Rate,0.90,0.53,1.42
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,183.97,67.28,361.11
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,111.86,24.44,246.84
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,72.11,42.83,114.27
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Deaths,Rate,0.54,0.31,0.84
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,163.50,52.37,334.74
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,121.32,27.92,268.85
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,42.17,24.45,65.89
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Deaths,Rate,0.74,0.41,1.13
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,179.10,58.84,345.69
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,123.49,27.65,260.45
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,55.61,31.19,85.24
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Deaths,Rate,0.36,0.20,0.55
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,153.27,44.92,321.57
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,126.05,29.65,279.85
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,27.22,15.27,41.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,128.50,31.57,298.45
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,128.50,31.57,298.45
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Deaths,Rate,0.23,0.13,0.35
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,137.06,41.19,289.24
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,122.01,32.64,266.23
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,15.05,8.55,23.01
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Deaths,Rate,0.93,0.54,1.41
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,153.54,53.33,300.42
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,104.76,24.78,226.22
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,48.78,28.54,74.20
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Deaths,Rate,1.33,0.77,2.06
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,189.37,70.62,359.69
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,109.04,24.11,235.50
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,80.33,46.52,124.19
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,98.65,22.32,204.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,98.65,22.32,204.93
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Deaths,Rate,1.02,0.61,1.50
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,144.03,49.98,279.29
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,92.68,19.44,203.66
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,51.34,30.54,75.62
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Deaths,Rate,2.73,1.61,4.13
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,213.21,94.72,383.13
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,89.16,21.41,195.12
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,124.05,73.31,188.01
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Deaths,Rate,0.66,0.37,1.02
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,114.37,35.96,245.76
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,87.46,20.93,204.49
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,26.91,15.03,41.27
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Deaths,Rate,1.86,1.03,2.81
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,159.55,57.57,309.60
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,95.61,22.18,212.97
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,63.94,35.40,96.63
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Deaths,Rate,2.38,1.32,3.58
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,179.12,68.89,332.38
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,93.99,21.41,204.53
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,85.13,47.48,127.85
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Deaths,Rate,2.92,1.59,4.42
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,199.63,74.23,372.49
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,109.49,24.97,236.08
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,90.15,49.27,136.41
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Deaths,Rate,2.58,1.41,3.95
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,191.13,64.63,372.74
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,123.50,27.64,269.15
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,67.63,36.98,103.60
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Deaths,Rate,1.47,0.80,2.25
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,167.01,51.70,331.14
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,128.45,30.61,272.07
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,38.57,21.09,59.08
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,135.02,34.55,275.94
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,135.02,34.55,275.94
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,143.47,38.42,294.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,143.47,38.42,294.79
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75+ years,Deaths,Rate,3.17,1.67,5.12
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,182.44,56.55,368.83
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,152.49,40.65,320.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,29.95,15.90,48.10
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Deaths,Rate,4.21,2.29,6.59
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,207.48,70.92,417.04
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,152.57,40.93,330.72
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,54.90,30.00,86.32
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,85+ years,Deaths,Rate,8.94,4.63,14.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,237.86,78.88,473.33
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,172.60,45.32,366.15
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,65.26,33.56,107.18
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,<1 year,Deaths,Rate,3.16,1.24,7.61
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,340.80,125.92,812.07
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,49.05,11.50,110.76
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,291.75,114.40,701.31
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Deaths,Rate,1.08,0.58,1.80
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,161.39,54.34,328.03
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,105.72,25.10,229.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,55.67,29.25,98.30
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,All ages,Deaths,Rate,1.02,0.55,1.73
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,161.12,53.89,329.61
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,105.62,25.13,229.56
PRY,Paraguay,Southern Cone,Epilepsy,2020,Female,All ages,Years of Life Lost (YLLs),Rate,55.50,28.76,100.05
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Deaths,Rate,2.73,1.04,6.83
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,334.27,115.43,809.81
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,86.48,20.61,190.75
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,247.79,94.82,619.07
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Deaths,Rate,1.32,0.58,2.97
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,232.60,76.12,525.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,116.51,25.93,262.47
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,116.08,50.19,263.48
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Deaths,Rate,1.24,0.58,2.65
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,233.20,77.85,516.32
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,126.87,29.27,286.23
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,106.33,48.59,230.10
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Deaths,Rate,1.18,0.56,2.42
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,233.51,77.73,506.70
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,135.08,31.62,301.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,98.43,46.11,205.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Deaths,Rate,0.31,0.16,1.10
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,84.42,20.87,222.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,50.84,10.83,123.18
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,33.58,10.04,98.70
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Deaths,Rate,2.15,0.82,5.37
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,286.02,96.21,687.40
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,92.84,22.25,205.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,193.18,73.96,482.40
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Deaths,Rate,0.98,0.37,2.45
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,196.74,58.30,462.35
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,108.72,24.60,242.56
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,88.02,33.70,219.79
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Deaths,Rate,5.52,2.11,13.80
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,571.63,209.45,"1,407.27"
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,62.07,14.35,134.83
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,509.55,195.10,"1,272.45"
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,122.01,26.57,274.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,122.01,26.57,274.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Deaths,Rate,1.15,0.67,1.82
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,237.14,85.23,477.12
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,144.59,31.27,331.27
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,92.55,53.97,145.86
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Deaths,Rate,1.02,0.59,1.61
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,235.73,82.02,475.78
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,158.47,37.69,354.01
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,77.26,44.34,121.78
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Deaths,Rate,0.98,0.58,1.58
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,235.24,83.65,484.18
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,161.48,40.42,365.58
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,73.76,43.23,118.61
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Deaths,Rate,0.95,0.54,1.50
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,235.01,80.39,475.09
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,165.55,40.96,365.61
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,69.46,39.42,109.49
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Deaths,Rate,0.93,0.51,1.43
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,234.79,77.23,466.31
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,169.49,41.49,365.64
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,65.30,35.74,100.67
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Deaths,Rate,1.86,1.15,2.79
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,283.68,114.94,540.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,162.07,39.93,358.39
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,121.61,75.00,182.07
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Deaths,Rate,1.60,0.98,2.44
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,224.17,86.76,430.76
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,134.76,32.01,295.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,89.41,54.75,135.57
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Deaths,Rate,0.84,0.52,1.24
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,193.94,65.66,376.53
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,143.25,34.24,301.97
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,50.68,31.42,74.56
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Deaths,Rate,0.74,0.46,1.12
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,168.08,54.44,336.66
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,127.28,28.96,274.49
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,40.80,25.48,62.17
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Deaths,Rate,3.28,2.00,5.02
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,279.34,126.64,517.99
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,114.15,25.90,264.81
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,165.19,100.75,253.18
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Deaths,Rate,1.74,1.02,2.74
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,185.11,72.11,359.62
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,105.99,25.54,235.11
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,79.12,46.57,124.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Deaths,Rate,2.61,1.46,4.18
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,207.00,81.47,398.37
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,101.10,22.11,228.59
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,105.91,59.35,169.78
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Deaths,Rate,3.11,1.68,4.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,221.65,86.95,425.36
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,108.95,25.75,245.86
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,112.70,61.20,179.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Deaths,Rate,3.95,2.13,6.23
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,247.44,101.86,463.43
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,106.21,25.83,240.48
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,141.24,76.02,222.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Deaths,Rate,2.75,1.44,4.42
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,209.67,75.52,415.85
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,124.48,31.17,279.15
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,85.19,44.35,136.70
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Deaths,Rate,1.22,0.59,1.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,175.80,53.74,367.49
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,143.86,38.03,316.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,31.94,15.71,51.02
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Deaths,Rate,3.10,1.59,4.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,221.51,75.68,439.25
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,151.25,39.68,326.99
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,70.26,35.98,112.26
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Deaths,Rate,5.71,2.97,9.11
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,284.86,106.08,538.73
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,161.48,41.97,341.57
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,123.37,64.09,197.15
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Deaths,Rate,12.38,6.62,20.26
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,388.15,154.81,722.54
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,175.45,41.17,374.28
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,212.70,113.66,348.30
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75+ years,Deaths,Rate,13.24,7.19,21.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,367.18,143.15,697.91
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,186.30,45.81,402.63
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,180.89,97.35,295.29
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Deaths,Rate,10.23,5.42,16.89
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,321.64,118.81,638.87
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,188.14,48.14,417.91
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,133.50,70.68,220.96
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,85+ years,Deaths,Rate,21.66,12.32,34.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,378.09,147.42,720.77
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,220.10,57.49,472.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,157.99,89.93,248.74
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,<1 year,Deaths,Rate,5.05,1.93,12.64
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,527.20,192.26,"1,299.22"
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,61.05,14.03,133.77
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,466.15,178.23,"1,165.45"
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Deaths,Rate,2.09,1.14,3.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,231.52,84.10,469.31
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,133.54,31.74,295.80
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,97.98,52.36,173.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,All ages,Deaths,Rate,1.84,1.00,3.15
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,230.82,83.10,471.42
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,133.53,31.65,295.74
PRY,Paraguay,Southern Cone,Epilepsy,2021,Male,All ages,Years of Life Lost (YLLs),Rate,97.28,51.45,175.68
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Deaths,Rate,1.89,0.72,4.71
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,243.96,83.74,583.06
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,73.04,18.36,155.96
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,170.92,65.38,427.10
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Deaths,Rate,0.66,0.25,1.66
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,156.50,45.46,363.42
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,96.32,22.44,213.04
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,60.18,23.02,150.38
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Deaths,Rate,0.51,0.20,1.28
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,149.99,42.07,344.27
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,103.72,24.37,228.65
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,46.27,17.70,115.62
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Deaths,Rate,0.59,0.26,1.32
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,159.16,47.49,356.02
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,109.11,26.20,242.12
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,50.05,21.29,113.90
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Deaths,Rate,0.33,0.17,1.17
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,84.55,20.55,225.90
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,47.95,9.52,118.30
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,36.59,10.86,107.60
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Deaths,Rate,1.56,0.60,3.89
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,217.40,73.44,513.71
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,77.65,19.94,164.73
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,139.75,53.50,348.98
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Deaths,Rate,0.71,0.27,1.77
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,154.18,45.43,356.77
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,90.52,21.06,197.80
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,63.66,24.37,158.97
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Deaths,Rate,3.49,1.33,8.70
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,376.38,135.23,923.06
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,55.25,12.29,121.13
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,321.12,122.96,801.93
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,101.29,21.99,225.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,101.29,21.99,225.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,117.27,27.55,264.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,117.27,27.55,264.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Deaths,Rate,0.32,0.17,0.51
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,147.94,42.97,317.11
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,125.69,30.72,280.98
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,22.26,12.25,36.14
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,128.34,30.78,280.56
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,128.34,30.78,280.56
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Deaths,Rate,0.48,0.26,0.77
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,163.50,50.79,343.96
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,129.95,32.33,289.49
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,33.54,18.46,54.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Deaths,Rate,0.94,0.52,1.52
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,197.27,70.02,404.86
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,131.50,33.81,298.07
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,65.77,36.20,106.79
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Deaths,Rate,0.86,0.46,1.37
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,180.66,57.55,371.75
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,124.71,27.47,282.32
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,55.95,30.08,89.43
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Deaths,Rate,1.52,0.85,2.41
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,194.39,72.71,373.26
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,107.10,23.74,235.05
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,87.29,48.97,138.21
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Deaths,Rate,2.44,1.35,3.91
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,258.67,107.28,476.57
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,111.53,25.54,240.39
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,147.14,81.74,236.19
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Deaths,Rate,2.37,1.36,3.69
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,232.15,96.48,417.58
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,101.14,21.32,213.55
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,131.01,75.15,204.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Deaths,Rate,0.56,0.32,0.87
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,123.46,37.47,255.94
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,95.26,21.14,211.90
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,28.21,16.34,44.04
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Deaths,Rate,1.06,0.61,1.65
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,138.99,48.35,275.46
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,90.90,20.67,200.43
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,48.09,27.68,75.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,89.89,18.21,198.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,89.89,18.21,198.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Deaths,Rate,1.07,0.59,1.66
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,136.06,41.59,274.87
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,99.28,21.39,217.39
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,36.78,20.20,57.48
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Deaths,Rate,2.32,1.28,3.62
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,180.68,67.57,344.48
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,97.78,21.85,214.93
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,82.91,45.72,129.55
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Deaths,Rate,0.96,0.51,1.49
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,143.72,41.16,293.55
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,114.32,25.26,247.60
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,29.41,15.89,45.95
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,128.83,30.72,291.74
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,128.83,30.72,291.74
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Deaths,Rate,0.77,0.42,1.20
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,148.38,40.05,316.66
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,131.82,31.06,290.54
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,16.56,8.98,26.11
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Deaths,Rate,1.80,0.98,2.83
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,174.69,52.60,350.21
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,135.84,31.53,288.93
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,38.85,21.08,61.27
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,144.55,37.19,302.31
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,144.55,37.19,302.31
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75+ years,Deaths,Rate,7.47,3.93,12.08
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,228.73,77.61,445.08
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,153.68,37.73,324.13
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,75.04,39.88,120.92
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Deaths,Rate,12.57,6.82,20.00
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,317.16,124.68,589.14
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,152.80,35.55,327.40
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,164.31,89.14,261.69
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,85+ years,Deaths,Rate,17.98,9.20,29.53
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,306.80,109.04,585.23
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,175.87,41.84,370.14
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,130.93,67.20,215.03
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,<1 year,Deaths,Rate,3.21,1.23,8.01
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,350.21,124.95,860.56
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,54.60,12.04,120.88
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,295.62,112.91,739.69
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Deaths,Rate,1.18,0.62,2.02
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,167.77,55.11,347.28
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,109.43,25.25,240.90
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,58.35,29.86,106.37
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,All ages,Deaths,Rate,1.16,0.61,2.02
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,170.12,56.12,352.97
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,109.35,25.26,240.85
PRY,Paraguay,Southern Cone,Epilepsy,2021,Female,All ages,Years of Life Lost (YLLs),Rate,60.77,30.85,112.11
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.13,0.45
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.13,0.45
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.19
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.19
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.23,0.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.45,0.23,0.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.36,0.17,0.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.36,0.17,0.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.33,1.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.62,0.33,1.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.48,1.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.87,0.48,1.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Deaths,Rate,0.25,0.11,0.47
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,17.66,8.04,32.89
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.66,0.95,2.56
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,16.00,7.09,30.33
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Deaths,Rate,0.06,0.03,0.12
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.82,4.16,13.37
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.71,2.34,5.58
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.11,1.82,7.79
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.79,1.67,4.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.79,1.67,4.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.12,2.60,6.22
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,4.12,2.60,6.22
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.38,3.47,8.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.38,3.47,8.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.53,4.36,9.55
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.53,4.36,9.55
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Deaths,Rate,0.69,0.33,1.36
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,35.32,18.35,65.71
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.48,5.00,10.67
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,27.84,13.35,55.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Deaths,Rate,0.27,0.13,0.54
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,18.81,10.12,33.59
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.68,4.78,11.59
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,11.13,5.33,22.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.84,4.65,12.45
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.84,4.65,12.45
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.78,4.61,11.88
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,7.78,4.61,11.88
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,7.67,4.65,11.33
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,7.67,4.65,11.33
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,7.57,4.66,11.24
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,7.57,4.66,11.24
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,7.42,4.67,11.12
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,7.42,4.67,11.12
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Deaths,Rate,3.25,1.41,6.10
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,63.21,29.44,115.56
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.19,4.93,10.40
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,55.99,24.48,105.16
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Deaths,Rate,1.78,0.77,3.34
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,37.39,18.03,67.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.74,4.62,9.76
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,30.63,13.39,57.53
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.59,4.54,9.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.59,4.54,9.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.54,3.73,8.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.54,3.73,8.06
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Deaths,Rate,0.11,0.05,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,6.76,3.62,11.69
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,3.14,1.97,4.73
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,3.61,1.65,6.96
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Deaths,Rate,0.09,0.04,0.16
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,5.96,3.17,10.35
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,2.70,1.68,4.08
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years of Life Lost (YLLs),Rate,3.26,1.49,6.27
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.06,0.02,0.10
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.06,0.02,0.10
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.09,0.33
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.19,0.09,0.33
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.47,0.25,0.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.47,0.25,0.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.06,0.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.06,0.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.80,0.43,1.31
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.80,0.43,1.31
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.33,1.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.62,0.33,1.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.12,0.62,1.83
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,1.12,0.62,1.83
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.60,0.90,2.55
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.60,0.90,2.55
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.12,1.80,4.79
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.12,1.80,4.79
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.51,3.71,10.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,6.51,3.71,10.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.14,3.17,7.66
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.14,3.17,7.66
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.41,4.70,10.61
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,7.41,4.70,10.61
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,9.26,5.62,14.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,9.26,5.62,14.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.51,4.47,19.57
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,10.51,4.47,19.57
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Deaths,Rate,0.66,0.34,1.19
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,38.73,19.07,70.17
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,11.82,5.23,21.96
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,26.91,13.83,48.21
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Deaths,Rate,0.53,0.27,0.95
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,32.50,15.69,58.93
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,12.29,5.62,22.65
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,20.21,10.07,36.27
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Deaths,Rate,0.79,0.38,1.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,41.19,19.71,74.82
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,12.81,6.05,23.78
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,28.38,13.66,51.03
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,12.29,5.62,22.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.29,5.62,22.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Deaths,Rate,1.28,0.60,2.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,45.79,20.82,84.87
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,11.98,5.29,21.31
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,33.82,15.54,63.57
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Deaths,Rate,2.35,1.05,4.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,66.04,29.63,122.93
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,11.74,5.33,20.80
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,54.30,24.30,102.14
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Deaths,Rate,3.76,1.65,7.08
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,92.90,41.31,173.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.42,5.38,20.12
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,81.48,35.93,153.32
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,11.22,4.89,20.17
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,11.22,4.89,20.17
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,10.62,4.62,18.94
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,10.62,4.62,18.94
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.64,4.71,18.65
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,10.64,4.71,18.65
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.25,3.88,16.54
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,9.25,3.88,16.54
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Deaths,Rate,0.19,0.09,0.36
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,10.75,5.27,19.09
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,5.22,2.65,8.92
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,5.54,2.62,10.18
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Deaths,Rate,0.16,0.08,0.30
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.40,4.64,16.61
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,4.72,2.42,8.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years of Life Lost (YLLs),Rate,4.69,2.22,8.61
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.04,0.01,0.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.11,0.05,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.11,0.05,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.26,0.14,0.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.26,0.14,0.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.20
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.45,0.24,0.74
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.45,0.24,0.74
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.36,0.19,0.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.36,0.19,0.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.62,0.34,1.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.62,0.34,1.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.87,0.49,1.41
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.87,0.49,1.41
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,1.66,0.94,2.60
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,1.66,0.94,2.60
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.76,2.36,5.60
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.76,2.36,5.60
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,2.81,1.69,4.35
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,2.81,1.69,4.35
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,4.17,2.60,6.14
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,4.17,2.60,6.14
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.45,3.44,8.05
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.45,3.44,8.05
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.59,4.43,9.47
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,6.59,4.43,9.47
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,7.32,4.34,11.01
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,7.32,4.34,11.01
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.60,4.63,11.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,7.60,4.63,11.62
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,7.78,4.84,12.09
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,7.78,4.84,12.09
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,7.78,4.81,11.91
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,7.78,4.81,11.91
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,7.68,4.63,12.34
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,7.68,4.63,12.34
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,7.54,4.50,11.88
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,7.54,4.50,11.88
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,7.33,4.33,11.26
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,7.33,4.33,11.26
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,7.22,4.91,10.40
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,7.22,4.91,10.40
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,6.77,4.59,9.75
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,6.77,4.59,9.75
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,6.61,4.46,9.49
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,6.61,4.46,9.49
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,5.54,3.70,8.01
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,5.54,3.70,8.01
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,3.14,1.94,4.76
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,3.14,1.94,4.76
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,2.72,1.68,4.13
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,2.72,1.68,4.13
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.02,0.10
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.05,0.02,0.10
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.18,0.09,0.32
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.18,0.09,0.32
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.46,0.25,0.74
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.46,0.25,0.74
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.16,0.06,0.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.16,0.06,0.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.79,0.44,1.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.79,0.44,1.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.61,0.32,1.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.61,0.32,1.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.63,1.80
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,1.11,0.63,1.80
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.59,0.92,2.53
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,1.59,0.92,2.53
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,3.11,1.79,4.71
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,3.11,1.79,4.71
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Deaths,Rate,0.09,0.04,0.18
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.17,5.74,19.27
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,6.50,3.61,10.30
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,4.67,2.12,8.97
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,5.15,3.23,7.73
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,5.15,3.23,7.73
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,7.46,4.69,10.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,7.46,4.69,10.77
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Deaths,Rate,0.56,0.25,1.07
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,37.46,18.26,68.79
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,9.25,5.43,14.60
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,28.21,12.83,54.18
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,10.18,3.79,18.84
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,10.18,3.79,18.84
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Deaths,Rate,0.64,0.30,1.22
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,37.77,17.73,70.58
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,11.58,5.43,21.23
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,26.20,12.30,49.35
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Deaths,Rate,0.51,0.24,0.96
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,30.03,13.93,55.71
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,12.05,5.54,21.57
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,17.98,8.39,34.13
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,12.37,5.36,21.85
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,12.37,5.36,21.85
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Deaths,Rate,0.96,0.44,1.82
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,41.72,19.56,78.09
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,12.31,5.93,21.71
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,29.41,13.62,56.38
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,12.01,5.64,21.64
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,12.01,5.64,21.64
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.05,5.60,21.65
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,12.05,5.60,21.65
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.10,5.55,21.66
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,12.10,5.55,21.66
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Deaths,Rate,2.44,1.02,5.04
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,53.03,23.08,107.12
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,11.21,5.34,20.45
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,41.81,17.74,86.69
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Deaths,Rate,1.22,0.51,2.52
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,31.55,13.76,62.46
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,10.68,4.90,19.19
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,20.88,8.86,43.29
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,10.69,4.78,19.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,10.69,4.78,19.02
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,9.42,4.07,16.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,9.42,4.07,16.48
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Deaths,Rate,0.14,0.06,0.28
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,10.18,4.90,18.43
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,5.18,2.61,8.80
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,4.99,2.28,9.63
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Deaths,Rate,0.12,0.06,0.24
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,9.08,4.40,16.35
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,4.73,2.42,7.98
PRY,Paraguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years of Life Lost (YLLs),Rate,4.34,1.98,8.38
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Deaths,Rate,4.27,2.42,6.91
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,482.88,244.07,827.45
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,95.46,24.47,200.32
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,387.43,219.60,627.13
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Deaths,Rate,2.79,1.65,4.40
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,660.10,183.11,"1,459.97"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,418.59,40.88,"1,078.40"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,241.50,142.24,381.57
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Deaths,Rate,2.86,1.70,4.48
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,796.70,193.46,"1,804.07"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,557.15,51.70,"1,427.93"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,239.55,141.75,376.15
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Deaths,Rate,2.71,1.61,4.23
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,853.92,192.55,"1,963.19"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,632.31,61.33,"1,617.00"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,221.62,131.22,346.19
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Deaths,Rate,0.78,0.47,1.09
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,141.09,51.91,289.19
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,75.61,15.12,185.05
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,65.32,36.79,104.14
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Deaths,Rate,3.19,1.80,5.26
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,387.76,188.43,683.94
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,101.88,26.61,212.11
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,285.88,161.82,471.83
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Deaths,Rate,2.05,1.20,3.32
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,398.98,139.52,824.86
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,217.49,33.50,531.33
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,181.49,106.02,293.53
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Deaths,Rate,9.38,5.33,14.76
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,934.15,507.23,"1,510.50"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,69.32,16.03,150.16
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,864.83,491.22,"1,360.34"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Deaths,Rate,1.09,0.69,1.66
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,408.53,97.88,944.83
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,315.91,39.37,803.10
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,92.61,58.51,141.73
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Deaths,Rate,2.92,1.79,4.46
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,132.96",204.91,"2,736.69"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,898.49,61.26,"2,378.45"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,234.47,143.65,358.24
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Deaths,Rate,2.70,1.63,4.12
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,155.90",206.85,"2,763.60"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,951.38,83.33,"2,451.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,204.51,123.52,312.14
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Deaths,Rate,3.10,1.86,4.76
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,246.57",227.52,"2,937.30"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"1,013.46",87.36,"2,579.01"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,233.11,140.17,358.29
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Deaths,Rate,2.59,1.55,3.95
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,167.42",207.82,"2,777.12"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,977.97,94.42,"2,488.15"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,189.45,113.40,288.97
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Deaths,Rate,2.10,1.24,3.16
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,091.03",188.80,"2,622.53"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,943.71,101.23,"2,400.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,147.32,87.56,222.07
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Deaths,Rate,3.92,2.56,5.90
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,122.64",262.70,"2,543.14"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,866.57,95.88,"2,157.75"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,256.08,166.83,385.39
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Deaths,Rate,4.22,2.66,6.42
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,039.26",264.64,"2,320.73"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,805.07,116.61,"1,966.16"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,234.19,148.02,354.57
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Deaths,Rate,2.88,1.83,4.21
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,991.31,215.20,"2,316.17"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,817.68,104.90,"2,062.22"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,173.63,110.30,253.96
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Deaths,Rate,3.94,2.53,5.79
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,003.45",257.42,"2,199.87"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,785.10,117.35,"1,879.40"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,218.34,140.07,320.46
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Deaths,Rate,5.02,3.14,7.55
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,020.49",290.51,"2,235.43"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,767.38,131.83,"1,854.64"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,253.11,158.68,380.78
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Deaths,Rate,6.55,3.89,10.74
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,041.55",332.96,"2,194.58"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,743.27,156.02,"1,705.95"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,298.27,176.95,488.63
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Deaths,Rate,10.28,5.24,19.81
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,138.72",385.86,"2,413.00"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,721.09,173.01,"1,608.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,417.62,212.84,804.21
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Deaths,Rate,11.85,5.09,26.34
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,170.31",400.66,"2,532.14"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,750.98,217.47,"1,612.34"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,419.32,183.18,919.81
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Deaths,Rate,7.95,3.33,17.36
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,025.52",334.95,"2,214.64"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,741.49,215.84,"1,593.97"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,284.02,119.11,620.67
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Deaths,Rate,19.44,7.18,48.34
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,410.96",510.59,"3,137.03"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,809.81,288.43,"1,642.15"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,601.15,222.16,"1,494.89"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Deaths,Rate,19.39,7.19,47.10
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,465.23",603.58,"3,082.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,956.90,414.98,"1,848.50"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,508.33,188.59,"1,234.29"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Deaths,Rate,31.82,12.82,75.50
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,828.13",798.40,"3,787.44"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,088.66",502.01,"2,029.89"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,739.47,296.39,"1,757.55"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Deaths,Rate,48.89,20.56,114.53
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,326.76","1,066.08","4,755.61"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,269.70",621.58,"2,279.10"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,057.05",444.51,"2,476.50"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Deaths,Rate,101.52,43.75,226.31
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,613.53","1,815.28","6,945.39"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,868.08","1,062.94","3,053.95"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,745.45",752.37,"3,891.44"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Deaths,Rate,144.21,54.95,334.98
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,474.78","2,309.35","8,296.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,614.81","1,571.94","4,039.38"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,859.97",737.44,"4,257.61"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Deaths,Rate,154.34,59.51,351.60
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"4,943.50","2,572.20","8,991.65"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,924.93","1,793.59","4,392.77"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"2,018.57",778.60,"4,598.89"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Deaths,Rate,269.35,84.38,669.76
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,529.84","3,498.99","11,594.76"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,567.54","2,884.78","6,715.52"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,962.30",614.31,"4,879.23"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Deaths,Rate,8.58,4.87,13.51
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,861.66,465.63,"1,398.87"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,69.90,15.95,153.35
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,791.76,449.67,"1,245.52"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Deaths,Rate,10.64,4.76,22.61
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,133.43",346.89,"2,473.77"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,801.84,175.26,"1,849.01"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,331.59,171.63,624.77
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,All ages,Deaths,Rate,7.94,3.76,16.18
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,057.15",302.51,"2,336.62"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,759.74,142.32,"1,799.24"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Male,All ages,Years of Life Lost (YLLs),Rate,297.41,160.19,537.38
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Deaths,Rate,2.89,1.60,4.94
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,343.10,165.01,619.41
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,80.68,20.08,172.31
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,262.43,144.94,447.10
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Deaths,Rate,1.94,1.11,3.18
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,795.22,133.27,"1,883.29"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,627.31,37.25,"1,608.34"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,167.92,96.02,274.96
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Deaths,Rate,2.18,1.26,3.49
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,019.50",156.43,"2,418.05"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,838.84,52.42,"2,128.21"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,180.66,104.02,289.84
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Deaths,Rate,2.02,1.17,3.22
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,110.48",161.52,"2,643.18"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,946.37,66.94,"2,380.86"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,164.11,94.58,262.32
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Deaths,Rate,0.66,0.33,1.00
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,124.49,42.16,260.61
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,68.55,12.12,163.83
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,55.94,30.04,96.94
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Deaths,Rate,2.22,1.20,3.88
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,284.68,129.38,529.60
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,85.61,21.53,180.93
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,199.07,107.85,348.68
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Deaths,Rate,1.37,0.76,2.34
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,403.24,96.89,894.80
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,281.57,29.85,687.31
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,121.67,67.04,207.49
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Deaths,Rate,6.08,3.46,9.90
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,620.46,333.13,"1,047.96"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,60.30,14.53,135.41
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,560.16,318.60,912.56
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Deaths,Rate,0.65,0.38,1.03
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,504.13,69.25,"1,205.54"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,448.32,36.94,"1,118.18"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,55.80,32.31,87.36
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Deaths,Rate,2.24,1.35,3.49
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,623.34",165.70,"4,052.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,443.08",57.19,"3,772.84"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,180.27,108.51,279.62
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Deaths,Rate,2.18,1.29,3.35
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,618.79",193.14,"3,926.04"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"1,453.37",95.48,"3,671.48"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,165.42,97.67,254.56
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Deaths,Rate,2.96,1.73,4.50
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,754.95",232.36,"4,171.66"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"1,532.50",102.14,"3,832.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,222.45,130.22,338.66
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Deaths,Rate,2.15,1.25,3.29
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,616.51",206.85,"3,862.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,458.51",114.60,"3,620.86"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,158.00,92.25,242.04
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Deaths,Rate,1.37,0.80,2.13
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,483.77",182.40,"3,566.86"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,387.56",126.55,"3,417.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,96.20,55.84,149.41
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Deaths,Rate,1.61,0.93,2.48
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,397.35",187.09,"3,307.18"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,291.97",126.02,"3,145.19"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,105.38,61.08,161.99
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Deaths,Rate,2.17,1.25,3.49
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,398.10",229.89,"3,191.05"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,281.82",162.65,"3,004.95"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,116.28,67.25,186.10
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Deaths,Rate,1.66,0.99,2.57
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,368.07",195.35,"3,117.03"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,267.66",135.89,"2,961.89"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,100.41,59.46,155.14
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Deaths,Rate,0.42,0.25,0.64
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,310.03",189.53,"2,974.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,286.53",175.54,"2,938.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,23.50,13.99,35.56
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Deaths,Rate,3.56,2.13,5.44
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,486.57",300.93,"3,316.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,306.87",193.61,"3,042.29"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,179.70,107.33,274.50
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Deaths,Rate,4.91,2.68,8.72
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,474.96",341.44,"3,273.14"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,251.66",219.38,"2,876.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,223.30,122.06,396.68
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Deaths,Rate,3.98,1.76,8.57
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,339.20",316.53,"2,950.88"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,177.72",245.35,"2,602.85"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,161.48,71.17,348.03
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Deaths,Rate,6.59,2.32,16.39
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,392.91",374.62,"3,069.41"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,165.11",293.18,"2,507.27"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,227.81,81.44,562.14
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Deaths,Rate,5.57,1.93,13.92
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,344.32",355.30,"2,951.37"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,145.40",286.20,"2,454.06"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,198.92,69.09,497.31
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Deaths,Rate,11.67,3.62,30.88
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,533.16",483.46,"3,392.81"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,172.29",371.29,"2,437.72"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,360.88,112.17,955.09
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Deaths,Rate,14.23,4.22,36.47
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,659.20",625.38,"3,452.08"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,286.21",514.63,"2,496.01"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,372.98,110.76,956.05
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Deaths,Rate,23.56,7.64,59.24
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,963.74",797.23,"4,055.07"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,417.07",620.96,"2,678.59"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,546.66,176.27,"1,376.47"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Deaths,Rate,35.95,12.18,89.46
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,367.82","1,025.25","4,855.16"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,590.71",762.05,"2,920.85"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,777.11,263.20,"1,934.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Deaths,Rate,53.22,17.51,127.95
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,127.57","1,542.90","5,838.76"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,212.33","1,241.97","3,638.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,915.24,300.93,"2,199.97"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Deaths,Rate,138.25,41.43,330.48
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,869.06","2,415.74","8,854.43"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,316.63","1,940.81","5,135.65"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"1,552.42",474.94,"3,718.78"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Deaths,Rate,173.31,53.19,416.87
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,669.36","2,662.44","10,703.58"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,402.56","1,966.50","5,250.53"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"2,266.80",695.98,"5,453.04"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Deaths,Rate,284.13,80.05,674.33
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,752.30","4,057.66","13,256.53"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,682.36","3,474.50","8,344.34"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"2,069.89",583.16,"4,912.19"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Deaths,Rate,5.58,3.16,9.13
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,575.87,306.97,977.19
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,61.04,14.31,137.96
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,514.84,292.68,839.24
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Deaths,Rate,7.99,2.94,18.02
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,419.48",318.92,"3,180.76"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,199.15",218.70,"2,737.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,220.33,100.22,443.46
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,All ages,Deaths,Rate,7.04,2.64,15.69
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,377.31",295.65,"3,104.69"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,170.37",198.92,"2,697.18"
PRY,Paraguay,Southern Cone,Neurological conditions,2020,Female,All ages,Years of Life Lost (YLLs),Rate,206.94,96.74,407.51
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Deaths,Rate,4.04,2.17,6.80
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,469.01,221.91,843.43
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,102.88,24.74,226.39
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,366.13,197.17,617.04
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Deaths,Rate,3.04,1.74,4.88
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,690.36,188.98,"1,544.08"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,428.89,39.38,"1,122.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,261.47,149.60,421.09
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Deaths,Rate,3.29,1.90,5.27
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,836.36,208.46,"1,909.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,563.75,51.57,"1,471.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,272.60,156.89,437.91
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Deaths,Rate,3.19,1.83,5.09
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,894.67,208.33,"2,066.67"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,636.83,60.47,"1,654.48"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,257.84,147.86,412.19
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Deaths,Rate,0.63,0.31,1.10
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,144.67,53.04,299.86
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,80.97,17.26,196.45
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,63.71,35.93,103.40
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Deaths,Rate,2.92,1.51,5.09
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,371.53,162.31,698.67
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,109.68,26.56,241.42
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,261.86,135.74,457.25
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Deaths,Rate,2.21,1.22,3.66
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,422.65,140.58,897.85
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,228.74,33.12,575.01
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,193.91,107.45,322.83
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Deaths,Rate,9.27,5.24,14.87
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,930.36,501.04,"1,534.75"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,75.18,17.47,163.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,855.16,483.57,"1,371.48"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Deaths,Rate,1.61,0.98,2.47
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,465.43,122.39,"1,064.55"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,328.39,38.61,854.22
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,137.04,83.78,210.33
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Deaths,Rate,3.46,2.08,5.32
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,184.94",223.80,"2,857.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,907.31,56.82,"2,430.49"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,277.64,166.98,427.31
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Deaths,Rate,3.45,2.01,5.39
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,214.81",234.59,"2,901.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,954.23,82.16,"2,494.38"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,260.59,152.43,407.61
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Deaths,Rate,4.12,2.41,6.56
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,323.95",273.52,"3,131.63"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,"1,014.15",92.26,"2,637.56"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,309.80,181.26,494.07
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Deaths,Rate,3.44,1.98,5.43
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,230.06",240.09,"2,924.55"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,978.17,95.09,"2,526.99"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,251.89,145.00,397.57
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Deaths,Rate,2.79,1.56,4.33
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,139.29",207.78,"2,724.36"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,943.39,97.83,"2,420.09"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,195.90,109.95,304.28
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Deaths,Rate,3.72,2.32,5.57
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,110.37",251.66,"2,529.93"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,867.15,100.18,"2,166.43"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,243.22,151.48,363.50
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Deaths,Rate,3.62,2.19,5.61
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,007.83",243.77,"2,266.26"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,804.91,120.73,"1,953.64"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,202.91,123.04,312.62
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Deaths,Rate,2.80,1.72,4.16
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,982.22,211.93,"2,226.71"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,813.27,108.13,"1,975.47"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,168.95,103.80,251.24
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Deaths,Rate,2.46,1.53,3.74
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,920.82,205.03,"2,097.46"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,784.83,120.46,"1,890.26"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,135.99,84.57,207.20
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Deaths,Rate,5.73,3.41,8.98
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,059.92",314.75,"2,331.92"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,770.84,142.59,"1,878.73"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,289.08,172.16,453.19
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Deaths,Rate,4.06,2.26,6.91
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,932.01,257.12,"2,025.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,747.39,154.22,"1,711.21"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,184.62,102.90,314.58
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Deaths,Rate,6.52,3.16,12.79
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,986.27,297.88,"2,126.76"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,721.50,169.38,"1,607.48"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,264.76,128.50,519.28
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Deaths,Rate,9.67,3.90,22.19
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,092.65",357.83,"2,396.15"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,752.93,218.85,"1,625.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,339.72,138.98,770.83
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Deaths,Rate,9.49,3.81,21.48
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,080.21",353.06,"2,368.87"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,741.25,217.05,"1,601.00"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,338.96,136.00,767.87
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Deaths,Rate,14.69,5.14,37.38
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,270.41",455.04,"2,840.68"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,816.05,296.22,"1,684.57"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,454.35,158.82,"1,156.11"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Deaths,Rate,14.63,5.21,36.61
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,344.52",556.22,"2,801.57"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,961.22,419.63,"1,842.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,383.30,136.58,959.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Deaths,Rate,30.02,11.69,71.98
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,781.59",777.76,"3,694.02"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,"1,093.62",510.99,"2,040.17"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,687.97,266.77,"1,653.86"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Deaths,Rate,51.36,20.68,121.02
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,387.43","1,084.85","4,931.08"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,277.14",637.63,"2,314.44"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,110.30",447.22,"2,616.66"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Deaths,Rate,105.15,44.56,239.58
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,680.71","1,817.24","7,188.88"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,872.76","1,050.97","3,069.58"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,807.92",766.26,"4,119.30"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Deaths,Rate,152.88,57.51,354.35
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"4,608.81","2,313.56","8,669.36"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,613.45","1,535.57","4,085.41"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,995.36",777.96,"4,583.95"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Deaths,Rate,183.73,69.21,414.86
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"5,342.43","2,638.25","9,971.36"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,939.21","1,733.16","4,544.92"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"2,403.28",905.03,"5,426.44"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Deaths,Rate,260.34,80.59,637.61
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"6,455.29","3,423.88","11,375.42"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,558.98","2,836.67","6,730.52"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,896.31",587.11,"4,644.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Deaths,Rate,8.50,4.81,13.63
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,858.72,460.20,"1,422.18"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,75.71,17.45,166.28
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,783.01,442.76,"1,255.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Deaths,Rate,10.50,4.54,22.49
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,131.57",339.49,"2,489.22"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,805.22,175.99,"1,867.71"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,326.34,163.50,621.51
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,All ages,Deaths,Rate,7.79,3.57,16.02
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,057.62",297.18,"2,355.13"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,762.59,143.32,"1,816.04"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Male,All ages,Years of Life Lost (YLLs),Rate,295.03,153.86,539.08
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Deaths,Rate,2.94,1.57,5.22
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,354.00,165.23,657.72
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,87.02,22.03,185.73
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,266.99,143.20,471.99
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Deaths,Rate,2.36,1.33,3.95
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,839.59,152.37,"1,984.77"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,636.52,38.18,"1,643.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,203.07,114.19,340.98
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Deaths,Rate,2.04,1.15,3.40
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,018.12",153.40,"2,449.22"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,844.64,55.59,"2,159.96"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,173.49,97.81,289.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Deaths,Rate,2.10,1.18,3.47
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,121.61",166.73,"2,693.27"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,949.88,69.89,"2,408.92"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,171.73,96.84,284.36
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Deaths,Rate,0.50,0.33,1.00
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,130.33,44.78,282.21
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,76.36,15.20,188.81
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,53.97,29.57,93.40
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Deaths,Rate,2.25,1.15,4.21
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,294.03,126.74,572.08
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,91.82,23.78,194.58
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,202.21,102.96,377.49
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Deaths,Rate,2.05,1.10,3.55
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,470.18,125.15,"1,047.86"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,291.04,28.64,736.88
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,179.13,96.51,310.97
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Deaths,Rate,6.20,3.59,10.02
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,639.62,346.23,"1,071.11"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,66.95,15.01,146.54
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,572.67,331.21,924.58
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Deaths,Rate,1.88,1.07,2.99
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,617.56,123.82,"1,445.93"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,457.73,32.70,"1,190.62"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,159.83,91.12,255.31
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Deaths,Rate,2.21,1.32,3.56
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,"1,629.16",168.71,"4,069.07"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,"1,451.63",62.37,"3,783.64"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,177.53,106.34,285.44
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Deaths,Rate,1.86,1.08,2.97
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,597.29",182.92,"3,922.20"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,"1,457.49",101.64,"3,698.70"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,139.80,81.28,223.50
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Deaths,Rate,1.00,0.58,1.56
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,611.83",156.82,"3,993.71"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,"1,536.72",113.48,"3,876.44"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,75.12,43.33,117.27
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Deaths,Rate,1.68,0.96,2.68
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,581.13",190.13,"3,847.72"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,"1,460.47",121.56,"3,655.63"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,120.67,68.57,192.09
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Deaths,Rate,2.34,1.32,3.76
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,551.64",222.13,"3,707.47"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,387.21",129.32,"3,443.49"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,164.43,92.81,263.98
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Deaths,Rate,1.93,1.05,3.10
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,414.68",194.17,"3,328.85"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,288.78",125.51,"3,126.72"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,125.90,68.66,202.13
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Deaths,Rate,3.06,1.71,4.98
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,454.07",260.07,"3,300.11"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,280.65",163.05,"3,018.91"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,173.42,97.02,281.20
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Deaths,Rate,4.07,2.29,6.54
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,517.55",281.61,"3,403.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,272.31",143.21,"3,008.83"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,245.24,138.40,394.49
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Deaths,Rate,4.34,2.47,6.83
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,524.18",299.09,"3,318.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,284.00",162.03,"2,940.54"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,240.18,137.06,378.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Deaths,Rate,1.68,0.97,2.70
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,388.97",248.43,"3,242.08"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,304.35",199.55,"3,105.88"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,84.62,48.88,136.19
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Deaths,Rate,3.17,1.67,5.73
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,391.51",298.10,"3,116.19"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,247.24",222.05,"2,855.68"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,144.28,76.05,260.51
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Deaths,Rate,1.94,0.82,4.18
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,254.71",279.28,"2,750.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,176.10",245.81,"2,581.25"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,78.60,33.47,169.54
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Deaths,Rate,7.60,2.52,19.15
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,428.65",382.66,"3,185.19"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,168.24",295.43,"2,531.88"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,260.40,87.23,653.32
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Deaths,Rate,10.83,3.65,27.42
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,537.23",418.10,"3,502.65"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,150.11",287.46,"2,522.50"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,387.12,130.65,980.15
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Deaths,Rate,11.42,3.46,29.53
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,533.43",482.04,"3,387.88"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,180.38",374.99,"2,474.79"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,353.06,107.04,913.10
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Deaths,Rate,16.64,4.99,42.35
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,727.90",650.08,"3,712.09"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,291.85",519.37,"2,602.20"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,436.05,130.71,"1,109.90"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Deaths,Rate,21.85,6.93,55.10
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,934.14",783.98,"4,042.53"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,417.85",620.98,"2,739.75"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,516.29,162.99,"1,302.78"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Deaths,Rate,28.86,9.56,72.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,211.76",964.21,"4,487.31"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,587.46",757.76,"2,924.91"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,624.30,206.43,"1,562.42"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Deaths,Rate,85.44,28.28,208.58
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,657.83","1,695.63","7,186.08"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,188.59","1,209.35","3,599.41"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"1,469.21",486.28,"3,586.67"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Deaths,Rate,178.94,53.97,425.94
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"5,389.94","2,567.49","10,133.64"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,282.33","1,917.83","5,102.58"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"2,107.60",649.68,"5,031.06"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Deaths,Rate,231.61,70.77,544.32
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"6,409.27","2,888.42","12,369.89"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,379.76","1,962.57","5,249.94"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"3,029.51",925.88,"7,119.95"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Deaths,Rate,325.36,91.17,771.64
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,045.37","4,156.02","13,994.76"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,675.17","3,491.92","8,373.52"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"2,370.20",664.15,"5,621.24"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Deaths,Rate,5.71,3.28,9.26
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,593.96,319.21,"1,000.39"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,67.79,15.02,150.33
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,526.17,304.17,850.06
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Deaths,Rate,9.59,3.45,21.66
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,460.33",334.88,"3,290.70"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,"1,200.99",220.09,"2,762.84"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,259.34,114.79,527.86
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,All ages,Deaths,Rate,8.52,3.14,19.03
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,420.65",314.01,"3,216.10"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,172.82",201.12,"2,722.12"
PRY,Paraguay,Southern Cone,Neurological conditions,2021,Female,All ages,Years of Life Lost (YLLs),Rate,247.83,112.89,493.98
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.06
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.06
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.00,0.12
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.05,0.00,0.12
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.33,0.03,0.85
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.33,0.03,0.85
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.48,1.41,6.56
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.48,1.41,6.56
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,1.07,0.40,2.22
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,1.07,0.40,2.22
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.88,1.40,4.90
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.88,1.40,4.90
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.97,1.86,12.34
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.97,1.86,12.34
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.36,5.20,20.21
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,11.36,5.20,20.21
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Deaths,Rate,2.74,2.04,3.58
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,129.65,88.93,179.46
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,18.29,6.33,34.06
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,111.37,82.61,145.40
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Deaths,Rate,2.85,2.13,3.68
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,124.77,84.78,173.20
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,26.04,11.18,45.58
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,98.72,73.61,127.62
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,26.53,11.12,47.49
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,26.53,11.12,47.49
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Deaths,Rate,6.79,5.08,8.70
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,247.32,175.93,330.02
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,37.40,18.76,60.87
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,209.91,157.17,269.15
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Deaths,Rate,7.74,5.88,9.90
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,263.59,187.37,353.28
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,60.66,33.20,93.68
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,202.91,154.16,259.58
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Deaths,Rate,13.00,9.84,16.56
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,376.14,270.76,497.34
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,74.47,42.25,112.93
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,301.67,228.51,384.40
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Deaths,Rate,20.23,15.29,25.72
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,530.78,385.34,695.28
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,93.43,54.69,139.38
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,437.36,330.65,555.90
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Deaths,Rate,42.34,31.84,53.26
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,862.64,634.97,"1,108.31"
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,134.66,87.30,192.63
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,727.98,547.68,915.65
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Deaths,Rate,58.14,43.89,72.98
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,893.58,659.30,"1,151.10"
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,143.21,91.72,206.86
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,750.35,567.58,944.25
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Deaths,Rate,58.03,44.74,73.82
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,920.28,690.99,"1,197.21"
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,161.43,105.56,231.90
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,758.79,585.43,965.36
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Deaths,Rate,111.29,82.76,137.60
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,949.90,684.58,"1,212.70"
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,139.52,81.96,210.08
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,810.38,602.62,"1,002.62"
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Deaths,Rate,2.95,2.23,3.73
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,65.80,46.73,87.94
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,13.24,7.11,21.10
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,52.56,39.62,66.84
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,All ages,Deaths,Rate,1.87,1.41,2.36
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,45.51,32.10,61.24
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,9.53,5.00,15.41
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Male,All ages,Years of Life Lost (YLLs),Rate,35.98,27.11,45.84
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.08
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.08
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.24,0.01,0.57
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.24,0.01,0.57
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.26,0.94,4.30
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.26,0.94,4.30
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.73,0.21,1.51
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.73,0.21,1.51
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.87,0.86,3.19
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,1.87,0.86,3.19
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.90,2.01,6.80
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.90,2.01,6.80
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,7.15,2.73,14.43
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,7.15,2.73,14.43
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Deaths,Rate,0.66,0.44,0.88
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,39.17,24.17,56.31
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,12.26,6.08,20.68
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,26.91,18.08,35.63
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Deaths,Rate,1.30,0.84,1.72
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,60.55,34.78,88.27
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,17.94,7.16,31.67
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,42.61,27.62,56.60
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,17.44,5.59,32.32
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,17.44,5.59,32.32
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Deaths,Rate,3.89,2.49,5.17
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,147.01,87.73,206.55
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,26.82,10.75,46.70
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,120.20,76.98,159.84
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Deaths,Rate,5.16,3.43,6.73
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,178.05,111.06,246.24
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,42.77,20.96,70.10
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,135.28,90.11,176.14
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Deaths,Rate,5.37,3.62,6.96
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,182.37,115.87,252.45
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,52.71,28.48,84.39
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,129.67,87.39,168.06
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Deaths,Rate,5.65,3.88,7.27
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,188.10,122.25,260.69
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,65.91,38.46,103.36
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,122.21,83.79,157.34
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Deaths,Rate,11.48,8.02,14.85
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,292.39,196.38,398.32
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,94.82,58.59,142.71
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,197.57,137.82,255.61
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Deaths,Rate,33.22,22.48,43.66
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,472.57,313.94,641.16
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,112.19,67.65,169.43
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,360.37,246.30,471.72
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Deaths,Rate,37.76,26.41,49.19
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,617.88,419.12,824.15
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,123.74,73.85,180.57
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,494.10,345.28,643.58
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Deaths,Rate,76.17,49.89,101.16
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,691.19,443.33,952.18
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,136.38,80.05,215.15
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,554.81,363.28,737.04
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Deaths,Rate,1.46,0.98,1.91
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,33.14,20.79,46.53
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,9.50,4.90,15.57
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,23.64,15.89,30.96
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,All ages,Deaths,Rate,1.24,0.83,1.63
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,27.86,17.44,39.18
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,8.04,4.12,13.20
PRY,Paraguay,Southern Cone,Parkinson disease,2020,Female,All ages,Years of Life Lost (YLLs),Rate,19.83,13.32,25.98
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.06
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.06
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.05,0.01,0.11
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.05,0.01,0.11
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.33,0.04,0.77
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.33,0.04,0.77
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.59,1.50,6.58
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.59,1.50,6.58
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,1.06,0.39,2.12
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,1.06,0.39,2.12
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,2.87,1.45,4.83
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,2.87,1.45,4.83
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,5.99,2.10,12.05
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,5.99,2.10,12.05
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,12.11,5.39,20.91
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,12.11,5.39,20.91
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Deaths,Rate,0.65,0.46,0.91
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.88,26.55,72.36
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,19.41,7.94,35.31
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,26.48,18.60,37.04
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Deaths,Rate,1.49,1.03,2.07
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,78.72,47.52,118.66
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,28.96,12.97,49.36
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,49.77,34.55,69.30
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Deaths,Rate,0.79,0.55,1.11
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,57.82,32.82,88.87
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,29.58,13.14,49.15
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,28.24,19.68,39.72
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Deaths,Rate,3.67,2.54,5.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,156.19,98.78,228.33
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,42.61,20.36,70.94
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,113.59,78.41,157.40
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Deaths,Rate,8.54,6.06,11.56
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,288.87,195.92,405.72
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,65.29,37.09,102.50
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,223.59,158.82,303.21
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Deaths,Rate,15.32,11.00,20.86
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,433.31,300.74,601.49
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,79.38,46.74,119.50
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,353.93,254.00,481.99
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Deaths,Rate,24.72,17.85,33.76
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,633.51,446.03,872.85
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,98.92,60.11,143.06
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,534.59,385.92,729.79
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Deaths,Rate,43.30,31.88,56.61
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,884.51,638.37,"1,178.30"
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,140.09,89.99,204.88
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,744.45,548.38,973.42
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Deaths,Rate,56.47,41.83,73.49
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,924.27,666.58,"1,232.22"
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,148.38,92.19,219.36
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,775.92,574.39,"1,012.86"
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Deaths,Rate,76.55,57.06,100.56
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,168.70",847.34,"1,562.54"
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,167.34,101.13,247.29
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,001.36",746.21,"1,315.25"
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Deaths,Rate,65.09,48.25,82.13
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,616.36,434.76,816.75
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,142.29,83.46,218.25
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,474.08,351.30,598.50
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Deaths,Rate,2.77,2.03,3.67
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,62.87,43.01,87.64
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,14.09,7.63,22.34
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,48.79,35.39,65.30
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,All ages,Deaths,Rate,1.76,1.28,2.34
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,43.04,29.16,60.46
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,10.20,5.41,16.35
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Male,All ages,Years of Life Lost (YLLs),Rate,32.84,23.76,44.11
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.05
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.05
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.04,0.00,0.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.04,0.00,0.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.02,0.62
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.25,0.02,0.62
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Deaths,Rate,0.07,0.05,0.11
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.69,3.13,9.33
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,2.31,0.95,4.41
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,3.38,2.17,4.92
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.76,0.22,1.58
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.76,0.22,1.58
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.88,0.89,3.23
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,1.88,0.89,3.23
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.91,2.02,6.75
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.91,2.02,6.75
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Deaths,Rate,0.53,0.34,0.77
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,31.40,18.15,49.96
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,7.35,2.68,14.93
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,24.05,15.47,35.04
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,12.10,3.59,23.81
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,12.10,3.59,23.81
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Deaths,Rate,0.79,0.51,1.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,44.39,24.09,70.40
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,18.79,7.49,34.81
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,25.60,16.60,35.59
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Deaths,Rate,0.77,0.50,1.08
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,46.48,25.83,74.14
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,18.84,7.77,35.41
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,27.64,18.06,38.73
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Deaths,Rate,1.90,1.23,2.63
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,86.87,50.53,130.76
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,28.06,12.58,49.41
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,58.80,37.95,81.36
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Deaths,Rate,3.83,2.54,5.23
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,145.01,90.49,209.61
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,44.73,23.95,72.52
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,100.28,66.54,137.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Deaths,Rate,6.02,4.03,8.13
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,195.69,123.73,276.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,55.36,29.86,86.53
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,140.33,93.87,189.56
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Deaths,Rate,8.98,6.03,12.04
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,263.92,168.46,365.57
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,69.67,37.81,105.37
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,194.25,130.65,260.20
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Deaths,Rate,29.18,19.90,38.96
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,605.17,403.30,821.97
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,103.41,61.13,152.23
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,501.76,342.17,669.74
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Deaths,Rate,39.34,26.48,52.65
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,627.67,414.27,857.16
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,120.88,70.64,180.02
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,506.78,343.63,677.13
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Deaths,Rate,46.08,31.75,61.26
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,735.90,494.41,993.76
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,133.34,79.10,192.31
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,602.56,415.31,801.40
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Deaths,Rate,53.93,34.72,72.93
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,537.61,334.51,759.18
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,144.84,81.49,227.93
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,392.78,253.02,531.25
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Deaths,Rate,1.65,1.11,2.23
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,37.79,23.71,54.01
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,10.03,5.10,16.46
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,27.75,18.61,37.55
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,All ages,Deaths,Rate,1.40,0.94,1.88
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.94,20.00,45.73
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.56,4.34,14.09
PRY,Paraguay,Southern Cone,Parkinson disease,2021,Female,All ages,Years of Life Lost (YLLs),Rate,23.38,15.66,31.63
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Deaths,Rate,0.25,0.00,0.70
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,17.56,0.00,49.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,17.56,0.00,49.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Deaths,Rate,0.40,0.00,1.13
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,28.18,0.00,79.29
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,28.18,0.00,79.29
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Deaths,Rate,0.59,0.00,1.66
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,41.52,0.00,116.85
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,41.52,0.00,116.85
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Deaths,Rate,1.15,0.00,3.26
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,81.32,0.00,228.85
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,81.32,0.00,228.85
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.74,1.34,7.90
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.74,1.34,7.90
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.59,0.96,5.32
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.59,0.96,5.32
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.52,6.26,37.14
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.52,6.26,37.14
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Deaths,Rate,1.23,0.19,4.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,92.38,28.69,238.72
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,42.64,20.98,72.39
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,49.74,7.72,166.33
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Deaths,Rate,3.38,0.66,10.44
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,194.05,67.98,476.26
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,83.31,46.47,132.69
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,110.74,21.52,343.56
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Deaths,Rate,1.22,0.22,3.96
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,121.79,50.92,265.11
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,78.00,42.93,123.57
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,43.79,7.98,141.54
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Deaths,Rate,8.47,1.74,25.57
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,400.10,135.04,"1,006.68"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,138.42,81.25,215.86
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,261.68,53.80,790.82
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Deaths,Rate,23.85,5.27,72.64
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,872.72,289.64,"2,277.51"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,247.77,151.51,373.79
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,624.94,138.13,"1,903.74"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Deaths,Rate,40.04,9.35,118.30
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,279.90",427.62,"3,269.48"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,352.40,211.84,523.97
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,927.50,215.78,"2,745.53"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Deaths,Rate,60.93,14.60,177.18
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,804.89",605.53,"4,548.48"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,487.29,289.63,717.61
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,317.59",315.90,"3,830.88"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Deaths,Rate,136.02,30.72,402.46
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"3,286.66","1,158.98","8,312.61"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,947.97,630.56,"1,392.63"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"2,338.69",528.41,"6,919.96"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Deaths,Rate,508.37,117.91,"1,432.18"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"7,016.92","2,406.24","17,241.20"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,853.88","1,211.74","2,636.03"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"5,163.04","1,194.51","14,605.16"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Deaths,Rate,468.12,108.92,"1,304.33"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,007.97","2,654.67","19,752.91"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,884.70","1,229.93","2,691.55"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"6,123.27","1,424.78","17,061.36"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Deaths,Rate,"1,277.05",297.31,"3,580.06"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"12,855.08","4,469.12","31,028.73"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,552.08","2,303.30","4,949.19"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"9,303.01","2,165.82","26,079.54"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Deaths,Rate,17.01,3.91,48.39
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,303.38,101.40,754.55
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,84.41,52.81,124.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,218.97,48.58,630.45
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Deaths,Rate,30.01,6.92,85.08
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,496.88,167.66,"1,231.49"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,136.88,86.44,199.52
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Male,All ages,Years of Life Lost (YLLs),Rate,360.00,81.22,"1,031.97"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Deaths,Rate,0.19,0.00,0.49
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,13.20,0.00,34.38
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,13.20,0.00,34.38
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Deaths,Rate,0.30,0.00,0.78
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,21.12,0.00,55.02
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,21.12,0.00,55.02
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Deaths,Rate,0.44,0.00,1.15
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,31.09,0.00,80.97
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,31.09,0.00,80.97
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Deaths,Rate,0.86,0.00,2.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,60.70,0.00,158.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,60.70,0.00,158.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Deaths,Rate,0.18,0.02,0.61
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,13.25,2.97,37.11
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.98,1.90,9.23
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,8.27,1.07,27.89
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.27,1.13,6.27
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.27,1.13,6.27
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Deaths,Rate,0.96,0.12,3.24
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,66.64,14.53,189.75
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,22.88,8.87,42.13
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,43.78,5.66,147.62
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,57.62,28.90,97.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,57.62,28.90,97.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Deaths,Rate,1.50,0.29,4.66
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,166.18,76.20,334.07
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,117.93,66.80,184.32
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,48.26,9.40,149.75
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Deaths,Rate,1.05,0.19,3.38
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,147.52,68.10,292.92
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,109.85,61.39,172.03
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,37.68,6.71,120.89
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Deaths,Rate,3.66,0.73,11.20
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,306.32,137.21,640.07
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,193.27,114.51,293.61
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,113.05,22.70,346.46
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Deaths,Rate,29.15,6.68,85.54
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,113.97",402.39,"2,763.46"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,349.95,227.35,521.62
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,764.03,175.03,"2,241.83"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Deaths,Rate,45.07,10.84,129.78
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,559.76",587.68,"3,785.47"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,513.29,336.75,768.04
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,"1,046.48",250.92,"3,017.43"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Deaths,Rate,63.64,15.70,181.40
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,079.95",803.89,"4,978.05"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,703.89,464.41,"1,055.58"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,376.06",339.47,"3,922.47"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Deaths,Rate,183.59,43.80,532.99
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"4,539.98","1,682.60","11,119.61"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,383.05",929.50,"1,954.83"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"3,156.93",753.10,"9,164.78"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Deaths,Rate,724.66,176.68,"1,921.03"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"9,906.27","3,711.58","22,410.34"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,187.43","2,069.20","4,431.14"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"6,718.85","1,642.38","17,979.20"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Deaths,Rate,479.38,121.44,"1,274.61"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,967.67","3,316.82","20,410.15"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,697.09","1,728.20","3,737.31"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"6,270.57","1,588.61","16,672.83"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Deaths,Rate,"1,449.85",350.79,"3,795.14"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"15,906.09","6,011.93","35,054.23"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,344.31","3,456.53","7,407.90"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"10,561.79","2,555.40","27,646.34"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Deaths,Rate,18.94,4.58,51.27
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,360.87,134.27,836.12
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,122.26,77.99,176.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,238.62,56.29,659.71
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Deaths,Rate,73.79,17.94,196.65
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,120.68",420.25,"2,553.91"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,371.24,239.23,524.91
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2020,Female,All ages,Years of Life Lost (YLLs),Rate,749.44,181.01,"2,029.00"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Deaths,Rate,0.05,0.00,0.13
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,4.00,0.00,11.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,4.00,0.00,11.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Deaths,Rate,0.03,0.00,0.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,2.93,0.00,8.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,2.93,0.00,8.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Deaths,Rate,0.11,0.00,0.30
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.78,0.00,21.88
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,7.78,0.00,21.88
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Deaths,Rate,0.08,0.00,0.22
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,6.71,0.00,18.87
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,6.71,0.00,18.87
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Deaths,Rate,0.13,0.00,0.38
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,11.28,0.00,31.74
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,11.28,0.00,31.74
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Deaths,Rate,0.12,0.00,0.35
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,8.73,0.00,24.58
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,8.73,0.00,24.58
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Deaths,Rate,0.18,0.00,0.52
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,12.88,0.00,36.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,12.88,0.00,36.25
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Deaths,Rate,0.36,0.00,1.01
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,25.27,0.00,71.11
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,25.27,0.00,71.11
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Deaths,Rate,0.29,0.03,1.03
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,17.45,2.65,57.37
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,3.79,1.17,7.65
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,13.67,1.48,49.72
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Deaths,Rate,0.74,0.06,2.78
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,39.52,4.08,145.66
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.58,0.87,5.18
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,36.94,3.21,140.48
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Deaths,Rate,0.77,0.10,2.68
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,52.84,9.96,157.80
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,17.52,5.33,35.45
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,35.32,4.63,122.35
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Deaths,Rate,0.78,0.12,2.60
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,73.66,25.19,177.92
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,42.24,20.25,72.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,31.43,4.95,105.51
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Deaths,Rate,4.89,0.96,15.34
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,242.22,77.64,632.88
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,82.82,46.44,132.59
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,159.40,31.20,500.30
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Deaths,Rate,3.26,0.59,10.28
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,193.76,63.66,490.29
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,77.11,42.56,122.74
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,116.65,21.10,367.55
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Deaths,Rate,11.65,2.39,36.24
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,497.76,155.88,"1,336.16"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,137.52,81.96,215.26
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,360.24,73.93,"1,120.90"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Deaths,Rate,31.88,6.95,96.63
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,083.53",332.88,"2,898.66"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,248.03,150.73,366.14
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,835.48,182.16,"2,532.52"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Deaths,Rate,55.99,12.83,166.79
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,644.67",511.49,"4,383.84"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,351.36,215.86,526.65
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,"1,293.30",295.64,"3,857.19"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Deaths,Rate,87.42,20.51,258.26
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,376.16",744.31,"6,319.89"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,486.06,300.76,735.89
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"1,890.11",443.58,"5,584.00"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Deaths,Rate,203.18,45.31,614.19
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"4,443.34","1,396.38","11,913.36"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,949.91,617.16,"1,352.62"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"3,493.43",779.19,"10,560.74"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Deaths,Rate,600.49,137.26,"1,687.50"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"8,026.84","2,638.68","20,032.89"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"1,874.18","1,237.56","2,630.33"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"6,152.66","1,401.11","17,402.55"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Deaths,Rate,484.97,110.74,"1,318.54"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"8,245.62","2,671.95","19,921.37"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"1,901.68","1,223.54","2,673.96"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"6,343.94","1,448.41","17,247.37"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Deaths,Rate,"1,493.35",343.63,"4,173.27"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"14,445.98","4,919.22","35,364.52"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"3,567.32","2,416.15","4,963.65"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"10,878.66","2,503.07","30,400.87"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Deaths,Rate,20.61,4.67,58.80
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,358.91,113.96,921.40
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,84.57,53.40,123.44
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,274.34,60.56,797.96
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Deaths,Rate,36.42,8.28,103.39
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,588.36,188.97,"1,499.08"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,138.65,88.54,200.56
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Male,All ages,Years of Life Lost (YLLs),Rate,449.71,100.43,"1,298.52"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Deaths,Rate,0.07,0.00,0.19
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,5.02,0.00,13.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,5.02,0.00,13.10
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Deaths,Rate,0.11,0.00,0.30
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,7.98,0.00,20.83
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,7.98,0.00,20.83
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Deaths,Rate,0.17,0.00,0.44
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,11.76,0.00,30.68
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,11.76,0.00,30.68
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Deaths,Rate,0.33,0.00,0.86
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,23.01,0.00,60.03
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,23.01,0.00,60.03
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Deaths,Rate,0.15,0.02,0.52
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.79,2.87,33.59
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,4.98,1.96,9.89
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,6.82,0.92,23.70
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,3.23,1.08,6.29
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,3.23,1.08,6.29
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Deaths,Rate,0.78,0.11,2.69
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,57.71,13.76,167.35
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,22.45,9.02,44.78
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,35.26,4.75,122.57
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Deaths,Rate,1.24,0.20,4.19
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,107.51,36.71,262.27
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,56.94,28.69,91.87
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,50.57,8.02,170.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Deaths,Rate,3.90,0.75,12.12
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,248.11,90.99,585.77
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,118.21,66.31,181.15
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,129.90,24.69,404.63
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Deaths,Rate,3.06,0.56,9.60
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,218.70,83.80,512.83
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,109.48,63.85,169.75
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,109.21,19.96,343.07
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Deaths,Rate,7.71,1.55,23.46
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,432.46,157.63,"1,015.68"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,194.09,109.73,290.27
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,238.37,47.90,725.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Deaths,Rate,33.27,7.69,98.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"1,217.54",422.68,"3,090.97"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,345.76,220.90,511.87
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,871.78,201.78,"2,579.10"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Deaths,Rate,55.77,13.58,160.98
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,796.81",643.96,"4,474.86"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,508.36,331.24,749.61
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,"1,288.45",312.72,"3,725.25"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Deaths,Rate,82.36,20.53,234.95
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"2,481.70",905.59,"6,111.07"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,700.61,461.70,"1,030.70"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,"1,781.09",443.89,"5,080.37"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Deaths,Rate,258.97,61.78,757.79
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"5,821.92","1,949.97","14,971.43"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"1,368.80",887.68,"1,941.41"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"4,453.11","1,062.29","13,030.02"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Deaths,Rate,870.96,211.21,"2,316.36"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"11,333.45","4,039.30","26,366.17"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,170.03","2,059.74","4,440.60"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"8,163.41","1,979.56","21,925.58"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Deaths,Rate,559.24,137.75,"1,472.47"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"9,985.06","3,515.34","22,973.84"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"2,669.75","1,713.59","3,712.99"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"7,315.31","1,801.74","19,260.85"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Deaths,Rate,"1,697.54",410.98,"4,460.28"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,645.13","6,441.91","39,884.56"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,279.04","3,448.07","7,392.81"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"12,366.09","2,993.84","32,491.75"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Deaths,Rate,23.17,5.58,63.09
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,419.55,147.56,"1,006.76"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,121.13,76.84,174.69
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,298.42,70.72,832.08
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Deaths,Rate,89.86,21.75,240.42
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,299.68",462.94,"3,052.97"
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,372.35,239.83,528.41
URY,Uruguay,Southern Cone,Alzheimer disease and other dementias,2021,Female,All ages,Years of Life Lost (YLLs),Rate,927.33,223.11,"2,524.55"
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Deaths,Rate,0.26,0.15,0.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,132.16,36.35,277.67
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,108.30,22.95,241.15
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,23.87,13.39,36.53
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Deaths,Rate,0.46,0.32,0.65
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,147.88,47.41,313.36
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,110.16,21.58,259.56
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,37.72,25.83,53.80
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Deaths,Rate,0.34,0.23,0.48
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,142.61,41.05,305.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,114.85,22.04,265.89
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,27.76,19.01,39.60
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Deaths,Rate,0.52,0.37,0.69
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,158.92,51.94,326.46
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,119.60,23.47,273.04
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,39.33,28.47,53.41
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,104.64,19.42,226.83
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,104.02,19.42,226.83
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Deaths,Rate,0.17,0.10,0.26
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,124.16,31.68,266.62
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,108.56,22.91,242.73
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,15.60,8.75,23.89
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Deaths,Rate,0.07,0.04,0.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,113.68,25.60,262.28
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,107.10,21.90,252.20
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,6.59,3.70,10.08
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Deaths,Rate,0.77,0.41,1.13
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,176.14,62.03,339.65
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,107.35,23.46,234.31
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,68.84,38.63,105.34
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,106.03,21.17,259.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,106.03,21.17,259.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Deaths,Rate,1.09,0.78,1.53
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,203.55,83.38,399.06
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,115.94,20.77,276.28
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,87.61,62.61,122.77
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Deaths,Rate,0.75,0.56,1.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,183.50,66.24,361.92
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,127.16,24.35,286.57
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,56.34,41.89,75.34
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,127.92,23.32,283.54
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,127.92,23.32,283.54
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Deaths,Rate,0.59,0.46,0.75
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,174.00,58.13,344.33
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,132.47,26.05,291.45
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,41.52,32.08,52.88
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Deaths,Rate,1.15,0.89,1.47
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,218.16,91.49,402.60
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,136.83,28.66,299.03
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,81.32,62.82,103.56
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,130.76,27.22,286.84
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,130.76,27.22,286.84
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Deaths,Rate,1.95,1.58,2.35
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,205.72,100.95,357.75
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,106.05,20.20,237.41
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,99.67,80.74,120.33
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Deaths,Rate,1.11,0.89,1.34
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,180.77,73.06,344.92
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,113.67,19.22,264.08
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,67.10,53.83,80.84
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Deaths,Rate,1.17,0.94,1.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,164.89,71.80,301.44
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,100.54,19.53,223.89
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,64.34,52.27,77.55
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Deaths,Rate,5.57,4.51,6.71
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,371.88,246.13,540.14
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,91.17,18.55,201.70
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,280.71,227.59,338.43
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Deaths,Rate,2.21,1.79,2.68
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,189.35,96.76,321.34
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,89.11,15.31,199.50
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,100.23,81.46,121.85
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Deaths,Rate,4.90,4.05,5.93
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,289.13,182.23,447.94
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,90.18,17.83,207.25
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,198.95,164.40,240.69
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Deaths,Rate,4.70,3.86,5.62
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,265.15,157.19,428.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,98.87,20.35,229.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,166.28,136.84,199.12
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Deaths,Rate,2.46,2.06,2.90
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,184.27,92.34,330.31
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,96.69,18.82,226.71
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,87.59,73.51,103.61
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Deaths,Rate,7.05,5.72,8.39
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,329.93,202.14,517.48
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,111.87,25.15,257.82
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,218.06,176.98,259.65
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Deaths,Rate,3.41,2.81,4.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,220.23,99.59,403.10
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,130.95,26.16,295.39
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,89.27,73.44,107.71
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Deaths,Rate,2.87,2.36,3.45
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,208.81,86.74,398.17
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,137.97,28.54,312.80
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,70.83,58.21,85.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Deaths,Rate,2.18,1.79,2.61
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,194.08,70.18,391.80
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,147.02,31.60,335.24
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,47.06,38.57,56.57
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Deaths,Rate,8.69,7.02,10.63
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,310.88,155.39,533.57
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,161.61,34.54,350.97
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,149.28,120.85,182.58
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75+ years,Deaths,Rate,8.02,6.47,9.76
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,280.94,124.12,511.97
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,175.59,38.91,383.35
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,105.34,85.20,128.61
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Deaths,Rate,4.45,3.60,5.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,231.82,85.64,452.06
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,173.50,38.48,380.14
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,58.32,47.12,71.88
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,85+ years,Deaths,Rate,11.49,9.26,13.82
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,289.09,115.50,550.54
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,205.24,47.89,449.80
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,83.80,67.60,100.79
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,<1 year,Deaths,Rate,0.70,0.38,1.03
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,169.96,58.40,329.91
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,107.06,23.11,233.67
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,62.90,35.29,96.24
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Deaths,Rate,1.91,1.54,2.33
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,194.65,86.49,358.62
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,114.29,22.55,259.18
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,80.36,63.94,99.44
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,All ages,Deaths,Rate,2.27,1.83,2.76
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,202.74,92.70,368.99
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,115.67,22.98,261.92
URY,Uruguay,Southern Cone,Epilepsy,2020,Male,All ages,Years of Life Lost (YLLs),Rate,87.07,69.72,107.07
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Deaths,Rate,0.22,0.12,0.33
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,103.04,27.95,215.44
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,83.20,16.81,185.08
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,19.84,11.14,30.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Deaths,Rate,0.42,0.28,0.62
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,126.13,42.93,259.23
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,89.75,18.59,205.86
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,36.38,24.35,53.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Deaths,Rate,0.96,0.70,1.26
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,168.45,74.50,312.64
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,93.07,19.64,212.76
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,75.38,54.86,99.88
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Deaths,Rate,0.75,0.55,0.99
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,156.12,63.05,300.06
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,97.13,20.12,221.90
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,58.99,42.93,78.16
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,68.70,12.01,159.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,68.70,12.01,159.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Deaths,Rate,0.18,0.10,0.27
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,100.94,26.22,213.36
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,85.07,17.31,189.07
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,15.87,8.91,24.29
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Deaths,Rate,0.67,0.45,0.98
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,145.77,57.64,278.99
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,88.43,18.90,195.11
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,57.33,38.74,83.88
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Deaths,Rate,0.44,0.25,0.69
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,117.04,38.35,231.46
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,74.82,14.64,166.84
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,42.23,23.71,64.62
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Deaths,Rate,1.03,0.71,1.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,178.26,80.40,326.55
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,90.87,20.06,199.48
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,87.37,60.35,127.07
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,94.36,18.68,230.42
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,94.36,18.68,230.42
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Deaths,Rate,0.81,0.61,1.01
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,163.94,67.36,315.34
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,103.04,21.07,239.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,60.90,46.28,75.94
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Deaths,Rate,2.44,1.85,3.05
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,286.01,162.18,460.99
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,102.30,22.56,231.92
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,183.71,139.61,229.07
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Deaths,Rate,1.19,0.90,1.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,196.76,90.31,355.39
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,107.13,22.20,243.63
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,89.63,68.11,111.75
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,111.73,21.86,254.79
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,111.73,21.86,254.79
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,109.35,22.40,251.09
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,109.35,22.40,251.09
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Deaths,Rate,0.36,0.30,0.44
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,115.28,33.41,245.78
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,98.74,19.91,225.78
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,16.54,13.50,20.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,103.57,21.63,220.51
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,103.57,21.63,220.51
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,97.18,17.58,228.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,97.18,17.58,228.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,93.09,19.76,221.53
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,93.09,19.76,221.53
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Deaths,Rate,1.93,1.57,2.33
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,176.53,89.15,310.31
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,88.99,17.71,204.44
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,87.54,71.45,105.87
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Deaths,Rate,3.14,2.52,3.85
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,213.34,119.91,355.95
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,85.98,17.79,199.40
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,127.36,102.12,156.54
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Deaths,Rate,2.57,2.11,3.08
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,182.96,95.19,320.18
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,89.70,18.90,207.88
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,93.26,76.29,112.30
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Deaths,Rate,2.11,1.76,2.51
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,163.05,80.86,295.18
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,87.69,17.98,205.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,75.35,62.88,89.68
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Deaths,Rate,2.44,2.02,2.86
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,171.36,83.70,308.22
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,96.00,21.13,219.85
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,75.36,62.56,88.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Deaths,Rate,2.77,2.31,3.29
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,176.57,84.52,313.41
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,103.81,23.99,227.12
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,72.77,60.52,86.29
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Deaths,Rate,2.24,1.85,2.71
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,162.80,69.74,302.03
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,107.34,24.04,235.31
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,55.47,45.70,66.72
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Deaths,Rate,1.62,1.32,2.03
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,146.74,52.50,288.74
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,111.46,24.10,244.87
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,35.28,28.41,43.87
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Deaths,Rate,3.83,3.02,4.64
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,185.40,75.55,343.37
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,119.62,23.47,263.46
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,65.77,52.08,79.91
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75+ years,Deaths,Rate,11.90,9.05,14.74
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,259.66,122.13,458.79
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,139.03,29.67,309.75
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,120.63,92.46,149.05
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Deaths,Rate,12.36,9.56,15.23
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,296.16,156.21,496.48
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,134.54,31.15,297.07
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,161.62,125.06,199.41
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,85+ years,Deaths,Rate,19.43,14.54,24.22
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,303.19,140.51,541.64
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,161.61,34.56,365.16
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,141.58,105.94,176.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,<1 year,Deaths,Rate,0.40,0.23,0.63
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,112.95,36.09,225.28
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,74.35,14.41,166.20
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,38.60,21.68,59.08
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Deaths,Rate,1.20,0.94,1.49
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,147.55,58.30,286.38
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,97.99,20.25,223.42
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,49.56,38.05,62.96
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,All ages,Deaths,Rate,2.13,1.65,2.63
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,157.88,65.07,301.22
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,101.30,21.10,230.38
URY,Uruguay,Southern Cone,Epilepsy,2020,Female,All ages,Years of Life Lost (YLLs),Rate,56.58,43.97,70.84
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Deaths,Rate,0.89,0.43,1.49
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,186.33,59.88,371.22
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,105.45,20.82,237.27
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,80.87,39.06,133.95
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Deaths,Rate,0.55,0.33,0.85
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,155.48,49.36,324.19
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,107.76,21.15,250.98
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,47.72,28.21,73.21
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Deaths,Rate,0.49,0.31,0.73
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,153.27,46.91,318.39
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,111.83,21.11,256.62
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,41.44,25.81,61.77
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Deaths,Rate,0.68,0.48,0.94
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,169.43,58.00,338.47
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,116.00,21.47,263.98
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,53.43,36.53,74.49
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,97.91,17.62,220.63
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,97.91,17.62,220.63
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Deaths,Rate,0.95,0.46,1.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,191.85,62.43,378.88
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,106.10,21.01,236.85
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,85.75,41.42,142.02
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Deaths,Rate,0.62,0.35,0.98
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,160.59,52.23,329.65
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,105.77,21.98,243.05
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,54.82,30.24,86.60
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Deaths,Rate,0.68,0.31,1.17
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,166.86,51.04,346.85
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,102.88,20.16,240.89
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,63.92,30.88,105.90
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Deaths,Rate,0.39,0.27,0.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,139.27,45.27,296.08
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,105.54,22.65,247.28
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,33.73,22.62,48.81
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Deaths,Rate,0.42,0.31,0.59
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,145.99,44.67,313.18
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,111.93,19.91,266.19
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,34.07,24.77,46.99
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Deaths,Rate,0.72,0.56,0.92
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,174.68,61.63,343.41
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,122.25,21.26,276.60
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,52.43,40.37,66.81
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Deaths,Rate,0.32,0.25,0.40
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,147.19,40.17,302.41
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,123.06,21.00,272.18
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,24.13,19.17,30.23
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Deaths,Rate,0.86,0.67,1.07
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,188.29,69.68,357.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,127.15,21.90,281.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,61.15,47.77,76.22
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Deaths,Rate,1.38,1.07,1.72
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,227.82,98.06,410.98
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,131.08,22.77,290.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,96.74,75.28,120.45
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Deaths,Rate,1.54,1.22,1.90
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,225.37,102.04,407.71
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,125.23,22.83,284.09
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,100.14,79.21,123.62
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Deaths,Rate,2.47,2.00,3.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,237.11,126.56,405.04
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,103.33,18.37,242.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,133.78,108.19,162.50
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Deaths,Rate,2.40,1.95,2.89
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,254.33,137.17,441.60
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,109.90,19.33,267.46
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,144.42,117.84,174.13
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Deaths,Rate,2.16,1.76,2.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,219.06,115.28,376.97
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,99.44,17.74,232.36
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,119.62,97.55,144.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Deaths,Rate,3.38,2.75,4.10
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,260.68,153.99,425.95
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,90.29,15.36,219.22
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,170.40,138.63,206.73
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Deaths,Rate,3.05,2.45,3.71
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,226.02,127.20,368.06
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,87.25,15.71,199.48
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,138.76,111.49,168.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Deaths,Rate,3.85,3.18,4.68
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,245.65,143.19,390.88
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,89.31,14.03,200.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,156.34,129.15,190.13
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Deaths,Rate,4.66,3.82,5.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,263.54,153.03,423.85
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,98.89,17.73,225.55
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,164.66,135.30,198.29
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Deaths,Rate,4.50,3.73,5.36
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,258.09,152.41,418.62
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,97.33,19.09,227.10
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,160.77,133.32,191.53
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Deaths,Rate,5.79,4.68,6.98
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,291.01,165.42,468.93
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,112.02,20.55,253.19
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,178.98,144.87,215.75
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Deaths,Rate,2.99,2.49,3.66
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,207.61,89.74,389.41
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,129.04,24.66,293.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,78.57,65.07,95.80
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Deaths,Rate,4.64,3.81,5.62
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,243.90,115.61,445.04
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,135.88,26.77,314.08
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,108.02,88.84,130.95
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Deaths,Rate,6.78,5.54,8.17
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,291.22,149.33,517.55
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,144.81,29.51,340.75
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,146.41,119.82,176.79
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Deaths,Rate,14.55,11.89,17.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,410.16,234.97,672.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,159.94,30.58,367.36
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,250.19,204.39,305.40
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75+ years,Deaths,Rate,15.83,12.90,19.37
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,377.82,200.53,644.44
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,173.13,33.64,393.44
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,204.68,166.90,250.99
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Deaths,Rate,13.65,11.12,17.08
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,348.94,178.33,617.34
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,170.31,32.90,393.66
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,178.63,145.43,223.69
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,85+ years,Deaths,Rate,21.03,17.11,25.33
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,354.75,164.90,626.59
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,201.45,40.32,441.96
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,153.30,124.58,184.63
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,<1 year,Deaths,Rate,0.62,0.28,1.07
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,160.91,48.16,335.96
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,102.45,19.94,239.20
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,58.41,28.22,96.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Deaths,Rate,2.50,2.00,3.09
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,216.01,102.09,388.27
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,111.59,20.47,256.97
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,104.41,81.62,131.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,All ages,Deaths,Rate,3.05,2.46,3.75
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,225.20,109.56,399.81
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,113.12,20.78,260.44
URY,Uruguay,Southern Cone,Epilepsy,2021,Male,All ages,Years of Life Lost (YLLs),Rate,112.07,88.79,139.38
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Deaths,Rate,0.39,0.19,0.64
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,113.51,32.88,238.35
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,78.93,16.18,181.06
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,34.59,16.71,57.29
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Deaths,Rate,0.38,0.25,0.57
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,120.98,39.17,254.68
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,88.22,18.21,205.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,32.76,20.96,49.14
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Deaths,Rate,0.62,0.45,0.84
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,140.85,54.02,277.37
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,91.08,18.29,209.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,49.77,35.73,67.84
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Deaths,Rate,0.48,0.35,0.66
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,133.50,46.54,270.91
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,94.59,18.61,217.88
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,38.91,27.93,53.03
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,62.41,12.48,151.17
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,62.41,12.48,151.17
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Deaths,Rate,0.40,0.19,0.66
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,116.82,34.10,243.12
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,81.33,16.96,184.33
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,35.50,17.15,58.79
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Deaths,Rate,0.61,0.40,0.90
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,139.24,51.93,272.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,86.84,17.99,194.43
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,52.40,33.95,78.18
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Deaths,Rate,0.39,0.19,0.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,101.68,28.65,222.52
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,68.41,12.60,167.43
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,33.26,16.05,55.09
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Deaths,Rate,0.74,0.53,1.07
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,154.43,64.01,292.57
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,90.58,18.69,201.26
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,63.84,45.32,91.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,93.54,19.41,230.13
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,93.54,19.41,230.13
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Deaths,Rate,0.42,0.34,0.53
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,132.07,44.54,272.59
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,100.06,19.23,233.06
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,32.01,25.31,39.53
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Deaths,Rate,1.28,1.01,1.59
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,195.38,94.77,339.64
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,98.93,18.50,220.52
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,96.46,76.26,119.12
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Deaths,Rate,0.63,0.50,0.78
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,150.30,56.43,292.68
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,103.15,19.14,234.44
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,47.16,37.28,58.24
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,107.18,19.76,247.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,107.18,19.76,247.76
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Deaths,Rate,1.27,1.00,1.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,186.17,85.39,338.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,103.66,19.82,233.57
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,82.51,65.57,105.00
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Deaths,Rate,1.29,1.04,1.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,162.72,72.31,305.89
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,94.45,16.87,221.92
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,68.27,55.44,83.97
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Deaths,Rate,0.29,0.23,0.36
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,116.85,33.56,268.06
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,99.33,19.45,246.54
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,17.52,14.11,21.53
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Deaths,Rate,1.09,0.92,1.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,154.74,65.93,292.64
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,94.08,15.36,220.24
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,60.66,50.57,72.38
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Deaths,Rate,1.49,1.21,1.80
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,164.15,77.38,300.14
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,89.16,16.25,209.22
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,75.00,61.13,90.92
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Deaths,Rate,2.35,1.91,2.88
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,191.51,99.90,328.25
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,84.65,12.92,197.22
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,106.86,86.99,131.03
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Deaths,Rate,2.49,2.00,3.09
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,182.91,95.77,309.48
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,81.46,14.72,184.12
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,101.45,81.06,125.36
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Deaths,Rate,3.03,2.50,3.64
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,193.06,104.00,325.18
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,85.99,15.82,196.35
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,107.07,88.18,128.83
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Deaths,Rate,3.03,2.53,3.63
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,192.56,107.00,327.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,84.26,16.75,197.57
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,108.30,90.25,129.74
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Deaths,Rate,3.62,3.02,4.25
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,204.61,109.64,339.86
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,92.79,16.02,208.26
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,111.82,93.63,131.61
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Deaths,Rate,2.66,2.21,3.15
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,170.98,76.62,321.67
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,101.10,18.65,239.23
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,69.88,57.99,82.44
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Deaths,Rate,2.26,1.87,2.74
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,159.49,65.04,312.26
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,103.87,19.23,245.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,55.62,45.81,66.95
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Deaths,Rate,1.79,1.46,2.25
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,145.90,51.33,301.14
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,107.14,19.93,252.49
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,38.76,31.41,48.65
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Deaths,Rate,6.50,5.13,7.97
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,229.00,111.90,398.52
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,117.25,23.56,261.58
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,111.75,88.35,136.94
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75+ years,Deaths,Rate,12.54,9.54,15.55
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,269.57,129.71,470.41
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,134.29,25.77,303.07
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,135.28,103.94,167.33
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Deaths,Rate,13.01,10.06,16.04
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,299.04,156.01,517.12
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,128.88,24.33,307.31
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,170.19,131.68,209.81
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,85+ years,Deaths,Rate,17.94,13.36,22.42
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,285.44,126.30,502.81
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,154.77,29.00,339.43
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,130.67,97.30,163.38
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,<1 year,Deaths,Rate,0.36,0.18,0.53
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,98.31,27.27,216.41
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,67.90,12.59,166.03
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,30.41,14.67,50.37
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Deaths,Rate,1.50,1.19,1.87
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,156.43,66.36,297.43
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,94.52,17.82,219.23
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,61.91,48.54,78.19
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,All ages,Deaths,Rate,2.50,1.96,3.08
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,168.52,74.30,314.39
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,97.74,18.32,226.19
URY,Uruguay,Southern Cone,Epilepsy,2021,Female,All ages,Years of Life Lost (YLLs),Rate,70.78,55.99,88.20
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.08,0.03,0.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.08,0.03,0.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.12,0.44
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.25,0.12,0.44
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.64,0.34,1.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.64,0.34,1.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.08,0.33
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.19,0.08,0.33
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.02,0.54,1.67
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,1.02,0.54,1.67
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.74,0.36,1.28
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.74,0.36,1.28
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.41,0.76,2.30
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.41,0.76,2.30
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,1.15,3.29
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,2.05,1.15,3.29
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.44,2.55,6.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,4.44,2.55,6.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Deaths,Rate,0.22,0.17,0.28
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,22.16,14.14,33.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,10.04,4.93,17.49
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,12.12,9.21,15.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,7.88,4.33,12.99
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,7.88,4.33,12.99
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Deaths,Rate,1.17,0.88,1.50
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,75.05,53.38,102.74
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.70,4.49,19.64
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,64.34,48.89,83.10
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,13.64,6.44,23.70
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,13.64,6.44,23.70
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.69,7.31,26.76
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,14.69,7.31,26.76
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,15.25,7.06,26.72
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,15.25,7.06,26.72
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.89,6.86,25.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,14.89,6.86,25.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,15.18,6.95,26.69
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,15.18,6.95,26.69
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.13,6.51,23.36
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.13,6.51,23.36
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.32,6.74,22.74
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,13.32,6.74,22.74
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.79,6.28,21.86
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,12.79,6.28,21.86
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.11,5.69,20.72
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,12.11,5.69,20.72
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Deaths,Rate,2.89,2.12,3.84
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,60.59,40.81,85.41
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.83,4.51,19.42
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,49.76,36.27,66.01
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Deaths,Rate,2.70,2.00,3.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,50.40,34.46,70.37
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.65,4.40,16.76
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,40.75,30.05,53.62
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Deaths,Rate,4.45,3.34,5.82
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,67.55,47.45,92.61
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.23,3.86,16.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,58.32,43.60,75.96
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.92,4.90,11.79
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,7.92,4.90,11.79
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Deaths,Rate,0.17,0.13,0.22
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,12.63,7.69,19.31
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,6.75,3.25,11.68
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,5.89,4.44,7.63
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Deaths,Rate,0.22,0.16,0.28
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,13.96,8.43,21.41
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,7.61,3.65,13.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Male,All ages,Years of Life Lost (YLLs),Rate,6.35,4.77,8.25
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.19,0.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.37,0.19,0.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.55,1.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.99,0.55,1.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.11,0.42
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.25,0.11,0.42
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.58,0.87,2.52
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.58,0.87,2.52
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.61,1.79
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.11,0.61,1.79
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.20,1.23,3.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.20,1.23,3.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.25,1.81,5.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.25,1.81,5.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,6.77,3.93,10.18
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,6.77,3.93,10.18
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Deaths,Rate,0.76,0.58,0.99
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,51.13,35.21,71.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,12.64,6.04,21.96
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,38.49,29.17,49.75
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,10.96,4.65,20.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,10.96,4.65,20.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Deaths,Rate,1.01,0.77,1.30
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,69.76,49.55,96.24
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,13.78,6.63,24.58
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,55.99,42.91,71.66
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Deaths,Rate,1.93,1.46,2.49
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,112.83,80.86,151.88
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,15.64,7.28,26.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,97.19,73.58,125.30
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Deaths,Rate,0.96,0.72,1.27
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,60.58,40.81,86.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.81,8.03,29.32
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,43.78,32.79,57.59
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,16.01,8.21,28.38
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.01,8.21,28.38
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Deaths,Rate,0.36,0.28,0.46
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,28.15,17.44,42.87
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,15.22,7.48,26.40
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,12.93,9.96,16.48
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Deaths,Rate,1.05,0.81,1.35
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,53.06,36.60,74.45
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,15.39,7.57,26.44
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,37.68,29.03,48.01
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,14.18,6.58,24.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,14.18,6.58,24.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,13.07,6.22,21.73
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,13.07,6.22,21.73
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,12.16,5.57,21.15
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,12.16,5.57,21.15
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.11,4.82,20.47
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.11,4.82,20.47
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,10.11,4.04,18.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.11,4.04,18.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,9.22,4.81,15.21
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.22,4.81,15.21
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,9.69,5.75,14.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,9.69,5.75,14.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.96,4.82,12.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.96,4.82,12.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Deaths,Rate,0.30,0.23,0.39
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,22.56,14.99,32.52
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,7.80,3.78,13.49
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,14.76,11.21,19.04
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Deaths,Rate,0.31,0.23,0.40
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,23.58,15.48,34.27
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,8.91,4.33,15.35
URY,Uruguay,Southern Cone,Multiple sclerosis,2020,Female,All ages,Years of Life Lost (YLLs),Rate,14.67,11.15,18.92
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.07,0.03,0.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.07,0.03,0.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.12,0.43
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.25,0.12,0.43
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.63,0.34,1.04
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.63,0.34,1.04
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.19,0.08,0.34
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.19,0.08,0.34
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.00,0.53,1.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,1.00,0.53,1.65
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.73,0.37,1.25
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.73,0.37,1.25
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.39,0.75,2.27
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,1.39,0.75,2.27
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.02,1.12,3.26
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,2.02,1.12,3.26
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,4.38,2.47,6.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,4.38,2.47,6.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Deaths,Rate,0.40,0.30,0.53
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,32.06,21.29,46.25
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,9.84,4.64,17.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,22.22,16.64,29.09
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Deaths,Rate,0.39,0.29,0.53
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,31.41,22.02,43.63
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,7.74,4.51,12.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,23.66,17.51,31.49
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Deaths,Rate,1.30,0.99,1.70
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,83.19,58.75,113.55
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,10.78,4.41,19.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,72.41,54.34,93.84
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Deaths,Rate,0.36,0.27,0.49
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,31.77,19.37,48.53
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,13.25,5.39,23.92
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,18.51,13.98,24.61
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,14.22,6.84,25.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,14.22,6.84,25.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Deaths,Rate,0.75,0.54,0.99
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,45.23,29.26,66.41
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,15.13,7.27,26.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,30.11,21.99,40.28
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Deaths,Rate,0.55,0.41,0.73
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,35.17,22.06,52.66
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,14.80,7.12,25.69
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,20.37,14.94,26.97
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Deaths,Rate,0.41,0.31,0.55
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,30.00,18.25,46.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,15.12,7.42,26.53
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,14.88,10.82,19.60
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Deaths,Rate,0.48,0.36,0.63
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,29.18,17.90,43.84
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,14.05,6.59,24.18
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,15.14,11.30,19.66
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Deaths,Rate,1.20,0.89,1.61
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,44.44,29.48,64.82
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,12.89,6.16,22.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,31.55,23.32,42.26
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Deaths,Rate,1.33,0.98,1.79
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.41,29.41,64.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,12.45,5.83,21.82
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,31.96,23.59,42.68
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Deaths,Rate,1.51,1.10,2.01
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,44.37,29.33,64.09
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,11.88,5.39,20.86
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,32.50,23.94,43.24
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Deaths,Rate,2.92,2.12,3.90
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,61.02,41.12,87.31
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,10.80,4.68,20.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,50.22,36.44,67.25
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Deaths,Rate,1.74,1.28,2.32
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,37.83,25.05,54.93
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,9.61,4.51,17.36
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,28.22,20.54,37.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Deaths,Rate,1.38,1.04,1.83
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,27.49,17.38,41.81
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,9.25,3.95,18.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,18.24,13.43,23.69
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.83,4.93,11.36
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,7.83,4.93,11.36
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Deaths,Rate,0.35,0.26,0.46
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,20.28,13.29,29.53
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,6.65,3.17,11.57
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,13.63,10.12,17.95
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Deaths,Rate,0.42,0.31,0.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,22.55,14.72,32.95
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,7.56,3.60,13.17
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Male,All ages,Years of Life Lost (YLLs),Rate,14.99,11.12,19.77
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.10,0.04,0.17
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.10,0.04,0.17
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.37,0.19,0.62
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.37,0.19,0.62
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.99,0.55,1.62
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.99,0.55,1.62
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.02,0.01,0.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.03,0.01,0.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.25,0.11,0.43
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.25,0.11,0.43
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,1.56,0.87,2.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,1.56,0.87,2.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,1.11,0.61,1.86
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,1.11,0.61,1.86
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,2.18,1.23,3.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,2.18,1.23,3.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,3.21,1.83,5.19
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,3.21,1.83,5.19
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,6.70,3.88,9.97
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,6.70,3.88,9.97
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Deaths,Rate,0.80,0.60,1.05
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,53.44,36.40,75.09
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,12.52,5.91,21.63
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,40.92,30.49,53.45
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Deaths,Rate,0.30,0.22,0.38
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,28.61,17.37,45.02
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,10.72,3.96,21.67
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,17.90,13.40,23.35
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Deaths,Rate,1.12,0.84,1.46
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,76.13,53.27,105.85
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,13.97,6.45,25.31
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,62.16,46.82,80.54
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Deaths,Rate,1.53,1.14,2.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,93.21,64.77,126.37
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,15.73,7.42,25.72
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,77.48,57.35,100.64
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Deaths,Rate,1.18,0.87,1.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,69.71,47.83,97.95
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,16.30,8.22,26.93
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,53.41,39.62,71.03
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Deaths,Rate,0.42,0.32,0.54
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,33.00,20.63,50.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,16.09,7.86,28.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,16.91,12.77,21.83
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Deaths,Rate,1.11,0.83,1.42
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,52.85,35.80,74.95
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,15.37,7.49,26.75
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,37.48,28.32,48.20
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Deaths,Rate,1.14,0.87,1.46
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,56.34,38.90,79.18
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,15.60,7.76,27.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,40.73,31.14,52.04
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Deaths,Rate,1.82,1.36,2.35
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,70.55,48.86,97.37
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,14.34,6.79,24.81
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,56.22,42.07,72.56
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Deaths,Rate,1.60,1.16,2.15
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,54.81,36.47,78.71
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,12.85,5.90,22.51
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,41.96,30.56,56.20
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Deaths,Rate,0.87,0.63,1.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,34.91,21.97,51.87
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,12.17,5.41,21.42
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,22.73,16.55,30.45
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,11.38,4.84,20.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,11.38,4.84,20.14
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Deaths,Rate,0.71,0.51,0.96
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,22.58,12.83,35.19
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,10.42,4.17,18.64
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,12.17,8.66,16.55
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Deaths,Rate,0.50,0.35,0.67
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,16.78,10.25,25.43
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,9.31,4.88,15.30
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,7.48,5.37,10.13
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Deaths,Rate,0.87,0.62,1.16
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,21.01,14.21,30.23
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,9.68,5.96,14.96
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,11.32,8.23,15.27
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,7.97,4.71,12.37
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,7.97,4.71,12.37
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Deaths,Rate,0.48,0.36,0.63
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,28.30,19.04,40.21
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,7.78,3.72,13.47
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,20.51,15.31,26.74
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Deaths,Rate,0.57,0.42,0.75
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,31.35,21.01,44.66
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,8.96,4.31,15.44
URY,Uruguay,Southern Cone,Multiple sclerosis,2021,Female,All ages,Years of Life Lost (YLLs),Rate,22.39,16.70,29.22
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Deaths,Rate,0.87,0.64,1.13
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,209.19,87.14,391.52
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,129.86,27.80,287.82
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,79.32,59.35,103.70
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Deaths,Rate,0.65,0.48,0.85
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,302.97,76.62,741.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,248.25,35.67,668.77
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,54.72,40.95,72.23
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Deaths,Rate,1.60,1.25,2.04
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,459.12,144.70,"1,039.72"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,333.88,47.27,880.46
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,125.24,97.43,159.27
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Deaths,Rate,3.51,2.75,4.38
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,654.48,259.42,"1,358.94"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,398.26,58.37,"1,038.64"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,256.22,201.05,320.29
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,166.68,31.96,360.92
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,166.05,31.33,360.92
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Deaths,Rate,0.38,0.29,0.48
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,163.03,53.58,330.03
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,129.10,27.58,287.20
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,33.94,26.02,42.84
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Deaths,Rate,0.16,0.12,0.20
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,180.63,40.98,442.94
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,166.31,30.00,424.85
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,14.33,10.98,18.08
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Deaths,Rate,3.50,2.55,4.62
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,451.86,265.89,712.36
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,130.34,28.62,284.14
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,321.52,237.28,428.16
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,193.49,31.76,525.42
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,193.49,31.76,525.42
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Deaths,Rate,1.09,0.82,1.45
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,495.12,112.10,"1,264.99"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,407.52,46.53,"1,148.46"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,87.61,65.58,116.52
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Deaths,Rate,5.38,4.23,6.71
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,928.85,381.39,"1,901.11"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,540.18,75.59,"1,416.54"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,388.67,305.80,484.57
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Deaths,Rate,4.28,3.39,5.34
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,894.64,334.58,"1,872.90"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,572.72,79.63,"1,470.88"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,321.93,254.96,402.02
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Deaths,Rate,7.41,5.85,9.19
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,134.29",508.95,"2,202.42"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,603.02,89.36,"1,543.53"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,531.27,419.59,658.89
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Deaths,Rate,10.42,8.22,12.88
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,363.98",676.07,"2,518.26"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,632.06,98.69,"1,613.16"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,731.92,577.39,905.10
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Deaths,Rate,4.52,3.58,5.56
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,946.25,332.42,"1,956.65"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,651.33,98.58,"1,593.60"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,294.91,233.84,363.05
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Deaths,Rate,7.75,6.23,9.56
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,116.86",489.54,"2,147.83"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,694.39,150.24,"1,627.90"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,422.48,339.30,519.93
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Deaths,Rate,6.67,5.35,8.14
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,074.98",444.69,"2,172.44"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,672.38,122.29,"1,681.37"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,402.60,322.40,491.08
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Deaths,Rate,10.46,8.51,12.59
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,285.13",626.28,"2,317.23"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,706.06,155.41,"1,619.75"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,579.07,470.87,697.47
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Deaths,Rate,10.02,8.11,12.28
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,234.65",596.05,"2,271.15"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,729.39,187.22,"1,651.84"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,505.27,408.83,619.31
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Deaths,Rate,7.71,6.09,10.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,072.81",476.73,"2,046.30"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,722.00,199.48,"1,591.58"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,350.81,277.25,454.71
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Deaths,Rate,13.47,10.05,19.71
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,241.46",620.40,"2,278.61"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,694.33,212.25,"1,478.38"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,547.12,408.14,800.22
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Deaths,Rate,22.48,15.05,37.64
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,481.27",758.03,"2,780.59"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,710.93,238.27,"1,501.40"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,770.35,519.76,"1,279.19"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Deaths,Rate,17.16,11.75,28.22
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,307.82",646.00,"2,513.60"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,694.72,226.30,"1,504.99"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,613.11,419.69,"1,008.61"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Deaths,Rate,39.49,24.90,70.15
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,970.80","1,053.44","3,694.03"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,749.67,283.45,"1,524.95"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,"1,221.14",770.00,"2,169.08"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Deaths,Rate,80.06,48.78,150.38
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,972.09","1,671.84","5,604.00"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,874.04,393.33,"1,662.76"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,"2,098.05","1,278.52","3,941.24"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Deaths,Rate,94.52,59.27,172.66
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,241.01","1,871.51","5,941.17"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,990.56,463.99,"1,819.38"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,"2,250.45","1,407.53","4,121.79"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Deaths,Rate,113.17,72.79,201.38
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,587.73","2,128.97","6,375.89"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,140.78",555.10,"2,021.32"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,"2,446.95","1,573.87","4,354.59"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Deaths,Rate,272.01,166.40,511.47
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"6,362.27","3,826.84","11,592.18"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,684.86",965.46,"2,797.61"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"4,677.38","2,861.38","8,794.57"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Deaths,Rate,737.20,345.39,"1,617.91"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"10,510.50","5,497.16","20,855.16"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,634.33","1,574.42","4,110.12"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"7,876.15","3,922.74","16,745.03"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Deaths,Rate,708.87,364.24,"1,468.86"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"11,983.47","6,397.46","23,444.95"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,711.06","1,632.94","4,231.26"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"9,272.37","4,764.51","19,213.69"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Deaths,Rate,"1,668.22",663.86,"3,941.41"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"16,507.35","7,501.46","35,180.43"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,354.81","2,665.45","6,468.33"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"12,152.54","4,836.02","28,712.05"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Deaths,Rate,3.19,2.33,4.22
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,427.23,245.68,682.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,133.48,28.85,290.77
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,293.75,216.83,391.23
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Deaths,Rate,33.14,18.40,65.11
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,337.58",639.32,"2,607.18"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,634.39,179.25,"1,422.33"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,703.19,460.07,"1,184.86"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,All ages,Deaths,Rate,52.87,27.89,107.81
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,650.78",810.20,"3,212.38"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,712.02,228.14,"1,536.37"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Male,All ages,Years of Life Lost (YLLs),Rate,938.76,582.06,"1,676.02"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Deaths,Rate,0.68,0.52,0.89
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,162.46,68.74,301.64
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,99.65,20.69,221.14
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,62.81,48.04,80.50
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Deaths,Rate,1.65,1.22,2.26
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,440.14,136.78,987.66
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,299.75,33.64,795.59
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,140.39,103.13,192.07
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Deaths,Rate,2.94,2.21,3.80
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,685.69,226.99,"1,490.95"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,452.77,52.22,"1,189.12"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,232.92,174.78,301.83
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Deaths,Rate,3.05,2.33,3.89
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,808.27,246.52,"1,768.99"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,573.20,67.10,"1,468.30"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,235.07,179.43,300.69
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,110.05,19.34,254.11
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,109.38,19.34,253.45
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Deaths,Rate,0.34,0.27,0.44
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,132.07,45.45,263.16
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,101.15,21.24,224.06
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,30.92,24.22,39.10
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Deaths,Rate,1.92,1.39,2.69
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,327.28,145.07,645.81
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,162.29,26.11,415.40
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,164.99,118.95,230.41
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Deaths,Rate,2.50,1.88,3.25
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,324.48,193.61,504.95
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,91.02,17.95,202.99
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,233.46,175.66,301.96
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Deaths,Rate,3.07,2.20,4.33
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,468.73,217.26,923.08
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,206.60,29.65,554.04
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,262.13,187.60,369.04
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Deaths,Rate,1.09,0.84,1.41
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,654.82,116.10,"1,652.89"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,567.91,48.96,"1,539.64"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,86.91,67.13,113.25
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Deaths,Rate,3.71,2.89,4.59
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,098.07",305.78,"2,451.26"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,823.31,92.10,"2,110.61"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,274.76,213.69,340.65
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Deaths,Rate,6.51,4.97,8.06
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,367.72",477.57,"2,888.90"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,877.81,103.81,"2,282.20"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,489.92,373.77,606.71
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Deaths,Rate,4.94,3.85,6.10
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,307.12",395.24,"2,827.78"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,943.77,112.44,"2,379.89"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,363.36,282.81,447.89
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Deaths,Rate,3.46,2.79,4.22
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,249.40",316.82,"2,769.56"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,"1,006.60",120.66,"2,472.95"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,242.79,196.16,296.61
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Deaths,Rate,3.84,3.03,4.73
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,299.37",324.72,"2,899.49"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,048.79",126.89,"2,590.59"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,250.58,197.83,308.89
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Deaths,Rate,4.69,3.76,5.92
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,374.17",412.82,"2,929.34"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,123.85",212.32,"2,615.00"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,250.31,200.51,314.34
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Deaths,Rate,3.26,2.64,3.98
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,289.12",329.90,"2,859.22"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,092.69",170.37,"2,619.13"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,196.42,159.52,240.08
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Deaths,Rate,2.02,1.65,2.43
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,263.22",331.76,"2,762.08"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,151.25",240.23,"2,627.16"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,111.97,91.52,134.92
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Deaths,Rate,6.74,5.52,8.24
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,532.14",542.10,"3,138.68"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,191.97",263.53,"2,723.20"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,340.16,278.58,415.49
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Deaths,Rate,7.69,6.00,10.37
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,493.30",545.76,"2,982.15"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,143.11",272.68,"2,510.49"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,350.18,273.08,471.65
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Deaths,Rate,6.27,4.31,10.32
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,324.87",444.22,"2,757.77"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,070.15",269.38,"2,338.74"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,254.72,174.84,419.03
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Deaths,Rate,13.68,7.87,26.90
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,513.05",578.13,"3,139.50"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,043.01",304.85,"2,222.75"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,470.04,273.28,916.75
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Deaths,Rate,15.82,9.35,30.46
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,589.62",625.73,"3,303.64"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,024.51",291.63,"2,214.86"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,565.11,334.10,"1,088.78"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Deaths,Rate,19.50,10.19,41.27
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,636.35",673.42,"3,379.92"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,033.42",358.46,"2,103.61"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,602.94,314.97,"1,276.32"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Deaths,Rate,54.14,26.38,119.18
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,521.82","1,162.12","5,233.88"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,102.90",470.78,"2,110.58"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,"1,418.91",691.34,"3,123.31"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Deaths,Rate,75.85,36.03,168.97
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,004.42","1,420.83","6,227.63"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,230.77",576.78,"2,279.77"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,"1,773.65",844.05,"3,947.86"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Deaths,Rate,101.18,47.28,227.07
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,567.56","1,722.72","7,387.23"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,379.98",700.46,"2,477.21"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,"2,187.58","1,022.25","4,910.02"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Deaths,Rate,246.71,104.34,586.43
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"6,290.26","2,975.60","13,390.62"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,048.14","1,181.46","3,307.01"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,"4,242.12","1,794.15","10,083.60"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Deaths,Rate,852.41,270.30,"2,093.60"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"11,927.89","5,029.15","25,445.68"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,856.35","2,330.48","5,779.97"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,"8,071.54","2,698.67","19,665.70"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Deaths,Rate,600.45,219.22,"1,420.33"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"11,248.63","4,882.18","23,707.48"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,394.25","2,014.65","5,128.58"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,"7,854.38","2,867.53","18,578.90"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Deaths,Rate,"1,646.16",473.45,"4,105.69"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,986.17","7,155.72","38,628.28"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,994.43","3,706.83","8,719.57"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,"11,991.74","3,448.90","29,908.71"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Deaths,Rate,2.29,1.72,3.03
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,306.03,178.72,483.44
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,92.59,18.13,207.32
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,213.44,160.59,276.07
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Deaths,Rate,28.14,11.69,63.54
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,482.12",529.47,"3,159.20"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,934.37,231.61,"2,093.83"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,547.74,297.86,"1,065.37"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,All ages,Deaths,Rate,93.12,32.33,223.13
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,365.35",915.59,"5,029.54"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,202.23",414.98,"2,450.55"
URY,Uruguay,Southern Cone,Neurological conditions,2020,Female,All ages,Years of Life Lost (YLLs),Rate,"1,163.12",500.61,"2,578.98"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Deaths,Rate,2.24,1.64,3.01
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,328.43,173.26,555.50
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,126.19,25.42,283.71
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,202.24,147.84,271.79
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Deaths,Rate,2.13,1.59,2.84
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,426.80,169.09,900.76
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,247.42,35.74,661.82
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,179.38,133.35,238.94
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Deaths,Rate,2.88,2.21,3.71
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,563.01,224.20,"1,168.85"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,332.62,47.47,871.64
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,230.39,176.73,297.22
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Deaths,Rate,4.12,3.22,5.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,707.57,300.37,"1,432.92"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,395.86,57.66,"1,039.88"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,311.71,242.71,393.04
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,156.01,28.72,351.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,156.01,28.07,351.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.65
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Deaths,Rate,2.08,1.54,2.77
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,312.35,164.16,529.04
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,125.93,25.54,280.87
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,186.42,138.62,248.17
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Deaths,Rate,1.31,0.96,1.77
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,282.42,114.96,569.61
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,166.71,30.54,413.48
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,115.70,84.42,156.13
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Deaths,Rate,3.27,2.28,4.50
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,425.75,232.76,708.13
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,124.70,24.59,291.75
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,301.05,208.16,416.44
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Deaths,Rate,0.79,0.56,1.09
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,262.01,81.42,597.27
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,194.51,33.95,503.90
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,67.49,47.47,93.38
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Deaths,Rate,3.40,2.59,4.47
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,675.33,254.02,"1,495.82"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,402.24,46.19,"1,137.56"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,273.09,207.83,358.26
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Deaths,Rate,5.71,4.51,7.10
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,954.39,405.71,"1,940.66"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,533.90,74.05,"1,417.65"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,420.49,331.66,523.01
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Deaths,Rate,4.93,3.94,6.09
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,938.37,376.04,"1,907.62"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,567.39,79.77,"1,449.82"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,370.97,296.26,457.80
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Deaths,Rate,6.81,5.42,8.34
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,086.88",477.73,"2,151.85"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,596.40,87.27,"1,550.62"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,490.48,390.45,601.23
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Deaths,Rate,8.61,6.84,10.52
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,229.71",575.52,"2,386.75"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,624.30,94.49,"1,647.58"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,605.41,481.04,739.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Deaths,Rate,8.45,6.79,10.33
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,194.41",536.89,"2,293.58"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,642.17,93.50,"1,619.15"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,552.23,443.38,674.42
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Deaths,Rate,9.38,7.54,11.61
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,205.62",562.65,"2,266.13"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,688.82,147.07,"1,628.25"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,516.80,415.59,637.89
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Deaths,Rate,7.54,6.11,9.21
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,119.06",485.77,"2,177.89"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,663.68,117.07,"1,622.32"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,455.37,368.70,555.57
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Deaths,Rate,10.23,8.32,12.34
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,269.63",621.30,"2,324.31"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,702.97,160.50,"1,640.84"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,566.66,460.81,683.47
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Deaths,Rate,10.77,8.69,13.28
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,268.67",622.75,"2,329.27"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,725.64,184.22,"1,659.81"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,543.02,438.53,669.46
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Deaths,Rate,10.26,8.05,13.39
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,187.55",559.28,"2,210.15"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,720.49,192.70,"1,601.00"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,467.07,366.57,609.14
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Deaths,Rate,16.04,11.93,23.45
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,344.88",685.76,"2,460.52"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,693.87,201.44,"1,508.51"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,651.01,484.32,952.02
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Deaths,Rate,27.95,18.71,46.85
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,667.93",884.14,"3,102.68"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,709.11,237.89,"1,509.21"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,958.82,646.25,"1,593.46"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Deaths,Rate,23.70,16.15,38.50
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,541.79",813.50,"2,891.54"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,694.55,236.16,"1,515.53"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,847.24,577.34,"1,376.01"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Deaths,Rate,46.96,29.67,84.21
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,195.88","1,200.51","4,106.65"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,743.89,283.09,"1,502.80"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,"1,451.99",917.41,"2,603.85"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Deaths,Rate,86.47,53.55,159.01
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"3,117.23","1,767.83","5,785.64"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,851.13,364.55,"1,618.23"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,"2,266.11","1,403.28","4,167.40"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Deaths,Rate,126.05,80.12,227.59
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,907.92","2,313.16","7,117.00"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,957.91,441.83,"1,783.24"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,"2,950.01","1,871.33","5,333.76"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Deaths,Rate,177.65,114.76,317.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"4,938.65","3,024.04","8,852.53"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,"1,097.11",542.56,"1,998.34"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,"3,841.54","2,481.48","6,854.19"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Deaths,Rate,369.14,228.28,693.41
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"7,969.37","4,828.72","14,598.81"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,"1,621.87",903.49,"2,675.81"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"6,347.51","3,925.25","11,923.00"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Deaths,Rate,837.66,403.04,"1,802.90"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"11,628.67","6,190.36","22,811.84"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,"2,571.16","1,543.28","3,982.07"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"9,057.53","4,647.08","18,829.75"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Deaths,Rate,728.27,385.71,"1,448.38"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"12,161.73","6,604.14","23,028.76"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,"2,635.47","1,558.52","4,083.03"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"9,526.26","5,045.62","18,945.69"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Deaths,Rate,"1,855.79",752.38,"4,337.64"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"17,782.26","8,200.92","37,892.63"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,"4,263.38","2,720.23","6,294.51"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"13,518.93","5,480.69","31,598.11"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Deaths,Rate,2.99,2.08,4.11
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,402.48,215.15,677.33
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,127.40,24.89,296.82
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,275.08,190.26,380.51
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Deaths,Rate,39.17,22.32,75.31
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,486.18",745.19,"2,842.78"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,626.55,175.28,"1,415.48"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,859.63,569.91,"1,427.30"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,All ages,Deaths,Rate,62.38,33.80,124.55
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,"1,845.83",943.79,"3,534.22"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,705.50,224.67,"1,532.53"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Male,All ages,Years of Life Lost (YLLs),Rate,"1,140.32",719.12,"2,001.69"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Deaths,Rate,0.96,0.71,1.30
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,181.61,84.37,332.73
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,94.32,19.58,216.14
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,87.30,64.80,116.58
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Deaths,Rate,2.07,1.55,2.78
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,477.47,165.49,"1,053.75"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,301.68,33.77,817.45
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,175.79,131.72,236.30
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Deaths,Rate,3.09,2.39,3.98
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,701.15,240.43,"1,498.53"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,453.87,49.67,"1,179.56"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,247.28,190.75,318.97
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Deaths,Rate,3.53,2.76,4.46
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,844.17,278.31,"1,816.16"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,572.60,66.10,"1,471.96"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,271.56,212.21,344.20
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,99.16,20.11,240.62
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,99.16,20.11,240.62
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Deaths,Rate,0.78,0.58,1.05
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,166.43,73.07,311.98
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,96.49,20.39,218.35
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,69.94,52.69,93.61
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Deaths,Rate,2.60,1.93,3.57
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,386.29,191.06,726.60
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,162.92,25.16,420.87
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,223.37,165.91,305.72
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Deaths,Rate,1.95,1.43,2.66
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,265.59,147.09,445.56
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,82.97,15.46,202.77
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,182.63,131.63,242.86
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Deaths,Rate,3.84,2.85,5.27
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,535.20,270.98,"1,007.41"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,207.91,28.39,558.03
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,327.29,242.59,449.38
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Deaths,Rate,1.21,0.94,1.51
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,664.75,126.70,"1,698.17"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,567.88,50.94,"1,576.80"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,96.87,75.75,121.37
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Deaths,Rate,4.11,3.28,5.04
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,120.40",332.33,"2,472.41"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,817.75,90.67,"2,101.56"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,302.64,241.66,370.85
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Deaths,Rate,5.89,4.69,7.26
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,"1,314.83",446.03,"2,718.81"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,871.42,93.31,"2,173.05"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,443.41,352.72,545.76
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Deaths,Rate,5.49,4.39,6.71
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,336.02",429.64,"2,838.81"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,936.00,109.47,"2,349.89"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,400.02,320.18,488.92
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Deaths,Rate,5.10,4.11,6.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,"1,356.29",413.97,"2,953.60"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,997.77,124.92,"2,519.05"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,358.52,289.05,434.55
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Deaths,Rate,4.67,3.71,5.89
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,"1,339.77",367.86,"2,919.97"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,"1,034.71",125.16,"2,535.42"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,305.05,242.70,384.56
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Deaths,Rate,5.51,4.40,7.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,405.64",439.50,"2,955.95"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,"1,112.75",205.30,"2,585.04"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,292.88,234.20,370.91
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Deaths,Rate,1.48,1.19,1.81
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,"1,172.17",244.69,"2,709.86"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,"1,082.91",172.75,"2,600.65"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,89.25,71.94,109.20
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Deaths,Rate,5.52,4.52,6.68
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,"1,448.18",470.84,"2,981.75"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,"1,142.62",220.55,"2,611.85"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,305.56,250.29,369.90
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Deaths,Rate,7.61,6.19,9.35
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,"1,561.60",567.24,"3,137.59"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,"1,177.83",255.08,"2,666.02"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,383.77,312.16,471.57
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Deaths,Rate,8.60,6.64,11.71
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,"1,527.81",566.60,"3,048.33"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,"1,136.73",264.28,"2,515.72"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,391.08,302.33,532.60
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Deaths,Rate,12.42,8.59,20.22
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,"1,563.52",606.83,"3,152.45"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,"1,059.22",257.96,"2,331.27"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,504.29,348.87,821.18
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Deaths,Rate,23.71,13.63,46.32
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,"1,841.58",767.69,"3,762.39"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,"1,033.87",297.88,"2,200.19"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,807.71,469.81,"1,562.20"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Deaths,Rate,20.13,11.99,37.94
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,"1,734.64",723.02,"3,543.13"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,"1,014.94",294.39,"2,187.05"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,719.70,428.64,"1,356.07"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Deaths,Rate,39.85,20.88,83.74
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,"2,259.34",990.60,"4,662.06"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,"1,027.05",344.91,"2,072.55"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,"1,232.29",645.68,"2,589.51"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Deaths,Rate,65.34,32.35,143.39
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,"2,809.32","1,310.50","5,836.43"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,"1,096.91",462.47,"2,078.21"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,"1,712.42",848.03,"3,758.22"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Deaths,Rate,96.20,46.26,213.53
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,"3,469.26","1,649.73","7,240.44"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,"1,226.87",569.11,"2,267.14"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,"2,242.40","1,080.61","4,973.30"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Deaths,Rate,132.69,62.70,296.45
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"4,249.53","2,050.80","8,900.44"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,"1,380.52",695.20,"2,490.51"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,"2,869.02","1,355.59","6,409.93"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Deaths,Rate,349.67,151.48,827.70
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"8,061.68","3,748.27","17,556.25"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,"2,049.05","1,143.56","3,324.14"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,"6,012.63","2,604.71","14,232.13"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Deaths,Rate,"1,027.00",328.87,"2,519.73"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"13,721.57","5,682.58","29,777.52"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,"3,860.08","2,338.38","5,820.59"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,"9,861.49","3,344.20","23,956.94"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Deaths,Rate,709.23,257.11,"1,659.21"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"12,668.46","5,383.38","26,857.22"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,"3,391.34","2,020.22","5,153.73"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,"9,277.12","3,363.17","21,703.52"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Deaths,Rate,"1,920.72",554.03,"4,804.05"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"19,945.79","7,762.63","43,719.04"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,"5,953.96","3,726.74","8,723.04"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,"13,991.82","4,035.89","34,996.00"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Deaths,Rate,1.78,1.31,2.44
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,251.34,136.27,428.00
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,84.35,15.86,205.95
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,166.98,120.41,222.05
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Deaths,Rate,35.22,14.93,79.11
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,"1,624.72",608.28,"3,439.06"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,927.26,226.85,"2,078.17"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,697.46,381.43,"1,360.89"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,All ages,Deaths,Rate,114.66,40.46,273.90
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,"2,669.37","1,055.18","5,692.53"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,"1,201.82",414.13,"2,448.49"
URY,Uruguay,Southern Cone,Neurological conditions,2021,Female,All ages,Years of Life Lost (YLLs),Rate,"1,467.55",641.05,"3,244.05"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.07
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.21,0.02,0.49
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.21,0.02,0.49
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,2.05,0.84,3.86
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years Lived with Disability (YLDs),Rate,2.05,0.84,3.86
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,25-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.60,0.16,1.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.60,0.16,1.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,1.34,0.60,2.41
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.34,0.60,2.41
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,35-39 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.76,1.47,4.82
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.76,1.47,4.82
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.87,2.18,11.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.87,2.18,11.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Deaths,Rate,2.45,2.29,2.63
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,112.09,98.54,128.54
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years Lived with Disability (YLDs),Rate,12.60,5.73,21.95
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-54 years,Years of Life Lost (YLLs),Rate,99.48,92.80,106.60
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Deaths,Rate,2.56,2.34,2.77
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,119.97,96.76,148.82
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years Lived with Disability (YLDs),Rate,30.35,14.58,51.71
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,50-64 years,Years of Life Lost (YLLs),Rate,89.63,82.18,97.12
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Deaths,Rate,1.22,1.12,1.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,71.17,50.99,98.67
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years Lived with Disability (YLDs),Rate,27.38,11.19,50.78
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,55-59 years,Years of Life Lost (YLLs),Rate,43.79,39.80,47.90
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Deaths,Rate,4.23,3.83,4.61
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,185.97,147.61,231.30
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years Lived with Disability (YLDs),Rate,55.13,29.15,88.61
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,60-64 years,Years of Life Lost (YLLs),Rate,130.83,118.45,142.70
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Deaths,Rate,11.92,10.89,12.94
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,419.62,349.88,499.89
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years Lived with Disability (YLDs),Rate,107.15,64.61,160.86
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-69 years,Years of Life Lost (YLLs),Rate,312.47,285.27,339.04
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Deaths,Rate,17.16,15.73,18.58
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,543.15,456.91,641.76
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years Lived with Disability (YLDs),Rate,141.07,88.79,206.84
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,65-74 years,Years of Life Lost (YLLs),Rate,402.09,368.12,434.92
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Deaths,Rate,23.93,21.96,25.84
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,702.42,594.92,824.67
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years Lived with Disability (YLDs),Rate,184.81,119.97,266.13
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,70-74 years,Years of Life Lost (YLLs),Rate,517.63,474.95,558.54
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Deaths,Rate,92.60,83.83,100.52
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,890.40","1,637.06","2,151.06"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years Lived with Disability (YLDs),Rate,298.11,195.50,422.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,592.31","1,441.56","1,728.71"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Deaths,Rate,151.63,135.42,165.76
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,159.06","1,851.96","2,494.45"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Years Lived with Disability (YLDs),Rate,348.48,225.93,519.15
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,810.58","1,626.04","1,975.29"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Deaths,Rate,160.49,145.51,174.98
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,499.85","2,172.54","2,896.01"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years Lived with Disability (YLDs),Rate,400.46,269.26,607.25
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,80-84 years,Years of Life Lost (YLLs),Rate,"2,099.39","1,903.28","2,288.76"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Deaths,Rate,253.13,220.99,278.69
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,219.60","1,836.31","2,617.30"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Years Lived with Disability (YLDs),Rate,375.76,226.49,587.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,843.84","1,609.88","2,029.96"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Deaths,Rate,5.70,5.12,6.22
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,110.36,93.17,129.96
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,22.48,13.61,34.41
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,Age-standardized,Years of Life Lost (YLLs),Rate,87.88,79.57,95.55
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,All ages,Deaths,Rate,9.55,8.57,10.42
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,171.88,145.45,201.81
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,All ages,Years Lived with Disability (YLDs),Rate,33.97,20.82,51.73
URY,Uruguay,Southern Cone,Parkinson disease,2020,Male,All ages,Years of Life Lost (YLLs),Rate,137.91,124.63,150.08
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.01
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.01
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.06
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.06
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.14,0.02,0.37
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.14,0.02,0.37
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Deaths,Rate,0.19,0.17,0.21
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,11.83,10.01,13.90
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.26,0.57,2.24
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,25-49 years,Years of Life Lost (YLLs),Rate,10.57,9.45,11.65
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.39,0.10,0.93
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.39,0.10,0.93
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Deaths,Rate,1.01,0.90,1.12
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,56.82,50.32,63.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.84,0.28,1.61
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,35-39 years,Years of Life Lost (YLLs),Rate,55.99,50.04,61.73
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.65,0.77,2.84
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.65,0.77,2.84
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.46,1.79,5.79
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.46,1.79,5.79
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,6.89,2.32,13.03
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years Lived with Disability (YLDs),Rate,6.89,2.32,13.03
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-54 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Deaths,Rate,1.12,1.02,1.22
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,52.60,39.65,68.97
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years Lived with Disability (YLDs),Rate,16.12,6.42,29.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,50-64 years,Years of Life Lost (YLLs),Rate,36.48,33.23,39.69
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Deaths,Rate,1.05,0.95,1.15
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,51.70,38.98,68.33
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years Lived with Disability (YLDs),Rate,14.02,4.96,27.13
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,55-59 years,Years of Life Lost (YLLs),Rate,37.68,34.01,41.20
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Deaths,Rate,2.44,2.23,2.64
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,103.95,81.52,131.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years Lived with Disability (YLDs),Rate,28.59,12.55,49.56
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,60-64 years,Years of Life Lost (YLLs),Rate,75.36,68.99,81.77
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Deaths,Rate,4.16,3.83,4.50
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,160.32,128.95,199.29
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years Lived with Disability (YLDs),Rate,51.17,28.72,81.41
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-69 years,Years of Life Lost (YLLs),Rate,109.15,100.23,117.90
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Deaths,Rate,9.02,8.27,9.76
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,273.91,228.31,324.84
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years Lived with Disability (YLDs),Rate,68.59,40.16,102.74
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,65-74 years,Years of Life Lost (YLLs),Rate,205.32,188.14,222.11
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Deaths,Rate,14.68,13.45,15.90
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,406.47,344.25,471.33
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years Lived with Disability (YLDs),Rate,88.92,53.50,127.62
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,70-74 years,Years of Life Lost (YLLs),Rate,317.55,290.73,343.71
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Deaths,Rate,32.51,28.81,35.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,705.89,588.75,817.25
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years Lived with Disability (YLDs),Rate,146.84,93.48,210.68
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75-79 years,Years of Life Lost (YLLs),Rate,559.04,495.26,606.56
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Deaths,Rate,64.22,53.09,71.28
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,872.26,691.12,"1,030.81"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Years Lived with Disability (YLDs),Rate,183.83,112.93,269.98
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,75+ years,Years of Life Lost (YLLs),Rate,688.44,578.19,760.83
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Deaths,Rate,64.25,54.52,71.04
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,048.25",845.26,"1,233.85"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years Lived with Disability (YLDs),Rate,207.86,132.04,304.56
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,80-84 years,Years of Life Lost (YLLs),Rate,840.39,713.22,929.29
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Deaths,Rate,95.23,75.71,106.70
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,894.57,668.25,"1,077.69"
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Years Lived with Disability (YLDs),Rate,200.85,116.71,300.39
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,85+ years,Years of Life Lost (YLLs),Rate,693.74,551.53,777.29
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Deaths,Rate,2.34,2.02,2.57
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,50.67,40.99,60.65
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,11.37,6.40,17.64
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,Age-standardized,Years of Life Lost (YLLs),Rate,39.31,34.59,43.01
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,All ages,Deaths,Rate,7.19,6.03,7.95
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,119.79,95.75,142.78
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,All ages,Years Lived with Disability (YLDs),Rate,26.62,15.53,40.34
URY,Uruguay,Southern Cone,Parkinson disease,2020,Female,All ages,Years of Life Lost (YLLs),Rate,93.17,80.21,102.45
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.04
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.04
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.03,0.00,0.07
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years Lived with Disability (YLDs),Rate,0.03,0.00,0.07
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.20,0.02,0.49
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years Lived with Disability (YLDs),Rate,0.20,0.02,0.49
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Deaths,Rate,0.08,0.06,0.10
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,6.31,3.95,9.62
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years Lived with Disability (YLDs),Rate,1.98,0.77,3.83
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,25-49 years,Years of Life Lost (YLLs),Rate,4.33,3.18,5.78
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.58,0.16,1.24
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years Lived with Disability (YLDs),Rate,0.58,0.16,1.24
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Deaths,Rate,0.41,0.30,0.55
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,24.16,17.35,33.06
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years Lived with Disability (YLDs),Rate,1.30,0.57,2.53
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,35-39 years,Years of Life Lost (YLLs),Rate,22.85,16.77,30.53
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,2.70,1.41,4.80
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years Lived with Disability (YLDs),Rate,2.70,1.41,4.80
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.59,1.89,11.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years Lived with Disability (YLDs),Rate,5.59,1.89,11.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Deaths,Rate,1.92,1.80,2.05
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,90.35,78.35,105.55
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years Lived with Disability (YLDs),Rate,12.17,5.44,22.26
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-54 years,Years of Life Lost (YLLs),Rate,78.17,72.90,83.28
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Deaths,Rate,2.26,2.06,2.46
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,107.73,85.79,136.64
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years Lived with Disability (YLDs),Rate,28.44,13.39,50.44
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,50-64 years,Years of Life Lost (YLLs),Rate,79.29,72.40,86.18
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Deaths,Rate,1.63,1.48,1.78
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,84.36,63.09,109.99
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years Lived with Disability (YLDs),Rate,26.07,10.19,46.15
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,55-59 years,Years of Life Lost (YLLs),Rate,58.31,52.90,63.83
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Deaths,Rate,3.38,3.04,3.73
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,155.16,120.68,204.08
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years Lived with Disability (YLDs),Rate,50.46,26.48,88.80
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,60-64 years,Years of Life Lost (YLLs),Rate,104.70,94.19,115.27
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Deaths,Rate,13.20,12.00,14.41
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,434.87,366.24,510.85
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years Lived with Disability (YLDs),Rate,88.85,51.95,133.29
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-69 years,Years of Life Lost (YLLs),Rate,346.02,314.29,377.56
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Deaths,Rate,25.76,23.56,27.96
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,705.55,611.96,810.72
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years Lived with Disability (YLDs),Rate,114.26,71.59,168.71
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,65-74 years,Years of Life Lost (YLLs),Rate,591.28,540.38,642.01
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Deaths,Rate,42.13,38.62,45.63
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,"1,058.39",932.28,"1,201.62"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years Lived with Disability (YLDs),Rate,147.40,97.19,214.88
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,70-74 years,Years of Life Lost (YLLs),Rate,911.00,835.09,986.73
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Deaths,Rate,97.08,87.62,105.51
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,"1,905.20","1,660.14","2,150.40"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years Lived with Disability (YLDs),Rate,236.08,153.40,336.26
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75-79 years,Years of Life Lost (YLLs),Rate,"1,669.11","1,506.75","1,814.11"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Deaths,Rate,141.41,126.80,154.57
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"2,004.20","1,735.62","2,282.31"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Years Lived with Disability (YLDs),Rate,269.29,174.40,389.79
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,75+ years,Years of Life Lost (YLLs),Rate,"1,734.90","1,561.21","1,892.52"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Deaths,Rate,151.44,137.41,164.75
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"2,293.58","2,002.57","2,606.71"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years Lived with Disability (YLDs),Rate,312.79,205.30,451.51
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,80-84 years,Years of Life Lost (YLLs),Rate,"1,980.75","1,797.28","2,155.20"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Deaths,Rate,211.31,186.32,233.16
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,814.31","1,530.77","2,108.58"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Years Lived with Disability (YLDs),Rate,275.03,173.65,409.91
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,85+ years,Years of Life Lost (YLLs),Rate,"1,539.28","1,357.12","1,698.72"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Deaths,Rate,5.85,5.27,6.39
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,114.34,97.62,133.18
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years Lived with Disability (YLDs),Rate,18.45,10.99,28.41
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,Age-standardized,Years of Life Lost (YLLs),Rate,95.89,86.63,104.77
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,All ages,Deaths,Rate,9.67,8.70,10.56
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,All ages,Disability-Adjusted Life Years (DALYs),Rate,176.14,150.82,204.30
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,All ages,Years Lived with Disability (YLDs),Rate,27.81,16.81,42.38
URY,Uruguay,Southern Cone,Parkinson disease,2021,Male,All ages,Years of Life Lost (YLLs),Rate,148.33,134.01,161.91
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.01
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.01
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,0-27 days,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-4 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,1-11 months,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,5-9 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-14 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.02
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,10-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-19 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years Lived with Disability (YLDs),Rate,0.01,0.00,0.03
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,15-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Disability-Adjusted Life Years (DALYs),Rate,0.02,0.00,0.06
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years Lived with Disability (YLDs),Rate,0.02,0.00,0.06
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,20-24 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Disability-Adjusted Life Years (DALYs),Rate,0.15,0.01,0.38
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years Lived with Disability (YLDs),Rate,0.15,0.01,0.38
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-29 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Deaths,Rate,0.07,0.06,0.08
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Disability-Adjusted Life Years (DALYs),Rate,5.29,4.15,6.72
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years Lived with Disability (YLDs),Rate,1.28,0.56,2.31
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,25-49 years,Years of Life Lost (YLLs),Rate,4.01,3.59,4.41
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Disability-Adjusted Life Years (DALYs),Rate,0.41,0.08,0.96
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years Lived with Disability (YLDs),Rate,0.41,0.08,0.96
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,30-34 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Deaths,Rate,0.38,0.34,0.43
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Disability-Adjusted Life Years (DALYs),Rate,22.14,19.31,25.07
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years Lived with Disability (YLDs),Rate,0.89,0.28,1.65
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,35-39 years,Years of Life Lost (YLLs),Rate,21.25,19.02,23.42
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Disability-Adjusted Life Years (DALYs),Rate,1.72,0.74,3.10
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years Lived with Disability (YLDs),Rate,1.72,0.74,3.10
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,40-44 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Disability-Adjusted Life Years (DALYs),Rate,3.43,1.80,5.73
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years Lived with Disability (YLDs),Rate,3.43,1.80,5.73
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,45-49 years,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Deaths,Rate,0.42,0.38,0.45
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Disability-Adjusted Life Years (DALYs),Rate,23.21,17.67,30.26
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years Lived with Disability (YLDs),Rate,6.42,2.24,12.03
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-54 years,Years of Life Lost (YLLs),Rate,16.79,15.43,18.23
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Deaths,Rate,1.80,1.64,1.96
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Disability-Adjusted Life Years (DALYs),Rate,74.98,60.35,91.88
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years Lived with Disability (YLDs),Rate,15.32,6.04,27.01
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,50-64 years,Years of Life Lost (YLLs),Rate,59.66,54.31,64.86
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Deaths,Rate,1.52,1.37,1.67
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Disability-Adjusted Life Years (DALYs),Rate,67.71,53.12,85.31
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years Lived with Disability (YLDs),Rate,13.29,4.16,25.72
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,55-59 years,Years of Life Lost (YLLs),Rate,54.40,48.96,59.59
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Deaths,Rate,3.62,3.30,3.92
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Disability-Adjusted Life Years (DALYs),Rate,138.99,114.45,165.76
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years Lived with Disability (YLDs),Rate,27.17,12.22,44.66
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,60-64 years,Years of Life Lost (YLLs),Rate,111.83,102.24,121.10
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Deaths,Rate,6.92,6.36,7.49
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Disability-Adjusted Life Years (DALYs),Rate,235.67,197.14,281.35
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years Lived with Disability (YLDs),Rate,54.23,30.35,85.11
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-69 years,Years of Life Lost (YLLs),Rate,181.46,166.78,196.25
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Deaths,Rate,12.73,11.63,13.78
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Disability-Adjusted Life Years (DALYs),Rate,366.43,310.36,433.88
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years Lived with Disability (YLDs),Rate,74.01,43.14,117.43
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,65-74 years,Years of Life Lost (YLLs),Rate,292.42,267.21,316.46
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Deaths,Rate,19.59,17.85,21.21
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Disability-Adjusted Life Years (DALYs),Rate,521.02,444.21,614.21
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years Lived with Disability (YLDs),Rate,97.40,58.26,155.65
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,70-74 years,Years of Life Lost (YLLs),Rate,423.61,385.96,458.58
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Deaths,Rate,40.41,36.05,43.92
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Disability-Adjusted Life Years (DALYs),Rate,861.98,722.47,998.87
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years Lived with Disability (YLDs),Rate,167.08,102.68,243.73
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75-79 years,Years of Life Lost (YLLs),Rate,694.89,619.79,755.16
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Deaths,Rate,72.27,60.13,80.18
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Disability-Adjusted Life Years (DALYs),Rate,"1,003.15",805.59,"1,184.11"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Years Lived with Disability (YLDs),Rate,212.02,136.00,310.56
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,75+ years,Years of Life Lost (YLLs),Rate,791.14,669.60,873.56
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Deaths,Rate,75.64,64.77,83.37
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Disability-Adjusted Life Years (DALYs),Rate,"1,228.66","1,006.92","1,438.33"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years Lived with Disability (YLDs),Rate,239.40,159.67,347.93
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,80-84 years,Years of Life Lost (YLLs),Rate,989.28,847.25,"1,090.39"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Deaths,Rate,100.10,79.52,112.33
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Disability-Adjusted Life Years (DALYs),Rate,962.96,728.72,"1,163.74"
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Years Lived with Disability (YLDs),Rate,233.70,149.45,345.38
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,85+ years,Years of Life Lost (YLLs),Rate,729.28,579.27,818.36
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Deaths,Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Disability-Adjusted Life Years (DALYs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Years Lived with Disability (YLDs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,<1 year,Years of Life Lost (YLLs),Rate,0.00,0.00,0.00
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Deaths,Rate,2.83,2.45,3.11
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Disability-Adjusted Life Years (DALYs),Rate,60.31,49.58,71.66
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years Lived with Disability (YLDs),Rate,12.34,7.09,19.27
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,Age-standardized,Years of Life Lost (YLLs),Rate,47.97,42.48,52.39
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,All ages,Deaths,Rate,8.42,7.12,9.31
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,All ages,Disability-Adjusted Life Years (DALYs),Rate,143.14,116.33,169.80
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,All ages,Years Lived with Disability (YLDs),Rate,29.92,18.10,45.52
URY,Uruguay,Southern Cone,Parkinson disease,2021,Female,All ages,Years of Life Lost (YLLs),Rate,113.22,98.24,124.28
